<?xml version="1.0" encoding="UTF-8"?>
<root id="root" uuid="51931469-aed8-4ff1-8152-fc80e01877a1-lbl">
   <Additions id="adds" size="2378">
      <Effectual id="effadds" size="2333">
         <Strengthening id="st" size="1">
            <Change id="1">
               <Axiom>Coagulation Factor X EquivalentTo Coagulation Factor and (Gene_Product_Encoded_By_Gene some F10 Gene) and (Gene_Product_Has_Biochemical_Function some Coagulation Factor) and (Gene_Product_Is_Element_In_Pathway some Intrinsic Prothrombin Activation Pathway) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation) and (Gene_Product_Plays_Role_In_Biological_Process some Homeostasis) and (Gene_Product_Plays_Role_In_Biological_Process some Proteolytic Processing)</Axiom>
               <Source>
                  <Axiom>Coagulation Factor X SubClassOf Coagulation Factor</Axiom>
               </Source>
            </Change>
         </Strengthening>
         <StrengtheningWithNewTerms id="stnt" size="0"/>
         <NewDescription id="newdesc" size="1791">
            <Change id="60">
               <Axiom>.Alpha.-D-Glucopyranose SubClassOf Carbohydrate</Axiom>
               <New_Terms>.Alpha.-D-Glucopyranose</New_Terms>
            </Change>
            <Change id="227">
               <Axiom>.Beta.-D-Fructopyranose SubClassOf Carbohydrate</Axiom>
               <New_Terms>.Beta.-D-Fructopyranose</New_Terms>
            </Change>
            <Change id="228">
               <Axiom>.Beta.-D-Xylopyranose SubClassOf Carbohydrate</Axiom>
               <New_Terms>.Beta.-D-Xylopyranose</New_Terms>
            </Change>
            <Change id="1636">
               <Axiom>1,1,2,2-Tetrafluoroethane SubClassOf Industrial Aid</Axiom>
               <New_Terms>1,1,2,2-Tetrafluoroethane</New_Terms>
            </Change>
            <Change id="1784">
               <Axiom>1,3-Dimethylol-5,5-Dimethyl-Hydantoin SubClassOf Industrial Aid</Axiom>
               <New_Terms>1,3-Dimethylol-5,5-Dimethyl-Hydantoin</New_Terms>
            </Change>
            <Change id="1174">
               <Axiom>1-Methyl-2-Pyrrolidinone SubClassOf Industrial Aid</Axiom>
               <New_Terms>1-Methyl-2-Pyrrolidinone</New_Terms>
            </Change>
            <Change id="1792">
               <Axiom>1-O-Tolylbiguanide SubClassOf Industrial Aid</Axiom>
               <New_Terms>1-O-Tolylbiguanide</New_Terms>
            </Change>
            <Change id="1183">
               <Axiom>2-(Diethylamino)Ethyl Methacrylate SubClassOf Industrial Aid</Axiom>
               <New_Terms>2-(Diethylamino)Ethyl Methacrylate</New_Terms>
            </Change>
            <Change id="1785">
               <Axiom>2-Amino-5-Nitrothiazole SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>2-Amino-5-Nitrothiazole</New_Terms>
            </Change>
            <Change id="1786">
               <Axiom>3,6-Diamino-10-methylacridinium Chloride SubClassOf Dye</Axiom>
               <New_Terms>3,6-Diamino-10-methylacridinium Chloride</New_Terms>
            </Change>
            <Change id="1787">
               <Axiom>3,6-Diamino-10-methylacridinium Chloride SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>3,6-Diamino-10-methylacridinium Chloride</New_Terms>
            </Change>
            <Change id="1788">
               <Axiom>4-Iodo-3-Nitrobenzamide SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
               <New_Terms>4-Iodo-3-Nitrobenzamide</New_Terms>
            </Change>
            <Change id="1789">
               <Axiom>50% Oxygen/50% Nitrous Oxide Premix SubClassOf Analgesic Agent</Axiom>
               <New_Terms>50% Oxygen/50% Nitrous Oxide Premix</New_Terms>
            </Change>
            <Change id="1790">
               <Axiom>99mTc-DTPA-Mannosyl-Dextran SubClassOf Radioconjugate</Axiom>
               <New_Terms>99mTc-DTPA-Mannosyl-Dextran</New_Terms>
            </Change>
            <Change id="2">
               <Axiom>Abdominal Fluid SubClassOf Biospecimen</Axiom>
               <New_Terms>Abdominal Fluid</New_Terms>
            </Change>
            <Change id="3">
               <Axiom>Abdominal Wall SubClassOf Body Part</Axiom>
               <New_Terms>Abdominal Wall</New_Terms>
            </Change>
            <Change id="4">
               <Axiom>Abecarnil SubClassOf Anxiolytic</Axiom>
               <New_Terms>Abecarnil</New_Terms>
            </Change>
            <Change id="5">
               <Axiom>Abiraterone SubClassOf Anti-Androgen</Axiom>
               <New_Terms>Abiraterone</New_Terms>
            </Change>
            <Change id="6">
               <Axiom>Acebrochol SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Acebrochol</New_Terms>
            </Change>
            <Change id="7">
               <Axiom>Acecarbromal SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Acecarbromal</New_Terms>
            </Change>
            <Change id="8">
               <Axiom>Acedapsone SubClassOf Sulfone Anti-Infective Agent</Axiom>
               <New_Terms>Acedapsone</New_Terms>
            </Change>
            <Change id="9">
               <Axiom>Acediasulfone SubClassOf Sulfone Anti-Infective Agent</Axiom>
               <New_Terms>Acediasulfone</New_Terms>
            </Change>
            <Change id="10">
               <Axiom>Acefluranol SubClassOf Antiestrogen</Axiom>
               <New_Terms>Acefluranol</New_Terms>
            </Change>
            <Change id="11">
               <Axiom>Aceglutamide SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Aceglutamide</New_Terms>
            </Change>
            <Change id="13">
               <Axiom>Acepromazine Maleate SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Acepromazine Maleate</New_Terms>
            </Change>
            <Change id="12">
               <Axiom>Acepromazine SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Acepromazine</New_Terms>
            </Change>
            <Change id="15">
               <Axiom>Acesulfame Potassium SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Acesulfame Potassium</New_Terms>
            </Change>
            <Change id="14">
               <Axiom>Acesulfame SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Acesulfame</New_Terms>
            </Change>
            <Change id="16">
               <Axiom>Acetanilide SubClassOf Industrial Aid</Axiom>
               <New_Terms>Acetanilide</New_Terms>
            </Change>
            <Change id="17">
               <Axiom>Acetomeroctol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Acetomeroctol</New_Terms>
            </Change>
            <Change id="18">
               <Axiom>Acetone Sodium Bisulfite SubClassOf Industrial Aid</Axiom>
               <New_Terms>Acetone Sodium Bisulfite</New_Terms>
            </Change>
            <Change id="19">
               <Axiom>Acetophenone SubClassOf Industrial Aid</Axiom>
               <New_Terms>Acetophenone</New_Terms>
            </Change>
            <Change id="21">
               <Axiom>Acetosulfone Sodium SubClassOf Sulfone Anti-Infective Agent</Axiom>
               <New_Terms>Acetosulfone Sodium</New_Terms>
            </Change>
            <Change id="20">
               <Axiom>Acetosulfone SubClassOf Sulfone Anti-Infective Agent</Axiom>
               <New_Terms>Acetosulfone</New_Terms>
            </Change>
            <Change id="22">
               <Axiom>Acetylcholine SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Acetylcholine</New_Terms>
            </Change>
            <Change id="23">
               <Axiom>Acetyltryptophan SubClassOf Amino Acid</Axiom>
               <New_Terms>Acetyltryptophan</New_Terms>
            </Change>
            <Change id="24">
               <Axiom>Acevaltrate SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Acevaltrate</New_Terms>
            </Change>
            <Change id="25">
               <Axiom>Aconiazide SubClassOf Antitubercular Agent</Axiom>
               <New_Terms>Aconiazide</New_Terms>
            </Change>
            <Change id="26">
               <Axiom>Acridorex SubClassOf Anorexiant</Axiom>
               <New_Terms>Acridorex</New_Terms>
            </Change>
            <Change id="27">
               <Axiom>Acrocinonide SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Acrocinonide</New_Terms>
            </Change>
            <Change id="28">
               <Axiom>Ad-sig-hMUC-1/ecdCD40L Vaccine SubClassOf Adenovirus Vaccine</Axiom>
               <New_Terms>Ad-sig-hMUC-1/ecdCD40L Vaccine</New_Terms>
            </Change>
            <Change id="29">
               <Axiom>Adaprolol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Adaprolol</New_Terms>
            </Change>
            <Change id="30">
               <Axiom>Adekalant SubClassOf Antiarrhythmic Agent</Axiom>
               <New_Terms>Adekalant</New_Terms>
            </Change>
            <Change id="32">
               <Axiom>Adinazolam Mesylate SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Adinazolam Mesylate</New_Terms>
            </Change>
            <Change id="31">
               <Axiom>Adinazolam SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Adinazolam</New_Terms>
            </Change>
            <Change id="33">
               <Axiom>Adiphenine SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Adiphenine</New_Terms>
            </Change>
            <Change id="34">
               <Axiom>Adipic Acid SubClassOf Industrial Aid</Axiom>
               <New_Terms>Adipic Acid</New_Terms>
            </Change>
            <Change id="35">
               <Axiom>Adipiplon SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Adipiplon</New_Terms>
            </Change>
            <Change id="36">
               <Axiom>Aerosol Sargramostim SubClassOf Recombinant Granulocyte-Macrophage Colony-Stimulating Factor</Axiom>
               <New_Terms>Aerosol Sargramostim</New_Terms>
            </Change>
            <Change id="37">
               <Axiom>Aglepristone SubClassOf Progesterone Antagonist</Axiom>
               <New_Terms>Aglepristone</New_Terms>
            </Change>
            <Change id="38">
               <Axiom>Ajellomyces capsulatus SubClassOf Ascomycota</Axiom>
               <New_Terms>Ajellomyces capsulatus, Ascomycota</New_Terms>
            </Change>
            <Change id="39">
               <Axiom>Aklomide SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Aklomide</New_Terms>
            </Change>
            <Change id="40">
               <Axiom>Alamifovir SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Alamifovir</New_Terms>
            </Change>
            <Change id="41">
               <Axiom>Albiglutide SubClassOf Anti-diabetic Agent</Axiom>
               <New_Terms>Albiglutide</New_Terms>
            </Change>
            <Change id="42">
               <Axiom>Alcloxa SubClassOf Astringent</Axiom>
               <New_Terms>Alcloxa</New_Terms>
            </Change>
            <Change id="43">
               <Axiom>Aldioxa SubClassOf Astringent</Axiom>
               <New_Terms>Aldioxa</New_Terms>
            </Change>
            <Change id="44">
               <Axiom>Alentemol SubClassOf Dopamine Agonist</Axiom>
               <New_Terms>Alentemol</New_Terms>
            </Change>
            <Change id="45">
               <Axiom>Alestramustine SubClassOf Nitrogen Mustard Compound</Axiom>
               <New_Terms>Alestramustine</New_Terms>
            </Change>
            <Change id="46">
               <Axiom>Aletamine SubClassOf Analgesic Agent</Axiom>
               <New_Terms>Aletamine</New_Terms>
            </Change>
            <Change id="47">
               <Axiom>Aletamine SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Aletamine</New_Terms>
            </Change>
            <Change id="48">
               <Axiom>Alifedrine SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Alifedrine</New_Terms>
            </Change>
            <Change id="49">
               <Axiom>Alitame Anhydrous SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Alitame Anhydrous</New_Terms>
            </Change>
            <Change id="50">
               <Axiom>Alletorphine SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Alletorphine</New_Terms>
            </Change>
            <Change id="51">
               <Axiom>Allobarbital SubClassOf Barbiturate</Axiom>
               <New_Terms>Allobarbital</New_Terms>
            </Change>
            <Change id="52">
               <Axiom>Allogeneic Human Adult Bone Marrow-Derived Progenitor Cells SubClassOf Biological Agent</Axiom>
               <New_Terms>Allogeneic Human Adult Bone Marrow-Derived Progenitor Cells</New_Terms>
            </Change>
            <Change id="53">
               <Axiom>Almokalant SubClassOf Antiarrhythmic Agent</Axiom>
               <New_Terms>Almokalant</New_Terms>
            </Change>
            <Change id="54">
               <Axiom>Alniditan SubClassOf Serotonin Agonist</Axiom>
               <New_Terms>Alniditan</New_Terms>
            </Change>
            <Change id="55">
               <Axiom>Alogliptin SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Alogliptin</New_Terms>
            </Change>
            <Change id="56">
               <Axiom>Aloin SubClassOf Laxative</Axiom>
               <New_Terms>Aloin</New_Terms>
            </Change>
            <Change id="57">
               <Axiom>Alonacic SubClassOf Mucolytic Agent</Axiom>
               <New_Terms>Alonacic</New_Terms>
            </Change>
            <Change id="58">
               <Axiom>Aloxistatin SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Aloxistatin</New_Terms>
            </Change>
            <Change id="59">
               <Axiom>Alpha-Cypermethrin SubClassOf Pesticide</Axiom>
               <New_Terms>Alpha-Cypermethrin</New_Terms>
            </Change>
            <Change id="61">
               <Axiom>Alpha-Terpineol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Alpha-Terpineol</New_Terms>
            </Change>
            <Change id="62">
               <Axiom>Altanserin SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Altanserin</New_Terms>
            </Change>
            <Change id="63">
               <Axiom>Alteconazole SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Alteconazole</New_Terms>
            </Change>
            <Change id="64">
               <Axiom>Altinicline SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Altinicline</New_Terms>
            </Change>
            <Change id="65">
               <Axiom>Aluminum Chloride SubClassOf Astringent</Axiom>
               <New_Terms>Aluminum Chloride</New_Terms>
            </Change>
            <Change id="66">
               <Axiom>Aluminum Monostearate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Aluminum Monostearate</New_Terms>
            </Change>
            <Change id="67">
               <Axiom>Aluminum Oxide SubClassOf Industrial Aid</Axiom>
               <New_Terms>Aluminum Oxide</New_Terms>
            </Change>
            <Change id="68">
               <Axiom>Aluminum Subacetate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Aluminum Subacetate</New_Terms>
            </Change>
            <Change id="70">
               <Axiom>Alvameline Maleate SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Alvameline Maleate</New_Terms>
            </Change>
            <Change id="69">
               <Axiom>Alvameline SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Alvameline</New_Terms>
            </Change>
            <Change id="71">
               <Axiom>Alverine SubClassOf Anticholinergic Agent</Axiom>
               <New_Terms>Alverine</New_Terms>
            </Change>
            <Change id="72">
               <Axiom>Alvespimycin Hydrochloride SubClassOf Heat Shock Protein Inhibitor</Axiom>
               <New_Terms>Alvespimycin Hydrochloride</New_Terms>
            </Change>
            <Change id="73">
               <Axiom>Alvimopan Anhydrous SubClassOf Opiate Antagonist</Axiom>
               <New_Terms>Alvimopan Anhydrous</New_Terms>
            </Change>
            <Change id="74">
               <Axiom>Ambroxol Hydrochloride SubClassOf Mucolytic Agent</Axiom>
               <New_Terms>Ambroxol Hydrochloride</New_Terms>
            </Change>
            <Change id="75">
               <Axiom>Ambuphylline SubClassOf Bronchodilator</Axiom>
               <New_Terms>Ambuphylline</New_Terms>
            </Change>
            <Change id="76">
               <Axiom>Amdoxovir SubClassOf Reverse Transcriptase Inhibitor</Axiom>
               <New_Terms>Amdoxovir</New_Terms>
            </Change>
            <Change id="77">
               <Axiom>Amibegron SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Amibegron</New_Terms>
            </Change>
            <Change id="79">
               <Axiom>Aminacrine Hydrochloride SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Aminacrine Hydrochloride</New_Terms>
            </Change>
            <Change id="78">
               <Axiom>Aminacrine SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Aminacrine</New_Terms>
            </Change>
            <Change id="80">
               <Axiom>Aminomethylpropanol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Aminomethylpropanol</New_Terms>
            </Change>
            <Change id="81">
               <Axiom>Aminometradine SubClassOf Diuretic</Axiom>
               <New_Terms>Aminometradine</New_Terms>
            </Change>
            <Change id="83">
               <Axiom>Aminopromazine Fumarate SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Aminopromazine Fumarate</New_Terms>
            </Change>
            <Change id="82">
               <Axiom>Aminopromazine SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Aminopromazine</New_Terms>
            </Change>
            <Change id="84">
               <Axiom>Aminopyrine SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Aminopyrine</New_Terms>
            </Change>
            <Change id="85">
               <Axiom>Aminosalicylate Calcium SubClassOf Antitubercular Agent</Axiom>
               <New_Terms>Aminosalicylate Calcium</New_Terms>
            </Change>
            <Change id="87">
               <Axiom>Amiprilose Hydrochloride SubClassOf Immunosuppressant</Axiom>
               <New_Terms>Amiprilose Hydrochloride</New_Terms>
            </Change>
            <Change id="86">
               <Axiom>Amiprilose SubClassOf Immunosuppressant</Axiom>
               <New_Terms>Amiprilose</New_Terms>
            </Change>
            <Change id="88">
               <Axiom>Amisometradine SubClassOf Diuretic</Axiom>
               <New_Terms>Amisometradine</New_Terms>
            </Change>
            <Change id="89">
               <Axiom>Ammonia SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ammonia</New_Terms>
            </Change>
            <Change id="90">
               <Axiom>Ammonium Acetate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ammonium Acetate</New_Terms>
            </Change>
            <Change id="91">
               <Axiom>Ammonium Bromide SubClassOf Industrial Product</Axiom>
               <New_Terms>Ammonium Bromide</New_Terms>
            </Change>
            <Change id="92">
               <Axiom>Ammonium Lauryl Sulfate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ammonium Lauryl Sulfate</New_Terms>
            </Change>
            <Change id="93">
               <Axiom>Ammonium Phosphate SubClassOf Industrial Product</Axiom>
               <New_Terms>Ammonium Phosphate</New_Terms>
            </Change>
            <Change id="94">
               <Axiom>Ammonium Salicylate SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Ammonium Salicylate</New_Terms>
            </Change>
            <Change id="95">
               <Axiom>Ammonium Sulfate SubClassOf Industrial Product</Axiom>
               <New_Terms>Ammonium Sulfate</New_Terms>
            </Change>
            <Change id="97">
               <Axiom>Amobarbital Sodium SubClassOf Barbiturate</Axiom>
               <New_Terms>Amobarbital Sodium</New_Terms>
            </Change>
            <Change id="96">
               <Axiom>Amobarbital SubClassOf Barbiturate</Axiom>
               <New_Terms>Amobarbital</New_Terms>
            </Change>
            <Change id="98">
               <Axiom>Amogastrin SubClassOf Diagnostic Reagent</Axiom>
               <New_Terms>Amogastrin</New_Terms>
            </Change>
            <Change id="99">
               <Axiom>Amotosalen SubClassOf DNA Intercalating Agent</Axiom>
               <New_Terms>Amotosalen</New_Terms>
            </Change>
            <Change id="100">
               <Axiom>Amperozide Hydrochloride SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Amperozide Hydrochloride</New_Terms>
            </Change>
            <Change id="101">
               <Axiom>Amphenidone SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Amphenidone</New_Terms>
            </Change>
            <Change id="102">
               <Axiom>Amphetamine Hydrochloride SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Amphetamine Hydrochloride</New_Terms>
            </Change>
            <Change id="103">
               <Axiom>Amprolium SubClassOf Antiparasitic Agent</Axiom>
               <New_Terms>Amprolium</New_Terms>
            </Change>
            <Change id="104">
               <Axiom>Ampullary Gland SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Ampullary Gland</New_Terms>
            </Change>
            <Change id="105">
               <Axiom>Ampyzine Sulfate SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Ampyzine Sulfate</New_Terms>
            </Change>
            <Change id="106">
               <Axiom>Amyl Acetate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Amyl Acetate</New_Terms>
            </Change>
            <Change id="108">
               <Axiom>Anaritide Acetate SubClassOf Therapeutic Hormone</Axiom>
               <New_Terms>Anaritide Acetate</New_Terms>
            </Change>
            <Change id="107">
               <Axiom>Anaritide SubClassOf Therapeutic Hormone</Axiom>
               <New_Terms>Anaritide</New_Terms>
            </Change>
            <Change id="109">
               <Axiom>Anazocine SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Anazocine</New_Terms>
            </Change>
            <Change id="110">
               <Axiom>Anethole SubClassOf Pesticide</Axiom>
               <New_Terms>Anethole</New_Terms>
            </Change>
            <Change id="111">
               <Axiom>Angiotensin Amide SubClassOf Therapeutic Hormone</Axiom>
               <New_Terms>Angiotensin Amide</New_Terms>
            </Change>
            <Change id="112">
               <Axiom>Animalia SubClassOf Other Organism Groupings</Axiom>
               <New_Terms>Animalia</New_Terms>
            </Change>
            <Change id="113">
               <Axiom>Anipamil SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Anipamil</New_Terms>
            </Change>
            <Change id="114">
               <Axiom>Anisperimus SubClassOf Immunosuppressant</Axiom>
               <New_Terms>Anisperimus</New_Terms>
            </Change>
            <Change id="115">
               <Axiom>Antazoline Hydrochloride SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Antazoline Hydrochloride</New_Terms>
            </Change>
            <Change id="116">
               <Axiom>Anti-CD200 Monoclonal Antibody ALXN6000 SubClassOf Monoclonal Antibody</Axiom>
               <New_Terms>Anti-CD200 Monoclonal Antibody ALXN6000</New_Terms>
            </Change>
            <Change id="117">
               <Axiom>Anti-CD30 Monoclonal Antibody MDX-1401 SubClassOf Monoclonal Antibody</Axiom>
               <New_Terms>Anti-CD30 Monoclonal Antibody MDX-1401</New_Terms>
            </Change>
            <Change id="118">
               <Axiom>Anti-CEA IgCD28TCR-Transduced Autologous T Cells SubClassOf Biological Agent</Axiom>
               <New_Terms>Anti-CEA IgCD28TCR-Transduced Autologous T Cells</New_Terms>
            </Change>
            <Change id="119">
               <Axiom>Anti-EpCAM/Anti-CD3 Recombinant Bispecific Monoclonal Antibody MT110 SubClassOf Bispecific Antibody</Axiom>
               <New_Terms>Anti-EpCAM/Anti-CD3 Recombinant Bispecific Monoclonal Antibody MT110</New_Terms>
            </Change>
            <Change id="120">
               <Axiom>Antimony Potassium Tartrate SubClassOf Pesticide</Axiom>
               <New_Terms>Antimony Potassium Tartrate</New_Terms>
            </Change>
            <Change id="121">
               <Axiom>Antipyrine SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Antipyrine</New_Terms>
            </Change>
            <Change id="122">
               <Axiom>Apafant SubClassOf Anticoagulant Agent</Axiom>
               <New_Terms>Apafant</New_Terms>
            </Change>
            <Change id="123">
               <Axiom>Apaflurane SubClassOf Industrial Aid</Axiom>
               <New_Terms>Apaflurane</New_Terms>
            </Change>
            <Change id="125">
               <Axiom>Aplaviroc Hydrochloride SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Aplaviroc Hydrochloride</New_Terms>
            </Change>
            <Change id="124">
               <Axiom>Aplaviroc SubClassOf Anti-HIV Agent</Axiom>
               <New_Terms>Aplaviroc</New_Terms>
            </Change>
            <Change id="127">
               <Axiom>Aplindore Fumarate SubClassOf Dopamine Agonist</Axiom>
               <New_Terms>Aplindore Fumarate</New_Terms>
            </Change>
            <Change id="126">
               <Axiom>Aplindore SubClassOf Dopamine Agonist</Axiom>
               <New_Terms>Aplindore</New_Terms>
            </Change>
            <Change id="128">
               <Axiom>Application Site SubClassOf Anatomic Site</Axiom>
               <New_Terms>Application Site</New_Terms>
            </Change>
            <Change id="129">
               <Axiom>Apratastat SubClassOf Matrix Metalloproteinase Inhibitor</Axiom>
               <New_Terms>Apratastat</New_Terms>
            </Change>
            <Change id="130">
               <Axiom>Apricoxib SubClassOf Cyclooxygenase Inhibitor</Axiom>
               <New_Terms>Apricoxib</New_Terms>
            </Change>
            <Change id="131">
               <Axiom>Aprikalim SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Aprikalim</New_Terms>
            </Change>
            <Change id="133">
               <Axiom>Aprindine Hydrochloride SubClassOf Antiarrhythmic Agent</Axiom>
               <New_Terms>Aprindine Hydrochloride</New_Terms>
            </Change>
            <Change id="132">
               <Axiom>Aprindine SubClassOf Antiarrhythmic Agent</Axiom>
               <New_Terms>Aprindine</New_Terms>
            </Change>
            <Change id="134">
               <Axiom>Aprobarbital SubClassOf Barbiturate</Axiom>
               <New_Terms>Aprobarbital</New_Terms>
            </Change>
            <Change id="135">
               <Axiom>Aprosulate Sodium SubClassOf Anticoagulant Agent</Axiom>
               <New_Terms>Aprosulate Sodium</New_Terms>
            </Change>
            <Change id="136">
               <Axiom>Arbitrary Fluorescence Units SubClassOf Fluorescence Units</Axiom>
               <New_Terms>Arbitrary Fluorescence Units</New_Terms>
            </Change>
            <Change id="137">
               <Axiom>Arecoline SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Arecoline</New_Terms>
            </Change>
            <Change id="138">
               <Axiom>Argimesna SubClassOf Uroprotective Agent</Axiom>
               <New_Terms>Argimesna</New_Terms>
            </Change>
            <Change id="139">
               <Axiom>Arginine Glutamate SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Arginine Glutamate</New_Terms>
            </Change>
            <Change id="140">
               <Axiom>Arildone SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Arildone</New_Terms>
            </Change>
            <Change id="141">
               <Axiom>Arsthinol SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Arsthinol</New_Terms>
            </Change>
            <Change id="142">
               <Axiom>Artemisinin SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Artemisinin</New_Terms>
            </Change>
            <Change id="143">
               <Axiom>Arthropoda SubClassOf Invertebrate</Axiom>
               <New_Terms>Arthropoda</New_Terms>
            </Change>
            <Change id="144">
               <Axiom>Ascomycota SubClassOf Fungus</Axiom>
               <New_Terms>Ascomycota</New_Terms>
            </Change>
            <Change id="145">
               <Axiom>Ashwagandha Root Powder Extract SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Ashwagandha Root Powder Extract</New_Terms>
            </Change>
            <Change id="146">
               <Axiom>Aspartame SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Aspartame</New_Terms>
            </Change>
            <Change id="147">
               <Axiom>Aspergillus SubClassOf Ascomycota</Axiom>
               <New_Terms>Ascomycota, Aspergillus</New_Terms>
            </Change>
            <Change id="148">
               <Axiom>Aspergillus flavus SubClassOf Aspergillus</Axiom>
               <New_Terms>Aspergillus flavus, Aspergillus</New_Terms>
            </Change>
            <Change id="149">
               <Axiom>Aspergillus fumigatus SubClassOf Aspergillus</Axiom>
               <New_Terms>Aspergillus fumigatus, Aspergillus</New_Terms>
            </Change>
            <Change id="150">
               <Axiom>Aspergillus niger SubClassOf Aspergillus</Axiom>
               <New_Terms>Aspergillus niger, Aspergillus</New_Terms>
            </Change>
            <Change id="151">
               <Axiom>Aspirin Aluminum SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Aspirin Aluminum</New_Terms>
            </Change>
            <Change id="152">
               <Axiom>Ataprost SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Ataprost</New_Terms>
            </Change>
            <Change id="153">
               <Axiom>Atilmotin SubClassOf Miscellaneous Hormone Agent</Axiom>
               <New_Terms>Atilmotin</New_Terms>
            </Change>
            <Change id="154">
               <Axiom>Atiprimod Dihydrochloride SubClassOf Signal Transduction Inhibitor</Axiom>
               <New_Terms>Atiprimod Dihydrochloride</New_Terms>
            </Change>
            <Change id="155">
               <Axiom>Atiprimod Dimaleate SubClassOf Signal Transduction Inhibitor</Axiom>
               <New_Terms>Atiprimod Dimaleate</New_Terms>
            </Change>
            <Change id="156">
               <Axiom>Atiprosin SubClassOf Alpha-Adrenergic Antagonist</Axiom>
               <New_Terms>Atiprosin</New_Terms>
            </Change>
            <Change id="157">
               <Axiom>Atolide SubClassOf Anticonvulsant Agent</Axiom>
               <New_Terms>Atolide</New_Terms>
            </Change>
            <Change id="158">
               <Axiom>Auricular Vein SubClassOf Vein</Axiom>
               <New_Terms>Auricular Vein</New_Terms>
            </Change>
            <Change id="159">
               <Axiom>Avridine SubClassOf Immunostimulant</Axiom>
               <New_Terms>Avridine</New_Terms>
            </Change>
            <Change id="160">
               <Axiom>Azacosterol Hydrochloride SubClassOf Antilipidemic Agent</Axiom>
               <New_Terms>Azacosterol Hydrochloride</New_Terms>
            </Change>
            <Change id="161">
               <Axiom>Azacosterol Hydrochloride SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Azacosterol Hydrochloride</New_Terms>
            </Change>
            <Change id="163">
               <Axiom>Azacyclonol Hydrochloride SubClassOf Anxiolytic</Axiom>
               <New_Terms>Azacyclonol Hydrochloride</New_Terms>
            </Change>
            <Change id="162">
               <Axiom>Azacyclonol SubClassOf Anxiolytic</Axiom>
               <New_Terms>Azacyclonol</New_Terms>
            </Change>
            <Change id="164">
               <Axiom>Azaribine SubClassOf Pyrimidine Antagonist</Axiom>
               <New_Terms>Azaribine</New_Terms>
            </Change>
            <Change id="165">
               <Axiom>Azasetron Hydrochloride SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Azasetron Hydrochloride</New_Terms>
            </Change>
            <Change id="166">
               <Axiom>Azastene SubClassOf Oral Contraceptive</Axiom>
               <New_Terms>Azastene</New_Terms>
            </Change>
            <Change id="167">
               <Axiom>Azatadine SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Azatadine</New_Terms>
            </Change>
            <Change id="168">
               <Axiom>Azetepa SubClassOf Ethylenimine Compound</Axiom>
               <New_Terms>Azetepa</New_Terms>
            </Change>
            <Change id="169">
               <Axiom>Azidocillin SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Azidocillin</New_Terms>
            </Change>
            <Change id="170">
               <Axiom>Azimilide Dihydrochloride SubClassOf Antiarrhythmic Agent</Axiom>
               <New_Terms>Azimilide Dihydrochloride</New_Terms>
            </Change>
            <Change id="171">
               <Axiom>Azolimine SubClassOf Diuretic</Axiom>
               <New_Terms>Azolimine</New_Terms>
            </Change>
            <Change id="172">
               <Axiom>Azosemide SubClassOf Loop Diuretic</Axiom>
               <New_Terms>Azosemide</New_Terms>
            </Change>
            <Change id="173">
               <Axiom>B7-DC Crosslinking Antibody rHIgM12B7 SubClassOf Monoclonal Antibody</Axiom>
               <New_Terms>B7-DC Crosslinking Antibody rHIgM12B7</New_Terms>
            </Change>
            <Change id="174">
               <Axiom>Bacillus Calmette-Guerin Antigen SubClassOf Antigen</Axiom>
               <New_Terms>Bacillus Calmette-Guerin Antigen</New_Terms>
            </Change>
            <Change id="175">
               <Axiom>Bacillus Calmette-Guerin Live Antigen, A SubClassOf Bacillus Calmette-Guerin Antigen</Axiom>
               <New_Terms>Bacillus Calmette-Guerin Antigen, Bacillus Calmette-Guerin Live Antigen, A</New_Terms>
            </Change>
            <Change id="176">
               <Axiom>Bacillus Calmette-Guerin Live Antigen, B SubClassOf Bacillus Calmette-Guerin Antigen</Axiom>
               <New_Terms>Bacillus Calmette-Guerin Antigen, Bacillus Calmette-Guerin Live Antigen, B</New_Terms>
            </Change>
            <Change id="177">
               <Axiom>Balaglitazone SubClassOf Anti-diabetic Agent</Axiom>
               <New_Terms>Balaglitazone</New_Terms>
            </Change>
            <Change id="178">
               <Axiom>Balamapimod SubClassOf Mitogen-Activated Protein Kinase Inhibitor</Axiom>
               <New_Terms>Balamapimod</New_Terms>
            </Change>
            <Change id="180">
               <Axiom>Bamifylline Hydrochloride SubClassOf Bronchodilator</Axiom>
               <New_Terms>Bamifylline Hydrochloride</New_Terms>
            </Change>
            <Change id="179">
               <Axiom>Bamifylline SubClassOf Bronchodilator</Axiom>
               <New_Terms>Bamifylline</New_Terms>
            </Change>
            <Change id="181">
               <Axiom>Barbexaclone SubClassOf Anticonvulsant Agent</Axiom>
               <New_Terms>Barbexaclone</New_Terms>
            </Change>
            <Change id="183">
               <Axiom>Barbital Sodium SubClassOf Barbiturate</Axiom>
               <New_Terms>Barbital Sodium</New_Terms>
            </Change>
            <Change id="182">
               <Axiom>Barbital SubClassOf Barbiturate</Axiom>
               <New_Terms>Barbital</New_Terms>
            </Change>
            <Change id="184">
               <Axiom>Basidiomycota SubClassOf Fungus</Axiom>
               <New_Terms>Basidiomycota</New_Terms>
            </Change>
            <Change id="186">
               <Axiom>Batelapine Maleate SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Batelapine Maleate</New_Terms>
            </Change>
            <Change id="185">
               <Axiom>Batelapine SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Batelapine</New_Terms>
            </Change>
            <Change id="187">
               <Axiom>Becanthone Hydrochloride SubClassOf Antiparasitic Agent</Axiom>
               <New_Terms>Becanthone Hydrochloride</New_Terms>
            </Change>
            <Change id="188">
               <Axiom>Becocalcidiol SubClassOf Vitamin D Analog</Axiom>
               <New_Terms>Becocalcidiol</New_Terms>
            </Change>
            <Change id="189">
               <Axiom>Bederocin SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Bederocin</New_Terms>
            </Change>
            <Change id="190">
               <Axiom>Bedoradrine Sulfate SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Bedoradrine Sulfate</New_Terms>
            </Change>
            <Change id="191">
               <Axiom>Befetupitant SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Befetupitant</New_Terms>
            </Change>
            <Change id="192">
               <Axiom>Befloxatone SubClassOf Monoamine Oxidase Inhibitor</Axiom>
               <New_Terms>Befloxatone</New_Terms>
            </Change>
            <Change id="193">
               <Axiom>Beloxamide SubClassOf Antilipidemic Agent</Axiom>
               <New_Terms>Beloxamide</New_Terms>
            </Change>
            <Change id="194">
               <Axiom>Beloxepin SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Beloxepin</New_Terms>
            </Change>
            <Change id="195">
               <Axiom>Bemegride SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Bemegride</New_Terms>
            </Change>
            <Change id="196">
               <Axiom>Bemitradine SubClassOf Diuretic</Axiom>
               <New_Terms>Bemitradine</New_Terms>
            </Change>
            <Change id="197">
               <Axiom>Benactyzine Hydrochloride SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Benactyzine Hydrochloride</New_Terms>
            </Change>
            <Change id="198">
               <Axiom>Benapryzine Hydrochloride SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Benapryzine Hydrochloride</New_Terms>
            </Change>
            <Change id="199">
               <Axiom>Bencisteine SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Bencisteine</New_Terms>
            </Change>
            <Change id="200">
               <Axiom>Bencisteine SubClassOf Mucolytic Agent</Axiom>
               <New_Terms>Bencisteine</New_Terms>
            </Change>
            <Change id="201">
               <Axiom>Benfurodil Hemisuccinate SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Benfurodil Hemisuccinate</New_Terms>
            </Change>
            <Change id="202">
               <Axiom>Benmoxin SubClassOf Monoamine Oxidase Inhibitor</Axiom>
               <New_Terms>Benmoxin</New_Terms>
            </Change>
            <Change id="203">
               <Axiom>Benolizime SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Benolizime</New_Terms>
            </Change>
            <Change id="204">
               <Axiom>Benoxaprofen SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Benoxaprofen</New_Terms>
            </Change>
            <Change id="205">
               <Axiom>Benproperine SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Benproperine</New_Terms>
            </Change>
            <Change id="206">
               <Axiom>Bentiamine SubClassOf Vitamin, Other</Axiom>
               <New_Terms>Bentiamine</New_Terms>
            </Change>
            <Change id="207">
               <Axiom>Bentipimine SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Bentipimine</New_Terms>
            </Change>
            <Change id="208">
               <Axiom>Benzestrol SubClassOf Therapeutic Estrogen</Axiom>
               <New_Terms>Benzestrol</New_Terms>
            </Change>
            <Change id="209">
               <Axiom>Benzethidine SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Benzethidine</New_Terms>
            </Change>
            <Change id="210">
               <Axiom>Benzethonium Chloride SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Benzethonium Chloride</New_Terms>
            </Change>
            <Change id="211">
               <Axiom>Benzetimide Hydrochloride SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Benzetimide Hydrochloride</New_Terms>
            </Change>
            <Change id="212">
               <Axiom>Benzobarbital SubClassOf Barbiturate</Axiom>
               <New_Terms>Benzobarbital</New_Terms>
            </Change>
            <Change id="213">
               <Axiom>Benzoclidine SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Benzoclidine</New_Terms>
            </Change>
            <Change id="214">
               <Axiom>Benzoin SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Benzoin</New_Terms>
            </Change>
            <Change id="215">
               <Axiom>Benzopyrronium Bromide SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Benzopyrronium Bromide</New_Terms>
            </Change>
            <Change id="216">
               <Axiom>Benzoquinonium Chloride SubClassOf Nicotinic Antagonist</Axiom>
               <New_Terms>Benzoquinonium Chloride</New_Terms>
            </Change>
            <Change id="217">
               <Axiom>Benzotript SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Benzotript</New_Terms>
            </Change>
            <Change id="218">
               <Axiom>Benzoxiquine SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Benzoxiquine</New_Terms>
            </Change>
            <Change id="219">
               <Axiom>Benzpyrinium Bromide SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Benzpyrinium Bromide</New_Terms>
            </Change>
            <Change id="220">
               <Axiom>Benzquinamide Hydrochloride SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Benzquinamide Hydrochloride</New_Terms>
            </Change>
            <Change id="221">
               <Axiom>Benzyl Alcohol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Benzyl Alcohol</New_Terms>
            </Change>
            <Change id="222">
               <Axiom>Benzyl Chloride SubClassOf Industrial Aid</Axiom>
               <New_Terms>Benzyl Chloride</New_Terms>
            </Change>
            <Change id="223">
               <Axiom>Bepafant SubClassOf Biological Response Modifier</Axiom>
               <New_Terms>Bepafant</New_Terms>
            </Change>
            <Change id="224">
               <Axiom>Bepotastine SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Bepotastine</New_Terms>
            </Change>
            <Change id="225">
               <Axiom>Beraprost SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Beraprost</New_Terms>
            </Change>
            <Change id="226">
               <Axiom>Bervastatin SubClassOf HMG-CoA Reductase Inhibitor</Axiom>
               <New_Terms>Bervastatin</New_Terms>
            </Change>
            <Change id="229">
               <Axiom>Beta-sitosterol SubClassOf Retired Concept</Axiom>
               <New_Terms>Beta-sitosterol</New_Terms>
            </Change>
            <Change id="230">
               <Axiom>Betacetylmethadol SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Betacetylmethadol</New_Terms>
            </Change>
            <Change id="231">
               <Axiom>Betamethadol SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Betamethadol</New_Terms>
            </Change>
            <Change id="232">
               <Axiom>Betamethasone Dihydrogen Phosphate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Betamethasone Dihydrogen Phosphate</New_Terms>
            </Change>
            <Change id="234">
               <Axiom>Bevirimat Dimeglumine SubClassOf Anti-HIV Agent</Axiom>
               <New_Terms>Bevirimat Dimeglumine</New_Terms>
            </Change>
            <Change id="233">
               <Axiom>Bevirimat SubClassOf Anti-HIV Agent</Axiom>
               <New_Terms>Bevirimat</New_Terms>
            </Change>
            <Change id="235">
               <Axiom>Bialamicol Hydrochloride SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Bialamicol Hydrochloride</New_Terms>
            </Change>
            <Change id="236">
               <Axiom>Bifluranol SubClassOf Anti-Androgen</Axiom>
               <New_Terms>Bifluranol</New_Terms>
            </Change>
            <Change id="237">
               <Axiom>Biopsy Site SubClassOf Anatomic Site</Axiom>
               <New_Terms>Biopsy Site</New_Terms>
            </Change>
            <Change id="238">
               <Axiom>Biriperone SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Biriperone</New_Terms>
            </Change>
            <Change id="239">
               <Axiom>Bisantrene Hydrochloride SubClassOf Anthraquinone Compound</Axiom>
               <New_Terms>Bisantrene Hydrochloride</New_Terms>
            </Change>
            <Change id="240">
               <Axiom>Bisfenazone SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Bisfenazone</New_Terms>
            </Change>
            <Change id="241">
               <Axiom>Bismuth Citrate SubClassOf Antidiarrheal Agent</Axiom>
               <New_Terms>Bismuth Citrate</New_Terms>
            </Change>
            <Change id="242">
               <Axiom>Bismuth Subcarbonate SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Bismuth Subcarbonate</New_Terms>
            </Change>
            <Change id="243">
               <Axiom>Bismuth Subgallate SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Bismuth Subgallate</New_Terms>
            </Change>
            <Change id="244">
               <Axiom>Bismuth Subnitrate SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Bismuth Subnitrate</New_Terms>
            </Change>
            <Change id="245">
               <Axiom>Bithionol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Bithionol</New_Terms>
            </Change>
            <Change id="246">
               <Axiom>Bithionoloxide SubClassOf Antihelminthic Agent</Axiom>
               <New_Terms>Bithionoloxide</New_Terms>
            </Change>
            <Change id="247">
               <Axiom>Black South or Central American SubClassOf Race</Axiom>
               <New_Terms>Black South or Central American</New_Terms>
            </Change>
            <Change id="252">
               <Axiom>Bone Marrow Smear SubClassOf Hematology Test</Axiom>
               <New_Terms>Bone Marrow Smear</New_Terms>
            </Change>
            <Change id="248">
               <Axiom>Bone Marrow, Femur SubClassOf Bone Marrow</Axiom>
               <New_Terms>Bone Marrow, Femur</New_Terms>
            </Change>
            <Change id="249">
               <Axiom>Bone Marrow, Humerus SubClassOf Bone Marrow</Axiom>
               <New_Terms>Bone Marrow, Humerus</New_Terms>
            </Change>
            <Change id="250">
               <Axiom>Bone Marrow, Rib SubClassOf Bone Marrow</Axiom>
               <New_Terms>Bone Marrow, Rib</New_Terms>
            </Change>
            <Change id="251">
               <Axiom>Bone Marrow, Scapula SubClassOf Bone Marrow</Axiom>
               <New_Terms>Bone Marrow, Scapula</New_Terms>
            </Change>
            <Change id="253">
               <Axiom>Bone Marrow, Sternum SubClassOf Bone Marrow</Axiom>
               <New_Terms>Bone Marrow, Sternum</New_Terms>
            </Change>
            <Change id="254">
               <Axiom>Bone Marrow, Tibia SubClassOf Bone Marrow</Axiom>
               <New_Terms>Bone Marrow, Tibia</New_Terms>
            </Change>
            <Change id="255">
               <Axiom>Bone Marrow, Vertebral SubClassOf Bone Marrow</Axiom>
               <New_Terms>Bone Marrow, Vertebral</New_Terms>
            </Change>
            <Change id="256">
               <Axiom>Bordetella Pertussis Antigen, A SubClassOf Bordetella Pertussis Antigen</Axiom>
               <New_Terms>Bordetella Pertussis Antigen, A</New_Terms>
            </Change>
            <Change id="257">
               <Axiom>Bordetella pertussis Filamentous Hemagglutinin Antigen, A SubClassOf Bordetella Pertussis Antigen</Axiom>
               <New_Terms>Bordetella pertussis Filamentous Hemagglutinin Antigen, A</New_Terms>
            </Change>
            <Change id="258">
               <Axiom>Bordetella pertussis Filamentous Hemagglutinin Antigen, B SubClassOf Bordetella Pertussis Antigen</Axiom>
               <New_Terms>Bordetella pertussis Filamentous Hemagglutinin Antigen, B</New_Terms>
            </Change>
            <Change id="259">
               <Axiom>Bordetella pertussis Filamentous Hemagglutinin Antigen, C SubClassOf Bordetella Pertussis Antigen</Axiom>
               <New_Terms>Bordetella pertussis Filamentous Hemagglutinin Antigen, C</New_Terms>
            </Change>
            <Change id="260">
               <Axiom>Bordetella pertussis Fimbriae 2/3 Antigen, A SubClassOf Bordetella Pertussis Antigen</Axiom>
               <New_Terms>Bordetella pertussis Fimbriae 2/3 Antigen, A</New_Terms>
            </Change>
            <Change id="261">
               <Axiom>Bordetella pertussis Pertactin Antigen, A SubClassOf Bordetella Pertussis Antigen</Axiom>
               <New_Terms>Bordetella pertussis Pertactin Antigen, A</New_Terms>
            </Change>
            <Change id="262">
               <Axiom>Bordetella pertussis Pertactin Antigen, B SubClassOf Bordetella Pertussis Antigen</Axiom>
               <New_Terms>Bordetella pertussis Pertactin Antigen, B</New_Terms>
            </Change>
            <Change id="263">
               <Axiom>Bordetella pertussis Toxoid Antigen, A SubClassOf Bordetella Pertussis Antigen</Axiom>
               <New_Terms>Bordetella pertussis Toxoid Antigen, A</New_Terms>
            </Change>
            <Change id="264">
               <Axiom>Bordetella pertussis Toxoid Antigen, B SubClassOf Bordetella Pertussis Antigen</Axiom>
               <New_Terms>Bordetella pertussis Toxoid Antigen, B</New_Terms>
            </Change>
            <Change id="265">
               <Axiom>Bordetella pertussis Toxoid Antigen, C SubClassOf Bordetella Pertussis Antigen</Axiom>
               <New_Terms>Bordetella pertussis Toxoid Antigen, C</New_Terms>
            </Change>
            <Change id="267">
               <Axiom>Brasofensine Maleate SubClassOf Antiparkinsonian Agent</Axiom>
               <New_Terms>Brasofensine Maleate</New_Terms>
            </Change>
            <Change id="266">
               <Axiom>Brasofensine SubClassOf Antiparkinsonian Agent</Axiom>
               <New_Terms>Brasofensine</New_Terms>
            </Change>
            <Change id="268">
               <Axiom>Brecanavir SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Brecanavir</New_Terms>
            </Change>
            <Change id="269">
               <Axiom>Bremelanotide SubClassOf Therapeutic Hormone</Axiom>
               <New_Terms>Bremelanotide</New_Terms>
            </Change>
            <Change id="270">
               <Axiom>Bretylium SubClassOf Alpha-Adrenergic Antagonist</Axiom>
               <New_Terms>Bretylium</New_Terms>
            </Change>
            <Change id="271">
               <Axiom>Brindoxime SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Brindoxime</New_Terms>
            </Change>
            <Change id="272">
               <Axiom>Brocresine SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Brocresine</New_Terms>
            </Change>
            <Change id="273">
               <Axiom>Bromisovalum SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Bromisovalum</New_Terms>
            </Change>
            <Change id="274">
               <Axiom>Bromperidol SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Bromperidol</New_Terms>
            </Change>
            <Change id="275">
               <Axiom>Bronopol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Bronopol</New_Terms>
            </Change>
            <Change id="276">
               <Axiom>Broparestrol SubClassOf Therapeutic Estrogen</Axiom>
               <New_Terms>Broparestrol</New_Terms>
            </Change>
            <Change id="277">
               <Axiom>Broperamole SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Broperamole</New_Terms>
            </Change>
            <Change id="278">
               <Axiom>Bucainide SubClassOf Antiarrhythmic Agent</Axiom>
               <New_Terms>Bucainide</New_Terms>
            </Change>
            <Change id="279">
               <Axiom>Bufeniode SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Bufeniode</New_Terms>
            </Change>
            <Change id="280">
               <Axiom>Bufogenin SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Bufogenin</New_Terms>
            </Change>
            <Change id="281">
               <Axiom>Bunamiodyl Sodium SubClassOf Contrast Agent</Axiom>
               <New_Terms>Bunamiodyl Sodium</New_Terms>
            </Change>
            <Change id="282">
               <Axiom>Bunazosin Hydrochloride SubClassOf Alpha-Adrenergic Antagonist</Axiom>
               <New_Terms>Bunazosin Hydrochloride</New_Terms>
            </Change>
            <Change id="283">
               <Axiom>Buquinolate SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Buquinolate</New_Terms>
            </Change>
            <Change id="284">
               <Axiom>Butacaine Sulfate SubClassOf Anesthetic Agent</Axiom>
               <New_Terms>Butacaine Sulfate</New_Terms>
            </Change>
            <Change id="285">
               <Axiom>Butalamine SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Butalamine</New_Terms>
            </Change>
            <Change id="286">
               <Axiom>Butaperazine Maleate SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Butaperazine Maleate</New_Terms>
            </Change>
            <Change id="287">
               <Axiom>Butinoline SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Butinoline</New_Terms>
            </Change>
            <Change id="288">
               <Axiom>Butixirate SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Butixirate</New_Terms>
            </Change>
            <Change id="289">
               <Axiom>Butocrolol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Butocrolol</New_Terms>
            </Change>
            <Change id="290">
               <Axiom>Butoctamide SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Butoctamide</New_Terms>
            </Change>
            <Change id="291">
               <Axiom>Butofilolol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Butofilolol</New_Terms>
            </Change>
            <Change id="292">
               <Axiom>Butopiprine SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Butopiprine</New_Terms>
            </Change>
            <Change id="293">
               <Axiom>Butopyrammonium Iodide SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Butopyrammonium Iodide</New_Terms>
            </Change>
            <Change id="294">
               <Axiom>Butopyronoxyl SubClassOf Pesticide</Axiom>
               <New_Terms>Butopyronoxyl</New_Terms>
            </Change>
            <Change id="295">
               <Axiom>Butoxylate SubClassOf Antidiarrheal Agent</Axiom>
               <New_Terms>Butoxylate</New_Terms>
            </Change>
            <Change id="296">
               <Axiom>Butyl Alcohol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Butyl Alcohol</New_Terms>
            </Change>
            <Change id="297">
               <Axiom>Butyl Stearate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Butyl Stearate</New_Terms>
            </Change>
            <Change id="298">
               <Axiom>Butylated Hydroxyanisole II SubClassOf Antioxidant</Axiom>
               <New_Terms>Butylated Hydroxyanisole II</New_Terms>
            </Change>
            <Change id="299">
               <Axiom>Butylene Glycol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Butylene Glycol</New_Terms>
            </Change>
            <Change id="300">
               <Axiom>Butylparaben SubClassOf Industrial Aid</Axiom>
               <New_Terms>Butylparaben</New_Terms>
            </Change>
            <Change id="301">
               <Axiom>Buzepide Metiodide SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Buzepide Metiodide</New_Terms>
            </Change>
            <Change id="302">
               <Axiom>CDH2 Gene SubClassOf Cell Adhesion Molecule Gene</Axiom>
               <New_Terms>CDH2 Gene</New_Terms>
            </Change>
            <Change id="303">
               <Axiom>CDH2 Gene SubClassOf Gene_Plays_Role_In_Process some Cell Adhesion</Axiom>
               <New_Terms>CDH2 Gene</New_Terms>
            </Change>
            <Change id="304">
               <Axiom>CDH2 wt Allele SubClassOf CDH2 Gene</Axiom>
               <New_Terms>CDH2 Gene, CDH2 wt Allele</New_Terms>
            </Change>
            <Change id="305">
               <Axiom>CDH2 wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <New_Terms>CDH2 wt Allele</New_Terms>
            </Change>
            <Change id="306">
               <Axiom>CDISC CDASH Terminology SubClassOf Clinical Data Interchange Standards Consortium Terminology</Axiom>
               <New_Terms>CDISC CDASH Terminology</New_Terms>
            </Change>
            <Change id="307">
               <Axiom>CDISC SEND Biospecimens Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Biospecimens Terminology, CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="308">
               <Axiom>CDISC SEND Laboratory Animal Species Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology, CDISC SEND Laboratory Animal Species Terminology</New_Terms>
            </Change>
            <Change id="309">
               <Axiom>CDISC SEND Laboratory Animal Strain Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology, CDISC SEND Laboratory Animal Strain Terminology</New_Terms>
            </Change>
            <Change id="310">
               <Axiom>CDISC SEND Pre-clinical Units of Measure Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology, CDISC SEND Pre-clinical Units of Measure Terminology</New_Terms>
            </Change>
            <Change id="311">
               <Axiom>CDISC SEND Terminology SubClassOf Clinical Data Interchange Standards Consortium Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="312">
               <Axiom>CF-1 Mouse SubClassOf Inbred Mouse Strains</Axiom>
               <New_Terms>CF-1 Mouse</New_Terms>
            </Change>
            <Change id="313">
               <Axiom>CHFR Gene SubClassOf Gene_Plays_Role_In_Process some Cell Cycle Checkpoint</Axiom>
               <New_Terms>CHFR Gene</New_Terms>
            </Change>
            <Change id="314">
               <Axiom>CHFR Gene SubClassOf Gene_Plays_Role_In_Process some Ubiquitination</Axiom>
               <New_Terms>CHFR Gene</New_Terms>
            </Change>
            <Change id="315">
               <Axiom>CHFR Gene SubClassOf Ubiquitin Ligase Gene</Axiom>
               <New_Terms>CHFR Gene</New_Terms>
            </Change>
            <Change id="316">
               <Axiom>CHFR wt Allele SubClassOf CHFR Gene</Axiom>
               <New_Terms>CHFR wt Allele, CHFR Gene</New_Terms>
            </Change>
            <Change id="317">
               <Axiom>CHFR wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <New_Terms>CHFR wt Allele</New_Terms>
            </Change>
            <Change id="318">
               <Axiom>CHRNA3 Gene SubClassOf Gene_Associated_With_Disease some Lung Carcinoma</Axiom>
               <New_Terms>CHRNA3 Gene</New_Terms>
            </Change>
            <Change id="319">
               <Axiom>CHRNA3 Gene SubClassOf Gene_Plays_Role_In_Process some Transport Reaction</Axiom>
               <New_Terms>CHRNA3 Gene</New_Terms>
            </Change>
            <Change id="320">
               <Axiom>CHRNA3 Gene SubClassOf Ion Channel Protein Gene</Axiom>
               <New_Terms>CHRNA3 Gene</New_Terms>
            </Change>
            <Change id="321">
               <Axiom>CHRNA3 wt Allele SubClassOf CHRNA3 Gene</Axiom>
               <New_Terms>CHRNA3 Gene, CHRNA3 wt Allele</New_Terms>
            </Change>
            <Change id="322">
               <Axiom>CHRNA3 wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <New_Terms>CHRNA3 wt Allele</New_Terms>
            </Change>
            <Change id="323">
               <Axiom>CHRNA3 wt Allele SubClassOf Gene_In_Chromosomal_Location some 15q24</Axiom>
               <New_Terms>CHRNA3 wt Allele</New_Terms>
            </Change>
            <Change id="324">
               <Axiom>CHRNA5 Gene SubClassOf Gene_Associated_With_Disease some Lung Carcinoma</Axiom>
               <New_Terms>CHRNA5 Gene</New_Terms>
            </Change>
            <Change id="325">
               <Axiom>CHRNA5 Gene SubClassOf Gene_Plays_Role_In_Process some Transport Reaction</Axiom>
               <New_Terms>CHRNA5 Gene</New_Terms>
            </Change>
            <Change id="326">
               <Axiom>CHRNA5 Gene SubClassOf Ion Channel Protein Gene</Axiom>
               <New_Terms>CHRNA5 Gene</New_Terms>
            </Change>
            <Change id="327">
               <Axiom>CHRNA5 wt Allele SubClassOf CHRNA5 Gene</Axiom>
               <New_Terms>CHRNA5 wt Allele, CHRNA5 Gene</New_Terms>
            </Change>
            <Change id="328">
               <Axiom>CHRNA5 wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <New_Terms>CHRNA5 wt Allele</New_Terms>
            </Change>
            <Change id="329">
               <Axiom>CHRNA5 wt Allele SubClassOf Gene_In_Chromosomal_Location some 15q24</Axiom>
               <New_Terms>CHRNA5 wt Allele</New_Terms>
            </Change>
            <Change id="330">
               <Axiom>CHRNB4 Gene SubClassOf Gene_Associated_With_Disease some Lung Carcinoma</Axiom>
               <New_Terms>CHRNB4 Gene</New_Terms>
            </Change>
            <Change id="331">
               <Axiom>CHRNB4 Gene SubClassOf Gene_Plays_Role_In_Process some Transport Reaction</Axiom>
               <New_Terms>CHRNB4 Gene</New_Terms>
            </Change>
            <Change id="332">
               <Axiom>CHRNB4 Gene SubClassOf Ion Channel Protein Gene</Axiom>
               <New_Terms>CHRNB4 Gene</New_Terms>
            </Change>
            <Change id="333">
               <Axiom>CHRNB4 wt Allele SubClassOf CHRNB4 Gene</Axiom>
               <New_Terms>CHRNB4 Gene, CHRNB4 wt Allele</New_Terms>
            </Change>
            <Change id="334">
               <Axiom>CHRNB4 wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <New_Terms>CHRNB4 wt Allele</New_Terms>
            </Change>
            <Change id="335">
               <Axiom>CHRNB4 wt Allele SubClassOf Gene_In_Chromosomal_Location some 15q24</Axiom>
               <New_Terms>CHRNB4 wt Allele</New_Terms>
            </Change>
            <Change id="336">
               <Axiom>Calcifediol Anhydrous SubClassOf Vitamin D Analog</Axiom>
               <New_Terms>Calcifediol Anhydrous</New_Terms>
            </Change>
            <Change id="337">
               <Axiom>Calcitonin, Human SubClassOf Thyroid Agent</Axiom>
               <New_Terms>Calcitonin, Human</New_Terms>
            </Change>
            <Change id="338">
               <Axiom>Calcium Ascorbate SubClassOf Vitamin, Other</Axiom>
               <New_Terms>Calcium Ascorbate</New_Terms>
            </Change>
            <Change id="339">
               <Axiom>Calcium Bromide SubClassOf Industrial Product</Axiom>
               <New_Terms>Calcium Bromide</New_Terms>
            </Change>
            <Change id="340">
               <Axiom>Calcium Cyclamate SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Calcium Cyclamate</New_Terms>
            </Change>
            <Change id="341">
               <Axiom>Calcium Hydroxide SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Calcium Hydroxide</New_Terms>
            </Change>
            <Change id="342">
               <Axiom>Calcium Hypophosphite SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Calcium Hypophosphite</New_Terms>
            </Change>
            <Change id="343">
               <Axiom>Calcium Lactate SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Calcium Lactate</New_Terms>
            </Change>
            <Change id="344">
               <Axiom>Calcium Lactobionate SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Calcium Lactobionate</New_Terms>
            </Change>
            <Change id="345">
               <Axiom>Calcium Lactophosphate SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Calcium Lactophosphate</New_Terms>
            </Change>
            <Change id="346">
               <Axiom>Calcium Levulinate SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Calcium Levulinate</New_Terms>
            </Change>
            <Change id="347">
               <Axiom>Calcium Mandelate SubClassOf Urinary Anti-Infective Agent</Axiom>
               <New_Terms>Calcium Mandelate</New_Terms>
            </Change>
            <Change id="348">
               <Axiom>Calcium Phosphate, Dibasic SubClassOf Industrial Aid</Axiom>
               <New_Terms>Calcium Phosphate, Dibasic</New_Terms>
            </Change>
            <Change id="349">
               <Axiom>Calcium Salicylate SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Calcium Salicylate</New_Terms>
            </Change>
            <Change id="350">
               <Axiom>Calcium Stearate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Calcium Stearate</New_Terms>
            </Change>
            <Change id="351">
               <Axiom>Caldaret SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Caldaret</New_Terms>
            </Change>
            <Change id="352">
               <Axiom>Calomel SubClassOf Pesticide</Axiom>
               <New_Terms>Calomel</New_Terms>
            </Change>
            <Change id="353">
               <Axiom>Camiverine SubClassOf Anticholinergic Agent</Axiom>
               <New_Terms>Camiverine</New_Terms>
            </Change>
            <Change id="354">
               <Axiom>Canadian Cardiovascular Society Grading Scale Class I SubClassOf Canadian Cardiovascular Society Grading Scale Class</Axiom>
               <New_Terms>Canadian Cardiovascular Society Grading Scale Class I</New_Terms>
            </Change>
            <Change id="355">
               <Axiom>Canadian Cardiovascular Society Grading Scale Class II SubClassOf Canadian Cardiovascular Society Grading Scale Class</Axiom>
               <New_Terms>Canadian Cardiovascular Society Grading Scale Class II</New_Terms>
            </Change>
            <Change id="356">
               <Axiom>Canadian Cardiovascular Society Grading Scale Class III SubClassOf Canadian Cardiovascular Society Grading Scale Class</Axiom>
               <New_Terms>Canadian Cardiovascular Society Grading Scale Class III</New_Terms>
            </Change>
            <Change id="357">
               <Axiom>Canadian Cardiovascular Society Grading Scale Class IV SubClassOf Canadian Cardiovascular Society Grading Scale Class</Axiom>
               <New_Terms>Canadian Cardiovascular Society Grading Scale Class IV</New_Terms>
            </Change>
            <Change id="358">
               <Axiom>Candida SubClassOf Ascomycota</Axiom>
               <New_Terms>Ascomycota, Candida</New_Terms>
            </Change>
            <Change id="359">
               <Axiom>Candida albicans SubClassOf Candida</Axiom>
               <New_Terms>Candida, Candida albicans</New_Terms>
            </Change>
            <Change id="360">
               <Axiom>Candida glabrata SubClassOf Candida</Axiom>
               <New_Terms>Candida glabrata, Candida</New_Terms>
            </Change>
            <Change id="361">
               <Axiom>Candida parapsilosis SubClassOf Candida</Axiom>
               <New_Terms>Candida, Candida parapsilosis</New_Terms>
            </Change>
            <Change id="362">
               <Axiom>Candida tropicalis SubClassOf Candida</Axiom>
               <New_Terms>Candida, Candida tropicalis</New_Terms>
            </Change>
            <Change id="363">
               <Axiom>Candocuronium Iodide SubClassOf Nicotinic Antagonist</Axiom>
               <New_Terms>Candocuronium Iodide</New_Terms>
            </Change>
            <Change id="364">
               <Axiom>Candoxatrilat SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Candoxatrilat</New_Terms>
            </Change>
            <Change id="365">
               <Axiom>Canertinib SubClassOf Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor</Axiom>
               <New_Terms>Canertinib</New_Terms>
            </Change>
            <Change id="366">
               <Axiom>Cangrelor SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Cangrelor</New_Terms>
            </Change>
            <Change id="367">
               <Axiom>Cangrelor Tetrasodium SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Cangrelor Tetrasodium</New_Terms>
            </Change>
            <Change id="368">
               <Axiom>Capeserod SubClassOf Serotonin Agonist</Axiom>
               <New_Terms>Capeserod</New_Terms>
            </Change>
            <Change id="369">
               <Axiom>Captan SubClassOf Pesticide</Axiom>
               <New_Terms>Captan</New_Terms>
            </Change>
            <Change id="370">
               <Axiom>Captodiame Hydrochloride SubClassOf Anxiolytic</Axiom>
               <New_Terms>Captodiame Hydrochloride</New_Terms>
            </Change>
            <Change id="371">
               <Axiom>Carabersat SubClassOf Anticonvulsant Agent</Axiom>
               <New_Terms>Carabersat</New_Terms>
            </Change>
            <Change id="372">
               <Axiom>Caramiphen Edisylate SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Caramiphen Edisylate</New_Terms>
            </Change>
            <Change id="373">
               <Axiom>Caramiphen Hydrochloride SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Caramiphen Hydrochloride</New_Terms>
            </Change>
            <Change id="374">
               <Axiom>Carazolol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Carazolol</New_Terms>
            </Change>
            <Change id="375">
               <Axiom>Carbamide Peroxide SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Carbamide Peroxide</New_Terms>
            </Change>
            <Change id="376">
               <Axiom>Carbaril SubClassOf Antiparasitic Agent</Axiom>
               <New_Terms>Carbaril</New_Terms>
            </Change>
            <Change id="377">
               <Axiom>Carbarsone SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Carbarsone</New_Terms>
            </Change>
            <Change id="378">
               <Axiom>Carbazochrome Salicylate SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Carbazochrome Salicylate</New_Terms>
            </Change>
            <Change id="380">
               <Axiom>Carbetapentane Citrate SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Carbetapentane Citrate</New_Terms>
            </Change>
            <Change id="379">
               <Axiom>Carbetapentane SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Carbetapentane</New_Terms>
            </Change>
            <Change id="381">
               <Axiom>Carbon Black SubClassOf Industrial Aid</Axiom>
               <New_Terms>Carbon Black</New_Terms>
            </Change>
            <Change id="382">
               <Axiom>Carbon Monoxide SubClassOf Industrial Product</Axiom>
               <New_Terms>Carbon Monoxide</New_Terms>
            </Change>
            <Change id="383">
               <Axiom>Carbromal SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Carbromal</New_Terms>
            </Change>
            <Change id="384">
               <Axiom>Carbubarb SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Carbubarb</New_Terms>
            </Change>
            <Change id="385">
               <Axiom>Carburazepam SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Carburazepam</New_Terms>
            </Change>
            <Change id="386">
               <Axiom>Carebastine SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Carebastine</New_Terms>
            </Change>
            <Change id="387">
               <Axiom>Carfentanil Citrate SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Carfentanil Citrate</New_Terms>
            </Change>
            <Change id="388">
               <Axiom>Carglumic Acid SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Carglumic Acid</New_Terms>
            </Change>
            <Change id="389">
               <Axiom>Caribbean Indian SubClassOf Race</Axiom>
               <New_Terms>Caribbean Indian</New_Terms>
            </Change>
            <Change id="390">
               <Axiom>Carnidazole SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Carnidazole</New_Terms>
            </Change>
            <Change id="391">
               <Axiom>Carocainide SubClassOf Antiarrhythmic Agent</Axiom>
               <New_Terms>Carocainide</New_Terms>
            </Change>
            <Change id="392">
               <Axiom>Carprazidil SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Carprazidil</New_Terms>
            </Change>
            <Change id="393">
               <Axiom>Carpronium Chloride SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Carpronium Chloride</New_Terms>
            </Change>
            <Change id="394">
               <Axiom>Carsalam SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Carsalam</New_Terms>
            </Change>
            <Change id="395">
               <Axiom>Cartasteine SubClassOf Mucolytic Agent</Axiom>
               <New_Terms>Cartasteine</New_Terms>
            </Change>
            <Change id="396">
               <Axiom>Casokefamide SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Casokefamide</New_Terms>
            </Change>
            <Change id="397">
               <Axiom>Catramilast SubClassOf Phosphodiesterase Inhibitor</Axiom>
               <New_Terms>Catramilast</New_Terms>
            </Change>
            <Change id="398">
               <Axiom>Cebaracetam SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Cebaracetam</New_Terms>
            </Change>
            <Change id="399">
               <Axiom>Cedefingol SubClassOf Antineoplastic Agent</Axiom>
               <New_Terms>Cedefingol</New_Terms>
            </Change>
            <Change id="400">
               <Axiom>Cefprozil Anhydrous, E-Isomer SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cefprozil Anhydrous, E-Isomer</New_Terms>
            </Change>
            <Change id="401">
               <Axiom>Cefprozil, E-Isomer SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cefprozil, E-Isomer</New_Terms>
            </Change>
            <Change id="402">
               <Axiom>Cefrotil SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cefrotil</New_Terms>
            </Change>
            <Change id="403">
               <Axiom>Ceftiofur Sodium SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Ceftiofur Sodium</New_Terms>
            </Change>
            <Change id="404">
               <Axiom>Center for Epidemiologic Studies Depression Scale SubClassOf Symptom Specific Assessment Tool</Axiom>
               <New_Terms>Center for Epidemiologic Studies Depression Scale</New_Terms>
            </Change>
            <Change id="405">
               <Axiom>Cephacetrile Sodium SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cephacetrile Sodium</New_Terms>
            </Change>
            <Change id="406">
               <Axiom>Cephaloglycin Anhydrous SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cephaloglycin Anhydrous</New_Terms>
            </Change>
            <Change id="407">
               <Axiom>Cephaloridine SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cephaloridine</New_Terms>
            </Change>
            <Change id="408">
               <Axiom>Cephapirin Benzathine SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cephapirin Benzathine</New_Terms>
            </Change>
            <Change id="409">
               <Axiom>Cetalkonium Chloride SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Cetalkonium Chloride</New_Terms>
            </Change>
            <Change id="410">
               <Axiom>Cetilistat SubClassOf Gastrointestinal Lipase Inhibitor</Axiom>
               <New_Terms>Cetilistat</New_Terms>
            </Change>
            <Change id="411">
               <Axiom>Cetohexazine SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Cetohexazine</New_Terms>
            </Change>
            <Change id="412">
               <Axiom>Cetyl Palmitate SubClassOf Fatty Acid</Axiom>
               <New_Terms>Cetyl Palmitate</New_Terms>
            </Change>
            <Change id="413">
               <Axiom>Cetylpyridinium Chloride SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Cetylpyridinium Chloride</New_Terms>
            </Change>
            <Change id="414">
               <Axiom>Cevipabulin SubClassOf Tubulin Binding Agent</Axiom>
               <New_Terms>Cevipabulin</New_Terms>
            </Change>
            <Change id="415">
               <Axiom>Charcoal, Activated SubClassOf Industrial Aid</Axiom>
               <New_Terms>Charcoal, Activated</New_Terms>
            </Change>
            <Change id="416">
               <Axiom>Chinese Hamster SubClassOf Hamster</Axiom>
               <New_Terms>Chinese Hamster</New_Terms>
            </Change>
            <Change id="417">
               <Axiom>Chinese Syrian Gold Hamster SubClassOf Hamster</Axiom>
               <New_Terms>Chinese Syrian Gold Hamster</New_Terms>
            </Change>
            <Change id="418">
               <Axiom>Chinese Syrian Hamster SubClassOf Hamster</Axiom>
               <New_Terms>Chinese Syrian Hamster</New_Terms>
            </Change>
            <Change id="419">
               <Axiom>Chiniofon SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Chiniofon</New_Terms>
            </Change>
            <Change id="420">
               <Axiom>Chloral SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Chloral</New_Terms>
            </Change>
            <Change id="421">
               <Axiom>Chloramine-T SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Chloramine-T</New_Terms>
            </Change>
            <Change id="422">
               <Axiom>Chlorbenzoxamine Hydrochloride SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Chlorbenzoxamine Hydrochloride</New_Terms>
            </Change>
            <Change id="423">
               <Axiom>Chlorbetamide SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Chlorbetamide</New_Terms>
            </Change>
            <Change id="424">
               <Axiom>Chlorcyclizine Hydrochloride SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Chlorcyclizine Hydrochloride</New_Terms>
            </Change>
            <Change id="425">
               <Axiom>Chlordimorine SubClassOf Analgesic Agent</Axiom>
               <New_Terms>Chlordimorine</New_Terms>
            </Change>
            <Change id="426">
               <Axiom>Chlordimorine SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Chlordimorine</New_Terms>
            </Change>
            <Change id="427">
               <Axiom>Chlorindanol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Chlorindanol</New_Terms>
            </Change>
            <Change id="428">
               <Axiom>Chlorisondamine Chloride SubClassOf Nicotinic Antagonist</Axiom>
               <New_Terms>Chlorisondamine Chloride</New_Terms>
            </Change>
            <Change id="429">
               <Axiom>Chlormerodrin, Hg-197 SubClassOf Diagnostic Reagent</Axiom>
               <New_Terms>Chlormerodrin, Hg-197</New_Terms>
            </Change>
            <Change id="430">
               <Axiom>Chlormidazole SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Chlormidazole</New_Terms>
            </Change>
            <Change id="431">
               <Axiom>Chloroazodin SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Chloroazodin</New_Terms>
            </Change>
            <Change id="432">
               <Axiom>Chlorocresol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Chlorocresol</New_Terms>
            </Change>
            <Change id="433">
               <Axiom>Chlorophenothane SubClassOf Pesticide</Axiom>
               <New_Terms>Chlorophenothane</New_Terms>
            </Change>
            <Change id="434">
               <Axiom>Chloroquine Sulfate SubClassOf Antimalarial Agent</Axiom>
               <New_Terms>Chloroquine Sulfate</New_Terms>
            </Change>
            <Change id="435">
               <Axiom>Chloroquine Sulfate SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Chloroquine Sulfate</New_Terms>
            </Change>
            <Change id="436">
               <Axiom>Chloroserpidine SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Chloroserpidine</New_Terms>
            </Change>
            <Change id="437">
               <Axiom>Chlorothen Citrate SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Chlorothen Citrate</New_Terms>
            </Change>
            <Change id="438">
               <Axiom>Chlorothymol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Chlorothymol</New_Terms>
            </Change>
            <Change id="439">
               <Axiom>Chloroxylenol SubClassOf Industrial Product</Axiom>
               <New_Terms>Chloroxylenol</New_Terms>
            </Change>
            <Change id="440">
               <Axiom>Chlorphenesin SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Chlorphenesin</New_Terms>
            </Change>
            <Change id="441">
               <Axiom>Chlorpheniramine Polistirex SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Chlorpheniramine Polistirex</New_Terms>
            </Change>
            <Change id="442">
               <Axiom>Chlorphenoctium Amsonate SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Chlorphenoctium Amsonate</New_Terms>
            </Change>
            <Change id="443">
               <Axiom>Chlorphenoxamine Hydrochloride SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Chlorphenoxamine Hydrochloride</New_Terms>
            </Change>
            <Change id="444">
               <Axiom>Chlorproethazine Hydrochloride SubClassOf Anticholinergic Agent</Axiom>
               <New_Terms>Chlorproethazine Hydrochloride</New_Terms>
            </Change>
            <Change id="445">
               <Axiom>Chlorproguanil Hydrochloride SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Chlorproguanil Hydrochloride</New_Terms>
            </Change>
            <Change id="446">
               <Axiom>Chlorquinaldol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Chlorquinaldol</New_Terms>
            </Change>
            <Change id="447">
               <Axiom>Chlortetracycline Bisulfate SubClassOf Tetracycline Antibiotic</Axiom>
               <New_Terms>Chlortetracycline Bisulfate</New_Terms>
            </Change>
            <Change id="448">
               <Axiom>Chlorthenoxazine SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Chlorthenoxazine</New_Terms>
            </Change>
            <Change id="449">
               <Axiom>Choline Bitartrate SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Choline Bitartrate</New_Terms>
            </Change>
            <Change id="450">
               <Axiom>Choline Chloride SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Choline Chloride</New_Terms>
            </Change>
            <Change id="451">
               <Axiom>Choline Salicylate SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Choline Salicylate</New_Terms>
            </Change>
            <Change id="452">
               <Axiom>Chromocarb SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Chromocarb</New_Terms>
            </Change>
            <Change id="453">
               <Axiom>Chymotrypsin SubClassOf Biological Agent</Axiom>
               <New_Terms>Chymotrypsin</New_Terms>
            </Change>
            <Change id="454">
               <Axiom>Cianergoline SubClassOf Dopamine Agonist</Axiom>
               <New_Terms>Cianergoline</New_Terms>
            </Change>
            <Change id="455">
               <Axiom>Ciapilome SubClassOf Uricosuric Agent</Axiom>
               <New_Terms>Ciapilome</New_Terms>
            </Change>
            <Change id="456">
               <Axiom>Ciclafrine Hydrochloride SubClassOf Adrenergic Agent</Axiom>
               <New_Terms>Ciclafrine Hydrochloride</New_Terms>
            </Change>
            <Change id="457">
               <Axiom>Cicletanine SubClassOf Diuretic</Axiom>
               <New_Terms>Cicletanine</New_Terms>
            </Change>
            <Change id="458">
               <Axiom>Ciclosidomine SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Ciclosidomine</New_Terms>
            </Change>
            <Change id="459">
               <Axiom>Ciclotizolam SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Ciclotizolam</New_Terms>
            </Change>
            <Change id="460">
               <Axiom>Cicloxilic Acid SubClassOf Cholagogues or Choleretic Agents</Axiom>
               <New_Terms>Cicloxilic Acid</New_Terms>
            </Change>
            <Change id="461">
               <Axiom>Cicortonide SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Cicortonide</New_Terms>
            </Change>
            <Change id="462">
               <Axiom>Cidofovir Anhydrous SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Cidofovir Anhydrous</New_Terms>
            </Change>
            <Change id="463">
               <Axiom>Cifostodine SubClassOf Pyrimidine Antagonist</Axiom>
               <New_Terms>Cifostodine</New_Terms>
            </Change>
            <Change id="464">
               <Axiom>Ciheptolane SubClassOf Analgesic Agent</Axiom>
               <New_Terms>Ciheptolane</New_Terms>
            </Change>
            <Change id="465">
               <Axiom>Ciheptolane SubClassOf Antihypertensive Agent</Axiom>
               <New_Terms>Ciheptolane</New_Terms>
            </Change>
            <Change id="466">
               <Axiom>Cilansetron Hydrochloride SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Cilansetron Hydrochloride</New_Terms>
            </Change>
            <Change id="467">
               <Axiom>Cilobamine Mesylate SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Cilobamine Mesylate</New_Terms>
            </Change>
            <Change id="468">
               <Axiom>Ciltoprazine SubClassOf Muscle Relaxant</Axiom>
               <New_Terms>Ciltoprazine</New_Terms>
            </Change>
            <Change id="469">
               <Axiom>Cimemoxin SubClassOf Monoamine Oxidase Inhibitor</Axiom>
               <New_Terms>Cimemoxin</New_Terms>
            </Change>
            <Change id="470">
               <Axiom>Cimepanol SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Cimepanol</New_Terms>
            </Change>
            <Change id="471">
               <Axiom>Cimicoxib SubClassOf Cyclooxygenase Inhibitor</Axiom>
               <New_Terms>Cimicoxib</New_Terms>
            </Change>
            <Change id="472">
               <Axiom>Cinamolol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Cinamolol</New_Terms>
            </Change>
            <Change id="473">
               <Axiom>Cinaproxen SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Cinaproxen</New_Terms>
            </Change>
            <Change id="474">
               <Axiom>Cinfenine SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Cinfenine</New_Terms>
            </Change>
            <Change id="475">
               <Axiom>Cinitapride SubClassOf Serotonin Agonist</Axiom>
               <New_Terms>Cinitapride</New_Terms>
            </Change>
            <Change id="476">
               <Axiom>Cinitapride SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Cinitapride</New_Terms>
            </Change>
            <Change id="477">
               <Axiom>Cinnamaldehyde SubClassOf Industrial Aid</Axiom>
               <New_Terms>Cinnamaldehyde</New_Terms>
            </Change>
            <Change id="478">
               <Axiom>Cinnamaverine SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Cinnamaverine</New_Terms>
            </Change>
            <Change id="479">
               <Axiom>Cinnofuradione SubClassOf Analgesic Agent</Axiom>
               <New_Terms>Cinnofuradione</New_Terms>
            </Change>
            <Change id="480">
               <Axiom>Cinolazepam SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Cinolazepam</New_Terms>
            </Change>
            <Change id="481">
               <Axiom>Cinoxate SubClassOf Sunscreen</Axiom>
               <New_Terms>Cinoxate</New_Terms>
            </Change>
            <Change id="482">
               <Axiom>Cinpropazide SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Cinpropazide</New_Terms>
            </Change>
            <Change id="484">
               <Axiom>Cipralisant Maleate SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Cipralisant Maleate</New_Terms>
            </Change>
            <Change id="483">
               <Axiom>Cipralisant SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Cipralisant</New_Terms>
            </Change>
            <Change id="485">
               <Axiom>Ciprazafone SubClassOf Anticonvulsant Agent</Axiom>
               <New_Terms>Ciprazafone</New_Terms>
            </Change>
            <Change id="486">
               <Axiom>Cipropride SubClassOf Antiemetic Agent</Axiom>
               <New_Terms>Cipropride</New_Terms>
            </Change>
            <Change id="487">
               <Axiom>Ciramadol SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Ciramadol</New_Terms>
            </Change>
            <Change id="488">
               <Axiom>Cirazoline SubClassOf Alpha-Adrenergic Agonist</Axiom>
               <New_Terms>Cirazoline</New_Terms>
            </Change>
            <Change id="489">
               <Axiom>Circumanal Gland SubClassOf Apocrine Sweat Gland</Axiom>
               <New_Terms>Circumanal Gland</New_Terms>
            </Change>
            <Change id="490">
               <Axiom>Cisatracurium SubClassOf Nicotinic Antagonist</Axiom>
               <New_Terms>Cisatracurium</New_Terms>
            </Change>
            <Change id="491">
               <Axiom>Cistinexine SubClassOf Expectorant</Axiom>
               <New_Terms>Cistinexine</New_Terms>
            </Change>
            <Change id="492">
               <Axiom>Cistinexine SubClassOf Mucolytic Agent</Axiom>
               <New_Terms>Cistinexine</New_Terms>
            </Change>
            <Change id="493">
               <Axiom>Citatepine SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Citatepine</New_Terms>
            </Change>
            <Change id="494">
               <Axiom>Citiolone SubClassOf Expectorant</Axiom>
               <New_Terms>Citiolone</New_Terms>
            </Change>
            <Change id="495">
               <Axiom>Citiolone SubClassOf Hepatoprotective Agent</Axiom>
               <New_Terms>Citiolone</New_Terms>
            </Change>
            <Change id="496">
               <Axiom>Cizolirtine SubClassOf Analgesic Agent</Axiom>
               <New_Terms>Cizolirtine</New_Terms>
            </Change>
            <Change id="497">
               <Axiom>Clamikalant SubClassOf Antiarrhythmic Agent</Axiom>
               <New_Terms>Clamikalant</New_Terms>
            </Change>
            <Change id="499">
               <Axiom>Clamoxyquin Hydrochloride SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Clamoxyquin Hydrochloride</New_Terms>
            </Change>
            <Change id="498">
               <Axiom>Clamoxyquin SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Clamoxyquin</New_Terms>
            </Change>
            <Change id="500">
               <Axiom>Clanfenur SubClassOf Antineoplastic Agent</Axiom>
               <New_Terms>Clanfenur</New_Terms>
            </Change>
            <Change id="501">
               <Axiom>Clanobutin SubClassOf Cholagogues or Choleretic Agents</Axiom>
               <New_Terms>Clanobutin</New_Terms>
            </Change>
            <Change id="502">
               <Axiom>Clantifen SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Clantifen</New_Terms>
            </Change>
            <Change id="503">
               <Axiom>Clavispora lusitaniae SubClassOf Candida</Axiom>
               <New_Terms>Clavispora lusitaniae, Candida</New_Terms>
            </Change>
            <Change id="504">
               <Axiom>Clazolimine SubClassOf Diuretic</Axiom>
               <New_Terms>Clazolimine</New_Terms>
            </Change>
            <Change id="505">
               <Axiom>Clefamide SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Clefamide</New_Terms>
            </Change>
            <Change id="506">
               <Axiom>Clenpirin SubClassOf Pesticide</Axiom>
               <New_Terms>Clenpirin</New_Terms>
            </Change>
            <Change id="507">
               <Axiom>Clibucaine SubClassOf Anesthetic Agent</Axiom>
               <New_Terms>Clibucaine</New_Terms>
            </Change>
            <Change id="508">
               <Axiom>Clidanac SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Clidanac</New_Terms>
            </Change>
            <Change id="509">
               <Axiom>Climazolam SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Climazolam</New_Terms>
            </Change>
            <Change id="510">
               <Axiom>Climbazole SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Climbazole</New_Terms>
            </Change>
            <Change id="511">
               <Axiom>Climiqualine SubClassOf Antilipidemic Agent</Axiom>
               <New_Terms>Climiqualine</New_Terms>
            </Change>
            <Change id="512">
               <Axiom>Clinical Test Result SubClassOf Finding</Axiom>
               <New_Terms>Clinical Test Result</New_Terms>
            </Change>
            <Change id="513">
               <Axiom>Clinofibrate SubClassOf Antilipidemic Agent</Axiom>
               <New_Terms>Clinofibrate</New_Terms>
            </Change>
            <Change id="514">
               <Axiom>Clinolamide SubClassOf Antilipidemic Agent</Axiom>
               <New_Terms>Clinolamide</New_Terms>
            </Change>
            <Change id="515">
               <Axiom>Cliprofen SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Cliprofen</New_Terms>
            </Change>
            <Change id="516">
               <Axiom>Cliropamine SubClassOf Dopamine Agonist</Axiom>
               <New_Terms>Cliropamine</New_Terms>
            </Change>
            <Change id="517">
               <Axiom>Clitoral Gland SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Clitoral Gland</New_Terms>
            </Change>
            <Change id="518">
               <Axiom>Clobenoside SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Clobenoside</New_Terms>
            </Change>
            <Change id="519">
               <Axiom>Clobenzepam SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Clobenzepam</New_Terms>
            </Change>
            <Change id="520">
               <Axiom>Clobenzorex SubClassOf Anorexiant</Axiom>
               <New_Terms>Clobenzorex</New_Terms>
            </Change>
            <Change id="522">
               <Axiom>Clobetasone Butyrate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Clobetasone Butyrate</New_Terms>
            </Change>
            <Change id="521">
               <Axiom>Clobetasone SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Clobetasone</New_Terms>
            </Change>
            <Change id="523">
               <Axiom>Clobutinol SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Clobutinol</New_Terms>
            </Change>
            <Change id="524">
               <Axiom>Clobuzarit SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Clobuzarit</New_Terms>
            </Change>
            <Change id="525">
               <Axiom>Clocapramine SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Clocapramine</New_Terms>
            </Change>
            <Change id="526">
               <Axiom>Clociguanil SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Clociguanil</New_Terms>
            </Change>
            <Change id="527">
               <Axiom>Clocinizine SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Clocinizine</New_Terms>
            </Change>
            <Change id="528">
               <Axiom>Clocortolone Acetate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Clocortolone Acetate</New_Terms>
            </Change>
            <Change id="529">
               <Axiom>Clocoumarol SubClassOf Anticoagulant Agent</Axiom>
               <New_Terms>Clocoumarol</New_Terms>
            </Change>
            <Change id="530">
               <Axiom>Clodacaine SubClassOf Anesthetic Agent</Axiom>
               <New_Terms>Clodacaine</New_Terms>
            </Change>
            <Change id="532">
               <Axiom>Clodazon Hydrochloride SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Clodazon Hydrochloride</New_Terms>
            </Change>
            <Change id="531">
               <Axiom>Clodazon SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Clodazon</New_Terms>
            </Change>
            <Change id="533">
               <Axiom>Clodoxopone SubClassOf Antilipidemic Agent</Axiom>
               <New_Terms>Clodoxopone</New_Terms>
            </Change>
            <Change id="534">
               <Axiom>Clofenamide SubClassOf Diuretic</Axiom>
               <New_Terms>Clofenamide</New_Terms>
            </Change>
            <Change id="535">
               <Axiom>Clofenciclan SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Clofenciclan</New_Terms>
            </Change>
            <Change id="537">
               <Axiom>Clofenetamine Hydrochloride SubClassOf Anticholinergic Agent</Axiom>
               <New_Terms>Clofenetamine Hydrochloride</New_Terms>
            </Change>
            <Change id="536">
               <Axiom>Clofenetamine SubClassOf Anticholinergic Agent</Axiom>
               <New_Terms>Clofenetamine</New_Terms>
            </Change>
            <Change id="538">
               <Axiom>Clofenoxyde SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Clofenoxyde</New_Terms>
            </Change>
            <Change id="539">
               <Axiom>Clofeverine SubClassOf Anticholinergic Agent</Axiom>
               <New_Terms>Clofeverine</New_Terms>
            </Change>
            <Change id="540">
               <Axiom>Clofexamide SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Clofexamide</New_Terms>
            </Change>
            <Change id="541">
               <Axiom>Clofezone SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Clofezone</New_Terms>
            </Change>
            <Change id="542">
               <Axiom>Clofibride SubClassOf Antilipidemic Agent</Axiom>
               <New_Terms>Clofibride</New_Terms>
            </Change>
            <Change id="543">
               <Axiom>Clofoctol SubClassOf Anti-Infective Agent</Axiom>
               <New_Terms>Clofoctol</New_Terms>
            </Change>
            <Change id="544">
               <Axiom>Clofurac SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Clofurac</New_Terms>
            </Change>
            <Change id="545">
               <Axiom>Clometacin SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Clometacin</New_Terms>
            </Change>
            <Change id="546">
               <Axiom>Clomoxir SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Clomoxir</New_Terms>
            </Change>
            <Change id="547">
               <Axiom>Clonazoline SubClassOf Alpha-Adrenergic Agonist</Axiom>
               <New_Terms>Clonazoline</New_Terms>
            </Change>
            <Change id="548">
               <Axiom>Clonitazene SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Clonitazene</New_Terms>
            </Change>
            <Change id="549">
               <Axiom>Cloperastine SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Cloperastine</New_Terms>
            </Change>
            <Change id="550">
               <Axiom>Clopidol SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Clopidol</New_Terms>
            </Change>
            <Change id="551">
               <Axiom>Clopimozide SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Clopimozide</New_Terms>
            </Change>
            <Change id="552">
               <Axiom>Cloprostenol Sodium SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Cloprostenol Sodium</New_Terms>
            </Change>
            <Change id="553">
               <Axiom>Cloprothiazole SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Cloprothiazole</New_Terms>
            </Change>
            <Change id="554">
               <Axiom>Clorazepate Monopotassium SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Clorazepate Monopotassium</New_Terms>
            </Change>
            <Change id="555">
               <Axiom>Clorgiline SubClassOf Monoamine Oxidase Inhibitor</Axiom>
               <New_Terms>Clorgiline</New_Terms>
            </Change>
            <Change id="556">
               <Axiom>Cloricromen SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Cloricromen</New_Terms>
            </Change>
            <Change id="557">
               <Axiom>Clorindanic Acid SubClassOf Cholagogues or Choleretic Agents</Axiom>
               <New_Terms>Clorindanic Acid</New_Terms>
            </Change>
            <Change id="558">
               <Axiom>Clormecaine SubClassOf Anesthetic Agent</Axiom>
               <New_Terms>Clormecaine</New_Terms>
            </Change>
            <Change id="559">
               <Axiom>Cloroqualone SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Cloroqualone</New_Terms>
            </Change>
            <Change id="560">
               <Axiom>Clorotepine SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Clorotepine</New_Terms>
            </Change>
            <Change id="561">
               <Axiom>Clostebol SubClassOf Anabolic Steroid</Axiom>
               <New_Terms>Clostebol</New_Terms>
            </Change>
            <Change id="562">
               <Axiom>Clostridium tetani Toxoid Antigen, A SubClassOf Clostridium Tetani Antigen</Axiom>
               <New_Terms>Clostridium tetani Toxoid Antigen, A</New_Terms>
            </Change>
            <Change id="563">
               <Axiom>Clostridium tetani Toxoid Antigen, B SubClassOf Clostridium Tetani Antigen</Axiom>
               <New_Terms>Clostridium tetani Toxoid Antigen, B</New_Terms>
            </Change>
            <Change id="564">
               <Axiom>Clostridium tetani Toxoid Antigen, C SubClassOf Clostridium Tetani Antigen</Axiom>
               <New_Terms>Clostridium tetani Toxoid Antigen, C</New_Terms>
            </Change>
            <Change id="565">
               <Axiom>Clotioxone SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Clotioxone</New_Terms>
            </Change>
            <Change id="566">
               <Axiom>Clovoxamine SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Clovoxamine</New_Terms>
            </Change>
            <Change id="567">
               <Axiom>Cloxacepride SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Cloxacepride</New_Terms>
            </Change>
            <Change id="568">
               <Axiom>Cloxacillin Benzathine SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Cloxacillin Benzathine</New_Terms>
            </Change>
            <Change id="569">
               <Axiom>Cloximate SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Cloximate</New_Terms>
            </Change>
            <Change id="570">
               <Axiom>Cloxypendyl SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Cloxypendyl</New_Terms>
            </Change>
            <Change id="571">
               <Axiom>Coagulating Gland SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Coagulating Gland</New_Terms>
            </Change>
            <Change id="572">
               <Axiom>Cobalt Chloride SubClassOf Industrial Aid</Axiom>
               <New_Terms>Cobalt Chloride</New_Terms>
            </Change>
            <Change id="573">
               <Axiom>Cobiprostone SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Cobiprostone</New_Terms>
            </Change>
            <Change id="574">
               <Axiom>Codeine Polistirex SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Codeine Polistirex</New_Terms>
            </Change>
            <Change id="575">
               <Axiom>Colesevelam SubClassOf Antilipidemic Agent</Axiom>
               <New_Terms>Colesevelam</New_Terms>
            </Change>
            <Change id="576">
               <Axiom>Colfenamate SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Colfenamate</New_Terms>
            </Change>
            <Change id="577">
               <Axiom>Coluracetam SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Coluracetam</New_Terms>
            </Change>
            <Change id="578">
               <Axiom>Cortisuzol SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Cortisuzol</New_Terms>
            </Change>
            <Change id="579">
               <Axiom>Corynebacterium diphtheriae Toxoid Antigen, A SubClassOf Corynebacterium Diphtheriae Antigen</Axiom>
               <New_Terms>Corynebacterium diphtheriae Toxoid Antigen, A</New_Terms>
            </Change>
            <Change id="580">
               <Axiom>Corynebacterium diphtheriae Toxoid Antigen, B SubClassOf Corynebacterium Diphtheriae Antigen</Axiom>
               <New_Terms>Corynebacterium diphtheriae Toxoid Antigen, B</New_Terms>
            </Change>
            <Change id="581">
               <Axiom>Corynebacterium diphtheriae Toxoid Antigen, C SubClassOf Corynebacterium Diphtheriae Antigen</Axiom>
               <New_Terms>Corynebacterium diphtheriae Toxoid Antigen, C</New_Terms>
            </Change>
            <Change id="582">
               <Axiom>Cotriptyline SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Cotriptyline</New_Terms>
            </Change>
            <Change id="583">
               <Axiom>Cotton Rat SubClassOf Rat</Axiom>
               <New_Terms>Cotton Rat</New_Terms>
            </Change>
            <Change id="584">
               <Axiom>Coumaphos SubClassOf Pesticide</Axiom>
               <New_Terms>Coumaphos</New_Terms>
            </Change>
            <Change id="585">
               <Axiom>Coumetarol SubClassOf Anticoagulant Agent</Axiom>
               <New_Terms>Coumetarol</New_Terms>
            </Change>
            <Change id="586">
               <Axiom>Cranial Cavity SubClassOf Body Cavity</Axiom>
               <New_Terms>Cranial Cavity</New_Terms>
            </Change>
            <Change id="587">
               <Axiom>Creatinolfosfate SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Creatinolfosfate</New_Terms>
            </Change>
            <Change id="588">
               <Axiom>Cresotamide SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Cresotamide</New_Terms>
            </Change>
            <Change id="589">
               <Axiom>Cridanimod SubClassOf Biological Response Modifier</Axiom>
               <New_Terms>Cridanimod</New_Terms>
            </Change>
            <Change id="590">
               <Axiom>Croconazole SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Croconazole</New_Terms>
            </Change>
            <Change id="591">
               <Axiom>Cromoglicate Lisetil SubClassOf Mast Cell Stabilizer</Axiom>
               <New_Terms>Cromoglicate Lisetil</New_Terms>
            </Change>
            <Change id="592">
               <Axiom>Crying SubClassOf Action</Axiom>
               <New_Terms>Crying</New_Terms>
            </Change>
            <Change id="593">
               <Axiom>Cryptococcus SubClassOf Basidiomycota</Axiom>
               <New_Terms>Basidiomycota, Cryptococcus</New_Terms>
            </Change>
            <Change id="594">
               <Axiom>Cryptosporidium SubClassOf Protista</Axiom>
               <New_Terms>Cryptosporidium, Protista</New_Terms>
            </Change>
            <Change id="595">
               <Axiom>Cyanamide SubClassOf Industrial Product</Axiom>
               <New_Terms>Cyanamide</New_Terms>
            </Change>
            <Change id="596">
               <Axiom>Cyclamic Acid SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Cyclamic Acid</New_Terms>
            </Change>
            <Change id="597">
               <Axiom>Cyclandelate SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Cyclandelate</New_Terms>
            </Change>
            <Change id="598">
               <Axiom>Cyclarbamate SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Cyclarbamate</New_Terms>
            </Change>
            <Change id="599">
               <Axiom>Cyclexanone SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Cyclexanone</New_Terms>
            </Change>
            <Change id="600">
               <Axiom>Cyclizine Hydrochloride SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Cyclizine Hydrochloride</New_Terms>
            </Change>
            <Change id="601">
               <Axiom>Cyclobendazole SubClassOf Antihelminthic Agent</Axiom>
               <New_Terms>Cyclobendazole</New_Terms>
            </Change>
            <Change id="602">
               <Axiom>Cyclofenil SubClassOf Antiestrogen</Axiom>
               <New_Terms>Cyclofenil</New_Terms>
            </Change>
            <Change id="603">
               <Axiom>Cyclopregnol SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Cyclopregnol</New_Terms>
            </Change>
            <Change id="604">
               <Axiom>Cyhalothrin SubClassOf Pesticide</Axiom>
               <New_Terms>Cyhalothrin</New_Terms>
            </Change>
            <Change id="605">
               <Axiom>Cynomolgus Maritius Monkey SubClassOf Macaque</Axiom>
               <New_Terms>Cynomolgus Maritius Monkey</New_Terms>
            </Change>
            <Change id="606">
               <Axiom>Cypermethrin SubClassOf Pesticide</Axiom>
               <New_Terms>Cypermethrin</New_Terms>
            </Change>
            <Change id="607">
               <Axiom>Cyprazepam SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Cyprazepam</New_Terms>
            </Change>
            <Change id="608">
               <Axiom>Cyprodenate SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Cyprodenate</New_Terms>
            </Change>
            <Change id="609">
               <Axiom>Cyromazine SubClassOf Pesticide</Axiom>
               <New_Terms>Cyromazine</New_Terms>
            </Change>
            <Change id="610">
               <Axiom>Cysteine Hydrochloride Anhydrous SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Cysteine Hydrochloride Anhydrous</New_Terms>
            </Change>
            <Change id="611">
               <Axiom>Cythioate SubClassOf Antiparasitic Agent</Axiom>
               <New_Terms>Cythioate</New_Terms>
            </Change>
            <Change id="616">
               <Axiom>D&amp;C Red No. 9 SubClassOf Dye</Axiom>
               <New_Terms>D&amp;C Red No. 9</New_Terms>
            </Change>
            <Change id="612">
               <Axiom>D-Arginine SubClassOf Amino Acid</Axiom>
               <New_Terms>D-Arginine</New_Terms>
            </Change>
            <Change id="613">
               <Axiom>D-Camphorsulfonic Acid SubClassOf Sunscreen</Axiom>
               <New_Terms>D-Camphorsulfonic Acid</New_Terms>
            </Change>
            <Change id="614">
               <Axiom>DL-Arginine SubClassOf Amino Acid</Axiom>
               <New_Terms>DL-Arginine</New_Terms>
            </Change>
            <Change id="761">
               <Axiom>DL-Methylephedrine Hydrochloride SubClassOf Adrenergic Agent</Axiom>
               <New_Terms>DL-Methylephedrine Hydrochloride</New_Terms>
            </Change>
            <Change id="615">
               <Axiom>DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015 SubClassOf Monoclonal Antibody</Axiom>
               <New_Terms>DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015</New_Terms>
            </Change>
            <Change id="617">
               <Axiom>Dapagliflozin SubClassOf Anti-diabetic Agent</Axiom>
               <New_Terms>Dapagliflozin</New_Terms>
            </Change>
            <Change id="618">
               <Axiom>Darenzepine SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Darenzepine</New_Terms>
            </Change>
            <Change id="619">
               <Axiom>Darifenacin Hydrobromide SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Darifenacin Hydrobromide</New_Terms>
            </Change>
            <Change id="620">
               <Axiom>Darunavir Ethanolate SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Darunavir Ethanolate</New_Terms>
            </Change>
            <Change id="621">
               <Axiom>Dasantafil SubClassOf Phosphodiesterase Inhibitor</Axiom>
               <New_Terms>Dasantafil</New_Terms>
            </Change>
            <Change id="622">
               <Axiom>Datelliptium Chloride SubClassOf DNA Intercalating Agent</Axiom>
               <New_Terms>Datelliptium Chloride</New_Terms>
            </Change>
            <Change id="623">
               <Axiom>Day of the Week SubClassOf Temporal Qualifier</Axiom>
               <New_Terms>Day of the Week</New_Terms>
            </Change>
            <Change id="624">
               <Axiom>Dazidamine SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Dazidamine</New_Terms>
            </Change>
            <Change id="625">
               <Axiom>Deanol Aceglumate SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Deanol Aceglumate</New_Terms>
            </Change>
            <Change id="626">
               <Axiom>Deanol Acetamidobenzoate SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Deanol Acetamidobenzoate</New_Terms>
            </Change>
            <Change id="627">
               <Axiom>Deboxamet SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Deboxamet</New_Terms>
            </Change>
            <Change id="628">
               <Axiom>Debrisoquin Sulfate SubClassOf Alpha-Adrenergic Antagonist</Axiom>
               <New_Terms>Debrisoquin Sulfate</New_Terms>
            </Change>
            <Change id="629">
               <Axiom>Debropol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Debropol</New_Terms>
            </Change>
            <Change id="630">
               <Axiom>Decamethonium SubClassOf Muscle Relaxant</Axiom>
               <New_Terms>Decamethonium</New_Terms>
            </Change>
            <Change id="631">
               <Axiom>Declenperone SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Declenperone</New_Terms>
            </Change>
            <Change id="632">
               <Axiom>Decloxizine SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Decloxizine</New_Terms>
            </Change>
            <Change id="633">
               <Axiom>Decoquinate SubClassOf Quinolone Compound</Axiom>
               <New_Terms>Decoquinate</New_Terms>
            </Change>
            <Change id="635">
               <Axiom>Deditonium Bromide SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Deditonium Bromide</New_Terms>
            </Change>
            <Change id="634">
               <Axiom>Deditonium SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Deditonium</New_Terms>
            </Change>
            <Change id="636">
               <Axiom>Deferitrin SubClassOf Chelating Agent</Axiom>
               <New_Terms>Deferitrin</New_Terms>
            </Change>
            <Change id="637">
               <Axiom>Dehydrocholate Sodium SubClassOf Cholagogues or Choleretic Agents</Axiom>
               <New_Terms>Dehydrocholate Sodium</New_Terms>
            </Change>
            <Change id="638">
               <Axiom>Dehydrocholic Acid SubClassOf Cholagogues or Choleretic Agents</Axiom>
               <New_Terms>Dehydrocholic Acid</New_Terms>
            </Change>
            <Change id="639">
               <Axiom>Delfantrine SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Delfantrine</New_Terms>
            </Change>
            <Change id="640">
               <Axiom>Delmetacin SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Delmetacin</New_Terms>
            </Change>
            <Change id="641">
               <Axiom>Delmopinol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Delmopinol</New_Terms>
            </Change>
            <Change id="642">
               <Axiom>Delucemine SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Delucemine</New_Terms>
            </Change>
            <Change id="643">
               <Axiom>Dembrexine SubClassOf Mucolytic Agent</Axiom>
               <New_Terms>Dembrexine</New_Terms>
            </Change>
            <Change id="644">
               <Axiom>Demelverine SubClassOf Anticholinergic Agent</Axiom>
               <New_Terms>Demelverine</New_Terms>
            </Change>
            <Change id="645">
               <Axiom>Demexiptiline SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Demexiptiline</New_Terms>
            </Change>
            <Change id="646">
               <Axiom>Democonazole SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Democonazole</New_Terms>
            </Change>
            <Change id="647">
               <Axiom>Denagliptin SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Denagliptin</New_Terms>
            </Change>
            <Change id="648">
               <Axiom>Denatonium Benzoate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Denatonium Benzoate</New_Terms>
            </Change>
            <Change id="649">
               <Axiom>Denaverine SubClassOf Anticholinergic Agent</Axiom>
               <New_Terms>Denaverine</New_Terms>
            </Change>
            <Change id="650">
               <Axiom>Denibulin SubClassOf Tubulin Binding Agent</Axiom>
               <New_Terms>Denibulin</New_Terms>
            </Change>
            <Change id="651">
               <Axiom>Denipride SubClassOf Antiemetic Agent</Axiom>
               <New_Terms>Denipride</New_Terms>
            </Change>
            <Change id="652">
               <Axiom>Denopamine SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Denopamine</New_Terms>
            </Change>
            <Change id="653">
               <Axiom>Denotivir SubClassOf Anti-Infective Agent</Axiom>
               <New_Terms>Denotivir</New_Terms>
            </Change>
            <Change id="654">
               <Axiom>Denotivir SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Denotivir</New_Terms>
            </Change>
            <Change id="655">
               <Axiom>Denpidazone SubClassOf Muscle Relaxant</Axiom>
               <New_Terms>Denpidazone</New_Terms>
            </Change>
            <Change id="656">
               <Axiom>Denufosol SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Denufosol</New_Terms>
            </Change>
            <Change id="657">
               <Axiom>Denzimol SubClassOf Anticonvulsant Agent</Axiom>
               <New_Terms>Denzimol</New_Terms>
            </Change>
            <Change id="658">
               <Axiom>Depramine SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Depramine</New_Terms>
            </Change>
            <Change id="659">
               <Axiom>Deprodone SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Deprodone</New_Terms>
            </Change>
            <Change id="660">
               <Axiom>Dequalinium Chloride SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Dequalinium Chloride</New_Terms>
            </Change>
            <Change id="661">
               <Axiom>Deriglidole SubClassOf Alpha-Adrenergic Antagonist</Axiom>
               <New_Terms>Deriglidole</New_Terms>
            </Change>
            <Change id="662">
               <Axiom>Dersalazine SubClassOf Biological Response Modifier</Axiom>
               <New_Terms>Dersalazine</New_Terms>
            </Change>
            <Change id="663">
               <Axiom>Desmeninol SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Desmeninol</New_Terms>
            </Change>
            <Change id="664">
               <Axiom>Desmethylmoramide SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Desmethylmoramide</New_Terms>
            </Change>
            <Change id="665">
               <Axiom>Detanosal SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Detanosal</New_Terms>
            </Change>
            <Change id="666">
               <Axiom>Detiviciclovir SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Detiviciclovir</New_Terms>
            </Change>
            <Change id="667">
               <Axiom>Devapamil SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Devapamil</New_Terms>
            </Change>
            <Change id="668">
               <Axiom>Dexamethasone Acefurate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Dexamethasone Acefurate</New_Terms>
            </Change>
            <Change id="669">
               <Axiom>Dexamethasone Acetate Anhydrous SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Dexamethasone Acetate Anhydrous</New_Terms>
            </Change>
            <Change id="670">
               <Axiom>Dexamethasone Acetate Monohydrate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Dexamethasone Acetate Monohydrate</New_Terms>
            </Change>
            <Change id="671">
               <Axiom>Dexamethasone Beloxil SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Dexamethasone Beloxil</New_Terms>
            </Change>
            <Change id="672">
               <Axiom>Dexamethasone Cipecilate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Dexamethasone Cipecilate</New_Terms>
            </Change>
            <Change id="673">
               <Axiom>Dexamethasone Dipropionate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Dexamethasone Dipropionate</New_Terms>
            </Change>
            <Change id="674">
               <Axiom>Dexamethasone Isonicotinate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Dexamethasone Isonicotinate</New_Terms>
            </Change>
            <Change id="675">
               <Axiom>Dexamethasone Phosphate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Dexamethasone Phosphate</New_Terms>
            </Change>
            <Change id="676">
               <Axiom>Dexamethasone Pivalate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Dexamethasone Pivalate</New_Terms>
            </Change>
            <Change id="677">
               <Axiom>Dexamisole SubClassOf Antihelminthic Agent</Axiom>
               <New_Terms>Dexamisole</New_Terms>
            </Change>
            <Change id="678">
               <Axiom>Dexecadotril SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Dexecadotril</New_Terms>
            </Change>
            <Change id="679">
               <Axiom>Dexefaroxan SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Dexefaroxan</New_Terms>
            </Change>
            <Change id="680">
               <Axiom>Dexelvucitabine SubClassOf Reverse Transcriptase Inhibitor</Axiom>
               <New_Terms>Dexelvucitabine</New_Terms>
            </Change>
            <Change id="681">
               <Axiom>Dexetimide SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Dexetimide</New_Terms>
            </Change>
            <Change id="682">
               <Axiom>Dexetozoline SubClassOf Antihypertensive Agent</Axiom>
               <New_Terms>Dexetozoline</New_Terms>
            </Change>
            <Change id="683">
               <Axiom>Deximafen SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Deximafen</New_Terms>
            </Change>
            <Change id="684">
               <Axiom>Dexindoprofen SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Dexindoprofen</New_Terms>
            </Change>
            <Change id="685">
               <Axiom>Dexlofexidine SubClassOf Alpha-Adrenergic Agonist</Axiom>
               <New_Terms>Dexlofexidine</New_Terms>
            </Change>
            <Change id="686">
               <Axiom>Dexnafenodone SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Dexnafenodone</New_Terms>
            </Change>
            <Change id="687">
               <Axiom>Dexoxadrol Hydrochloride SubClassOf Anesthetic Agent</Axiom>
               <New_Terms>Dexoxadrol Hydrochloride</New_Terms>
            </Change>
            <Change id="689">
               <Axiom>Dexpropranolol Hydrochloride SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Dexpropranolol Hydrochloride</New_Terms>
            </Change>
            <Change id="688">
               <Axiom>Dexpropranolol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Dexpropranolol</New_Terms>
            </Change>
            <Change id="690">
               <Axiom>Dexproxibutene SubClassOf Analgesic Agent</Axiom>
               <New_Terms>Dexproxibutene</New_Terms>
            </Change>
            <Change id="691">
               <Axiom>Dextilidine SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Dextilidine</New_Terms>
            </Change>
            <Change id="692">
               <Axiom>Dextiopronin SubClassOf Uroprotective Agent</Axiom>
               <New_Terms>Dextiopronin</New_Terms>
            </Change>
            <Change id="693">
               <Axiom>Dextofisopam SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Dextofisopam</New_Terms>
            </Change>
            <Change id="694">
               <Axiom>Dextroamphetamine Phosphate SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Dextroamphetamine Phosphate</New_Terms>
            </Change>
            <Change id="695">
               <Axiom>Dextrofemine SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Dextrofemine</New_Terms>
            </Change>
            <Change id="696">
               <Axiom>Dextromoramide Tartrate SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Dextromoramide Tartrate</New_Terms>
            </Change>
            <Change id="697">
               <Axiom>Diacetamate SubClassOf Analgesic Agent</Axiom>
               <New_Terms>Diacetamate</New_Terms>
            </Change>
            <Change id="698">
               <Axiom>Diamfenetide SubClassOf Antiparasitic Agent</Axiom>
               <New_Terms>Diamfenetide</New_Terms>
            </Change>
            <Change id="699">
               <Axiom>Diampromide SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Diampromide</New_Terms>
            </Change>
            <Change id="700">
               <Axiom>Diarbarone SubClassOf Anticoagulant Agent</Axiom>
               <New_Terms>Diarbarone</New_Terms>
            </Change>
            <Change id="701">
               <Axiom>Diathymosulfone SubClassOf Sulfone Anti-Infective Agent</Axiom>
               <New_Terms>Diathymosulfone</New_Terms>
            </Change>
            <Change id="702">
               <Axiom>Dibemethine SubClassOf Analgesic Agent</Axiom>
               <New_Terms>Dibemethine</New_Terms>
            </Change>
            <Change id="703">
               <Axiom>Dibuprol SubClassOf Cholagogues or Choleretic Agents</Axiom>
               <New_Terms>Dibuprol</New_Terms>
            </Change>
            <Change id="704">
               <Axiom>Dibupyrone SubClassOf Analgesic and Antipyretic</Axiom>
               <New_Terms>Dibupyrone</New_Terms>
            </Change>
            <Change id="705">
               <Axiom>Dibusadol SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Dibusadol</New_Terms>
            </Change>
            <Change id="706">
               <Axiom>Dibutyl Phthalate SubClassOf Industrial Product</Axiom>
               <New_Terms>Dibutyl Phthalate</New_Terms>
            </Change>
            <Change id="707">
               <Axiom>Dibutyl Sebacate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Dibutyl Sebacate</New_Terms>
            </Change>
            <Change id="708">
               <Axiom>Dicarbine SubClassOf Antiarrhythmic Agent</Axiom>
               <New_Terms>Dicarbine</New_Terms>
            </Change>
            <Change id="709">
               <Axiom>Dicarbine SubClassOf Antioxidant</Axiom>
               <New_Terms>Dicarbine</New_Terms>
            </Change>
            <Change id="710">
               <Axiom>Dicarfen SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Dicarfen</New_Terms>
            </Change>
            <Change id="711">
               <Axiom>Dichlorisone SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Dichlorisone</New_Terms>
            </Change>
            <Change id="712">
               <Axiom>Dichlormezanone SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Dichlormezanone</New_Terms>
            </Change>
            <Change id="713">
               <Axiom>Dichlorobenzyl Alcohol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Dichlorobenzyl Alcohol</New_Terms>
            </Change>
            <Change id="714">
               <Axiom>Dichlorodifluoromethane SubClassOf Industrial Product</Axiom>
               <New_Terms>Dichlorodifluoromethane</New_Terms>
            </Change>
            <Change id="715">
               <Axiom>Dichlorofluoromethane SubClassOf Industrial Aid</Axiom>
               <New_Terms>Dichlorofluoromethane</New_Terms>
            </Change>
            <Change id="716">
               <Axiom>Dichlorotetrafluoroethane SubClassOf Industrial Product</Axiom>
               <New_Terms>Dichlorotetrafluoroethane</New_Terms>
            </Change>
            <Change id="717">
               <Axiom>Dichloroxylenol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Dichloroxylenol</New_Terms>
            </Change>
            <Change id="718">
               <Axiom>Dichlorvos SubClassOf Pesticide</Axiom>
               <New_Terms>Dichlorvos</New_Terms>
            </Change>
            <Change id="719">
               <Axiom>Diclazuril SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Diclazuril</New_Terms>
            </Change>
            <Change id="720">
               <Axiom>Diclofenac Epolamine SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Diclofenac Epolamine</New_Terms>
            </Change>
            <Change id="721">
               <Axiom>Diclofensine SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Diclofensine</New_Terms>
            </Change>
            <Change id="722">
               <Axiom>Diclofurime SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Diclofurime</New_Terms>
            </Change>
            <Change id="723">
               <Axiom>Diclonixin SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Diclonixin</New_Terms>
            </Change>
            <Change id="724">
               <Axiom>Dicloralurea SubClassOf Industrial Aid</Axiom>
               <New_Terms>Dicloralurea</New_Terms>
            </Change>
            <Change id="725">
               <Axiom>Didrovaltrate SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Didrovaltrate</New_Terms>
            </Change>
            <Change id="726">
               <Axiom>Diethadione SubClassOf Anticonvulsant Agent</Axiom>
               <New_Terms>Diethadione</New_Terms>
            </Change>
            <Change id="727">
               <Axiom>Diethanolamine SubClassOf Industrial Product</Axiom>
               <New_Terms>Diethanolamine</New_Terms>
            </Change>
            <Change id="728">
               <Axiom>Diethyl Phthalate SubClassOf Industrial Product</Axiom>
               <New_Terms>Diethyl Phthalate</New_Terms>
            </Change>
            <Change id="729">
               <Axiom>Diethyl Sebacate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Diethyl Sebacate</New_Terms>
            </Change>
            <Change id="730">
               <Axiom>Diethylthiambutene SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Diethylthiambutene</New_Terms>
            </Change>
            <Change id="731">
               <Axiom>Dietifen SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Dietifen</New_Terms>
            </Change>
            <Change id="732">
               <Axiom>Difebarbamate SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Difebarbamate</New_Terms>
            </Change>
            <Change id="733">
               <Axiom>Difemetorex SubClassOf Anorexiant</Axiom>
               <New_Terms>Difemetorex</New_Terms>
            </Change>
            <Change id="734">
               <Axiom>Difenamizole SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Difenamizole</New_Terms>
            </Change>
            <Change id="736">
               <Axiom>Difencloxazine Hydrochloride SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Difencloxazine Hydrochloride</New_Terms>
            </Change>
            <Change id="735">
               <Axiom>Difencloxazine SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Difencloxazine</New_Terms>
            </Change>
            <Change id="737">
               <Axiom>Difenoximide Hydrochloride SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Difenoximide Hydrochloride</New_Terms>
            </Change>
            <Change id="738">
               <Axiom>Difetarsone SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Difetarsone</New_Terms>
            </Change>
            <Change id="739">
               <Axiom>Difeterol SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Difeterol</New_Terms>
            </Change>
            <Change id="740">
               <Axiom>Difolatan SubClassOf Pesticide</Axiom>
               <New_Terms>Difolatan</New_Terms>
            </Change>
            <Change id="741">
               <Axiom>Digalloyl Trioleate SubClassOf Sunscreen</Axiom>
               <New_Terms>Digalloyl Trioleate</New_Terms>
            </Change>
            <Change id="742">
               <Axiom>Dihydroxyacetone SubClassOf Carbohydrate</Axiom>
               <New_Terms>Dihydroxyacetone</New_Terms>
            </Change>
            <Change id="743">
               <Axiom>Dihydroxyaluminum Sodium Carbonate SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Dihydroxyaluminum Sodium Carbonate</New_Terms>
            </Change>
            <Change id="744">
               <Axiom>Diisopropyl Adipate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Diisopropyl Adipate</New_Terms>
            </Change>
            <Change id="745">
               <Axiom>Dimepheptanol SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Dimepheptanol</New_Terms>
            </Change>
            <Change id="746">
               <Axiom>Dimethindene Maleate SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Dimethindene Maleate</New_Terms>
            </Change>
            <Change id="747">
               <Axiom>Dimethoxanate Hydrochloride SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Dimethoxanate Hydrochloride</New_Terms>
            </Change>
            <Change id="748">
               <Axiom>Dimethyl Phthalate SubClassOf Industrial Product</Axiom>
               <New_Terms>Dimethyl Phthalate</New_Terms>
            </Change>
            <Change id="749">
               <Axiom>Dimetridazole SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Dimetridazole</New_Terms>
            </Change>
            <Change id="750">
               <Axiom>Dioxyline Phosphate SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Dioxyline Phosphate</New_Terms>
            </Change>
            <Change id="751">
               <Axiom>Diphemanil SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Diphemanil</New_Terms>
            </Change>
            <Change id="752">
               <Axiom>Diphenidol Pamoate SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Diphenidol Pamoate</New_Terms>
            </Change>
            <Change id="753">
               <Axiom>Dipipanone Hydrochloride SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Dipipanone Hydrochloride</New_Terms>
            </Change>
            <Change id="754">
               <Axiom>Diprotrizoate Sodium SubClassOf Contrast Agent</Axiom>
               <New_Terms>Diprotrizoate Sodium</New_Terms>
            </Change>
            <Change id="755">
               <Axiom>Diprotrizoic Acid SubClassOf Contrast Agent</Axiom>
               <New_Terms>Diprotrizoic Acid</New_Terms>
            </Change>
            <Change id="756">
               <Axiom>Dirlotapide SubClassOf Anorexiant</Axiom>
               <New_Terms>Dirlotapide</New_Terms>
            </Change>
            <Change id="757">
               <Axiom>Disogluside SubClassOf Antilipidemic Agent</Axiom>
               <New_Terms>Disogluside</New_Terms>
            </Change>
            <Change id="758">
               <Axiom>Disufenton Sodium SubClassOf Antioxidant</Axiom>
               <New_Terms>Disufenton Sodium</New_Terms>
            </Change>
            <Change id="759">
               <Axiom>Ditercalinium Chloride SubClassOf DNA Intercalating Agent</Axiom>
               <New_Terms>Ditercalinium Chloride</New_Terms>
            </Change>
            <Change id="760">
               <Axiom>Ditiocade Sodium SubClassOf Industrial Product</Axiom>
               <New_Terms>Ditiocade Sodium</New_Terms>
            </Change>
            <Change id="762">
               <Axiom>Docebenone SubClassOf Lipooxygenase Inhibitor</Axiom>
               <New_Terms>Docebenone</New_Terms>
            </Change>
            <Change id="764">
               <Axiom>Docusate Potassium SubClassOf Stool Softener</Axiom>
               <New_Terms>Docusate Potassium</New_Terms>
            </Change>
            <Change id="763">
               <Axiom>Docusate SubClassOf Stool Softener</Axiom>
               <New_Terms>Docusate</New_Terms>
            </Change>
            <Change id="765">
               <Axiom>Domazoline Fumarate SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Domazoline Fumarate</New_Terms>
            </Change>
            <Change id="766">
               <Axiom>Domestic Short Hair Cat SubClassOf Felidae</Axiom>
               <New_Terms>Domestic Short Hair Cat</New_Terms>
            </Change>
            <Change id="767">
               <Axiom>Donetidine SubClassOf Histamine-2 Receptor Antagonist</Axiom>
               <New_Terms>Donetidine</New_Terms>
            </Change>
            <Change id="768">
               <Axiom>Donor Cellular Infusion SubClassOf Infusion Procedure</Axiom>
               <New_Terms>Donor Cellular Infusion</New_Terms>
            </Change>
            <Change id="769">
               <Axiom>Dopexamine Hydrochloride SubClassOf Dopamine Agonist</Axiom>
               <New_Terms>Dopexamine Hydrochloride</New_Terms>
            </Change>
            <Change id="770">
               <Axiom>Doramapimod SubClassOf Mitogen-Activated Protein Kinase Inhibitor</Axiom>
               <New_Terms>Doramapimod</New_Terms>
            </Change>
            <Change id="771">
               <Axiom>Doreptide SubClassOf Antiparkinsonian Agent</Axiom>
               <New_Terms>Doreptide</New_Terms>
            </Change>
            <Change id="772">
               <Axiom>Doretinel SubClassOf Vitamin, Other</Axiom>
               <New_Terms>Doretinel</New_Terms>
            </Change>
            <Change id="773">
               <Axiom>Dorsolateral Prostate Gland SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Dorsolateral Prostate Gland</New_Terms>
            </Change>
            <Change id="774">
               <Axiom>Dotarizine SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Dotarizine</New_Terms>
            </Change>
            <Change id="775">
               <Axiom>Dotarizine SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Dotarizine</New_Terms>
            </Change>
            <Change id="776">
               <Axiom>Dothiepin Hydrochloride SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Dothiepin Hydrochloride</New_Terms>
            </Change>
            <Change id="777">
               <Axiom>Doxycycline Anhydrous SubClassOf Tetracycline Antibiotic</Axiom>
               <New_Terms>Doxycycline Anhydrous</New_Terms>
            </Change>
            <Change id="778">
               <Axiom>Drometrizole SubClassOf Sunscreen</Axiom>
               <New_Terms>Drometrizole</New_Terms>
            </Change>
            <Change id="779">
               <Axiom>Dunkin Hartley Guinea Pig SubClassOf Guinea Pig</Axiom>
               <New_Terms>Dunkin Hartley Guinea Pig</New_Terms>
            </Change>
            <Change id="780">
               <Axiom>Duroc Pig SubClassOf Pig</Axiom>
               <New_Terms>Duroc Pig</New_Terms>
            </Change>
            <Change id="781">
               <Axiom>Dutacatib SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Dutacatib</New_Terms>
            </Change>
            <Change id="782">
               <Axiom>E3 Ubiquitin-Protein Ligase CHFR EquivalentTo E3 Ubiquitin Ligase and (Gene_Product_Encoded_By_Gene some CHFR Gene) and (Gene_Product_Has_Biochemical_Function some E3 Ubiquitin Ligase) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Has_Structural_Domain_Or_Motif some Ring Finger Domain) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Cycle Checkpoint) and (Gene_Product_Plays_Role_In_Biological_Process some Ubiquitination)</Axiom>
               <New_Terms>E3 Ubiquitin-Protein Ligase CHFR, CHFR Gene</New_Terms>
            </Change>
            <Change id="783">
               <Axiom>Eastern European SubClassOf Race</Axiom>
               <New_Terms>Eastern European</New_Terms>
            </Change>
            <Change id="784">
               <Axiom>Ebastine SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Ebastine</New_Terms>
            </Change>
            <Change id="785">
               <Axiom>Ebiratide SubClassOf Pituitary Agent</Axiom>
               <New_Terms>Ebiratide</New_Terms>
            </Change>
            <Change id="786">
               <Axiom>Ebrotidine SubClassOf Histamine-2 Receptor Antagonist</Axiom>
               <New_Terms>Ebrotidine</New_Terms>
            </Change>
            <Change id="787">
               <Axiom>Ecomustine SubClassOf Nitrosourea Compound</Axiom>
               <New_Terms>Ecomustine</New_Terms>
            </Change>
            <Change id="788">
               <Axiom>Ecopladib SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Ecopladib</New_Terms>
            </Change>
            <Change id="789">
               <Axiom>Ecraprost SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Ecraprost</New_Terms>
            </Change>
            <Change id="790">
               <Axiom>Ectylurea SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Ectylurea</New_Terms>
            </Change>
            <Change id="791">
               <Axiom>Edetate Sodium SubClassOf Chelating Agent</Axiom>
               <New_Terms>Edetate Sodium</New_Terms>
            </Change>
            <Change id="792">
               <Axiom>Edetate Tripotassium SubClassOf Chelating Agent</Axiom>
               <New_Terms>Edetate Tripotassium</New_Terms>
            </Change>
            <Change id="793">
               <Axiom>Edetate Trisodium SubClassOf Chelating Agent</Axiom>
               <New_Terms>Edetate Trisodium</New_Terms>
            </Change>
            <Change id="794">
               <Axiom>Edetol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Edetol</New_Terms>
            </Change>
            <Change id="796">
               <Axiom>Edonentan Anhydrous SubClassOf Cardiovascular Agent</Axiom>
               <New_Terms>Edonentan Anhydrous</New_Terms>
            </Change>
            <Change id="795">
               <Axiom>Edonentan SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Edonentan</New_Terms>
            </Change>
            <Change id="797">
               <Axiom>Efipladib SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Efipladib</New_Terms>
            </Change>
            <Change id="798">
               <Axiom>Efonidipine Hydrochloride SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Efonidipine Hydrochloride</New_Terms>
            </Change>
            <Change id="799">
               <Axiom>Eglumetad SubClassOf Anxiolytic</Axiom>
               <New_Terms>Eglumetad</New_Terms>
            </Change>
            <Change id="800">
               <Axiom>Elanzepine SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Elanzepine</New_Terms>
            </Change>
            <Change id="801">
               <Axiom>Elgodipine SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Elgodipine</New_Terms>
            </Change>
            <Change id="802">
               <Axiom>Eltenac SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Eltenac</New_Terms>
            </Change>
            <Change id="803">
               <Axiom>Elvitegravir SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Elvitegravir</New_Terms>
            </Change>
            <Change id="804">
               <Axiom>Emricasan SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Emricasan</New_Terms>
            </Change>
            <Change id="805">
               <Axiom>Emylcamate SubClassOf Anxiolytic</Axiom>
               <New_Terms>Emylcamate</New_Terms>
            </Change>
            <Change id="807">
               <Axiom>Endralazine Mesylate SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Endralazine Mesylate</New_Terms>
            </Change>
            <Change id="806">
               <Axiom>Endralazine SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Endralazine</New_Terms>
            </Change>
            <Change id="808">
               <Axiom>Entecavir Anhydrous SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Entecavir Anhydrous</New_Terms>
            </Change>
            <Change id="809">
               <Axiom>Enzastaurin SubClassOf Protein Kinase C Inhibitor</Axiom>
               <New_Terms>Enzastaurin</New_Terms>
            </Change>
            <Change id="810">
               <Axiom>Epervudine SubClassOf Pyrimidine Antagonist</Axiom>
               <New_Terms>Epervudine</New_Terms>
            </Change>
            <Change id="811">
               <Axiom>Epipropidine SubClassOf Antineoplastic Agent</Axiom>
               <New_Terms>Epipropidine</New_Terms>
            </Change>
            <Change id="812">
               <Axiom>Epithiazide SubClassOf Thiazide Diuretic</Axiom>
               <New_Terms>Epithiazide</New_Terms>
            </Change>
            <Change id="813">
               <Axiom>Epothilone KOS-1584 SubClassOf Tubulin Binding Agent</Axiom>
               <New_Terms>Epothilone KOS-1584</New_Terms>
            </Change>
            <Change id="815">
               <Axiom>ErbB Kinase Inhibitor AZD8931 SubClassOf Tyrosine Kinase Inhibitor</Axiom>
               <New_Terms>ErbB Kinase Inhibitor AZD8931</New_Terms>
            </Change>
            <Change id="814">
               <Axiom>ErbB-2 Inhibitor ARRY-380 SubClassOf Tyrosine Kinase Inhibitor</Axiom>
               <New_Terms>ErbB-2 Inhibitor ARRY-380</New_Terms>
            </Change>
            <Change id="816">
               <Axiom>Ergonovine Maleate SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Ergonovine Maleate</New_Terms>
            </Change>
            <Change id="817">
               <Axiom>Eribaxaban SubClassOf Anticoagulant Agent</Axiom>
               <New_Terms>Eribaxaban</New_Terms>
            </Change>
            <Change id="818">
               <Axiom>Erythromycin Ethylcarbonate SubClassOf Macrolide Antibiotic</Axiom>
               <New_Terms>Erythromycin Ethylcarbonate</New_Terms>
            </Change>
            <Change id="819">
               <Axiom>Escherichia SubClassOf Proteobacteria</Axiom>
               <New_Terms>Escherichia</New_Terms>
            </Change>
            <Change id="821">
               <Axiom>Esmirtazapine Maleate SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Esmirtazapine Maleate</New_Terms>
            </Change>
            <Change id="820">
               <Axiom>Esmirtazapine SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Esmirtazapine</New_Terms>
            </Change>
            <Change id="822">
               <Axiom>Estradiol Enanthate SubClassOf Therapeutic Estrogen</Axiom>
               <New_Terms>Estradiol Enanthate</New_Terms>
            </Change>
            <Change id="823">
               <Axiom>Etafedrine SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Etafedrine</New_Terms>
            </Change>
            <Change id="824">
               <Axiom>Eterobarb SubClassOf Barbiturate</Axiom>
               <New_Terms>Eterobarb</New_Terms>
            </Change>
            <Change id="825">
               <Axiom>Ethamivan SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Ethamivan</New_Terms>
            </Change>
            <Change id="826">
               <Axiom>Ethisterone SubClassOf Progestin</Axiom>
               <New_Terms>Ethisterone</New_Terms>
            </Change>
            <Change id="828">
               <Axiom>Ethoheptazine Citrate SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Ethoheptazine Citrate</New_Terms>
            </Change>
            <Change id="827">
               <Axiom>Ethoheptazine SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Ethoheptazine</New_Terms>
            </Change>
            <Change id="829">
               <Axiom>Ethohexadiol SubClassOf Pesticide</Axiom>
               <New_Terms>Ethohexadiol</New_Terms>
            </Change>
            <Change id="830">
               <Axiom>Ethopabate SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Ethopabate</New_Terms>
            </Change>
            <Change id="831">
               <Axiom>Ethyl Acetate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ethyl Acetate</New_Terms>
            </Change>
            <Change id="832">
               <Axiom>Ethyl Docosahexaenoate SubClassOf Antioxidant</Axiom>
               <New_Terms>Ethyl Docosahexaenoate</New_Terms>
            </Change>
            <Change id="833">
               <Axiom>Ethyl Maltol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ethyl Maltol</New_Terms>
            </Change>
            <Change id="834">
               <Axiom>Ethyl Oleate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ethyl Oleate</New_Terms>
            </Change>
            <Change id="835">
               <Axiom>Ethyl Vanillin SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ethyl Vanillin</New_Terms>
            </Change>
            <Change id="838">
               <Axiom>Ethylene Glycol Monoethyl Ether SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ethylene Glycol Monoethyl Ether</New_Terms>
            </Change>
            <Change id="837">
               <Axiom>Ethylene Glycol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ethylene Glycol</New_Terms>
            </Change>
            <Change id="836">
               <Axiom>Ethylene SubClassOf Industrial Product</Axiom>
               <New_Terms>Ethylene</New_Terms>
            </Change>
            <Change id="839">
               <Axiom>Ethylmorphine Hydrochloride SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Ethylmorphine Hydrochloride</New_Terms>
            </Change>
            <Change id="840">
               <Axiom>Ethylnorepinephrine Hydrochloride SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Ethylnorepinephrine Hydrochloride</New_Terms>
            </Change>
            <Change id="841">
               <Axiom>Ethylparaben SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ethylparaben</New_Terms>
            </Change>
            <Change id="842">
               <Axiom>Etidocaine Hydrochloride SubClassOf Anesthetic Agent</Axiom>
               <New_Terms>Etidocaine Hydrochloride</New_Terms>
            </Change>
            <Change id="843">
               <Axiom>Etiracetam SubClassOf Anticonvulsant Agent</Axiom>
               <New_Terms>Etiracetam</New_Terms>
            </Change>
            <Change id="844">
               <Axiom>Eucalyptol SubClassOf Mucolytic Agent</Axiom>
               <New_Terms>Eucalyptol</New_Terms>
            </Change>
            <Change id="845">
               <Axiom>Exteriorization Site SubClassOf Anatomic Site</Axiom>
               <New_Terms>Exteriorization Site</New_Terms>
            </Change>
            <Change id="846">
               <Axiom>FGF Receptor Antagonist FP-1039 SubClassOf Antineoplastic Agent</Axiom>
               <New_Terms>FGF Receptor Antagonist FP-1039</New_Terms>
            </Change>
            <Change id="847">
               <Axiom>Fadolmidine Hydrochloride SubClassOf Alpha-Adrenergic Agonist</Axiom>
               <New_Terms>Fadolmidine Hydrochloride</New_Terms>
            </Change>
            <Change id="849">
               <Axiom>Famotine Hydrochloride SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Famotine Hydrochloride</New_Terms>
            </Change>
            <Change id="848">
               <Axiom>Famotine SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Famotine</New_Terms>
            </Change>
            <Change id="850">
               <Axiom>Fampridine SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Fampridine</New_Terms>
            </Change>
            <Change id="851">
               <Axiom>Fear SubClassOf Emotion</Axiom>
               <New_Terms>Fear</New_Terms>
            </Change>
            <Change id="852">
               <Axiom>Feelings SubClassOf Mental Process</Axiom>
               <New_Terms>Feelings</New_Terms>
            </Change>
            <Change id="853">
               <Axiom>Fenabutene SubClassOf Hormone Antagonist</Axiom>
               <New_Terms>Fenabutene</New_Terms>
            </Change>
            <Change id="854">
               <Axiom>Fenaftic Acid SubClassOf Cholagogues or Choleretic Agents</Axiom>
               <New_Terms>Fenaftic Acid</New_Terms>
            </Change>
            <Change id="855">
               <Axiom>Fenoctimine SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Fenoctimine</New_Terms>
            </Change>
            <Change id="856">
               <Axiom>Fenoctimine Sulfate SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Fenoctimine Sulfate</New_Terms>
            </Change>
            <Change id="857">
               <Axiom>Fenpipramide Hydrochloride SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Fenpipramide Hydrochloride</New_Terms>
            </Change>
            <Change id="858">
               <Axiom>Fenprostalene SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Fenprostalene</New_Terms>
            </Change>
            <Change id="859">
               <Axiom>Fenthion SubClassOf Pesticide</Axiom>
               <New_Terms>Fenthion</New_Terms>
            </Change>
            <Change id="860">
               <Axiom>Ferret SubClassOf Mustelidae</Axiom>
               <New_Terms>Ferret, Mustelidae</New_Terms>
            </Change>
            <Change id="861">
               <Axiom>Ferric Chloride SubClassOf Industrial Product</Axiom>
               <New_Terms>Ferric Chloride</New_Terms>
            </Change>
            <Change id="862">
               <Axiom>Ferric Hypophosphite SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ferric Hypophosphite</New_Terms>
            </Change>
            <Change id="863">
               <Axiom>Ferric Sulfate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Ferric Sulfate</New_Terms>
            </Change>
            <Change id="864">
               <Axiom>Ferrocholinate SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Ferrocholinate</New_Terms>
            </Change>
            <Change id="865">
               <Axiom>Ferrous Sulfate Anhydrous SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Ferrous Sulfate Anhydrous</New_Terms>
            </Change>
            <Change id="866">
               <Axiom>Firategrast SubClassOf Immunosuppressant</Axiom>
               <New_Terms>Firategrast</New_Terms>
            </Change>
            <Change id="867">
               <Axiom>Flindokalner SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Flindokalner</New_Terms>
            </Change>
            <Change id="868">
               <Axiom>Flumethasone 21-Acetate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Flumethasone 21-Acetate</New_Terms>
            </Change>
            <Change id="869">
               <Axiom>Flunixin Meglumine SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Flunixin Meglumine</New_Terms>
            </Change>
            <Change id="870">
               <Axiom>Flunoprost SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Flunoprost</New_Terms>
            </Change>
            <Change id="871">
               <Axiom>Fluprednidene SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Fluprednidene</New_Terms>
            </Change>
            <Change id="872">
               <Axiom>Fluprostenol SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Fluprostenol</New_Terms>
            </Change>
            <Change id="873">
               <Axiom>Flurogestone Acetate SubClassOf Progestin</Axiom>
               <New_Terms>Flurogestone Acetate</New_Terms>
            </Change>
            <Change id="874">
               <Axiom>Flurothyl SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Flurothyl</New_Terms>
            </Change>
            <Change id="875">
               <Axiom>Fluticasone Furoate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Fluticasone Furoate</New_Terms>
            </Change>
            <Change id="876">
               <Axiom>Follicle Stimulating Hormone Beta Polypeptide SubClassOf Pituitary Agent</Axiom>
               <New_Terms>Follicle Stimulating Hormone Beta Polypeptide</New_Terms>
            </Change>
            <Change id="877">
               <Axiom>Foot/Footpad SubClassOf Tissue Sample</Axiom>
               <New_Terms>Foot/Footpad</New_Terms>
            </Change>
            <Change id="878">
               <Axiom>Forestomach SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Forestomach</New_Terms>
            </Change>
            <Change id="879">
               <Axiom>Fosfonet Sodium SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Fosfonet Sodium</New_Terms>
            </Change>
            <Change id="880">
               <Axiom>Fospropofol SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Fospropofol</New_Terms>
            </Change>
            <Change id="881">
               <Axiom>Frakefamide SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Frakefamide</New_Terms>
            </Change>
            <Change id="882">
               <Axiom>Friendly SubClassOf General Qualifier</Axiom>
               <New_Terms>Friendly</New_Terms>
            </Change>
            <Change id="883">
               <Axiom>Furbucillin SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Furbucillin</New_Terms>
            </Change>
            <Change id="884">
               <Axiom>Fusarium SubClassOf Ascomycota</Axiom>
               <New_Terms>Fusarium, Ascomycota</New_Terms>
            </Change>
            <Change id="885">
               <Axiom>Gabexate SubClassOf Serine Proteinase Inhibitor</Axiom>
               <New_Terms>Gabexate</New_Terms>
            </Change>
            <Change id="886">
               <Axiom>Gacyclidine SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Gacyclidine</New_Terms>
            </Change>
            <Change id="887">
               <Axiom>Gadobenate Dimeglumine SubClassOf Contrast Agent</Axiom>
               <New_Terms>Gadobenate Dimeglumine</New_Terms>
            </Change>
            <Change id="888">
               <Axiom>Gadopenamide SubClassOf Contrast Agent</Axiom>
               <New_Terms>Gadopenamide</New_Terms>
            </Change>
            <Change id="889">
               <Axiom>Gadoxetate Disodium SubClassOf Contrast Agent</Axiom>
               <New_Terms>Gadoxetate Disodium</New_Terms>
            </Change>
            <Change id="890">
               <Axiom>Gadoxetic Acid SubClassOf Contrast Agent</Axiom>
               <New_Terms>Gadoxetic Acid</New_Terms>
            </Change>
            <Change id="891">
               <Axiom>Galamustine SubClassOf Nitrosourea Compound</Axiom>
               <New_Terms>Galamustine</New_Terms>
            </Change>
            <Change id="892">
               <Axiom>Gallium Cation SubClassOf Industrial Aid</Axiom>
               <New_Terms>Gallium Cation</New_Terms>
            </Change>
            <Change id="893">
               <Axiom>Ganirelix SubClassOf Gonadotropin Releasing Hormone Antagonist</Axiom>
               <New_Terms>Ganirelix</New_Terms>
            </Change>
            <Change id="894">
               <Axiom>Gastric Content SubClassOf Biospecimen</Axiom>
               <New_Terms>Gastric Content</New_Terms>
            </Change>
            <Change id="895">
               <Axiom>Gentisic Acid SubClassOf Industrial Aid</Axiom>
               <New_Terms>Gentisic Acid</New_Terms>
            </Change>
            <Change id="896">
               <Axiom>Gerbil SubClassOf Rodent</Axiom>
               <New_Terms>Gerbil</New_Terms>
            </Change>
            <Change id="897">
               <Axiom>Giardia SubClassOf Protozoa</Axiom>
               <New_Terms>Protozoa, Giardia</New_Terms>
            </Change>
            <Change id="898">
               <Axiom>Gizzard SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Gizzard</New_Terms>
            </Change>
            <Change id="899">
               <Axiom>Gland of the Third Eyelid SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Gland of the Third Eyelid</New_Terms>
            </Change>
            <Change id="900">
               <Axiom>Glandular Stomach SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Glandular Stomach</New_Terms>
            </Change>
            <Change id="901">
               <Axiom>Glidazamide SubClassOf Anti-diabetic Agent</Axiom>
               <New_Terms>Glidazamide</New_Terms>
            </Change>
            <Change id="902">
               <Axiom>Gluceptate Sodium SubClassOf Chelating Agent</Axiom>
               <New_Terms>Gluceptate Sodium</New_Terms>
            </Change>
            <Change id="903">
               <Axiom>Glucosamine Sulfate/Chondroitin Sulfate Tablet SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Glucosamine Sulfate/Chondroitin Sulfate Tablet</New_Terms>
            </Change>
            <Change id="904">
               <Axiom>Glyceryl Distearate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Glyceryl Distearate</New_Terms>
            </Change>
            <Change id="905">
               <Axiom>Glyceryl Oleate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Glyceryl Oleate</New_Terms>
            </Change>
            <Change id="906">
               <Axiom>Glyceryl Palmitate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Glyceryl Palmitate</New_Terms>
            </Change>
            <Change id="907">
               <Axiom>Glycobiarsol SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Glycobiarsol</New_Terms>
            </Change>
            <Change id="908">
               <Axiom>Glycocholic Acid SubClassOf Steroid Compound</Axiom>
               <New_Terms>Glycocholic Acid</New_Terms>
            </Change>
            <Change id="909">
               <Axiom>Glycosylated Recombinant Human Interleukin-7 SubClassOf Recombinant Interleukin</Axiom>
               <New_Terms>Glycosylated Recombinant Human Interleukin-7</New_Terms>
            </Change>
            <Change id="910">
               <Axiom>Glycyrrhizin, Ammoniated SubClassOf Industrial Aid</Axiom>
               <New_Terms>Glycyrrhizin, Ammoniated</New_Terms>
            </Change>
            <Change id="911">
               <Axiom>Golotimod SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Golotimod</New_Terms>
            </Change>
            <Change id="912">
               <Axiom>Gottingen Pig SubClassOf Pig</Axiom>
               <New_Terms>Gottingen Pig</New_Terms>
            </Change>
            <Change id="913">
               <Axiom>Gravid Uterus SubClassOf Reproductive System Finding</Axiom>
               <New_Terms>Gravid Uterus</New_Terms>
            </Change>
            <Change id="914">
               <Axiom>Guaiacol SubClassOf Expectorant</Axiom>
               <New_Terms>Guaiacol</New_Terms>
            </Change>
            <Change id="915">
               <Axiom>Guaiacol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Guaiacol</New_Terms>
            </Change>
            <Change id="916">
               <Axiom>Guanidine SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Guanidine</New_Terms>
            </Change>
            <Change id="917">
               <Axiom>Guanoxabenz SubClassOf Alpha-Adrenergic Agonist</Axiom>
               <New_Terms>Guanoxabenz</New_Terms>
            </Change>
            <Change id="918">
               <Axiom>HDAC Inhibitor JNJ-26481585 SubClassOf ((Chemical_Or_Drug_Affects_Gene_Product some Histone Deacetylase) and (Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition) and (Chemical_Or_Drug_Has_Physiologic_Effect some Cell Cycle Inhibition) and (Chemical_Or_Drug_Has_Physiologic_Effect some Cell Differentiation Induction) and (Chemical_Or_Drug_Has_Physiologic_Effect some Chromatin Structure Alteration) and (Chemical_Or_Drug_Has_Physiologic_Effect some Gene Expression Alteration)) or ((Chemical_Or_Drug_Has_Mechanism_Of_Action some Free Radical Formation) and (Chemical_Or_Drug_Has_Physiologic_Effect some Apoptosis) and (Chemical_Or_Drug_Has_Physiologic_Effect some Mitochondrial Damage))</Axiom>
               <New_Terms>HDAC Inhibitor JNJ-26481585</New_Terms>
            </Change>
            <Change id="919">
               <Axiom>HDAC Inhibitor JNJ-26481585 SubClassOf Histone Deacetylase Inhibitor</Axiom>
               <New_Terms>HDAC Inhibitor JNJ-26481585</New_Terms>
            </Change>
            <Change id="920">
               <Axiom>HDM2 Inhibitor JNJ-26854165 SubClassOf Antineoplastic Agent</Axiom>
               <New_Terms>HDM2 Inhibitor JNJ-26854165</New_Terms>
            </Change>
            <Change id="921">
               <Axiom>HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine SubClassOf Peptide Vaccine</Axiom>
               <New_Terms>HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine</New_Terms>
            </Change>
            <Change id="923">
               <Axiom>HLA-A*0201-Restricted VEGFR1 Peptide Vaccine SubClassOf Peptide Vaccine</Axiom>
               <New_Terms>HLA-A*0201-Restricted VEGFR1 Peptide Vaccine</New_Terms>
            </Change>
            <Change id="922">
               <Axiom>HLA-A*0201-Restricted VEGFR1-VEGFR2 Multipeptide Vaccine SubClassOf Peptide Vaccine</Axiom>
               <New_Terms>HLA-A*0201-Restricted VEGFR1-VEGFR2 Multipeptide Vaccine</New_Terms>
            </Change>
            <Change id="924">
               <Axiom>HLA-A*2402-Restricted KOC1-TTK-CO16-DEPDC1-MPHOSPH1 Multipeptide Vaccine SubClassOf Peptide Vaccine</Axiom>
               <New_Terms>HLA-A*2402-Restricted KOC1-TTK-CO16-DEPDC1-MPHOSPH1 Multipeptide Vaccine</New_Terms>
            </Change>
            <Change id="925">
               <Axiom>HLA-A*2402-Restricted URLC10-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine SubClassOf Peptide Vaccine</Axiom>
               <New_Terms>HLA-A*2402-Restricted URLC10-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine</New_Terms>
            </Change>
            <Change id="926">
               <Axiom>HLA-A*2402-Restricted URLC10-TTK-KOC1 Multipeptide Vaccine SubClassOf Peptide Vaccine</Axiom>
               <New_Terms>HLA-A*2402-Restricted URLC10-TTK-KOC1 Multipeptide Vaccine</New_Terms>
            </Change>
            <Change id="927">
               <Axiom>HLA-A*2402-Restricted VEGFR1 Peptide Vaccine SubClassOf Peptide Vaccine</Axiom>
               <New_Terms>HLA-A*2402-Restricted VEGFR1 Peptide Vaccine</New_Terms>
            </Change>
            <Change id="928">
               <Axiom>HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine SubClassOf Peptide Vaccine</Axiom>
               <New_Terms>HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine</New_Terms>
            </Change>
            <Change id="929">
               <Axiom>HPV DNA Plasmids Therapeutic Vaccine VGX-3100 SubClassOf DNA Vaccine</Axiom>
               <New_Terms>HPV DNA Plasmids Therapeutic Vaccine VGX-3100</New_Terms>
            </Change>
            <Change id="930">
               <Axiom>Haemophilus influenzae Type B Polysaccharide Conjugate Antigen, A SubClassOf Haemophilus Influenzae Type B Antigen</Axiom>
               <New_Terms>Haemophilus influenzae Type B Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="931">
               <Axiom>Haemophilus influenzae Type B Polysaccharide Conjugate Antigen, B SubClassOf Haemophilus Influenzae Type B Antigen</Axiom>
               <New_Terms>Haemophilus influenzae Type B Polysaccharide Conjugate Antigen, B</New_Terms>
            </Change>
            <Change id="932">
               <Axiom>Haemophilus influenzae Type B Polysaccharide Conjugate Antigen, C SubClassOf Haemophilus Influenzae Type B Antigen</Axiom>
               <New_Terms>Haemophilus influenzae Type B Polysaccharide Conjugate Antigen, C</New_Terms>
            </Change>
            <Change id="933">
               <Axiom>Haloperidol Lactate SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Haloperidol Lactate</New_Terms>
            </Change>
            <Change id="934">
               <Axiom>Hampshire Pig SubClassOf Pig</Axiom>
               <New_Terms>Hampshire Pig</New_Terms>
            </Change>
            <Change id="935">
               <Axiom>Hanford Pig SubClassOf Pig</Axiom>
               <New_Terms>Hanford Pig</New_Terms>
            </Change>
            <Change id="936">
               <Axiom>Harderian Gland SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Harderian Gland</New_Terms>
            </Change>
            <Change id="937">
               <Axiom>Hartley Albino Hairless Guinea Pig SubClassOf Guinea Pig</Axiom>
               <New_Terms>Hartley Albino Hairless Guinea Pig</New_Terms>
            </Change>
            <Change id="938">
               <Axiom>Hartley Guinea Pig SubClassOf Guinea Pig</Axiom>
               <New_Terms>Hartley Guinea Pig</New_Terms>
            </Change>
            <Change id="939">
               <Axiom>Hepatic Lymph Node SubClassOf Lymph Node</Axiom>
               <New_Terms>Hepatic Lymph Node</New_Terms>
            </Change>
            <Change id="940">
               <Axiom>Hepatitis B Virus Surface Protein Antigen, A SubClassOf Hepatitis B Surface Antigen</Axiom>
               <New_Terms>Hepatitis B Virus Surface Protein Antigen, A</New_Terms>
            </Change>
            <Change id="941">
               <Axiom>Hepatitis B Virus Surface Protein Antigen, B SubClassOf Hepatitis B Surface Antigen</Axiom>
               <New_Terms>Hepatitis B Virus Surface Protein Antigen, B</New_Terms>
            </Change>
            <Change id="942">
               <Axiom>Heptabarbital SubClassOf Barbiturate</Axiom>
               <New_Terms>Heptabarbital</New_Terms>
            </Change>
            <Change id="943">
               <Axiom>Hexadecylamine SubClassOf Industrial Aid</Axiom>
               <New_Terms>Hexadecylamine</New_Terms>
            </Change>
            <Change id="944">
               <Axiom>Hexamethonium Chloride SubClassOf Nicotinic Antagonist</Axiom>
               <New_Terms>Hexamethonium Chloride</New_Terms>
            </Change>
            <Change id="945">
               <Axiom>Hexane SubClassOf Industrial Aid</Axiom>
               <New_Terms>Hexane</New_Terms>
            </Change>
            <Change id="946">
               <Axiom>Hexetidine SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Hexetidine</New_Terms>
            </Change>
            <Change id="947">
               <Axiom>Hexobarbital SubClassOf Barbiturate</Axiom>
               <New_Terms>Hexobarbital</New_Terms>
            </Change>
            <Change id="948">
               <Axiom>Hexocyclium SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Hexocyclium</New_Terms>
            </Change>
            <Change id="949">
               <Axiom>Hexylene Glycol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Hexylene Glycol</New_Terms>
            </Change>
            <Change id="950">
               <Axiom>Hind Limb SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Hind Limb</New_Terms>
            </Change>
            <Change id="951">
               <Axiom>Histoplasmosis SubClassOf Fungal Infection</Axiom>
               <New_Terms>Histoplasmosis</New_Terms>
            </Change>
            <Change id="952">
               <Axiom>Histrelin Acetate SubClassOf Gonadotropin-Releasing Hormone Analogue</Axiom>
               <New_Terms>Histrelin Acetate</New_Terms>
            </Change>
            <Change id="953">
               <Axiom>Hoof Wall SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Hoof Wall</New_Terms>
            </Change>
            <Change id="954">
               <Axiom>Hope SubClassOf Emotion</Axiom>
               <New_Terms>Hope</New_Terms>
            </Change>
            <Change id="955">
               <Axiom>Hsp90 Inhibitor STA-9090 SubClassOf Heat Shock Protein Inhibitor</Axiom>
               <New_Terms>Hsp90 Inhibitor STA-9090</New_Terms>
            </Change>
            <Change id="956">
               <Axiom>Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307 SubClassOf Monoclonal Antibody</Axiom>
               <New_Terms>Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307</New_Terms>
            </Change>
            <Change id="957">
               <Axiom>Human Papillomavirus Type 11 Capsid Protein Antigen, A SubClassOf Human Papillomavirus Antigen</Axiom>
               <New_Terms>Human Papillomavirus Type 11 Capsid Protein Antigen, A</New_Terms>
            </Change>
            <Change id="958">
               <Axiom>Human Papillomavirus Type 16 Capsid Protein Antigen, A SubClassOf Human Papillomavirus Antigen</Axiom>
               <New_Terms>Human Papillomavirus Type 16 Capsid Protein Antigen, A</New_Terms>
            </Change>
            <Change id="959">
               <Axiom>Human Papillomavirus Type 18 Capsid Protein Antigen, A SubClassOf Human Papillomavirus Antigen</Axiom>
               <New_Terms>Human Papillomavirus Type 18 Capsid Protein Antigen, A</New_Terms>
            </Change>
            <Change id="960">
               <Axiom>Human Papillomavirus Type 6 Capsid Protein Antigen, A SubClassOf Human Papillomavirus Antigen</Axiom>
               <New_Terms>Human Papillomavirus Type 6 Capsid Protein Antigen, A</New_Terms>
            </Change>
            <Change id="961">
               <Axiom>Hydrochloric Acid SubClassOf Industrial Aid</Axiom>
               <New_Terms>Hydrochloric Acid</New_Terms>
            </Change>
            <Change id="962">
               <Axiom>Hydrocodone Polistirex SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Hydrocodone Polistirex</New_Terms>
            </Change>
            <Change id="963">
               <Axiom>Hydrogen Cyanide SubClassOf Industrial Aid</Axiom>
               <New_Terms>Hydrogen Cyanide</New_Terms>
            </Change>
            <Change id="964">
               <Axiom>Hydroxocobalamin Acetate SubClassOf Vitamin, Other</Axiom>
               <New_Terms>Hydroxocobalamin Acetate</New_Terms>
            </Change>
            <Change id="965">
               <Axiom>Hydroxymethanesulfinic Acid SubClassOf Industrial Aid</Axiom>
               <New_Terms>Hydroxymethanesulfinic Acid</New_Terms>
            </Change>
            <Change id="966">
               <Axiom>IDH1 Gene SubClassOf Gene_Plays_Role_In_Process some Carbohydrate Metabolism</Axiom>
               <New_Terms>IDH1 Gene</New_Terms>
            </Change>
            <Change id="967">
               <Axiom>IDH1 Gene SubClassOf Oxidoreductase Gene</Axiom>
               <New_Terms>IDH1 Gene</New_Terms>
            </Change>
            <Change id="968">
               <Axiom>IDH1 wt Allele SubClassOf Gene_Associated_With_Disease some Glioblastoma</Axiom>
               <New_Terms>IDH1 wt Allele</New_Terms>
            </Change>
            <Change id="969">
               <Axiom>IDH1 wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <New_Terms>IDH1 wt Allele</New_Terms>
            </Change>
            <Change id="970">
               <Axiom>IDH1 wt Allele SubClassOf Gene_Is_Element_In_Pathway some Citrate Cycle (TCA Cycle) Pathway</Axiom>
               <New_Terms>IDH1 wt Allele</New_Terms>
            </Change>
            <Change id="971">
               <Axiom>IDH1 wt Allele SubClassOf IDH1 Gene</Axiom>
               <New_Terms>IDH1 Gene, IDH1 wt Allele</New_Terms>
            </Change>
            <Change id="972">
               <Axiom>IMT-1012 Immunotherapeutic Vaccine SubClassOf Peptide Vaccine</Axiom>
               <New_Terms>IMT-1012 Immunotherapeutic Vaccine</New_Terms>
            </Change>
            <Change id="973">
               <Axiom>ING2 Gene SubClassOf Apoptosis Regulation Gene</Axiom>
               <New_Terms>ING2 Gene</New_Terms>
            </Change>
            <Change id="974">
               <Axiom>ING2 Gene SubClassOf Gene_Associated_With_Disease some Colon Carcinoma</Axiom>
               <New_Terms>ING2 Gene</New_Terms>
            </Change>
            <Change id="975">
               <Axiom>ING2 Gene SubClassOf Gene_Plays_Role_In_Process some Histone Deacetylation</Axiom>
               <New_Terms>ING2 Gene</New_Terms>
            </Change>
            <Change id="976">
               <Axiom>ING2 Gene SubClassOf Gene_Plays_Role_In_Process some Induction of Apoptosis</Axiom>
               <New_Terms>ING2 Gene</New_Terms>
            </Change>
            <Change id="977">
               <Axiom>ING2 Gene SubClassOf Gene_Plays_Role_In_Process some Protein Acetylation</Axiom>
               <New_Terms>ING2 Gene</New_Terms>
            </Change>
            <Change id="978">
               <Axiom>ING2 Gene SubClassOf Gene_Plays_Role_In_Process some Transcriptional Regulation</Axiom>
               <New_Terms>ING2 Gene</New_Terms>
            </Change>
            <Change id="979">
               <Axiom>ING2 wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <New_Terms>ING2 wt Allele</New_Terms>
            </Change>
            <Change id="980">
               <Axiom>ING2 wt Allele SubClassOf Gene_In_Chromosomal_Location some 4q35.1</Axiom>
               <New_Terms>ING2 wt Allele</New_Terms>
            </Change>
            <Change id="981">
               <Axiom>ING2 wt Allele SubClassOf ING2 Gene</Axiom>
               <New_Terms>ING2 Gene, ING2 wt Allele</New_Terms>
            </Change>
            <Change id="982">
               <Axiom>ITGA2B Gene SubClassOf Cell Adhesion Molecule Gene</Axiom>
               <New_Terms>ITGA2B Gene</New_Terms>
            </Change>
            <Change id="983">
               <Axiom>ITGA2B Gene SubClassOf Gene_Plays_Role_In_Process some Cell Adhesion</Axiom>
               <New_Terms>ITGA2B Gene</New_Terms>
            </Change>
            <Change id="984">
               <Axiom>ITGA2B Gene SubClassOf Gene_Plays_Role_In_Process some Platelet Aggregation</Axiom>
               <New_Terms>ITGA2B Gene</New_Terms>
            </Change>
            <Change id="985">
               <Axiom>ITGA2B Gene SubClassOf Gene_Plays_Role_In_Process some Protein-Protein Interaction</Axiom>
               <New_Terms>ITGA2B Gene</New_Terms>
            </Change>
            <Change id="986">
               <Axiom>ITGA2B Gene SubClassOf Gene_Plays_Role_In_Process some Receptor Signaling</Axiom>
               <New_Terms>ITGA2B Gene</New_Terms>
            </Change>
            <Change id="987">
               <Axiom>ITGA2B Gene SubClassOf Gene_Plays_Role_In_Process some Wound Repair</Axiom>
               <New_Terms>ITGA2B Gene</New_Terms>
            </Change>
            <Change id="988">
               <Axiom>ITGA2B wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <New_Terms>ITGA2B wt Allele</New_Terms>
            </Change>
            <Change id="989">
               <Axiom>ITGA2B wt Allele SubClassOf ITGA2B Gene</Axiom>
               <New_Terms>ITGA2B wt Allele, ITGA2B Gene</New_Terms>
            </Change>
            <Change id="990">
               <Axiom>Ileocecocolic Lymph Node SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Ileocecocolic Lymph Node</New_Terms>
            </Change>
            <Change id="991">
               <Axiom>Imidocarb Hydrochloride SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Imidocarb Hydrochloride</New_Terms>
            </Change>
            <Change id="992">
               <Axiom>Implantation Site SubClassOf Anatomic Site</Axiom>
               <New_Terms>Implantation Site</New_Terms>
            </Change>
            <Change id="993">
               <Axiom>Inamrinone Lactate SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Inamrinone Lactate</New_Terms>
            </Change>
            <Change id="994">
               <Axiom>Incision Site SubClassOf Anatomic Site</Axiom>
               <New_Terms>Incision Site</New_Terms>
            </Change>
            <Change id="995">
               <Axiom>Indium In-111 Oxyquinoline SubClassOf Radiopharmaceutical Compound</Axiom>
               <New_Terms>Indium In-111 Oxyquinoline</New_Terms>
            </Change>
            <Change id="996">
               <Axiom>Indopine Hydrochloride SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Indopine Hydrochloride</New_Terms>
            </Change>
            <Change id="997">
               <Axiom>Influenza A Virus H1N1 Hemagglutinin Antigen, A SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Hemagglutinin Antigen, A</New_Terms>
            </Change>
            <Change id="998">
               <Axiom>Influenza A Virus H1N1 Hemagglutinin Antigen, B SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Hemagglutinin Antigen, B</New_Terms>
            </Change>
            <Change id="999">
               <Axiom>Influenza A Virus H1N1 Hemagglutinin Antigen, C SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Hemagglutinin Antigen, C</New_Terms>
            </Change>
            <Change id="1000">
               <Axiom>Influenza A Virus H1N1 Hemagglutinin Antigen, D SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Hemagglutinin Antigen, D</New_Terms>
            </Change>
            <Change id="1001">
               <Axiom>Influenza A Virus H1N1 Hemagglutinin Antigen, E SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Hemagglutinin Antigen, E</New_Terms>
            </Change>
            <Change id="1002">
               <Axiom>Influenza A Virus H1N1 Live Antigen, A SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Live Antigen, A</New_Terms>
            </Change>
            <Change id="1003">
               <Axiom>Influenza A Virus H1N1 Neuraminidase Antigen, A SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Neuraminidase Antigen, A</New_Terms>
            </Change>
            <Change id="1004">
               <Axiom>Influenza A Virus H1N1 Neuraminidase Antigen, B SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Neuraminidase Antigen, B</New_Terms>
            </Change>
            <Change id="1005">
               <Axiom>Influenza A Virus H1N1 Neuraminidase Antigen, C SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Neuraminidase Antigen, C</New_Terms>
            </Change>
            <Change id="1006">
               <Axiom>Influenza A Virus H1N1 Neuraminidase Antigen, D SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Neuraminidase Antigen, D</New_Terms>
            </Change>
            <Change id="1007">
               <Axiom>Influenza A Virus H1N1 Neuraminidase Antigen, E SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H1N1 Neuraminidase Antigen, E</New_Terms>
            </Change>
            <Change id="1008">
               <Axiom>Influenza A Virus H3N2 Hemagglutinin Antigen, A SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Hemagglutinin Antigen, A</New_Terms>
            </Change>
            <Change id="1009">
               <Axiom>Influenza A Virus H3N2 Hemagglutinin Antigen, B SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Hemagglutinin Antigen, B</New_Terms>
            </Change>
            <Change id="1010">
               <Axiom>Influenza A Virus H3N2 Hemagglutinin Antigen, C SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Hemagglutinin Antigen, C</New_Terms>
            </Change>
            <Change id="1011">
               <Axiom>Influenza A Virus H3N2 Hemagglutinin Antigen, D SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Hemagglutinin Antigen, D</New_Terms>
            </Change>
            <Change id="1012">
               <Axiom>Influenza A Virus H3N2 Hemagglutinin Antigen, E SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Hemagglutinin Antigen, E</New_Terms>
            </Change>
            <Change id="1013">
               <Axiom>Influenza A Virus H3N2 Live Antigen, A SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Live Antigen, A</New_Terms>
            </Change>
            <Change id="1014">
               <Axiom>Influenza A Virus H3N2 Neuraminidase Antigen, A SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Neuraminidase Antigen, A</New_Terms>
            </Change>
            <Change id="1015">
               <Axiom>Influenza A Virus H3N2 Neuraminidase Antigen, B SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Neuraminidase Antigen, B</New_Terms>
            </Change>
            <Change id="1016">
               <Axiom>Influenza A Virus H3N2 Neuraminidase Antigen, C SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Neuraminidase Antigen, C</New_Terms>
            </Change>
            <Change id="1017">
               <Axiom>Influenza A Virus H3N2 Neuraminidase Antigen, D SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Neuraminidase Antigen, D</New_Terms>
            </Change>
            <Change id="1018">
               <Axiom>Influenza A Virus H3N2 Neuraminidase Antigen, E SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H3N2 Neuraminidase Antigen, E</New_Terms>
            </Change>
            <Change id="1019">
               <Axiom>Influenza A Virus H5N1 Hemagglutinin Antigen, A SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H5N1 Hemagglutinin Antigen, A</New_Terms>
            </Change>
            <Change id="1020">
               <Axiom>Influenza A Virus H5N1 Neuraminidase Antigen, A SubClassOf Influenza A Virus Antigen</Axiom>
               <New_Terms>Influenza A Virus H5N1 Neuraminidase Antigen, A</New_Terms>
            </Change>
            <Change id="1021">
               <Axiom>Influenza B Virus Hemagglutinin Antigen, A SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Hemagglutinin Antigen, A</New_Terms>
            </Change>
            <Change id="1022">
               <Axiom>Influenza B Virus Hemagglutinin Antigen, B SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Hemagglutinin Antigen, B</New_Terms>
            </Change>
            <Change id="1023">
               <Axiom>Influenza B Virus Hemagglutinin Antigen, C SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Hemagglutinin Antigen, C</New_Terms>
            </Change>
            <Change id="1024">
               <Axiom>Influenza B Virus Hemagglutinin Antigen, D SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Hemagglutinin Antigen, D</New_Terms>
            </Change>
            <Change id="1025">
               <Axiom>Influenza B Virus Hemagglutinin Antigen, E SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Hemagglutinin Antigen, E</New_Terms>
            </Change>
            <Change id="1026">
               <Axiom>Influenza B Virus Live Antigen, A SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Live Antigen, A</New_Terms>
            </Change>
            <Change id="1027">
               <Axiom>Influenza B Virus Neuraminidase Antigen, A SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Neuraminidase Antigen, A</New_Terms>
            </Change>
            <Change id="1028">
               <Axiom>Influenza B Virus Neuraminidase Antigen, B SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Neuraminidase Antigen, B</New_Terms>
            </Change>
            <Change id="1029">
               <Axiom>Influenza B Virus Neuraminidase Antigen, C SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Neuraminidase Antigen, C</New_Terms>
            </Change>
            <Change id="1030">
               <Axiom>Influenza B Virus Neuraminidase Antigen, D SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Neuraminidase Antigen, D</New_Terms>
            </Change>
            <Change id="1031">
               <Axiom>Influenza B Virus Neuraminidase Antigen, E SubClassOf Influenza B Virus Antigen</Axiom>
               <New_Terms>Influenza B Virus Neuraminidase Antigen, E</New_Terms>
            </Change>
            <Change id="1032">
               <Axiom>Infusion Site SubClassOf Anatomic Site</Axiom>
               <New_Terms>Infusion Site</New_Terms>
            </Change>
            <Change id="1033">
               <Axiom>Inhibitor of Growth Protein 2 EquivalentTo Apoptosis Regulator and (Gene_Product_Encoded_By_Gene some ING2 Gene) and (Gene_Product_Has_Biochemical_Function some Apoptosis Promoter) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Malfunction_Associated_With_Disease some Colon Carcinoma) and (Gene_Product_Plays_Role_In_Biological_Process some Histone Deacetylation) and (Gene_Product_Plays_Role_In_Biological_Process some Induction of Apoptosis) and (Gene_Product_Plays_Role_In_Biological_Process some Protein Acetylation) and (Gene_Product_Plays_Role_In_Biological_Process some Transcriptional Regulation)</Axiom>
               <New_Terms>ING2 Gene, Inhibitor of Growth Protein 2</New_Terms>
            </Change>
            <Change id="1034">
               <Axiom>Injection Site SubClassOf Anatomic Site</Axiom>
               <New_Terms>Injection Site</New_Terms>
            </Change>
            <Change id="1035">
               <Axiom>Injury Site SubClassOf Anatomic Site</Axiom>
               <New_Terms>Injury Site</New_Terms>
            </Change>
            <Change id="1036">
               <Axiom>Integrin Alpha-IIb EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGA2B Gene) and (Gene_Product_Has_Biochemical_Function some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation) and (Gene_Product_Plays_Role_In_Biological_Process some Protein-Protein Interaction) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling) and (Gene_Product_Plays_Role_In_Biological_Process some Wound Repair)</Axiom>
               <New_Terms>ITGA2B Gene, Integrin Alpha-IIb</New_Terms>
            </Change>
            <Change id="1037">
               <Axiom>Integrin Alpha-IIb/Beta-3 SubClassOf Gene_Product_Has_Biochemical_Function some Integrin</Axiom>
               <New_Terms>Integrin Alpha-IIb/Beta-3</New_Terms>
            </Change>
            <Change id="1038">
               <Axiom>Integrin Alpha-IIb/Beta-3 SubClassOf Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion</Axiom>
               <New_Terms>Integrin Alpha-IIb/Beta-3</New_Terms>
            </Change>
            <Change id="1039">
               <Axiom>Integrin Alpha-IIb/Beta-3 SubClassOf Gene_Product_Plays_Role_In_Biological_Process some Platelet Aggregation</Axiom>
               <New_Terms>Integrin Alpha-IIb/Beta-3</New_Terms>
            </Change>
            <Change id="1040">
               <Axiom>Integrin Alpha-IIb/Beta-3 SubClassOf Gene_Product_Plays_Role_In_Biological_Process some Protein-Protein Interaction</Axiom>
               <New_Terms>Integrin Alpha-IIb/Beta-3</New_Terms>
            </Change>
            <Change id="1041">
               <Axiom>Integrin Alpha-IIb/Beta-3 SubClassOf Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling</Axiom>
               <New_Terms>Integrin Alpha-IIb/Beta-3</New_Terms>
            </Change>
            <Change id="1042">
               <Axiom>Integrin Alpha-IIb/Beta-3 SubClassOf Gene_Product_Plays_Role_In_Biological_Process some Wound Repair</Axiom>
               <New_Terms>Integrin Alpha-IIb/Beta-3</New_Terms>
            </Change>
            <Change id="1043">
               <Axiom>Integrin Alpha-IIb/Beta-3 SubClassOf Protein or Riboprotein Complex</Axiom>
               <New_Terms>Integrin Alpha-IIb/Beta-3</New_Terms>
            </Change>
            <Change id="1044">
               <Axiom>Intercostal Lymph Node SubClassOf Thoracic Lymph Node</Axiom>
               <New_Terms>Intercostal Lymph Node</New_Terms>
            </Change>
            <Change id="1045">
               <Axiom>Iodine I 123 Anti-CEA Recombinant Diabody T84.66 SubClassOf Radioimmunoconjugate</Axiom>
               <New_Terms>Iodine I 123 Anti-CEA Recombinant Diabody T84.66</New_Terms>
            </Change>
            <Change id="1046">
               <Axiom>Iodoantipyrine SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Iodoantipyrine</New_Terms>
            </Change>
            <Change id="1047">
               <Axiom>Iodofiltic Acid I 123 SubClassOf Image Enhancement Agent</Axiom>
               <New_Terms>Iodofiltic Acid I 123</New_Terms>
            </Change>
            <Change id="1048">
               <Axiom>Iodoform SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Iodoform</New_Terms>
            </Change>
            <Change id="1049">
               <Axiom>Ioseric Acid SubClassOf Contrast Agent</Axiom>
               <New_Terms>Ioseric Acid</New_Terms>
            </Change>
            <Change id="1050">
               <Axiom>Ipenoxazone SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Ipenoxazone</New_Terms>
            </Change>
            <Change id="1051">
               <Axiom>Ipodic Acid SubClassOf Contrast Agent</Axiom>
               <New_Terms>Ipodic Acid</New_Terms>
            </Change>
            <Change id="1052">
               <Axiom>Ipronidazole SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Ipronidazole</New_Terms>
            </Change>
            <Change id="1053">
               <Axiom>Iralukast SubClassOf Anti-asthmatic Agent</Axiom>
               <New_Terms>Iralukast</New_Terms>
            </Change>
            <Change id="1054">
               <Axiom>Irindalone SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Irindalone</New_Terms>
            </Change>
            <Change id="1055">
               <Axiom>Iron Dextran SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Iron Dextran</New_Terms>
            </Change>
            <Change id="1056">
               <Axiom>Irritation SubClassOf Emotion</Axiom>
               <New_Terms>Irritation</New_Terms>
            </Change>
            <Change id="1057">
               <Axiom>Isbogrel SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Isbogrel</New_Terms>
            </Change>
            <Change id="1058">
               <Axiom>Isocitrate Dehydrogenase [NADP] Cytoplasmic EquivalentTo Oxidoreductase and (Gene_Product_Encoded_By_Gene some IDH1 Gene) and (Gene_Product_Has_Biochemical_Function some Oxidoreductase) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Is_Element_In_Pathway some Citrate Cycle (TCA Cycle) Pathway) and (Gene_Product_Malfunction_Associated_With_Disease some Glioblastoma) and (Gene_Product_Plays_Role_In_Biological_Process some Carbohydrate Metabolism)</Axiom>
               <New_Terms>IDH1 Gene, Isocitrate Dehydrogenase [NADP] Cytoplasmic</New_Terms>
            </Change>
            <Change id="1060">
               <Axiom>Isoflupredone Acetate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Isoflupredone Acetate</New_Terms>
            </Change>
            <Change id="1059">
               <Axiom>Isoflupredone SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Isoflupredone</New_Terms>
            </Change>
            <Change id="1061">
               <Axiom>Isopropyl Myristate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Isopropyl Myristate</New_Terms>
            </Change>
            <Change id="1062">
               <Axiom>Isopropyl Palmitate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Isopropyl Palmitate</New_Terms>
            </Change>
            <Change id="1063">
               <Axiom>Isovaleramide SubClassOf Anxiolytic</Axiom>
               <New_Terms>Isovaleramide</New_Terms>
            </Change>
            <Change id="1064">
               <Axiom>Ispinesib Mesylate SubClassOf Mitotic Kinesin Modulator</Axiom>
               <New_Terms>Ispinesib Mesylate</New_Terms>
            </Change>
            <Change id="1065">
               <Axiom>Issatchenkia orientalis SubClassOf Candida</Axiom>
               <New_Terms>Candida, Issatchenkia orientalis</New_Terms>
            </Change>
            <Change id="1066">
               <Axiom>Joy SubClassOf Emotion</Axiom>
               <New_Terms>Joy</New_Terms>
            </Change>
            <Change id="1067">
               <Axiom>Ketotrexate SubClassOf Folate Antagonist</Axiom>
               <New_Terms>Ketotrexate</New_Terms>
            </Change>
            <Change id="1068">
               <Axiom>Killip Class I SubClassOf Killip Class</Axiom>
               <New_Terms>Killip Class I</New_Terms>
            </Change>
            <Change id="1069">
               <Axiom>Killip Class II SubClassOf Killip Class</Axiom>
               <New_Terms>Killip Class II</New_Terms>
            </Change>
            <Change id="1070">
               <Axiom>Killip Class III SubClassOf Killip Class</Axiom>
               <New_Terms>Killip Class III</New_Terms>
            </Change>
            <Change id="1071">
               <Axiom>Killip Class IV SubClassOf Killip Class</Axiom>
               <New_Terms>Killip Class IV</New_Terms>
            </Change>
            <Change id="1072">
               <Axiom>LVG Hamster SubClassOf Hamster</Axiom>
               <New_Terms>LVG Hamster</New_Terms>
            </Change>
            <Change id="1073">
               <Axiom>Lactic Acid SubClassOf Reagent</Axiom>
               <New_Terms>Lactic Acid</New_Terms>
            </Change>
            <Change id="1074">
               <Axiom>Lactitol Monohydrate SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Lactitol Monohydrate</New_Terms>
            </Change>
            <Change id="1075">
               <Axiom>Lactose Monohydrate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Lactose Monohydrate</New_Terms>
            </Change>
            <Change id="1076">
               <Axiom>Ladostigil SubClassOf Acetylcholinesterase Inhibitor</Axiom>
               <New_Terms>Ladostigil</New_Terms>
            </Change>
            <Change id="1077">
               <Axiom>Ladostigil SubClassOf Monoamine Oxidase Inhibitor</Axiom>
               <New_Terms>Ladostigil</New_Terms>
            </Change>
            <Change id="1078">
               <Axiom>Landrace Pig SubClassOf Pig</Axiom>
               <New_Terms>Landrace Pig</New_Terms>
            </Change>
            <Change id="1079">
               <Axiom>Lanicemine SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Lanicemine</New_Terms>
            </Change>
            <Change id="1081">
               <Axiom>Laquinimod Sodium SubClassOf Immunosuppressant</Axiom>
               <New_Terms>Laquinimod Sodium</New_Terms>
            </Change>
            <Change id="1080">
               <Axiom>Laquinimod SubClassOf Biological Response Modifier</Axiom>
               <New_Terms>Laquinimod</New_Terms>
            </Change>
            <Change id="1082">
               <Axiom>Lauric Diethanolamide SubClassOf Industrial Aid</Axiom>
               <New_Terms>Lauric Diethanolamide</New_Terms>
            </Change>
            <Change id="1083">
               <Axiom>Leghorn Chicken SubClassOf Chicken</Axiom>
               <New_Terms>Leghorn Chicken</New_Terms>
            </Change>
            <Change id="1084">
               <Axiom>Lenperone Hydrochloride SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Lenperone Hydrochloride</New_Terms>
            </Change>
            <Change id="1085">
               <Axiom>Lenperone Hydrochloride SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Lenperone Hydrochloride</New_Terms>
            </Change>
            <Change id="1086">
               <Axiom>Levamisole Phosphate SubClassOf Antihelminthic Agent</Axiom>
               <New_Terms>Levamisole Phosphate</New_Terms>
            </Change>
            <Change id="1087">
               <Axiom>Levamisole Phosphate SubClassOf Biological Response Modifier</Axiom>
               <New_Terms>Levamisole Phosphate</New_Terms>
            </Change>
            <Change id="1088">
               <Axiom>Levamlodipine Malate SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Levamlodipine Malate</New_Terms>
            </Change>
            <Change id="1089">
               <Axiom>Levomepromazine Hydrochloride SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Levomepromazine Hydrochloride</New_Terms>
            </Change>
            <Change id="1090">
               <Axiom>Levonorgestrel Acetate SubClassOf Progestin</Axiom>
               <New_Terms>Levonorgestrel Acetate</New_Terms>
            </Change>
            <Change id="1091">
               <Axiom>Levotofisopam SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Levotofisopam</New_Terms>
            </Change>
            <Change id="1092">
               <Axiom>Like SubClassOf Emotion</Axiom>
               <New_Terms>Like</New_Terms>
            </Change>
            <Change id="1093">
               <Axiom>Linaclotide Acetate SubClassOf Therapeutic Hormone</Axiom>
               <New_Terms>Linaclotide Acetate</New_Terms>
            </Change>
            <Change id="1094">
               <Axiom>Linarotene SubClassOf Vitamin, Other</Axiom>
               <New_Terms>Linarotene</New_Terms>
            </Change>
            <Change id="1095">
               <Axiom>Lisdexamfetamine Dimesylate SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Lisdexamfetamine Dimesylate</New_Terms>
            </Change>
            <Change id="1096">
               <Axiom>Lithium Hydroxide Anhydrous SubClassOf Industrial Aid</Axiom>
               <New_Terms>Lithium Hydroxide Anhydrous</New_Terms>
            </Change>
            <Change id="1097">
               <Axiom>Lithium Hydroxide Monohydrate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Lithium Hydroxide Monohydrate</New_Terms>
            </Change>
            <Change id="1098">
               <Axiom>Liver/Gallbladder SubClassOf Tissue Sample</Axiom>
               <New_Terms>Liver/Gallbladder</New_Terms>
            </Change>
            <Change id="1099">
               <Axiom>Lovastatin Acid SubClassOf HMG-CoA Reductase Inhibitor</Axiom>
               <New_Terms>Lovastatin Acid</New_Terms>
            </Change>
            <Change id="1100">
               <Axiom>Loxapine Hydrochloride SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Loxapine Hydrochloride</New_Terms>
            </Change>
            <Change id="1101">
               <Axiom>Loxapine Hydrochloride SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Loxapine Hydrochloride</New_Terms>
            </Change>
            <Change id="1102">
               <Axiom>Lubazodone SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Lubazodone</New_Terms>
            </Change>
            <Change id="1103">
               <Axiom>Lufenuron SubClassOf Pesticide</Axiom>
               <New_Terms>Lufenuron</New_Terms>
            </Change>
            <Change id="1106">
               <Axiom>Lurasidone Hydrochloride SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Lurasidone Hydrochloride</New_Terms>
            </Change>
            <Change id="1107">
               <Axiom>Lurasidone Hydrochloride SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Lurasidone Hydrochloride</New_Terms>
            </Change>
            <Change id="1104">
               <Axiom>Lurasidone SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Lurasidone</New_Terms>
            </Change>
            <Change id="1105">
               <Axiom>Lurasidone SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Lurasidone</New_Terms>
            </Change>
            <Change id="1108">
               <Axiom>Lusupultide SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Lusupultide</New_Terms>
            </Change>
            <Change id="1109">
               <Axiom>Lymecycline SubClassOf Tetracycline Antibiotic</Axiom>
               <New_Terms>Lymecycline</New_Terms>
            </Change>
            <Change id="1110">
               <Axiom>MEK Inhibitor GSK1120212 SubClassOf Tyrosine Kinase Inhibitor</Axiom>
               <New_Terms>MEK Inhibitor GSK1120212</New_Terms>
            </Change>
            <Change id="1111">
               <Axiom>MKC-1106-MT SubClassOf Biological Agent</Axiom>
               <New_Terms>MKC-1106-MT</New_Terms>
            </Change>
            <Change id="1112">
               <Axiom>Magnesium Chloride Anhydrous SubClassOf Electrolyte Replacement Agent</Axiom>
               <New_Terms>Magnesium Chloride Anhydrous</New_Terms>
            </Change>
            <Change id="1113">
               <Axiom>Magnesium Salicylate, Anhydrous SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Magnesium Salicylate, Anhydrous</New_Terms>
            </Change>
            <Change id="1114">
               <Axiom>Magnesium Sulfate Heptahydrate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Magnesium Sulfate Heptahydrate</New_Terms>
            </Change>
            <Change id="1115">
               <Axiom>Maleylsulfathiazole SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Maleylsulfathiazole</New_Terms>
            </Change>
            <Change id="1116">
               <Axiom>Maltitol SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Maltitol</New_Terms>
            </Change>
            <Change id="1117">
               <Axiom>Maltol SubClassOf Phytochemical</Axiom>
               <New_Terms>Maltol</New_Terms>
            </Change>
            <Change id="1118">
               <Axiom>Manganese Chloride Anhydrous SubClassOf Electrolyte Replacement Agent</Axiom>
               <New_Terms>Manganese Chloride Anhydrous</New_Terms>
            </Change>
            <Change id="1119">
               <Axiom>Manganese Sulfate Anhydrous SubClassOf Electrolyte Replacement Agent</Axiom>
               <New_Terms>Manganese Sulfate Anhydrous</New_Terms>
            </Change>
            <Change id="1120">
               <Axiom>Marmoset SubClassOf Monkey</Axiom>
               <New_Terms>Marmoset</New_Terms>
            </Change>
            <Change id="1121">
               <Axiom>Maropitant Citrate SubClassOf Antiemetic Agent</Axiom>
               <New_Terms>Maropitant Citrate</New_Terms>
            </Change>
            <Change id="1122">
               <Axiom>Mavacoxib SubClassOf Cyclooxygenase Inhibitor</Axiom>
               <New_Terms>Mavacoxib</New_Terms>
            </Change>
            <Change id="1123">
               <Axiom>Measles Virus Live Antigen, A SubClassOf Measles Virus Antigen</Axiom>
               <New_Terms>Measles Virus Live Antigen, A</New_Terms>
            </Change>
            <Change id="1124">
               <Axiom>Meclizine Hydrochloride Anhydrous SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Meclizine Hydrochloride Anhydrous</New_Terms>
            </Change>
            <Change id="1125">
               <Axiom>Mediterranean SubClassOf Race</Axiom>
               <New_Terms>Mediterranean</New_Terms>
            </Change>
            <Change id="1126">
               <Axiom>Medronate Disodium SubClassOf Biphosphonate</Axiom>
               <New_Terms>Medronate Disodium</New_Terms>
            </Change>
            <Change id="1127">
               <Axiom>Mefeclorazine SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Mefeclorazine</New_Terms>
            </Change>
            <Change id="1128">
               <Axiom>Mefenorex Hydrochldride SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Mefenorex Hydrochldride</New_Terms>
            </Change>
            <Change id="1129">
               <Axiom>Mephenesin SubClassOf Muscle Relaxant</Axiom>
               <New_Terms>Mephenesin</New_Terms>
            </Change>
            <Change id="1130">
               <Axiom>Mephobarbital SubClassOf Barbiturate</Axiom>
               <New_Terms>Mephobarbital</New_Terms>
            </Change>
            <Change id="1131">
               <Axiom>Meprochol SubClassOf Fungicide</Axiom>
               <New_Terms>Meprochol</New_Terms>
            </Change>
            <Change id="1132">
               <Axiom>Mersalyl Sodium SubClassOf Diuretic</Axiom>
               <New_Terms>Mersalyl Sodium</New_Terms>
            </Change>
            <Change id="1133">
               <Axiom>Mesenteric Lymph Node SubClassOf Lymph Node</Axiom>
               <New_Terms>Mesenteric Lymph Node</New_Terms>
            </Change>
            <Change id="1134">
               <Axiom>Methenamine Mandelate SubClassOf Urinary Anti-Infective Agent</Axiom>
               <New_Terms>Methenamine Mandelate</New_Terms>
            </Change>
            <Change id="1135">
               <Axiom>Methisazone SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Methisazone</New_Terms>
            </Change>
            <Change id="1137">
               <Axiom>Methoxyamine Hydrochloride SubClassOf Antineoplastic Agent</Axiom>
               <New_Terms>Methoxyamine Hydrochloride</New_Terms>
            </Change>
            <Change id="1136">
               <Axiom>Methoxyamine SubClassOf Antineoplastic Agent</Axiom>
               <New_Terms>Methoxyamine</New_Terms>
            </Change>
            <Change id="1138">
               <Axiom>Methyl Aminolevulinate Hydrochloride SubClassOf Photosensitizing Agent</Axiom>
               <New_Terms>Methyl Aminolevulinate Hydrochloride</New_Terms>
            </Change>
            <Change id="1139">
               <Axiom>Methyl Chloride SubClassOf Industrial Aid</Axiom>
               <New_Terms>Methyl Chloride</New_Terms>
            </Change>
            <Change id="1140">
               <Axiom>Methyl Ethyl Ketone SubClassOf Industrial Aid</Axiom>
               <New_Terms>Methyl Ethyl Ketone</New_Terms>
            </Change>
            <Change id="1141">
               <Axiom>Methyl Stearate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Methyl Stearate</New_Terms>
            </Change>
            <Change id="1143">
               <Axiom>Methylparaben Sodium SubClassOf Industrial Aid</Axiom>
               <New_Terms>Methylparaben Sodium</New_Terms>
            </Change>
            <Change id="1142">
               <Axiom>Methylparaben SubClassOf Industrial Aid</Axiom>
               <New_Terms>Methylparaben</New_Terms>
            </Change>
            <Change id="1144">
               <Axiom>Methylprednisolone Suleptanate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Methylprednisolone Suleptanate</New_Terms>
            </Change>
            <Change id="1145">
               <Axiom>Metipranolol Hydrochloride SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Metipranolol Hydrochloride</New_Terms>
            </Change>
            <Change id="1147">
               <Axiom>Metoserpate Hydrochloride SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Metoserpate Hydrochloride</New_Terms>
            </Change>
            <Change id="1146">
               <Axiom>Metoserpate SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Metoserpate</New_Terms>
            </Change>
            <Change id="1148">
               <Axiom>Metrizoic Acid SubClassOf Contrast Agent</Axiom>
               <New_Terms>Metrizoic Acid</New_Terms>
            </Change>
            <Change id="1149">
               <Axiom>Microchip Site SubClassOf Anatomic Site</Axiom>
               <New_Terms>Microchip Site</New_Terms>
            </Change>
            <Change id="1150">
               <Axiom>Micrococcus SubClassOf Actinobacteria</Axiom>
               <New_Terms>Micrococcus</New_Terms>
            </Change>
            <Change id="1151">
               <Axiom>Micropig SubClassOf Pig</Axiom>
               <New_Terms>Micropig</New_Terms>
            </Change>
            <Change id="1152">
               <Axiom>Middle Eastern SubClassOf Race</Axiom>
               <New_Terms>Middle Eastern</New_Terms>
            </Change>
            <Change id="1154">
               <Axiom>Migalastat Hydrochloride SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Migalastat Hydrochloride</New_Terms>
            </Change>
            <Change id="1153">
               <Axiom>Migalastat SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Migalastat</New_Terms>
            </Change>
            <Change id="1155">
               <Axiom>Milk Protein-Based Energy Drink SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Milk Protein-Based Energy Drink</New_Terms>
            </Change>
            <Change id="1156">
               <Axiom>Milk Serum SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Milk Serum</New_Terms>
            </Change>
            <Change id="1158">
               <Axiom>Milnacipran Hydrochloride SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Milnacipran Hydrochloride</New_Terms>
            </Change>
            <Change id="1157">
               <Axiom>Milnacipran SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Milnacipran</New_Terms>
            </Change>
            <Change id="1160">
               <Axiom>Milveterol Hydrochloride SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Milveterol Hydrochloride</New_Terms>
            </Change>
            <Change id="1159">
               <Axiom>Milveterol SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Milveterol</New_Terms>
            </Change>
            <Change id="1161">
               <Axiom>Minipig SubClassOf Pig</Axiom>
               <New_Terms>Minipig</New_Terms>
            </Change>
            <Change id="1162">
               <Axiom>Molgramostim SubClassOf Immunostimulant</Axiom>
               <New_Terms>Molgramostim</New_Terms>
            </Change>
            <Change id="1163">
               <Axiom>Mongolian Gerbil SubClassOf Gerbil</Axiom>
               <New_Terms>Gerbil, Mongolian Gerbil</New_Terms>
            </Change>
            <Change id="1164">
               <Axiom>Monoxerutin SubClassOf Flavonoid</Axiom>
               <New_Terms>Monoxerutin</New_Terms>
            </Change>
            <Change id="1165">
               <Axiom>Montirelin SubClassOf Therapeutic Hormone</Axiom>
               <New_Terms>Montirelin</New_Terms>
            </Change>
            <Change id="1166">
               <Axiom>Mozavaptan SubClassOf Recombinant Vasopressin</Axiom>
               <New_Terms>Mozavaptan</New_Terms>
            </Change>
            <Change id="1167">
               <Axiom>Mozenavir SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Mozenavir</New_Terms>
            </Change>
            <Change id="1168">
               <Axiom>Multitargeted Kinase Inhibitor JNJ-26483327 SubClassOf Tyrosine Kinase Inhibitor</Axiom>
               <New_Terms>Multitargeted Kinase Inhibitor JNJ-26483327</New_Terms>
            </Change>
            <Change id="1169">
               <Axiom>Mumps Virus Live Antigen, A SubClassOf Mumps Virus Antigen</Axiom>
               <New_Terms>Mumps Virus Live Antigen, A</New_Terms>
            </Change>
            <Change id="1170">
               <Axiom>Murine TYRP2 Plasmid DNA Vaccine SubClassOf DNA Vaccine</Axiom>
               <New_Terms>Murine TYRP2 Plasmid DNA Vaccine</New_Terms>
            </Change>
            <Change id="1171">
               <Axiom>Mustelidae SubClassOf Mammal</Axiom>
               <New_Terms>Mustelidae</New_Terms>
            </Change>
            <Change id="1184">
               <Axiom>N,N,4-Trimethylbenzenamine SubClassOf Industrial Aid</Axiom>
               <New_Terms>N,N,4-Trimethylbenzenamine</New_Terms>
            </Change>
            <Change id="1731">
               <Axiom>N-(4-Chloro-3-((3-Methyl-2-Butenyl)Oxy)Phenyl)-2-Methyl-3-Furancarbothioamide SubClassOf Anti-HIV Agent</Axiom>
               <New_Terms>N-(4-Chloro-3-((3-Methyl-2-Butenyl)Oxy)Phenyl)-2-Methyl-3-Furancarbothioamide</New_Terms>
            </Change>
            <Change id="1172">
               <Axiom>N-Acetyl-.Alpha.-D-Glucosamine SubClassOf Dietary Supplement</Axiom>
               <New_Terms>N-Acetyl-.Alpha.-D-Glucosamine</New_Terms>
            </Change>
            <Change id="1173">
               <Axiom>N-Lauroylsarcosine SubClassOf Industrial Aid</Axiom>
               <New_Terms>N-Lauroylsarcosine</New_Terms>
            </Change>
            <Change id="1175">
               <Axiom>NACHT, LRR and PYD Domains-Containing Protein 3 EquivalentTo Apoptosis Regulator and (Gene_Product_Encoded_By_Gene some NLRP3 Gene) and (Gene_Product_Has_Biochemical_Function some Apoptosis Promoter) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Induction of Apoptosis) and (Gene_Product_Plays_Role_In_Biological_Process some Inflammatory Response)</Axiom>
               <New_Terms>NACHT, LRR and PYD Domains-Containing Protein 3, NLRP3 Gene</New_Terms>
            </Change>
            <Change id="1176">
               <Axiom>NAE Inhibitor MLN4924 SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>NAE Inhibitor MLN4924</New_Terms>
            </Change>
            <Change id="1177">
               <Axiom>NLRP3 Gene SubClassOf Apoptosis Regulation Gene</Axiom>
               <New_Terms>NLRP3 Gene</New_Terms>
            </Change>
            <Change id="1178">
               <Axiom>NLRP3 Gene SubClassOf Gene_Plays_Role_In_Process some Induction of Apoptosis</Axiom>
               <New_Terms>NLRP3 Gene</New_Terms>
            </Change>
            <Change id="1179">
               <Axiom>NLRP3 Gene SubClassOf Gene_Plays_Role_In_Process some Inflammatory Response</Axiom>
               <New_Terms>NLRP3 Gene</New_Terms>
            </Change>
            <Change id="1180">
               <Axiom>NLRP3 wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <New_Terms>NLRP3 wt Allele</New_Terms>
            </Change>
            <Change id="1181">
               <Axiom>NLRP3 wt Allele SubClassOf Gene_In_Chromosomal_Location some 1q44</Axiom>
               <New_Terms>NLRP3 wt Allele</New_Terms>
            </Change>
            <Change id="1182">
               <Axiom>NLRP3 wt Allele SubClassOf NLRP3 Gene</Axiom>
               <New_Terms>NLRP3 wt Allele, NLRP3 Gene</New_Terms>
            </Change>
            <Change id="1185">
               <Axiom>Nafagrel SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Nafagrel</New_Terms>
            </Change>
            <Change id="1186">
               <Axiom>Nafcaproic Acid SubClassOf Cholagogues or Choleretic Agents</Axiom>
               <New_Terms>Nafcaproic Acid</New_Terms>
            </Change>
            <Change id="1187">
               <Axiom>Nafiverine SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Nafiverine</New_Terms>
            </Change>
            <Change id="1188">
               <Axiom>Nalorphine Hydrochloride SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Nalorphine Hydrochloride</New_Terms>
            </Change>
            <Change id="1189">
               <Axiom>Naminidil SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Naminidil</New_Terms>
            </Change>
            <Change id="1190">
               <Axiom>Nanofin SubClassOf Nicotinic Antagonist</Axiom>
               <New_Terms>Nanofin</New_Terms>
            </Change>
            <Change id="1191">
               <Axiom>Nanterinone SubClassOf Phosphodiesterase Inhibitor</Axiom>
               <New_Terms>Nanterinone</New_Terms>
            </Change>
            <Change id="1192">
               <Axiom>Naphthonone SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Naphthonone</New_Terms>
            </Change>
            <Change id="1193">
               <Axiom>Napirimus SubClassOf Immunosuppressant</Axiom>
               <New_Terms>Napirimus</New_Terms>
            </Change>
            <Change id="1194">
               <Axiom>Nardeterol SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Nardeterol</New_Terms>
            </Change>
            <Change id="1195">
               <Axiom>Nasal-Associated Lymphoid Tissue SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Nasal-Associated Lymphoid Tissue</New_Terms>
            </Change>
            <Change id="1196">
               <Axiom>Natalizumab SubClassOf Monoclonal Antibody</Axiom>
               <New_Terms>Natalizumab</New_Terms>
            </Change>
            <Change id="1197">
               <Axiom>Neisseria meningitidis Group A Polysaccharide Antigen, A SubClassOf Neisseria meningitidis Antigen</Axiom>
               <New_Terms>Neisseria meningitidis Group A Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1198">
               <Axiom>Neisseria meningitidis Group A Polysaccharide Conjugate Antigen, A SubClassOf Neisseria meningitidis Antigen</Axiom>
               <New_Terms>Neisseria meningitidis Group A Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1199">
               <Axiom>Neisseria meningitidis Group C Polysaccharide Antigen, A SubClassOf Neisseria meningitidis Antigen</Axiom>
               <New_Terms>Neisseria meningitidis Group C Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1200">
               <Axiom>Neisseria meningitidis Group C Polysaccharide Conjugate Antigen, A SubClassOf Neisseria meningitidis Antigen</Axiom>
               <New_Terms>Neisseria meningitidis Group C Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1201">
               <Axiom>Neisseria meningitidis Group W-135 Polysaccharide Antigen, A SubClassOf Neisseria meningitidis Antigen</Axiom>
               <New_Terms>Neisseria meningitidis Group W-135 Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1202">
               <Axiom>Neisseria meningitidis Group W-135 Polysaccharide Conjugate Antigen, A SubClassOf Neisseria meningitidis Antigen</Axiom>
               <New_Terms>Neisseria meningitidis Group W-135 Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1203">
               <Axiom>Neisseria meningitidis Group Y Polysaccharide Antigen, A SubClassOf Neisseria meningitidis Antigen</Axiom>
               <New_Terms>Neisseria meningitidis Group Y Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1204">
               <Axiom>Neisseria meningitidis Group Y Polysaccharide Conjugate Antigen, A SubClassOf Neisseria meningitidis Antigen</Axiom>
               <New_Terms>Neisseria meningitidis Group Y Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1205">
               <Axiom>Neostigmine Bromide SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Neostigmine Bromide</New_Terms>
            </Change>
            <Change id="1206">
               <Axiom>Neostigmine Methylsulfate SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Neostigmine Methylsulfate</New_Terms>
            </Change>
            <Change id="1207">
               <Axiom>Nepinalone SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Nepinalone</New_Terms>
            </Change>
            <Change id="1208">
               <Axiom>Nequinate SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Nequinate</New_Terms>
            </Change>
            <Change id="1209">
               <Axiom>Neramexane SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Neramexane</New_Terms>
            </Change>
            <Change id="1210">
               <Axiom>Neraminol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Neraminol</New_Terms>
            </Change>
            <Change id="1211">
               <Axiom>Nesbuvir SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Nesbuvir</New_Terms>
            </Change>
            <Change id="1212">
               <Axiom>Neuronal Acetylcholine Receptor Subunit Alpha-3 EquivalentTo Ion Channel Protein and (Gene_Product_Encoded_By_Gene some CHRNA3 Gene) and (Gene_Product_Has_Biochemical_Function some Ion Channel Protein) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Malfunction_Associated_With_Disease some Lung Carcinoma) and (Gene_Product_Plays_Role_In_Biological_Process some Transport Process)</Axiom>
               <New_Terms>Neuronal Acetylcholine Receptor Subunit Alpha-3, CHRNA3 Gene</New_Terms>
            </Change>
            <Change id="1213">
               <Axiom>Neuronal Acetylcholine Receptor Subunit Alpha-5 EquivalentTo Ion Channel Protein and (Gene_Product_Encoded_By_Gene some CHRNA5 Gene) and (Gene_Product_Has_Biochemical_Function some Ion Channel Protein) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Malfunction_Associated_With_Disease some Lung Carcinoma) and (Gene_Product_Plays_Role_In_Biological_Process some Transport Process)</Axiom>
               <New_Terms>CHRNA5 Gene, Neuronal Acetylcholine Receptor Subunit Alpha-5</New_Terms>
            </Change>
            <Change id="1214">
               <Axiom>Neuronal Acetylcholine Receptor Subunit Beta-4 EquivalentTo Ion Channel Protein and (Gene_Product_Encoded_By_Gene some CHRNB4 Gene) and (Gene_Product_Has_Biochemical_Function some Ion Channel Protein) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Malfunction_Associated_With_Disease some Lung Carcinoma) and (Gene_Product_Plays_Role_In_Biological_Process some Transport Process)</Axiom>
               <New_Terms>CHRNB4 Gene, Neuronal Acetylcholine Receptor Subunit Beta-4</New_Terms>
            </Change>
            <Change id="1215">
               <Axiom>New Zealand Black Rabbit SubClassOf Rabbit</Axiom>
               <New_Terms>New Zealand Black Rabbit</New_Terms>
            </Change>
            <Change id="1216">
               <Axiom>New Zealand Hybrid Rabbit SubClassOf Rabbit</Axiom>
               <New_Terms>New Zealand Hybrid Rabbit</New_Terms>
            </Change>
            <Change id="1217">
               <Axiom>New Zealand Red Rabbit SubClassOf Rabbit</Axiom>
               <New_Terms>New Zealand Red Rabbit</New_Terms>
            </Change>
            <Change id="1218">
               <Axiom>New Zealand White Rabbit SubClassOf Rabbit</Axiom>
               <New_Terms>New Zealand White Rabbit</New_Terms>
            </Change>
            <Change id="1219">
               <Axiom>Niaprazine SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Niaprazine</New_Terms>
            </Change>
            <Change id="1220">
               <Axiom>Nicainoprol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Nicainoprol</New_Terms>
            </Change>
            <Change id="1221">
               <Axiom>Nicametate SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Nicametate</New_Terms>
            </Change>
            <Change id="1222">
               <Axiom>Nicaraven SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Nicaraven</New_Terms>
            </Change>
            <Change id="1223">
               <Axiom>Nicogrelate SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Nicogrelate</New_Terms>
            </Change>
            <Change id="1224">
               <Axiom>Nicoracetam SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Nicoracetam</New_Terms>
            </Change>
            <Change id="1225">
               <Axiom>Nicotinyl Alcohol Tartrate SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Nicotinyl Alcohol Tartrate</New_Terms>
            </Change>
            <Change id="1226">
               <Axiom>Nicoxamat SubClassOf Uricosuric Agent</Axiom>
               <New_Terms>Nicoxamat</New_Terms>
            </Change>
            <Change id="1227">
               <Axiom>Nictindole SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Nictindole</New_Terms>
            </Change>
            <Change id="1228">
               <Axiom>Nictitating Membrane SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Nictitating Membrane</New_Terms>
            </Change>
            <Change id="1229">
               <Axiom>Nifenalol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Nifenalol</New_Terms>
            </Change>
            <Change id="1230">
               <Axiom>Nifenazone SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Nifenazone</New_Terms>
            </Change>
            <Change id="1231">
               <Axiom>Niflumic Acid SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Niflumic Acid</New_Terms>
            </Change>
            <Change id="1232">
               <Axiom>Nifluridide SubClassOf Pesticide</Axiom>
               <New_Terms>Nifluridide</New_Terms>
            </Change>
            <Change id="1233">
               <Axiom>Nifuraldezone SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Nifuraldezone</New_Terms>
            </Change>
            <Change id="1234">
               <Axiom>Nifuroquine SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Nifuroquine</New_Terms>
            </Change>
            <Change id="1235">
               <Axiom>Nifuroxime SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Nifuroxime</New_Terms>
            </Change>
            <Change id="1236">
               <Axiom>Nikethamide SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Nikethamide</New_Terms>
            </Change>
            <Change id="1237">
               <Axiom>Nileprost SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Nileprost</New_Terms>
            </Change>
            <Change id="1238">
               <Axiom>Nilprazole SubClassOf Proton Pump Inhibitor</Axiom>
               <New_Terms>Nilprazole</New_Terms>
            </Change>
            <Change id="1239">
               <Axiom>Niludipine SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Niludipine</New_Terms>
            </Change>
            <Change id="1240">
               <Axiom>Nimetazepam SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Nimetazepam</New_Terms>
            </Change>
            <Change id="1241">
               <Axiom>Nimidane SubClassOf Pesticide</Axiom>
               <New_Terms>Nimidane</New_Terms>
            </Change>
            <Change id="1242">
               <Axiom>Nimorazole SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Nimorazole</New_Terms>
            </Change>
            <Change id="1243">
               <Axiom>Nipradilol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Nipradilol</New_Terms>
            </Change>
            <Change id="1244">
               <Axiom>Niprofazone SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Niprofazone</New_Terms>
            </Change>
            <Change id="1245">
               <Axiom>Nitarsone SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Nitarsone</New_Terms>
            </Change>
            <Change id="1246">
               <Axiom>Nitrocefin SubClassOf Beta-Lactam Antibiotic</Axiom>
               <New_Terms>Nitrocefin</New_Terms>
            </Change>
            <Change id="1247">
               <Axiom>Nitrocycline SubClassOf Tetracycline Antibiotic</Axiom>
               <New_Terms>Nitrocycline</New_Terms>
            </Change>
            <Change id="1248">
               <Axiom>Nitrofurantoin Monohydrate SubClassOf Urinary Anti-Infective Agent</Axiom>
               <New_Terms>Nitrofurantoin Monohydrate</New_Terms>
            </Change>
            <Change id="1249">
               <Axiom>Nitroprusside SubClassOf Diagnostic Reagent</Axiom>
               <New_Terms>Nitroprusside</New_Terms>
            </Change>
            <Change id="1250">
               <Axiom>Nitroprusside SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Nitroprusside</New_Terms>
            </Change>
            <Change id="1251">
               <Axiom>Nixylic Acid SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Nixylic Acid</New_Terms>
            </Change>
            <Change id="1252">
               <Axiom>Nizofenone SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Nizofenone</New_Terms>
            </Change>
            <Change id="1253">
               <Axiom>Nonglandular Stomach SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Nonglandular Stomach</New_Terms>
            </Change>
            <Change id="1254">
               <Axiom>Norbudrine SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Norbudrine</New_Terms>
            </Change>
            <Change id="1255">
               <Axiom>Norclostebol SubClassOf Anabolic Steroid</Axiom>
               <New_Terms>Norclostebol</New_Terms>
            </Change>
            <Change id="1256">
               <Axiom>Norfloxacin Succinil SubClassOf Quinolone Compound</Axiom>
               <New_Terms>Norfloxacin Succinil</New_Terms>
            </Change>
            <Change id="1257">
               <Axiom>Norflurane SubClassOf Industrial Aid</Axiom>
               <New_Terms>Norflurane</New_Terms>
            </Change>
            <Change id="1258">
               <Axiom>Norgestomet SubClassOf Progestin</Axiom>
               <New_Terms>Norgestomet</New_Terms>
            </Change>
            <Change id="1259">
               <Axiom>Normethadone SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Normethadone</New_Terms>
            </Change>
            <Change id="1260">
               <Axiom>Nortetrazepam SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Nortetrazepam</New_Terms>
            </Change>
            <Change id="1261">
               <Axiom>North American SubClassOf Race</Axiom>
               <New_Terms>North American</New_Terms>
            </Change>
            <Change id="1262">
               <Axiom>North Coast of Africa SubClassOf Race</Axiom>
               <New_Terms>North Coast of Africa</New_Terms>
            </Change>
            <Change id="1263">
               <Axiom>Northern European SubClassOf Race</Axiom>
               <New_Terms>Northern European</New_Terms>
            </Change>
            <Change id="1264">
               <Axiom>Ocaperidone SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Ocaperidone</New_Terms>
            </Change>
            <Change id="1265">
               <Axiom>Ocfentanil Hydrochloride SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Ocfentanil Hydrochloride</New_Terms>
            </Change>
            <Change id="1266">
               <Axiom>Octisalate SubClassOf Sunscreen</Axiom>
               <New_Terms>Octisalate</New_Terms>
            </Change>
            <Change id="1267">
               <Axiom>Octyldodecanol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Octyldodecanol</New_Terms>
            </Change>
            <Change id="1268">
               <Axiom>Olanzapine Pamoate SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Olanzapine Pamoate</New_Terms>
            </Change>
            <Change id="1269">
               <Axiom>Oleyl Alcohol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Oleyl Alcohol</New_Terms>
            </Change>
            <Change id="1270">
               <Axiom>Oral JAK Inhibitor INCB18424 SubClassOf Tyrosine Kinase Inhibitor</Axiom>
               <New_Terms>Oral JAK Inhibitor INCB18424</New_Terms>
            </Change>
            <Change id="1271">
               <Axiom>Oral Milataxel SubClassOf Taxane-Pocket Binding Agent</Axiom>
               <New_Terms>Oral Milataxel</New_Terms>
            </Change>
            <Change id="1272">
               <Axiom>Oral Mucosa SubClassOf Mucosa</Axiom>
               <New_Terms>Oral Mucosa</New_Terms>
            </Change>
            <Change id="1273">
               <Axiom>Oral Zoledronic Acid SubClassOf Biphosphonate</Axiom>
               <New_Terms>Oral Zoledronic Acid</New_Terms>
            </Change>
            <Change id="1274">
               <Axiom>Orange B SubClassOf Dye</Axiom>
               <New_Terms>Orange B</New_Terms>
            </Change>
            <Change id="1275">
               <Axiom>Orestrate SubClassOf Therapeutic Estrogen</Axiom>
               <New_Terms>Orestrate</New_Terms>
            </Change>
            <Change id="1276">
               <Axiom>Orientation SubClassOf Mental Process</Axiom>
               <New_Terms>Orientation</New_Terms>
            </Change>
            <Change id="1277">
               <Axiom>Ormetoprim SubClassOf Dihydrofolate Reductase Inhibitor</Axiom>
               <New_Terms>Ormetoprim</New_Terms>
            </Change>
            <Change id="1278">
               <Axiom>Orphenadrine Hydrochloride SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Orphenadrine Hydrochloride</New_Terms>
            </Change>
            <Change id="1279">
               <Axiom>Osalmid SubClassOf Cholagogues or Choleretic Agents</Axiom>
               <New_Terms>Osalmid</New_Terms>
            </Change>
            <Change id="1280">
               <Axiom>Ospemifene SubClassOf Selective Estrogen Receptor Modulator</Axiom>
               <New_Terms>Ospemifene</New_Terms>
            </Change>
            <Change id="1281">
               <Axiom>Oteracil SubClassOf Pyrimidine Antagonist</Axiom>
               <New_Terms>Oteracil</New_Terms>
            </Change>
            <Change id="1282">
               <Axiom>Oviduct SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Oviduct</New_Terms>
            </Change>
            <Change id="1283">
               <Axiom>Oxetorone Fumarate SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Oxetorone Fumarate</New_Terms>
            </Change>
            <Change id="1284">
               <Axiom>Oxetorone Fumarate SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Oxetorone Fumarate</New_Terms>
            </Change>
            <Change id="1285">
               <Axiom>Oxolinic Acid SubClassOf Quinolone Compound</Axiom>
               <New_Terms>Oxolinic Acid</New_Terms>
            </Change>
            <Change id="1286">
               <Axiom>Oxpheneridine SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Oxpheneridine</New_Terms>
            </Change>
            <Change id="1287">
               <Axiom>Oxyfedrine Hydrochloride SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Oxyfedrine Hydrochloride</New_Terms>
            </Change>
            <Change id="1288">
               <Axiom>Oxyfedrine Hydrochloride SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Oxyfedrine Hydrochloride</New_Terms>
            </Change>
            <Change id="1289">
               <Axiom>Oxyphenonium SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Oxyphenonium</New_Terms>
            </Change>
            <Change id="1290">
               <Axiom>Palmitamine Oxide SubClassOf Industrial Aid</Axiom>
               <New_Terms>Palmitamine Oxide</New_Terms>
            </Change>
            <Change id="1291">
               <Axiom>Pancreatic Lymph Node SubClassOf Lymph Node</Axiom>
               <New_Terms>Pancreatic Lymph Node</New_Terms>
            </Change>
            <Change id="1292">
               <Axiom>Paraaortic Lymph Node SubClassOf Lymph Node</Axiom>
               <New_Terms>Paraaortic Lymph Node</New_Terms>
            </Change>
            <Change id="1293">
               <Axiom>Paw SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Paw</New_Terms>
            </Change>
            <Change id="1294">
               <Axiom>Pegademase Bovine SubClassOf Industrial Aid</Axiom>
               <New_Terms>Pegademase Bovine</New_Terms>
            </Change>
            <Change id="1296">
               <Axiom>Pelanserin Hydrochloride SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Pelanserin Hydrochloride</New_Terms>
            </Change>
            <Change id="1295">
               <Axiom>Pelanserin SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Pelanserin</New_Terms>
            </Change>
            <Change id="1297">
               <Axiom>Pelitrexol SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Pelitrexol</New_Terms>
            </Change>
            <Change id="1298">
               <Axiom>Pentadecalactone SubClassOf Industrial Aid</Axiom>
               <New_Terms>Pentadecalactone</New_Terms>
            </Change>
            <Change id="1299">
               <Axiom>Pentafluranol SubClassOf Non-Steroidal Estrogen</Axiom>
               <New_Terms>Pentafluranol</New_Terms>
            </Change>
            <Change id="1300">
               <Axiom>Pentasodium Triphosphate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Pentasodium Triphosphate</New_Terms>
            </Change>
            <Change id="1301">
               <Axiom>Pentazocine Lactate SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Pentazocine Lactate</New_Terms>
            </Change>
            <Change id="1302">
               <Axiom>Pentetate Zinc Trisodium SubClassOf Chelating Agent</Axiom>
               <New_Terms>Pentetate Zinc Trisodium</New_Terms>
            </Change>
            <Change id="1303">
               <Axiom>Pentolinium SubClassOf Nicotinic Antagonist</Axiom>
               <New_Terms>Pentolinium</New_Terms>
            </Change>
            <Change id="1304">
               <Axiom>Perflubutane SubClassOf Contrast Agent</Axiom>
               <New_Terms>Perflubutane</New_Terms>
            </Change>
            <Change id="1305">
               <Axiom>Perianal Gland SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Perianal Gland</New_Terms>
            </Change>
            <Change id="1306">
               <Axiom>Perineal Gland SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Perineal Gland</New_Terms>
            </Change>
            <Change id="1307">
               <Axiom>Peritoneal Fluid SubClassOf Biospecimen</Axiom>
               <New_Terms>Peritoneal Fluid</New_Terms>
            </Change>
            <Change id="1308">
               <Axiom>Peritoneal Lymph Node SubClassOf Lymph Node</Axiom>
               <New_Terms>Peritoneal Lymph Node</New_Terms>
            </Change>
            <Change id="1309">
               <Axiom>Pexacerfont SubClassOf Anxiolytic</Axiom>
               <New_Terms>Pexacerfont</New_Terms>
            </Change>
            <Change id="1310">
               <Axiom>Phenbutazone Sodium Glycerate SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Phenbutazone Sodium Glycerate</New_Terms>
            </Change>
            <Change id="1311">
               <Axiom>Phenethyl Alcohol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Phenethyl Alcohol</New_Terms>
            </Change>
            <Change id="1312">
               <Axiom>Phenobarbital Sodium SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Phenobarbital Sodium</New_Terms>
            </Change>
            <Change id="1313">
               <Axiom>Phenolsulfonphthalein SubClassOf Diagnostic Reagent</Axiom>
               <New_Terms>Phenolsulfonphthalein</New_Terms>
            </Change>
            <Change id="1314">
               <Axiom>Phenoxyethanol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Phenoxyethanol</New_Terms>
            </Change>
            <Change id="1315">
               <Axiom>Phenylacetic Acid SubClassOf Industrial Aid</Axiom>
               <New_Terms>Phenylacetic Acid</New_Terms>
            </Change>
            <Change id="1316">
               <Axiom>Phosmet SubClassOf Pesticide</Axiom>
               <New_Terms>Phosmet</New_Terms>
            </Change>
            <Change id="1317">
               <Axiom>Phthalylsulfamethizole SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Phthalylsulfamethizole</New_Terms>
            </Change>
            <Change id="1318">
               <Axiom>Picenadol Hydrochloride SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Picenadol Hydrochloride</New_Terms>
            </Change>
            <Change id="1319">
               <Axiom>Pichia guilliermondii SubClassOf Candida</Axiom>
               <New_Terms>Pichia guilliermondii, Candida</New_Terms>
            </Change>
            <Change id="1320">
               <Axiom>Picobenzide SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Picobenzide</New_Terms>
            </Change>
            <Change id="1321">
               <Axiom>Picolamine SubClassOf Industrial Aid</Axiom>
               <New_Terms>Picolamine</New_Terms>
            </Change>
            <Change id="1322">
               <Axiom>Piconol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Piconol</New_Terms>
            </Change>
            <Change id="1323">
               <Axiom>Picoperine SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Picoperine</New_Terms>
            </Change>
            <Change id="1325">
               <Axiom>Picumeterol Fumarate SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Picumeterol Fumarate</New_Terms>
            </Change>
            <Change id="1324">
               <Axiom>Picumeterol SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Picumeterol</New_Terms>
            </Change>
            <Change id="1326">
               <Axiom>Pidobenzone SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Pidobenzone</New_Terms>
            </Change>
            <Change id="1327">
               <Axiom>Pidotimod SubClassOf Immunostimulant</Axiom>
               <New_Terms>Pidotimod</New_Terms>
            </Change>
            <Change id="1328">
               <Axiom>Pifarnine SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Pifarnine</New_Terms>
            </Change>
            <Change id="1329">
               <Axiom>Pifexole SubClassOf Muscle Relaxant</Axiom>
               <New_Terms>Pifexole</New_Terms>
            </Change>
            <Change id="1330">
               <Axiom>Pimagedine Hydrochloride SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Pimagedine Hydrochloride</New_Terms>
            </Change>
            <Change id="1331">
               <Axiom>Pimavanserin SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Pimavanserin</New_Terms>
            </Change>
            <Change id="1332">
               <Axiom>Pimeclone SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Pimeclone</New_Terms>
            </Change>
            <Change id="1333">
               <Axiom>Pimelautide SubClassOf Biological Response Modifier</Axiom>
               <New_Terms>Pimelautide</New_Terms>
            </Change>
            <Change id="1334">
               <Axiom>Pimilprost SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Pimilprost</New_Terms>
            </Change>
            <Change id="1335">
               <Axiom>Pinafide SubClassOf DNA Intercalating Agent</Axiom>
               <New_Terms>Pinafide</New_Terms>
            </Change>
            <Change id="1336">
               <Axiom>Pinoxepin Hydrochloride SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Pinoxepin Hydrochloride</New_Terms>
            </Change>
            <Change id="1337">
               <Axiom>Pipecuronium SubClassOf Nicotinic Antagonist</Axiom>
               <New_Terms>Pipecuronium</New_Terms>
            </Change>
            <Change id="1338">
               <Axiom>Piperazine Phosphate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Piperazine Phosphate</New_Terms>
            </Change>
            <Change id="1339">
               <Axiom>Piragliatin SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Piragliatin</New_Terms>
            </Change>
            <Change id="1341">
               <Axiom>Pirazmonam Sodium SubClassOf Beta-Lactam Antibiotic</Axiom>
               <New_Terms>Pirazmonam Sodium</New_Terms>
            </Change>
            <Change id="1340">
               <Axiom>Pirazmonam SubClassOf Beta-Lactam Antibiotic</Axiom>
               <New_Terms>Pirazmonam</New_Terms>
            </Change>
            <Change id="1342">
               <Axiom>Pirbuterol Hydrochloride SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Pirbuterol Hydrochloride</New_Terms>
            </Change>
            <Change id="1343">
               <Axiom>Piridicillin Sodium SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Piridicillin Sodium</New_Terms>
            </Change>
            <Change id="1344">
               <Axiom>Piridoxilate SubClassOf Cardiovascular Agent</Axiom>
               <New_Terms>Piridoxilate</New_Terms>
            </Change>
            <Change id="1345">
               <Axiom>Piroxicillin SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Piroxicillin</New_Terms>
            </Change>
            <Change id="1346">
               <Axiom>Plantar Nerve SubClassOf Peripheral Nerve</Axiom>
               <New_Terms>Plantar Nerve</New_Terms>
            </Change>
            <Change id="1347">
               <Axiom>Pleural Fluid SubClassOf Biospecimen</Axiom>
               <New_Terms>Pleural Fluid</New_Terms>
            </Change>
            <Change id="1348">
               <Axiom>Polyethylene Glycol-Based Laxative SubClassOf Laxative</Axiom>
               <New_Terms>Polyethylene Glycol-Based Laxative</New_Terms>
            </Change>
            <Change id="1349">
               <Axiom>Polyvalent Antigen-KLH Conjugate Vaccine SubClassOf Antineoplastic Vaccine</Axiom>
               <New_Terms>Polyvalent Antigen-KLH Conjugate Vaccine</New_Terms>
            </Change>
            <Change id="1350">
               <Axiom>Poor SubClassOf General Qualifier</Axiom>
               <New_Terms>Poor</New_Terms>
            </Change>
            <Change id="1351">
               <Axiom>Portal Lymph Node SubClassOf Lymph Node</Axiom>
               <New_Terms>Portal Lymph Node</New_Terms>
            </Change>
            <Change id="1352">
               <Axiom>Potassium Bisulfite SubClassOf Industrial Aid</Axiom>
               <New_Terms>Potassium Bisulfite</New_Terms>
            </Change>
            <Change id="1353">
               <Axiom>Potassium Bromide SubClassOf Industrial Aid</Axiom>
               <New_Terms>Potassium Bromide</New_Terms>
            </Change>
            <Change id="1354">
               <Axiom>Potassium Lactate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Potassium Lactate</New_Terms>
            </Change>
            <Change id="1355">
               <Axiom>Potassium Permanganate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Potassium Permanganate</New_Terms>
            </Change>
            <Change id="1356">
               <Axiom>Potassium Sorbate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Potassium Sorbate</New_Terms>
            </Change>
            <Change id="1357">
               <Axiom>Povidone SubClassOf Industrial Aid</Axiom>
               <New_Terms>Povidone</New_Terms>
            </Change>
            <Change id="1358">
               <Axiom>Practolol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Practolol</New_Terms>
            </Change>
            <Change id="1359">
               <Axiom>Pralidoxime SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Pralidoxime</New_Terms>
            </Change>
            <Change id="1360">
               <Axiom>Pralnacasan SubClassOf Matrix Metalloproteinase Inhibitor</Axiom>
               <New_Terms>Pralnacasan</New_Terms>
            </Change>
            <Change id="1361">
               <Axiom>Prasterone Sodium Sulfate SubClassOf Therapeutic Androgen</Axiom>
               <New_Terms>Prasterone Sodium Sulfate</New_Terms>
            </Change>
            <Change id="1362">
               <Axiom>Preladenant SubClassOf Antiparkinsonian Agent</Axiom>
               <New_Terms>Preladenant</New_Terms>
            </Change>
            <Change id="1363">
               <Axiom>Prescapular Lymph Node SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Prescapular Lymph Node</New_Terms>
            </Change>
            <Change id="1364">
               <Axiom>Prethcamide SubClassOf CNS Stimulant</Axiom>
               <New_Terms>Prethcamide</New_Terms>
            </Change>
            <Change id="1365">
               <Axiom>Primidolol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Primidolol</New_Terms>
            </Change>
            <Change id="1366">
               <Axiom>Prinaberel SubClassOf Selective Estrogen Receptor Modulator</Axiom>
               <New_Terms>Prinaberel</New_Terms>
            </Change>
            <Change id="1367">
               <Axiom>Prizidilol Hydrochloride Anhydrous SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Prizidilol Hydrochloride Anhydrous</New_Terms>
            </Change>
            <Change id="1368">
               <Axiom>Probarbital Sodium SubClassOf Barbiturate</Axiom>
               <New_Terms>Probarbital Sodium</New_Terms>
            </Change>
            <Change id="1369">
               <Axiom>Proctocolitis SubClassOf Non-Neoplastic Gastrointestinal Disorder</Axiom>
               <New_Terms>Proctocolitis</New_Terms>
            </Change>
            <Change id="1370">
               <Axiom>Proflavine SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Proflavine</New_Terms>
            </Change>
            <Change id="1371">
               <Axiom>Proflavine Sulfate SubClassOf DNA Intercalating Agent</Axiom>
               <New_Terms>Proflavine Sulfate</New_Terms>
            </Change>
            <Change id="1372">
               <Axiom>Proligestone SubClassOf Progestin</Axiom>
               <New_Terms>Proligestone</New_Terms>
            </Change>
            <Change id="1373">
               <Axiom>Promestriene SubClassOf Therapeutic Estrogen</Axiom>
               <New_Terms>Promestriene</New_Terms>
            </Change>
            <Change id="1374">
               <Axiom>Propane SubClassOf Industrial Aid</Axiom>
               <New_Terms>Propane</New_Terms>
            </Change>
            <Change id="1375">
               <Axiom>Propantheline SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Propantheline</New_Terms>
            </Change>
            <Change id="1376">
               <Axiom>Propetamphos SubClassOf Pesticide</Axiom>
               <New_Terms>Propetamphos</New_Terms>
            </Change>
            <Change id="1377">
               <Axiom>Propoxate SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Propoxate</New_Terms>
            </Change>
            <Change id="1378">
               <Axiom>Propyl Docetrizoate SubClassOf Contrast Agent</Axiom>
               <New_Terms>Propyl Docetrizoate</New_Terms>
            </Change>
            <Change id="1379">
               <Axiom>Propyl Gallate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Propyl Gallate</New_Terms>
            </Change>
            <Change id="1380">
               <Axiom>Propylene Carbonate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Propylene Carbonate</New_Terms>
            </Change>
            <Change id="1381">
               <Axiom>Propylene Glycol Diacetate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Propylene Glycol Diacetate</New_Terms>
            </Change>
            <Change id="1382">
               <Axiom>Propylene Glycol Monolaurate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Propylene Glycol Monolaurate</New_Terms>
            </Change>
            <Change id="1383">
               <Axiom>Propylparaben SubClassOf Industrial Aid</Axiom>
               <New_Terms>Propylparaben</New_Terms>
            </Change>
            <Change id="1384">
               <Axiom>Prostalene SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Prostalene</New_Terms>
            </Change>
            <Change id="1385">
               <Axiom>Prostate Health Cocktail Dietary Supplement SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Prostate Health Cocktail Dietary Supplement</New_Terms>
            </Change>
            <Change id="1386">
               <Axiom>Prostate/Seminal Vesicles SubClassOf Tissue Sample</Axiom>
               <New_Terms>Prostate/Seminal Vesicles</New_Terms>
            </Change>
            <Change id="1387">
               <Axiom>Protheobromine SubClassOf Diuretic</Axiom>
               <New_Terms>Protheobromine</New_Terms>
            </Change>
            <Change id="1388">
               <Axiom>Protista SubClassOf Organism</Axiom>
               <New_Terms>Protista</New_Terms>
            </Change>
            <Change id="1389">
               <Axiom>Protoporphyrin Disodium SubClassOf Hepatoprotective Agent</Axiom>
               <New_Terms>Protoporphyrin Disodium</New_Terms>
            </Change>
            <Change id="1390">
               <Axiom>Protozoa SubClassOf Invertebrate</Axiom>
               <New_Terms>Protozoa</New_Terms>
            </Change>
            <Change id="1391">
               <Axiom>Pyrilamine SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Pyrilamine</New_Terms>
            </Change>
            <Change id="1392">
               <Axiom>Pyrophenindane SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Pyrophenindane</New_Terms>
            </Change>
            <Change id="1393">
               <Axiom>Pyroxamine Maleate SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Pyroxamine Maleate</New_Terms>
            </Change>
            <Change id="1394">
               <Axiom>Pyrvinium SubClassOf Antiparasitic Agent</Axiom>
               <New_Terms>Pyrvinium</New_Terms>
            </Change>
            <Change id="1395">
               <Axiom>Quinestradol SubClassOf Therapeutic Estrogen</Axiom>
               <New_Terms>Quinestradol</New_Terms>
            </Change>
            <Change id="1396">
               <Axiom>Quinezamide SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Quinezamide</New_Terms>
            </Change>
            <Change id="1397">
               <Axiom>Racefemine SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Racefemine</New_Terms>
            </Change>
            <Change id="1398">
               <Axiom>Racemoramide SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Racemoramide</New_Terms>
            </Change>
            <Change id="1399">
               <Axiom>Racepinephrine SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Racepinephrine</New_Terms>
            </Change>
            <Change id="1400">
               <Axiom>Radafaxine Hydrochloride SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Radafaxine Hydrochloride</New_Terms>
            </Change>
            <Change id="1401">
               <Axiom>Ramatroban SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Ramatroban</New_Terms>
            </Change>
            <Change id="1402">
               <Axiom>Ramixotidine SubClassOf Histamine-2 Receptor Antagonist</Axiom>
               <New_Terms>Ramixotidine</New_Terms>
            </Change>
            <Change id="1403">
               <Axiom>Ramnodigin SubClassOf Cardiovascular Agent</Axiom>
               <New_Terms>Ramnodigin</New_Terms>
            </Change>
            <Change id="1404">
               <Axiom>Ranelic Acid SubClassOf Bone Resorption Inhibitor</Axiom>
               <New_Terms>Ranelic Acid</New_Terms>
            </Change>
            <Change id="1405">
               <Axiom>Ranelic Acid SubClassOf Chelating Agent</Axiom>
               <New_Terms>Ranelic Acid</New_Terms>
            </Change>
            <Change id="1406">
               <Axiom>Rating SubClassOf Action</Axiom>
               <New_Terms>Rating</New_Terms>
            </Change>
            <Change id="1407">
               <Axiom>Razinodil SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Razinodil</New_Terms>
            </Change>
            <Change id="1408">
               <Axiom>Rebimastat SubClassOf Matrix Metalloproteinase Inhibitor</Axiom>
               <New_Terms>Rebimastat</New_Terms>
            </Change>
            <Change id="1409">
               <Axiom>Recumbent Position SubClassOf Body Position</Axiom>
               <New_Terms>Recumbent Position</New_Terms>
            </Change>
            <Change id="1410">
               <Axiom>Relative Fluorescence Units SubClassOf Fluorescence Units</Axiom>
               <New_Terms>Relative Fluorescence Units</New_Terms>
            </Change>
            <Change id="1411">
               <Axiom>Relocation SubClassOf Action</Axiom>
               <New_Terms>Relocation</New_Terms>
            </Change>
            <Change id="1412">
               <Axiom>Relomycin SubClassOf Macrolide Antibiotic</Axiom>
               <New_Terms>Relomycin</New_Terms>
            </Change>
            <Change id="1413">
               <Axiom>Renal Lymph Node SubClassOf Lymph Node</Axiom>
               <New_Terms>Renal Lymph Node</New_Terms>
            </Change>
            <Change id="1414">
               <Axiom>Renal Tumor RNA/CD40L-Transfected Dendritic Cell Vaccine SubClassOf Dendritic Cell Vaccine</Axiom>
               <New_Terms>Renal Tumor RNA/CD40L-Transfected Dendritic Cell Vaccine</New_Terms>
            </Change>
            <Change id="1415">
               <Axiom>Resorcinol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Resorcinol</New_Terms>
            </Change>
            <Change id="1416">
               <Axiom>Retinoid Analogue NRX 195183 SubClassOf Retinoic Acid Agent</Axiom>
               <New_Terms>Retinoid Analogue NRX 195183</New_Terms>
            </Change>
            <Change id="1417">
               <Axiom>Retosiban SubClassOf Hormone Antagonist</Axiom>
               <New_Terms>Retosiban</New_Terms>
            </Change>
            <Change id="1418">
               <Axiom>Retropharyngeal Lymph Node SubClassOf Head and Neck Lymph Node</Axiom>
               <New_Terms>Retropharyngeal Lymph Node</New_Terms>
            </Change>
            <Change id="1419">
               <Axiom>Retrosacral Lymph Node SubClassOf Lymph Node by Anatomic Site</Axiom>
               <New_Terms>Retrosacral Lymph Node</New_Terms>
            </Change>
            <Change id="1420">
               <Axiom>Revaprazan SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Revaprazan</New_Terms>
            </Change>
            <Change id="1421">
               <Axiom>Revizinone SubClassOf Phosphodiesterase Inhibitor</Axiom>
               <New_Terms>Revizinone</New_Terms>
            </Change>
            <Change id="1422">
               <Axiom>Revospirone SubClassOf Anxiolytic</Axiom>
               <New_Terms>Revospirone</New_Terms>
            </Change>
            <Change id="1423">
               <Axiom>Rhinovirus SubClassOf Picornavirus</Axiom>
               <New_Terms>Rhinovirus</New_Terms>
            </Change>
            <Change id="1424">
               <Axiom>Rhizopus SubClassOf Zygomycota</Axiom>
               <New_Terms>Zygomycota, Rhizopus</New_Terms>
            </Change>
            <Change id="1425">
               <Axiom>Ricasetron SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Ricasetron</New_Terms>
            </Change>
            <Change id="1426">
               <Axiom>Ridazolol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Ridazolol</New_Terms>
            </Change>
            <Change id="1427">
               <Axiom>Rilapine SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Rilapine</New_Terms>
            </Change>
            <Change id="1428">
               <Axiom>Rilapladib SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Rilapladib</New_Terms>
            </Change>
            <Change id="1429">
               <Axiom>Rilmazafone SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Rilmazafone</New_Terms>
            </Change>
            <Change id="1430">
               <Axiom>Rilpivirine SubClassOf Reverse Transcriptase Inhibitor</Axiom>
               <New_Terms>Rilpivirine</New_Terms>
            </Change>
            <Change id="1431">
               <Axiom>Rimazolium Metilsulfate SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Rimazolium Metilsulfate</New_Terms>
            </Change>
            <Change id="1432">
               <Axiom>Riodipine SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Riodipine</New_Terms>
            </Change>
            <Change id="1433">
               <Axiom>Rivaroxaban SubClassOf Anticoagulant Agent</Axiom>
               <New_Terms>Rivaroxaban</New_Terms>
            </Change>
            <Change id="1435">
               <Axiom>Robenidine Hydrochloride SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Robenidine Hydrochloride</New_Terms>
            </Change>
            <Change id="1434">
               <Axiom>Robenidine SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Robenidine</New_Terms>
            </Change>
            <Change id="1436">
               <Axiom>Rofleponide SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Rofleponide</New_Terms>
            </Change>
            <Change id="1437">
               <Axiom>Roflumilast SubClassOf Phosphodiesterase Inhibitor</Axiom>
               <New_Terms>Roflumilast</New_Terms>
            </Change>
            <Change id="1438">
               <Axiom>Ronnel SubClassOf Pesticide</Axiom>
               <New_Terms>Ronnel</New_Terms>
            </Change>
            <Change id="1439">
               <Axiom>Ropidoxuridine SubClassOf Pyrimidine Antagonist</Axiom>
               <New_Terms>Ropidoxuridine</New_Terms>
            </Change>
            <Change id="1440">
               <Axiom>Rosabulin SubClassOf Tubulin Binding Agent</Axiom>
               <New_Terms>Rosabulin</New_Terms>
            </Change>
            <Change id="1441">
               <Axiom>Ross Chicken SubClassOf Chicken</Axiom>
               <New_Terms>Ross Chicken</New_Terms>
            </Change>
            <Change id="1444">
               <Axiom>Rotavirus G1 P(8) Live Antigen, A SubClassOf Rotavirus Antigen</Axiom>
               <New_Terms>Rotavirus G1 P(8) Live Antigen, A</New_Terms>
            </Change>
            <Change id="1443">
               <Axiom>Rotavirus G1 P7(5) Live Antigen, A SubClassOf Rotavirus Antigen</Axiom>
               <New_Terms>Rotavirus G1 P7(5) Live Antigen, A</New_Terms>
            </Change>
            <Change id="1445">
               <Axiom>Rotavirus G2 P7(5) Live Antigen, A SubClassOf Rotavirus Antigen</Axiom>
               <New_Terms>Rotavirus G2 P7(5) Live Antigen, A</New_Terms>
            </Change>
            <Change id="1446">
               <Axiom>Rotavirus G3 P7(5) Live Antigen, A SubClassOf Rotavirus Antigen</Axiom>
               <New_Terms>Rotavirus G3 P7(5) Live Antigen, A</New_Terms>
            </Change>
            <Change id="1447">
               <Axiom>Rotavirus G4 P7(5) Live Antigen, A SubClassOf Rotavirus Antigen</Axiom>
               <New_Terms>Rotavirus G4 P7(5) Live Antigen, A</New_Terms>
            </Change>
            <Change id="1448">
               <Axiom>Rotavirus G6 P1a(8) Live Antigen, A SubClassOf Rotavirus Antigen</Axiom>
               <New_Terms>Rotavirus G6 P1a(8) Live Antigen, A</New_Terms>
            </Change>
            <Change id="1442">
               <Axiom>Rotavirus SubClassOf Double Stranded RNA Virus</Axiom>
               <New_Terms>Rotavirus</New_Terms>
            </Change>
            <Change id="1449">
               <Axiom>Rotigotine SubClassOf Dopamine Agonist</Axiom>
               <New_Terms>Rotigotine</New_Terms>
            </Change>
            <Change id="1450">
               <Axiom>Rotoxamine Tartrate SubClassOf Histamine-1 Receptor Antagonist</Axiom>
               <New_Terms>Rotoxamine Tartrate</New_Terms>
            </Change>
            <Change id="1451">
               <Axiom>Rotraxate SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Rotraxate</New_Terms>
            </Change>
            <Change id="1452">
               <Axiom>Roxarsone SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Roxarsone</New_Terms>
            </Change>
            <Change id="1453">
               <Axiom>Roxoperone SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Roxoperone</New_Terms>
            </Change>
            <Change id="1455">
               <Axiom>Rubella Virus Live Antigen, A SubClassOf Rubella Virus Antigen</Axiom>
               <New_Terms>Rubella Virus Live Antigen, A</New_Terms>
            </Change>
            <Change id="1454">
               <Axiom>Rubella Virus SubClassOf Togaviridae</Axiom>
               <New_Terms>Rubella Virus, Togaviridae</New_Terms>
            </Change>
            <Change id="1456">
               <Axiom>SLC5A1 Gene SubClassOf Gene_Plays_Role_In_Process some Transport Process</Axiom>
               <New_Terms>SLC5A1 Gene</New_Terms>
            </Change>
            <Change id="1457">
               <Axiom>SLC5A1 Gene SubClassOf Transport Protein Gene</Axiom>
               <New_Terms>SLC5A1 Gene</New_Terms>
            </Change>
            <Change id="1458">
               <Axiom>SLC5A1 wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <New_Terms>SLC5A1 wt Allele</New_Terms>
            </Change>
            <Change id="1459">
               <Axiom>SLC5A1 wt Allele SubClassOf SLC5A1 Gene</Axiom>
               <New_Terms>SLC5A1 wt Allele, SLC5A1 Gene</New_Terms>
            </Change>
            <Change id="1462">
               <Axiom>Saccharin Sodium Anhydrous SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Saccharin Sodium Anhydrous</New_Terms>
            </Change>
            <Change id="1461">
               <Axiom>Saccharin Sodium SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Saccharin Sodium</New_Terms>
            </Change>
            <Change id="1460">
               <Axiom>Saccharin SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Saccharin</New_Terms>
            </Change>
            <Change id="1463">
               <Axiom>Sacral Lymph Node SubClassOf Lymph Node</Axiom>
               <New_Terms>Sacral Lymph Node</New_Terms>
            </Change>
            <Change id="1464">
               <Axiom>Safinamide SubClassOf Monoamine Oxidase Inhibitor</Axiom>
               <New_Terms>Safinamide</New_Terms>
            </Change>
            <Change id="1465">
               <Axiom>Salinomycin SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Salinomycin</New_Terms>
            </Change>
            <Change id="1466">
               <Axiom>Salmefamol SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Salmefamol</New_Terms>
            </Change>
            <Change id="1467">
               <Axiom>Salmonella Typhi Antigen, B SubClassOf Salmonella typhi Antigen</Axiom>
               <New_Terms>Salmonella Typhi Antigen, B</New_Terms>
            </Change>
            <Change id="1469">
               <Axiom>Salmonella typhi Ty2 Polysaccharide Antigen, A SubClassOf Salmonella typhi Antigen</Axiom>
               <New_Terms>Salmonella typhi Ty2 Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1468">
               <Axiom>Salmonella typhi Ty21a Live Antigen, A SubClassOf Salmonella typhi Antigen</Axiom>
               <New_Terms>Salmonella typhi Ty21a Live Antigen, A</New_Terms>
            </Change>
            <Change id="1471">
               <Axiom>Sapropterin Dihydrochloride SubClassOf Antioxidant</Axiom>
               <New_Terms>Sapropterin Dihydrochloride</New_Terms>
            </Change>
            <Change id="1470">
               <Axiom>Sapropterin SubClassOf Antioxidant</Axiom>
               <New_Terms>Sapropterin</New_Terms>
            </Change>
            <Change id="1474">
               <Axiom>Sarizotan Hydrochloride SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Sarizotan Hydrochloride</New_Terms>
            </Change>
            <Change id="1472">
               <Axiom>Sarizotan SubClassOf Dopamine Agonist</Axiom>
               <New_Terms>Sarizotan</New_Terms>
            </Change>
            <Change id="1473">
               <Axiom>Sarizotan SubClassOf Serotonin Agonist</Axiom>
               <New_Terms>Sarizotan</New_Terms>
            </Change>
            <Change id="1475">
               <Axiom>Seganserin SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Seganserin</New_Terms>
            </Change>
            <Change id="1476">
               <Axiom>Selprazine SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Selprazine</New_Terms>
            </Change>
            <Change id="1477">
               <Axiom>Semorphone SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Semorphone</New_Terms>
            </Change>
            <Change id="1478">
               <Axiom>Senicapoc SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Senicapoc</New_Terms>
            </Change>
            <Change id="1479">
               <Axiom>Sergliflozin SubClassOf Anti-diabetic Agent</Axiom>
               <New_Terms>Sergliflozin</New_Terms>
            </Change>
            <Change id="1480">
               <Axiom>Sermetacin SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Sermetacin</New_Terms>
            </Change>
            <Change id="1481">
               <Axiom>Setipafant SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Setipafant</New_Terms>
            </Change>
            <Change id="1482">
               <Axiom>Sevelamer Carbonate SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Sevelamer Carbonate</New_Terms>
            </Change>
            <Change id="1483">
               <Axiom>Sevopramide SubClassOf Muscle Relaxant</Axiom>
               <New_Terms>Sevopramide</New_Terms>
            </Change>
            <Change id="1485">
               <Axiom>Sibenadet Hydrochloride SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Sibenadet Hydrochloride</New_Terms>
            </Change>
            <Change id="1486">
               <Axiom>Sibenadet Hydrochloride SubClassOf Dopamine Agonist</Axiom>
               <New_Terms>Sibenadet Hydrochloride</New_Terms>
            </Change>
            <Change id="1484">
               <Axiom>Sibenadet SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Sibenadet</New_Terms>
            </Change>
            <Change id="1487">
               <Axiom>Silver Nitrate SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Silver Nitrate</New_Terms>
            </Change>
            <Change id="1489">
               <Axiom>Sitafloxacin Anhydrous SubClassOf Quinolone Compound</Axiom>
               <New_Terms>Sitafloxacin Anhydrous</New_Terms>
            </Change>
            <Change id="1488">
               <Axiom>Sitafloxacin SubClassOf Quinolone Compound</Axiom>
               <New_Terms>Sitafloxacin</New_Terms>
            </Change>
            <Change id="1490">
               <Axiom>Sivelestat Sodium SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Sivelestat Sodium</New_Terms>
            </Change>
            <Change id="1491">
               <Axiom>Skinfold Thickness Analysis SubClassOf Diagnostic Procedure</Axiom>
               <New_Terms>Skinfold Thickness Analysis</New_Terms>
            </Change>
            <Change id="1492">
               <Axiom>Smoothened Antagonist BMS-833923 SubClassOf Signal Transduction Inhibitor</Axiom>
               <New_Terms>Smoothened Antagonist BMS-833923</New_Terms>
            </Change>
            <Change id="1493">
               <Axiom>Sodium Aminobenzoate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Aminobenzoate</New_Terms>
            </Change>
            <Change id="1494">
               <Axiom>Sodium Bisulfate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Bisulfate</New_Terms>
            </Change>
            <Change id="1495">
               <Axiom>Sodium Bisulfide SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Bisulfide</New_Terms>
            </Change>
            <Change id="1497">
               <Axiom>Sodium Borate Decahydrate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Borate Decahydrate</New_Terms>
            </Change>
            <Change id="1496">
               <Axiom>Sodium Borate SubClassOf Industrial Product</Axiom>
               <New_Terms>Sodium Borate</New_Terms>
            </Change>
            <Change id="1498">
               <Axiom>Sodium Chlorate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Chlorate</New_Terms>
            </Change>
            <Change id="1499">
               <Axiom>Sodium Dithionite SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Dithionite</New_Terms>
            </Change>
            <Change id="1500">
               <Axiom>Sodium Feredetate SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Sodium Feredetate</New_Terms>
            </Change>
            <Change id="1501">
               <Axiom>Sodium Ferric Gluconate Complex SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Sodium Ferric Gluconate Complex</New_Terms>
            </Change>
            <Change id="1502">
               <Axiom>Sodium Formaldehyde Sulfoxylate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Formaldehyde Sulfoxylate</New_Terms>
            </Change>
            <Change id="1507">
               <Axiom>Sodium Glycididazole SubClassOf Radiosensitizing Agent</Axiom>
               <New_Terms>Sodium Glycididazole</New_Terms>
            </Change>
            <Change id="1508">
               <Axiom>Sodium Lauryl Sulfate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Lauryl Sulfate</New_Terms>
            </Change>
            <Change id="1509">
               <Axiom>Sodium Metabisulfite SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Metabisulfite</New_Terms>
            </Change>
            <Change id="1510">
               <Axiom>Sodium Phosphate, Tribasic Dodecahydrate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Phosphate, Tribasic Dodecahydrate</New_Terms>
            </Change>
            <Change id="1511">
               <Axiom>Sodium Pyrophosphate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Pyrophosphate</New_Terms>
            </Change>
            <Change id="1512">
               <Axiom>Sodium Stearate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Stearate</New_Terms>
            </Change>
            <Change id="1513">
               <Axiom>Sodium Tartrate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Tartrate</New_Terms>
            </Change>
            <Change id="1514">
               <Axiom>Sodium Thioglycolate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Thioglycolate</New_Terms>
            </Change>
            <Change id="1515">
               <Axiom>Sodium Trimetaphosphate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Sodium Trimetaphosphate</New_Terms>
            </Change>
            <Change id="1503">
               <Axiom>Sodium/Glucose Cotransporter 1 SubClassOf Gene_Product_Encoded_By_Gene some SLC5A1 Gene</Axiom>
               <New_Terms>Sodium/Glucose Cotransporter 1, SLC5A1 Gene</New_Terms>
            </Change>
            <Change id="1504">
               <Axiom>Sodium/Glucose Cotransporter 1 SubClassOf Gene_Product_Has_Biochemical_Function some Transport Protein</Axiom>
               <New_Terms>Sodium/Glucose Cotransporter 1</New_Terms>
            </Change>
            <Change id="1505">
               <Axiom>Sodium/Glucose Cotransporter 1 SubClassOf Gene_Product_Plays_Role_In_Biological_Process some Transport Process</Axiom>
               <New_Terms>Sodium/Glucose Cotransporter 1</New_Terms>
            </Change>
            <Change id="1506">
               <Axiom>Sodium/Glucose Cotransporter 1 SubClassOf Transport Protein</Axiom>
               <New_Terms>Sodium/Glucose Cotransporter 1</New_Terms>
            </Change>
            <Change id="1516">
               <Axiom>Sotirimod SubClassOf Immunostimulant</Axiom>
               <New_Terms>Sotirimod</New_Terms>
            </Change>
            <Change id="1517">
               <Axiom>South or Central American Indian SubClassOf Race</Axiom>
               <New_Terms>South or Central American Indian</New_Terms>
            </Change>
            <Change id="1518">
               <Axiom>Span SubClassOf Distance</Axiom>
               <New_Terms>Span</New_Terms>
            </Change>
            <Change id="1519">
               <Axiom>Squalane SubClassOf Industrial Aid</Axiom>
               <New_Terms>Squalane</New_Terms>
            </Change>
            <Change id="1520">
               <Axiom>Squalene SubClassOf Terpene Compound</Axiom>
               <New_Terms>Squalene</New_Terms>
            </Change>
            <Change id="1521">
               <Axiom>Squirrel Monkey SubClassOf Monkey</Axiom>
               <New_Terms>Squirrel Monkey</New_Terms>
            </Change>
            <Change id="1522">
               <Axiom>Stannous Chloride Anhydrous SubClassOf Industrial Aid</Axiom>
               <New_Terms>Stannous Chloride Anhydrous</New_Terms>
            </Change>
            <Change id="1523">
               <Axiom>Stannous Fluoride SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Stannous Fluoride</New_Terms>
            </Change>
            <Change id="1524">
               <Axiom>Stannous Tartrate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Stannous Tartrate</New_Terms>
            </Change>
            <Change id="1525">
               <Axiom>Stearalkonium Chloride SubClassOf Industrial Aid</Axiom>
               <New_Terms>Stearalkonium Chloride</New_Terms>
            </Change>
            <Change id="1526">
               <Axiom>Stearyl Alcohol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Stearyl Alcohol</New_Terms>
            </Change>
            <Change id="1527">
               <Axiom>Strawberry-Blackberry-Black Raspberry-Blueberry Mixture SubClassOf Dietary Supplement</Axiom>
               <New_Terms>Strawberry-Blackberry-Black Raspberry-Blueberry Mixture</New_Terms>
            </Change>
            <Change id="1540">
               <Axiom>Streptococcus pneumoniae Type 1 Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 1 Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1528">
               <Axiom>Streptococcus pneumoniae Type 10A Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 10A Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1529">
               <Axiom>Streptococcus pneumoniae Type 11A Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 11A Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1530">
               <Axiom>Streptococcus pneumoniae Type 12F Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 12F Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1531">
               <Axiom>Streptococcus pneumoniae Type 14 Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 14 Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1532">
               <Axiom>Streptococcus pneumoniae Type 14 Polysaccharide Conjugate Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 14 Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1533">
               <Axiom>Streptococcus pneumoniae Type 15B Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 15B Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1534">
               <Axiom>Streptococcus pneumoniae Type 17F Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 17F Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1535">
               <Axiom>Streptococcus pneumoniae Type 18C Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 18C Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1536">
               <Axiom>Streptococcus pneumoniae Type 18C Polysaccharide Conjugate Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 18C Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1537">
               <Axiom>Streptococcus pneumoniae Type 19A Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 19A Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1538">
               <Axiom>Streptococcus pneumoniae Type 19F Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 19F Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1539">
               <Axiom>Streptococcus pneumoniae Type 19F Polysaccharide Conjugate Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 19F Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1545">
               <Axiom>Streptococcus pneumoniae Type 2 Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 2 Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1541">
               <Axiom>Streptococcus pneumoniae Type 20 Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 20 Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1542">
               <Axiom>Streptococcus pneumoniae Type 22F Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 22F Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1543">
               <Axiom>Streptococcus pneumoniae Type 23F Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 23F Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1544">
               <Axiom>Streptococcus pneumoniae Type 23F Polysaccharide Conjugate Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 23F Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1547">
               <Axiom>Streptococcus pneumoniae Type 3 Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 3 Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1546">
               <Axiom>Streptococcus pneumoniae Type 33F Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 33F Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1548">
               <Axiom>Streptococcus pneumoniae Type 4 Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 4 Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1549">
               <Axiom>Streptococcus pneumoniae Type 4 Polysaccharide Conjugate Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 4 Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1550">
               <Axiom>Streptococcus pneumoniae Type 5 Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 5 Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1551">
               <Axiom>Streptococcus pneumoniae Type 6B Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 6B Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1552">
               <Axiom>Streptococcus pneumoniae Type 6B Polysaccharide Conjugate Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 6B Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1553">
               <Axiom>Streptococcus pneumoniae Type 7F Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 7F Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1554">
               <Axiom>Streptococcus pneumoniae Type 8 Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 8 Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1555">
               <Axiom>Streptococcus pneumoniae Type 9N Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 9N Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1556">
               <Axiom>Streptococcus pneumoniae Type 9V Polysaccharide Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 9V Polysaccharide Antigen, A</New_Terms>
            </Change>
            <Change id="1557">
               <Axiom>Streptococcus pneumoniae Type 9V Polysaccharide Conjugate Antigen, A SubClassOf Streptococcus pneumoniae Antigen</Axiom>
               <New_Terms>Streptococcus pneumoniae Type 9V Polysaccharide Conjugate Antigen, A</New_Terms>
            </Change>
            <Change id="1558">
               <Axiom>Sublumbar Lymph Node SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Sublumbar Lymph Node</New_Terms>
            </Change>
            <Change id="1559">
               <Axiom>Submandibular Lymph Node SubClassOf Head and Neck Lymph Node</Axiom>
               <New_Terms>Submandibular Lymph Node</New_Terms>
            </Change>
            <Change id="1560">
               <Axiom>Sugammadex Sodium SubClassOf Pharmacologic Substance</Axiom>
               <New_Terms>Sugammadex Sodium</New_Terms>
            </Change>
            <Change id="1561">
               <Axiom>Sulfacecole SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Sulfacecole</New_Terms>
            </Change>
            <Change id="1562">
               <Axiom>Sulfachlorpyridazine SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfachlorpyridazine</New_Terms>
            </Change>
            <Change id="1564">
               <Axiom>Sulfadimethoxine Sodium SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfadimethoxine Sodium</New_Terms>
            </Change>
            <Change id="1563">
               <Axiom>Sulfadimethoxine SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfadimethoxine</New_Terms>
            </Change>
            <Change id="1565">
               <Axiom>Sulfaguanidine SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfaguanidine</New_Terms>
            </Change>
            <Change id="1566">
               <Axiom>Sulfan Blue SubClassOf Dye</Axiom>
               <New_Terms>Sulfan Blue</New_Terms>
            </Change>
            <Change id="1567">
               <Axiom>Sulfanitran SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfanitran</New_Terms>
            </Change>
            <Change id="1568">
               <Axiom>Sulfaquinoxaline SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfaquinoxaline</New_Terms>
            </Change>
            <Change id="1569">
               <Axiom>Sulfasomizole SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfasomizole</New_Terms>
            </Change>
            <Change id="1570">
               <Axiom>Sulfasuccinamide SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfasuccinamide</New_Terms>
            </Change>
            <Change id="1571">
               <Axiom>Sulfathiourea SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfathiourea</New_Terms>
            </Change>
            <Change id="1572">
               <Axiom>Sulfatolamide SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfatolamide</New_Terms>
            </Change>
            <Change id="1573">
               <Axiom>Sulfatrozole SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfatrozole</New_Terms>
            </Change>
            <Change id="1574">
               <Axiom>Sulfonterol SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Sulfonterol</New_Terms>
            </Change>
            <Change id="1575">
               <Axiom>Suloxifen SubClassOf Bronchodilator</Axiom>
               <New_Terms>Suloxifen</New_Terms>
            </Change>
            <Change id="1576">
               <Axiom>Sulukast SubClassOf Bronchodilator</Axiom>
               <New_Terms>Sulukast</New_Terms>
            </Change>
            <Change id="1577">
               <Axiom>Sumanirole SubClassOf Dopamine Agonist</Axiom>
               <New_Terms>Sumanirole</New_Terms>
            </Change>
            <Change id="1578">
               <Axiom>Suprapharyngeal Lymph Node SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Suprapharyngeal Lymph Node</New_Terms>
            </Change>
            <Change id="1579">
               <Axiom>Sural Nerve SubClassOf Peripheral Nerve</Axiom>
               <New_Terms>Sural Nerve</New_Terms>
            </Change>
            <Change id="1580">
               <Axiom>Suxemerid Sulfate SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Suxemerid Sulfate</New_Terms>
            </Change>
            <Change id="1581">
               <Axiom>Symetine SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Symetine</New_Terms>
            </Change>
            <Change id="1582">
               <Axiom>Syrian Hamster SubClassOf Hamster</Axiom>
               <New_Terms>Syrian Hamster</New_Terms>
            </Change>
            <Change id="1583">
               <Axiom>T-Butylhydroquinone SubClassOf Industrial Aid</Axiom>
               <New_Terms>T-Butylhydroquinone</New_Terms>
            </Change>
            <Change id="1584">
               <Axiom>TGF-b-Resistant LMP-Specific Cytotoxic T-Lymphocytes SubClassOf Biological Agent</Axiom>
               <New_Terms>TGF-b-Resistant LMP-Specific Cytotoxic T-Lymphocytes</New_Terms>
            </Change>
            <Change id="1585">
               <Axiom>TLR Agonist CADI-05 SubClassOf Immunostimulant</Axiom>
               <New_Terms>TLR Agonist CADI-05</New_Terms>
            </Change>
            <Change id="1586">
               <Axiom>Tabilautide SubClassOf Biological Response Modifier</Axiom>
               <New_Terms>Tabilautide</New_Terms>
            </Change>
            <Change id="1587">
               <Axiom>Tabimorelin SubClassOf Growth Hormone-Releasing Hormone Analogue</Axiom>
               <New_Terms>Tabimorelin</New_Terms>
            </Change>
            <Change id="1588">
               <Axiom>Tacapenem SubClassOf Beta-Lactam Antibiotic</Axiom>
               <New_Terms>Tacapenem</New_Terms>
            </Change>
            <Change id="1589">
               <Axiom>Tacedinaline SubClassOf Histone Deacetylase Inhibitor</Axiom>
               <New_Terms>Tacedinaline</New_Terms>
            </Change>
            <Change id="1590">
               <Axiom>Tail SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Tail</New_Terms>
            </Change>
            <Change id="1591">
               <Axiom>Talibegron Hydrochloride SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Talibegron Hydrochloride</New_Terms>
            </Change>
            <Change id="1592">
               <Axiom>Talmetacin SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Talmetacin</New_Terms>
            </Change>
            <Change id="1593">
               <Axiom>Talmetoprim SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Talmetoprim</New_Terms>
            </Change>
            <Change id="1594">
               <Axiom>Talnetant SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Talnetant</New_Terms>
            </Change>
            <Change id="1595">
               <Axiom>Talosalate SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Talosalate</New_Terms>
            </Change>
            <Change id="1596">
               <Axiom>Taltirelin SubClassOf Therapeutic Hormone</Axiom>
               <New_Terms>Taltirelin</New_Terms>
            </Change>
            <Change id="1597">
               <Axiom>Tameridone SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Tameridone</New_Terms>
            </Change>
            <Change id="1598">
               <Axiom>Tamitinol SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Tamitinol</New_Terms>
            </Change>
            <Change id="1599">
               <Axiom>Tamolarizine SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Tamolarizine</New_Terms>
            </Change>
            <Change id="1600">
               <Axiom>Taniplon SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Taniplon</New_Terms>
            </Change>
            <Change id="1601">
               <Axiom>Taprostene SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Taprostene</New_Terms>
            </Change>
            <Change id="1602">
               <Axiom>Tarazepide SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Tarazepide</New_Terms>
            </Change>
            <Change id="1604">
               <Axiom>Taribavirin Hydrochloride SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Taribavirin Hydrochloride</New_Terms>
            </Change>
            <Change id="1603">
               <Axiom>Taribavirin SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Taribavirin</New_Terms>
            </Change>
            <Change id="1605">
               <Axiom>Tasidotin SubClassOf Tubulin Binding Agent</Axiom>
               <New_Terms>Tasidotin</New_Terms>
            </Change>
            <Change id="1606">
               <Axiom>Tattoo Site SubClassOf Anatomic Site</Axiom>
               <New_Terms>Tattoo Site</New_Terms>
            </Change>
            <Change id="1607">
               <Axiom>Tazanolast SubClassOf Mast Cell Stabilizer</Axiom>
               <New_Terms>Tazanolast</New_Terms>
            </Change>
            <Change id="1608">
               <Axiom>Tazeprofen SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Tazeprofen</New_Terms>
            </Change>
            <Change id="1609">
               <Axiom>Taziprinone SubClassOf Antitussive Agent</Axiom>
               <New_Terms>Taziprinone</New_Terms>
            </Change>
            <Change id="1610">
               <Axiom>Tazofelone SubClassOf Immunosuppressant</Axiom>
               <New_Terms>Tazofelone</New_Terms>
            </Change>
            <Change id="1611">
               <Axiom>Teat SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Teat</New_Terms>
            </Change>
            <Change id="1612">
               <Axiom>Tebanicline SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Tebanicline</New_Terms>
            </Change>
            <Change id="1613">
               <Axiom>Tebipenem Pivoxil SubClassOf Beta-Lactam Antibiotic</Axiom>
               <New_Terms>Tebipenem Pivoxil</New_Terms>
            </Change>
            <Change id="1614">
               <Axiom>Tecadenoson SubClassOf Antiarrhythmic Agent</Axiom>
               <New_Terms>Tecadenoson</New_Terms>
            </Change>
            <Change id="1616">
               <Axiom>Tecalcet Hydrochloride SubClassOf Hormone Antagonist</Axiom>
               <New_Terms>Tecalcet Hydrochloride</New_Terms>
            </Change>
            <Change id="1615">
               <Axiom>Tecalcet SubClassOf Hormone Antagonist</Axiom>
               <New_Terms>Tecalcet</New_Terms>
            </Change>
            <Change id="1617">
               <Axiom>Teclothiazide SubClassOf Thiazide Diuretic</Axiom>
               <New_Terms>Teclothiazide</New_Terms>
            </Change>
            <Change id="1618">
               <Axiom>Teflutixol SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Teflutixol</New_Terms>
            </Change>
            <Change id="1619">
               <Axiom>Tegaserod Maleate SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Tegaserod Maleate</New_Terms>
            </Change>
            <Change id="1620">
               <Axiom>Telinavir SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Telinavir</New_Terms>
            </Change>
            <Change id="1621">
               <Axiom>Temocillin SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Temocillin</New_Terms>
            </Change>
            <Change id="1622">
               <Axiom>Temodox SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Temodox</New_Terms>
            </Change>
            <Change id="1623">
               <Axiom>Tenilapine SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Tenilapine</New_Terms>
            </Change>
            <Change id="1624">
               <Axiom>Tenilsetam SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Tenilsetam</New_Terms>
            </Change>
            <Change id="1625">
               <Axiom>Tenosal SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Tenosal</New_Terms>
            </Change>
            <Change id="1626">
               <Axiom>Tenosiprol SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Tenosiprol</New_Terms>
            </Change>
            <Change id="1627">
               <Axiom>Tepirindole SubClassOf Dopamine Antagonist</Axiom>
               <New_Terms>Tepirindole</New_Terms>
            </Change>
            <Change id="1628">
               <Axiom>Tepoxalin SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Tepoxalin</New_Terms>
            </Change>
            <Change id="1629">
               <Axiom>Terflavoxate SubClassOf Antispasmotic Agent</Axiom>
               <New_Terms>Terflavoxate</New_Terms>
            </Change>
            <Change id="1630">
               <Axiom>Teriflunomide SubClassOf Enzyme Inhibitor</Axiom>
               <New_Terms>Teriflunomide</New_Terms>
            </Change>
            <Change id="1631">
               <Axiom>Terlipressin SubClassOf Recombinant Vasopressin</Axiom>
               <New_Terms>Terlipressin</New_Terms>
            </Change>
            <Change id="1632">
               <Axiom>Ternidazole SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Ternidazole</New_Terms>
            </Change>
            <Change id="1633">
               <Axiom>Terofenamate SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Terofenamate</New_Terms>
            </Change>
            <Change id="1634">
               <Axiom>Tesamorelin SubClassOf Gonadotropin-Releasing Hormone Analogue</Axiom>
               <New_Terms>Tesamorelin</New_Terms>
            </Change>
            <Change id="1635">
               <Axiom>Testis/Epididymis SubClassOf Tissue Sample</Axiom>
               <New_Terms>Testis/Epididymis</New_Terms>
            </Change>
            <Change id="1637">
               <Axiom>Tetroxoprim SubClassOf Dihydrofolate Reductase Inhibitor</Axiom>
               <New_Terms>Tetroxoprim</New_Terms>
            </Change>
            <Change id="1638">
               <Axiom>Texacromil SubClassOf Mast Cell Stabilizer</Axiom>
               <New_Terms>Texacromil</New_Terms>
            </Change>
            <Change id="1639">
               <Axiom>Tezampanel SubClassOf Analgesic Agent</Axiom>
               <New_Terms>Tezampanel</New_Terms>
            </Change>
            <Change id="1640">
               <Axiom>Thialbarbital SubClassOf Barbiturate</Axiom>
               <New_Terms>Thialbarbital</New_Terms>
            </Change>
            <Change id="1641">
               <Axiom>Thiocarbanidin SubClassOf Antitubercular Agent</Axiom>
               <New_Terms>Thiocarbanidin</New_Terms>
            </Change>
            <Change id="1642">
               <Axiom>Thioglycerol SubClassOf Industrial Aid</Axiom>
               <New_Terms>Thioglycerol</New_Terms>
            </Change>
            <Change id="1643">
               <Axiom>Thioglycolic Acid SubClassOf Industrial Aid</Axiom>
               <New_Terms>Thioglycolic Acid</New_Terms>
            </Change>
            <Change id="1644">
               <Axiom>Thiophanate SubClassOf Pesticide</Axiom>
               <New_Terms>Thiophanate</New_Terms>
            </Change>
            <Change id="1646">
               <Axiom>Thiphencillin Potassium SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Thiphencillin Potassium</New_Terms>
            </Change>
            <Change id="1645">
               <Axiom>Thiphencillin SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Thiphencillin</New_Terms>
            </Change>
            <Change id="1647">
               <Axiom>Thymol SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Thymol</New_Terms>
            </Change>
            <Change id="1648">
               <Axiom>Thymotrinan SubClassOf Immunostimulant</Axiom>
               <New_Terms>Thymotrinan</New_Terms>
            </Change>
            <Change id="1649">
               <Axiom>Thyroid/Parathyroid SubClassOf Tissue Sample</Axiom>
               <New_Terms>Thyroid/Parathyroid</New_Terms>
            </Change>
            <Change id="1650">
               <Axiom>Tiametonium Iodide SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Tiametonium Iodide</New_Terms>
            </Change>
            <Change id="1651">
               <Axiom>Tianafac SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Tianafac</New_Terms>
            </Change>
            <Change id="1652">
               <Axiom>Tiazuril SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Tiazuril</New_Terms>
            </Change>
            <Change id="1653">
               <Axiom>Ticagrelor SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Ticagrelor</New_Terms>
            </Change>
            <Change id="1654">
               <Axiom>Tidiacic SubClassOf Hepatoprotective Agent</Axiom>
               <New_Terms>Tidiacic</New_Terms>
            </Change>
            <Change id="1655">
               <Axiom>Tienocarbine SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Tienocarbine</New_Terms>
            </Change>
            <Change id="1656">
               <Axiom>Tilisolol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Tilisolol</New_Terms>
            </Change>
            <Change id="1657">
               <Axiom>Tilmacoxib SubClassOf Cyclooxygenase Inhibitor</Axiom>
               <New_Terms>Tilmacoxib</New_Terms>
            </Change>
            <Change id="1658">
               <Axiom>Tilnoprofen Arbamel SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Tilnoprofen Arbamel</New_Terms>
            </Change>
            <Change id="1659">
               <Axiom>Timelotem SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Timelotem</New_Terms>
            </Change>
            <Change id="1660">
               <Axiom>Timiperone SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Timiperone</New_Terms>
            </Change>
            <Change id="1661">
               <Axiom>Timirdine SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Timirdine</New_Terms>
            </Change>
            <Change id="1662">
               <Axiom>Tinoridine SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Tinoridine</New_Terms>
            </Change>
            <Change id="1663">
               <Axiom>Tioctilate SubClassOf Pesticide</Axiom>
               <New_Terms>Tioctilate</New_Terms>
            </Change>
            <Change id="1664">
               <Axiom>Tiomesterone SubClassOf Therapeutic Androgen</Axiom>
               <New_Terms>Tiomesterone</New_Terms>
            </Change>
            <Change id="1665">
               <Axiom>Tiopropamine SubClassOf Anti-ulcer Agent</Axiom>
               <New_Terms>Tiopropamine</New_Terms>
            </Change>
            <Change id="1666">
               <Axiom>Tioxacin SubClassOf Quinolone Compound</Axiom>
               <New_Terms>Tioxacin</New_Terms>
            </Change>
            <Change id="1667">
               <Axiom>Tioxaprofen SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Tioxaprofen</New_Terms>
            </Change>
            <Change id="1668">
               <Axiom>Tioxolone SubClassOf Astringent</Axiom>
               <New_Terms>Tioxolone</New_Terms>
            </Change>
            <Change id="1669">
               <Axiom>Tipepidine SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Tipepidine</New_Terms>
            </Change>
            <Change id="1670">
               <Axiom>Tipetropium Bromide SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Tipetropium Bromide</New_Terms>
            </Change>
            <Change id="1671">
               <Axiom>Tipindole SubClassOf Serotonin Antagonist</Axiom>
               <New_Terms>Tipindole</New_Terms>
            </Change>
            <Change id="1672">
               <Axiom>Tiplasinin SubClassOf Thrombolytic Agent</Axiom>
               <New_Terms>Tiplasinin</New_Terms>
            </Change>
            <Change id="1673">
               <Axiom>Tiprinast Meglumine SubClassOf Mast Cell Stabilizer</Axiom>
               <New_Terms>Tiprinast Meglumine</New_Terms>
            </Change>
            <Change id="1674">
               <Axiom>Tipropidil Hydrochloride SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Tipropidil Hydrochloride</New_Terms>
            </Change>
            <Change id="1675">
               <Axiom>Tiprotimod SubClassOf Immunostimulant</Axiom>
               <New_Terms>Tiprotimod</New_Terms>
            </Change>
            <Change id="1676">
               <Axiom>Tirofiban SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Tirofiban</New_Terms>
            </Change>
            <Change id="1677">
               <Axiom>Tiviciclovir SubClassOf Antiviral Agent</Axiom>
               <New_Terms>Tiviciclovir</New_Terms>
            </Change>
            <Change id="1678">
               <Axiom>Tivirapine SubClassOf Reverse Transcriptase Inhibitor</Axiom>
               <New_Terms>Tivirapine</New_Terms>
            </Change>
            <Change id="1679">
               <Axiom>Tixadil SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Tixadil</New_Terms>
            </Change>
            <Change id="1680">
               <Axiom>Tobicillin SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Tobicillin</New_Terms>
            </Change>
            <Change id="1681">
               <Axiom>Tobuterol SubClassOf Beta-Adrenergic Agonist</Axiom>
               <New_Terms>Tobuterol</New_Terms>
            </Change>
            <Change id="1682">
               <Axiom>Todralazine SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Todralazine</New_Terms>
            </Change>
            <Change id="1683">
               <Axiom>Tofimilast SubClassOf Phosphodiesterase Inhibitor</Axiom>
               <New_Terms>Tofimilast</New_Terms>
            </Change>
            <Change id="1684">
               <Axiom>Tofisoline SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Tofisoline</New_Terms>
            </Change>
            <Change id="1685">
               <Axiom>Togaviridae SubClassOf Positive Sense ssRNA Virus</Axiom>
               <New_Terms>Togaviridae</New_Terms>
            </Change>
            <Change id="1686">
               <Axiom>Tolbutamide Sodium SubClassOf Anti-diabetic Agent</Axiom>
               <New_Terms>Tolbutamide Sodium</New_Terms>
            </Change>
            <Change id="1687">
               <Axiom>Toliodium Chloride SubClassOf Topical Anti-Infective Agent</Axiom>
               <New_Terms>Toliodium Chloride</New_Terms>
            </Change>
            <Change id="1688">
               <Axiom>Tolpiprazole SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Tolpiprazole</New_Terms>
            </Change>
            <Change id="1689">
               <Axiom>Toluene SubClassOf Aromatic Hydrocarbon</Axiom>
               <New_Terms>Toluene</New_Terms>
            </Change>
            <Change id="1690">
               <Axiom>Toluene SubClassOf Reagent</Axiom>
               <New_Terms>Toluene</New_Terms>
            </Change>
            <Change id="1691">
               <Axiom>Tolufazepam SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Tolufazepam</New_Terms>
            </Change>
            <Change id="1692">
               <Axiom>Tolvaptan SubClassOf Vasopressin Antagonist</Axiom>
               <New_Terms>Tolvaptan</New_Terms>
            </Change>
            <Change id="1693">
               <Axiom>Tomopenem SubClassOf Beta-Lactam Antibiotic</Axiom>
               <New_Terms>Tomopenem</New_Terms>
            </Change>
            <Change id="1694">
               <Axiom>Toprilidine SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Toprilidine</New_Terms>
            </Change>
            <Change id="1695">
               <Axiom>Tosagestin SubClassOf Progestin</Axiom>
               <New_Terms>Tosagestin</New_Terms>
            </Change>
            <Change id="1696">
               <Axiom>Tosulur SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Tosulur</New_Terms>
            </Change>
            <Change id="1697">
               <Axiom>Totrombopag Choline SubClassOf Chemoprotective Agent</Axiom>
               <New_Terms>Totrombopag Choline</New_Terms>
            </Change>
            <Change id="1698">
               <Axiom>Tracheobronchial Lymph Node SubClassOf Lymph Node by Anatomic Site</Axiom>
               <New_Terms>Tracheobronchial Lymph Node</New_Terms>
            </Change>
            <Change id="1699">
               <Axiom>Tramiprosate SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Tramiprosate</New_Terms>
            </Change>
            <Change id="1700">
               <Axiom>Triamcinolone Furetonide SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Triamcinolone Furetonide</New_Terms>
            </Change>
            <Change id="1701">
               <Axiom>Tribendilol SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Tribendilol</New_Terms>
            </Change>
            <Change id="1702">
               <Axiom>Tribuzone SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Tribuzone</New_Terms>
            </Change>
            <Change id="1703">
               <Axiom>Trichloromonofluoromethane SubClassOf Industrial Product</Axiom>
               <New_Terms>Trichloromonofluoromethane</New_Terms>
            </Change>
            <Change id="1704">
               <Axiom>Triclodazol SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Triclodazol</New_Terms>
            </Change>
            <Change id="1705">
               <Axiom>Triclofylline SubClassOf Bronchodilator</Axiom>
               <New_Terms>Triclofylline</New_Terms>
            </Change>
            <Change id="1706">
               <Axiom>Tridihexethyl SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Tridihexethyl</New_Terms>
            </Change>
            <Change id="1707">
               <Axiom>Triethyl Citrate SubClassOf Industrial Aid</Axiom>
               <New_Terms>Triethyl Citrate</New_Terms>
            </Change>
            <Change id="1708">
               <Axiom>Trifenagrel SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Trifenagrel</New_Terms>
            </Change>
            <Change id="1709">
               <Axiom>Trifezolac SubClassOf Nonsteroidal Antiinflammatory Drug</Axiom>
               <New_Terms>Trifezolac</New_Terms>
            </Change>
            <Change id="1710">
               <Axiom>Triflocin SubClassOf Diuretic</Axiom>
               <New_Terms>Triflocin</New_Terms>
            </Change>
            <Change id="1711">
               <Axiom>Trifluomeprazine SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Trifluomeprazine</New_Terms>
            </Change>
            <Change id="1712">
               <Axiom>Trifluperidol SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Trifluperidol</New_Terms>
            </Change>
            <Change id="1713">
               <Axiom>Triflusal SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Triflusal</New_Terms>
            </Change>
            <Change id="1714">
               <Axiom>Trifosmin SubClassOf Diagnostic Reagent</Axiom>
               <New_Terms>Trifosmin</New_Terms>
            </Change>
            <Change id="1715">
               <Axiom>Trimeperidine SubClassOf Opioid Receptor Agonist</Axiom>
               <New_Terms>Trimeperidine</New_Terms>
            </Change>
            <Change id="1716">
               <Axiom>Trimetazidine SubClassOf Cardiovascular Agent</Axiom>
               <New_Terms>Trimetazidine</New_Terms>
            </Change>
            <Change id="1717">
               <Axiom>Trimethaphan SubClassOf Nicotinic Antagonist</Axiom>
               <New_Terms>Trimethaphan</New_Terms>
            </Change>
            <Change id="1718">
               <Axiom>Trimethoprim Hydrochloride SubClassOf Dihydrofolate Reductase Inhibitor</Axiom>
               <New_Terms>Trimethoprim Hydrochloride</New_Terms>
            </Change>
            <Change id="1719">
               <Axiom>Trimetozine SubClassOf Anxiolytic</Axiom>
               <New_Terms>Trimetozine</New_Terms>
            </Change>
            <Change id="1720">
               <Axiom>Trimexiline SubClassOf Nitrogen Compound</Axiom>
               <New_Terms>Trimexiline</New_Terms>
            </Change>
            <Change id="1721">
               <Axiom>Triolein SubClassOf Lipid</Axiom>
               <New_Terms>Triolein</New_Terms>
            </Change>
            <Change id="1722">
               <Axiom>Tristearin SubClassOf Lipid</Axiom>
               <New_Terms>Tristearin</New_Terms>
            </Change>
            <Change id="1723">
               <Axiom>Tropantiol SubClassOf Chelating Agent</Axiom>
               <New_Terms>Tropantiol</New_Terms>
            </Change>
            <Change id="1724">
               <Axiom>Troquidazole SubClassOf Antiprotozoal Agent</Axiom>
               <New_Terms>Troquidazole</New_Terms>
            </Change>
            <Change id="1725">
               <Axiom>Trospium SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Trospium</New_Terms>
            </Change>
            <Change id="1726">
               <Axiom>Trovirdine SubClassOf Reverse Transcriptase Inhibitor</Axiom>
               <New_Terms>Trovirdine</New_Terms>
            </Change>
            <Change id="1727">
               <Axiom>Tubulin Inhibitor CYT997 SubClassOf Tubulin Binding Agent</Axiom>
               <New_Terms>Tubulin Inhibitor CYT997</New_Terms>
            </Change>
            <Change id="1728">
               <Axiom>Tyropanic Acid SubClassOf Contrast Agent</Axiom>
               <New_Terms>Tyropanic Acid</New_Terms>
            </Change>
            <Change id="1729">
               <Axiom>Tyroserleutide SubClassOf Antineoplastic Agent</Axiom>
               <New_Terms>Tyroserleutide</New_Terms>
            </Change>
            <Change id="1730">
               <Axiom>Tyrosine Kinase Inhibitor MGCD265 SubClassOf Tyrosine Kinase Inhibitor</Axiom>
               <New_Terms>Tyrosine Kinase Inhibitor MGCD265</New_Terms>
            </Change>
            <Change id="1732">
               <Axiom>Ufiprazole SubClassOf Proton Pump Inhibitor</Axiom>
               <New_Terms>Ufiprazole</New_Terms>
            </Change>
            <Change id="1733">
               <Axiom>Ulifloxacin SubClassOf Quinolone Compound</Axiom>
               <New_Terms>Ulifloxacin</New_Terms>
            </Change>
            <Change id="1734">
               <Axiom>Umbilicus SubClassOf Other Anatomic Concept</Axiom>
               <New_Terms>Umbilicus</New_Terms>
            </Change>
            <Change id="1735">
               <Axiom>Unit of Radiant Flux SubClassOf Unit of Illuminance</Axiom>
               <New_Terms>Unit of Radiant Flux</New_Terms>
            </Change>
            <Change id="1736">
               <Axiom>Unit of Radioactive Decay SubClassOf Unit of Radiation</Axiom>
               <New_Terms>Unit of Radioactive Decay</New_Terms>
            </Change>
            <Change id="1738">
               <Axiom>Unit per Gram SubClassOf Arbitrary Unit of Substance Rate</Axiom>
               <New_Terms>Unit per Gram</New_Terms>
            </Change>
            <Change id="1737">
               <Axiom>Unit per Gram SubClassOf Dose Calculation Unit</Axiom>
               <New_Terms>Unit per Gram</New_Terms>
            </Change>
            <Change id="1740">
               <Axiom>Unit per Milliliter SubClassOf Arbitrary Unit of Substance Rate</Axiom>
               <New_Terms>Unit per Milliliter</New_Terms>
            </Change>
            <Change id="1739">
               <Axiom>Unit per Milliliter SubClassOf Dose Calculation Unit</Axiom>
               <New_Terms>Unit per Milliliter</New_Terms>
            </Change>
            <Change id="1741">
               <Axiom>Unoprostone SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Unoprostone</New_Terms>
            </Change>
            <Change id="1742">
               <Axiom>Unusual SubClassOf General Qualifier</Axiom>
               <New_Terms>Unusual</New_Terms>
            </Change>
            <Change id="1743">
               <Axiom>Urban SubClassOf General Qualifier</Axiom>
               <New_Terms>Urban</New_Terms>
            </Change>
            <Change id="1744">
               <Axiom>Uterus/Ovaries SubClassOf Tissue Sample</Axiom>
               <New_Terms>Uterus/Ovaries</New_Terms>
            </Change>
            <Change id="1745">
               <Axiom>VEGFR1-1084 Peptide Vaccine SubClassOf Peptide Vaccine</Axiom>
               <New_Terms>VEGFR1-1084 Peptide Vaccine</New_Terms>
            </Change>
            <Change id="1746">
               <Axiom>Vaccinia Virus Live Antigen, A SubClassOf Vaccinia Virus Antigen</Axiom>
               <New_Terms>Vaccinia Virus Live Antigen, A</New_Terms>
            </Change>
            <Change id="1747">
               <Axiom>Vaccinia Virus Live Antigen, B SubClassOf Vaccinia Virus Antigen</Axiom>
               <New_Terms>Vaccinia Virus Live Antigen, B</New_Terms>
            </Change>
            <Change id="1748">
               <Axiom>Valofane SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Valofane</New_Terms>
            </Change>
            <Change id="1749">
               <Axiom>Vanillin SubClassOf Industrial Aid</Axiom>
               <New_Terms>Vanillin</New_Terms>
            </Change>
            <Change id="1751">
               <Axiom>Vapiprost Hydrochloride SubClassOf Prostaglandin Compound</Axiom>
               <New_Terms>Vapiprost Hydrochloride</New_Terms>
            </Change>
            <Change id="1750">
               <Axiom>Vapiprost SubClassOf Antiplatelet Agent</Axiom>
               <New_Terms>Vapiprost</New_Terms>
            </Change>
            <Change id="1752">
               <Axiom>Vardenafil Dihydrochloride SubClassOf Phosphodiesterase Inhibitor</Axiom>
               <New_Terms>Vardenafil Dihydrochloride</New_Terms>
            </Change>
            <Change id="1753">
               <Axiom>Varicella-Zoster Virus Live Antigen, A SubClassOf Varicella-Zoster Virus Antigen</Axiom>
               <New_Terms>Varicella-Zoster Virus Live Antigen, A</New_Terms>
            </Change>
            <Change id="1754">
               <Axiom>Ventral Prostate Gland SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Ventral Prostate Gland</New_Terms>
            </Change>
            <Change id="1755">
               <Axiom>Vidarabine Anhydrous SubClassOf Purine Antagonist</Axiom>
               <New_Terms>Vidarabine Anhydrous</New_Terms>
            </Change>
            <Change id="1757">
               <Axiom>Vinbarbital Sodium SubClassOf Barbiturate</Axiom>
               <New_Terms>Vinbarbital Sodium</New_Terms>
            </Change>
            <Change id="1756">
               <Axiom>Vinbarbital SubClassOf Barbiturate</Axiom>
               <New_Terms>Vinbarbital</New_Terms>
            </Change>
            <Change id="1758">
               <Axiom>Vincantril SubClassOf Vasodilating Agent</Axiom>
               <New_Terms>Vincantril</New_Terms>
            </Change>
            <Change id="1759">
               <Axiom>Vinconate SubClassOf Cholinergic Agonist</Axiom>
               <New_Terms>Vinconate</New_Terms>
            </Change>
            <Change id="1760">
               <Axiom>Vintoperol SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Vintoperol</New_Terms>
            </Change>
            <Change id="1761">
               <Axiom>Vomitus SubClassOf Biospecimen</Axiom>
               <New_Terms>Vomitus</New_Terms>
            </Change>
            <Change id="1762">
               <Axiom>Western European SubClassOf Race</Axiom>
               <New_Terms>Western European</New_Terms>
            </Change>
            <Change id="1763">
               <Axiom>White Caribbean SubClassOf Race</Axiom>
               <New_Terms>White Caribbean</New_Terms>
            </Change>
            <Change id="1764">
               <Axiom>White Color Worker SubClassOf Population Group</Axiom>
               <New_Terms>White Color Worker</New_Terms>
            </Change>
            <Change id="1765">
               <Axiom>White South or Central American SubClassOf Race</Axiom>
               <New_Terms>White South or Central American</New_Terms>
            </Change>
            <Change id="1766">
               <Axiom>Whole Animal SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Whole Animal</New_Terms>
            </Change>
            <Change id="1767">
               <Axiom>Workforce SubClassOf Population Group</Axiom>
               <New_Terms>Workforce</New_Terms>
            </Change>
            <Change id="1768">
               <Axiom>World SubClassOf Population Group</Axiom>
               <New_Terms>World</New_Terms>
            </Change>
            <Change id="1769">
               <Axiom>Xenon, Xe-127 SubClassOf Isotope</Axiom>
               <New_Terms>Xenon, Xe-127</New_Terms>
            </Change>
            <Change id="1770">
               <Axiom>Ximelagatran SubClassOf Anticoagulant Agent</Axiom>
               <New_Terms>Ximelagatran</New_Terms>
            </Change>
            <Change id="1771">
               <Axiom>Xylitol SubClassOf Artificial Sweetener</Axiom>
               <New_Terms>Xylitol</New_Terms>
            </Change>
            <Change id="1772">
               <Axiom>Yellow Fever Virus Live Antigen, A SubClassOf Yellow Fever Virus Antigen</Axiom>
               <New_Terms>Yellow Fever Virus Live Antigen, A</New_Terms>
            </Change>
            <Change id="1773">
               <Axiom>Yohimbine SubClassOf Alpha-Adrenergic Antagonist</Axiom>
               <New_Terms>Yohimbine</New_Terms>
            </Change>
            <Change id="1774">
               <Axiom>Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A SubClassOf Radioimmunoconjugate</Axiom>
               <New_Terms>Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A</New_Terms>
            </Change>
            <Change id="1775">
               <Axiom>Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody cT84.66 SubClassOf Radioimmunoconjugate</Axiom>
               <New_Terms>Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody cT84.66</New_Terms>
            </Change>
            <Change id="1776">
               <Axiom>Yucatan Pig SubClassOf Pig</Axiom>
               <New_Terms>Yucatan Pig</New_Terms>
            </Change>
            <Change id="1777">
               <Axiom>Zeranol SubClassOf Non-Steroidal Estrogen</Axiom>
               <New_Terms>Zeranol</New_Terms>
            </Change>
            <Change id="1778">
               <Axiom>Zinc Phosphide SubClassOf Pesticide</Axiom>
               <New_Terms>Zinc Phosphide</New_Terms>
            </Change>
            <Change id="1779">
               <Axiom>Zolazepam Hydrochloride SubClassOf Sedative and Hypnotic</Axiom>
               <New_Terms>Zolazepam Hydrochloride</New_Terms>
            </Change>
            <Change id="1780">
               <Axiom>Zygomatic Gland SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Zygomatic Gland</New_Terms>
            </Change>
            <Change id="1781">
               <Axiom>Zygomycosis SubClassOf Fungal Infection</Axiom>
               <New_Terms>Zygomycosis</New_Terms>
            </Change>
            <Change id="1782">
               <Axiom>Zygomycota SubClassOf Fungus</Axiom>
               <New_Terms>Zygomycota</New_Terms>
            </Change>
            <Change id="1783">
               <Axiom>Zymbal Gland SubClassOf Experimental Organism Anatomical Concept</Axiom>
               <New_Terms>Zymbal Gland</New_Terms>
            </Change>
            <Change id="1791">
               <Axiom>c-Met Inhibitor JNJ-38877605 SubClassOf Tyrosine Kinase Inhibitor</Axiom>
               <New_Terms>c-Met Inhibitor JNJ-38877605</New_Terms>
            </Change>
         </NewDescription>
         <PureAddition id="padd" size="459">
            <Change id="1793">
               <Axiom>Abnormal Hard Tissue Formation in Pulp SubClassOf Oral Cavity Finding</Axiom>
            </Change>
            <Change id="1794">
               <Axiom>Accelerated Idioventricular Rhythm SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="1795">
               <Axiom>Age Group SubClassOf Group</Axiom>
            </Change>
            <Change id="1796">
               <Axiom>Algeldrate SubClassOf Antacid Preparation</Axiom>
            </Change>
            <Change id="1797">
               <Axiom>Allele_Has_Activity Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1798">
               <Axiom>Allele_Has_Activity Range NCI_Kind</Axiom>
            </Change>
            <Change id="1799">
               <Axiom>Allele_Is_Cancer_Related_Type Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1800">
               <Axiom>Allele_Is_Cancer_Related_Type Range NCI_Kind</Axiom>
            </Change>
            <Change id="1801">
               <Axiom>Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1802">
               <Axiom>Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug Range NCI_Kind</Axiom>
            </Change>
            <Change id="1803">
               <Axiom>Allylisopropylacetamide SubClassOf Enzyme Inhibitor</Axiom>
            </Change>
            <Change id="1804">
               <Axiom>Aminohippuric Acid SubClassOf Diagnostic Reagent</Axiom>
            </Change>
            <Change id="1805">
               <Axiom>Anatomic_Structure_Has_Location Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1806">
               <Axiom>Anatomic_Structure_Has_Location Range NCI_Kind</Axiom>
            </Change>
            <Change id="1807">
               <Axiom>Anatomic_Structure_Is_Physical_Part_Of Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1808">
               <Axiom>Anatomic_Structure_Is_Physical_Part_Of Range NCI_Kind</Axiom>
            </Change>
            <Change id="1809">
               <Axiom>Angina Pectoris Prompting Medical Attention Event SubClassOf History of Coronary Artery Disease</Axiom>
            </Change>
            <Change id="1810">
               <Axiom>Antigen Processing Cell SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="1811">
               <Axiom>Antitubercular Agent SubClassOf Antibacterial Agent</Axiom>
            </Change>
            <Change id="1812">
               <Axiom>Arbaclofen Placarbil SubClassOf Adjuvant Analgesic</Axiom>
            </Change>
            <Change id="1813">
               <Axiom>Astaxanthin SubClassOf Canthaxanthin</Axiom>
            </Change>
            <Change id="1814">
               <Axiom>Atrial Flutter SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="1815">
               <Axiom>Atrial Premature Complex SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="1816">
               <Axiom>Atrioventricular Nodal Reentry Tachycardia SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="1817">
               <Axiom>Atrioventricular Reentrant Tachycardia SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="1818">
               <Axiom>Average Fluorescence Units SubClassOf Fluorescence Units</Axiom>
            </Change>
            <Change id="1819">
               <Axiom>Bigeminy SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="1820">
               <Axiom>Biological_Process_Has_Associated_Location Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1821">
               <Axiom>Biological_Process_Has_Associated_Location Range NCI_Kind</Axiom>
            </Change>
            <Change id="1822">
               <Axiom>Biological_Process_Has_Initiator_Chemical_Or_Drug Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1823">
               <Axiom>Biological_Process_Has_Initiator_Chemical_Or_Drug Range NCI_Kind</Axiom>
            </Change>
            <Change id="1824">
               <Axiom>Biological_Process_Has_Initiator_Process Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1825">
               <Axiom>Biological_Process_Has_Initiator_Process Range NCI_Kind</Axiom>
            </Change>
            <Change id="1826">
               <Axiom>Biological_Process_Has_Result_Anatomy Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1827">
               <Axiom>Biological_Process_Has_Result_Anatomy Range NCI_Kind</Axiom>
            </Change>
            <Change id="1828">
               <Axiom>Biological_Process_Has_Result_Biological_Process Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1829">
               <Axiom>Biological_Process_Has_Result_Biological_Process Range NCI_Kind</Axiom>
            </Change>
            <Change id="1830">
               <Axiom>Biological_Process_Has_Result_Chemical_Or_Drug Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1831">
               <Axiom>Biological_Process_Has_Result_Chemical_Or_Drug Range NCI_Kind</Axiom>
            </Change>
            <Change id="1832">
               <Axiom>Biological_Process_Is_Part_Of_Process Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1833">
               <Axiom>Biological_Process_Is_Part_Of_Process Range NCI_Kind</Axiom>
            </Change>
            <Change id="1834">
               <Axiom>Birth Cohort SubClassOf Cohort</Axiom>
            </Change>
            <Change id="1835">
               <Axiom>Bordetella Pertussis Antigen, B SubClassOf Bordetella Pertussis Antigen</Axiom>
            </Change>
            <Change id="1836">
               <Axiom>Bordetella Pertussis Antigen, C SubClassOf Bordetella Pertussis Antigen</Axiom>
            </Change>
            <Change id="1837">
               <Axiom>Bordetella Pertussis Antigen, D SubClassOf Bordetella Pertussis Antigen</Axiom>
            </Change>
            <Change id="1838">
               <Axiom>Bordetella Pertussis Antigen, E SubClassOf Bordetella Pertussis Antigen</Axiom>
            </Change>
            <Change id="1839">
               <Axiom>Bordetella Pertussis Antigen, F SubClassOf Bordetella Pertussis Antigen</Axiom>
            </Change>
            <Change id="1840">
               <Axiom>Bordetella Pertussis Antigen, G SubClassOf Bordetella Pertussis Antigen</Axiom>
            </Change>
            <Change id="1841">
               <Axiom>Bordetella Pertussis Antigen, H SubClassOf Bordetella Pertussis Antigen</Axiom>
            </Change>
            <Change id="1842">
               <Axiom>Bordetella Pertussis Antigen, I SubClassOf Bordetella Pertussis Antigen</Axiom>
            </Change>
            <Change id="1843">
               <Axiom>Brodimoprim SubClassOf Dihydrofolate Reductase Inhibitor</Axiom>
            </Change>
            <Change id="1845">
               <Axiom>CD6 Gene SubClassOf Gene_Plays_Role_In_Process some Cell-Cell Adhesion</Axiom>
            </Change>
            <Change id="1846">
               <Axiom>CD6 Gene SubClassOf Gene_Plays_Role_In_Process some T-Cell Development</Axiom>
            </Change>
            <Change id="1848">
               <Axiom>CDISC SDTM Package 2 Terminology SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="1849">
               <Axiom>Capsule per Animal SubClassOf Capsule Dosing Unit</Axiom>
            </Change>
            <Change id="1850">
               <Axiom>Capsule per Animal SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="1851">
               <Axiom>Cardiac Arrest SubClassOf Cardiovascular System Finding</Axiom>
            </Change>
            <Change id="1852">
               <Axiom>Cells per Femur SubClassOf Cell-Based Unit</Axiom>
            </Change>
            <Change id="1853">
               <Axiom>Chemical_Or_Drug_Affects_Abnormal_Cell Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1854">
               <Axiom>Chemical_Or_Drug_Affects_Abnormal_Cell Range NCI_Kind</Axiom>
            </Change>
            <Change id="1855">
               <Axiom>Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1856">
               <Axiom>Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue Range NCI_Kind</Axiom>
            </Change>
            <Change id="1857">
               <Axiom>Chemical_Or_Drug_Affects_Gene_Product Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1858">
               <Axiom>Chemical_Or_Drug_Affects_Gene_Product Range NCI_Kind</Axiom>
            </Change>
            <Change id="1859">
               <Axiom>Chemical_Or_Drug_FDA_Approved_For_Disease Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1860">
               <Axiom>Chemical_Or_Drug_FDA_Approved_For_Disease Range NCI_Kind</Axiom>
            </Change>
            <Change id="1861">
               <Axiom>Chemical_Or_Drug_Has_Accepted_Therapeutic_Use_For Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1862">
               <Axiom>Chemical_Or_Drug_Has_Accepted_Therapeutic_Use_For Range NCI_Kind</Axiom>
            </Change>
            <Change id="1863">
               <Axiom>Chemical_Or_Drug_Has_Mechanism_Of_Action Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1864">
               <Axiom>Chemical_Or_Drug_Has_Mechanism_Of_Action Range NCI_Kind</Axiom>
            </Change>
            <Change id="1865">
               <Axiom>Chemical_Or_Drug_Has_Physiologic_Effect Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1866">
               <Axiom>Chemical_Or_Drug_Has_Physiologic_Effect Range NCI_Kind</Axiom>
            </Change>
            <Change id="1867">
               <Axiom>Chemical_Or_Drug_Has_Study_Therapeutic_Use_For Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1868">
               <Axiom>Chemical_Or_Drug_Has_Study_Therapeutic_Use_For Range NCI_Kind</Axiom>
            </Change>
            <Change id="1869">
               <Axiom>Chemical_Or_Drug_Is_Metabolized_By_Enzyme Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1870">
               <Axiom>Chemical_Or_Drug_Is_Metabolized_By_Enzyme Range NCI_Kind</Axiom>
            </Change>
            <Change id="1871">
               <Axiom>Chemical_Or_Drug_Plays_Role_In_Biological_Process Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1872">
               <Axiom>Chemical_Or_Drug_Plays_Role_In_Biological_Process Range NCI_Kind</Axiom>
            </Change>
            <Change id="1873">
               <Axiom>Chemotherapy_Regimen_Has_Component Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1874">
               <Axiom>Chemotherapy_Regimen_Has_Component Range NCI_Kind</Axiom>
            </Change>
            <Change id="1875">
               <Axiom>Chenodiol SubClassOf Cholagogues or Choleretic Agents</Axiom>
            </Change>
            <Change id="1876">
               <Axiom>Cinacalcet SubClassOf Antithyroid Agent</Axiom>
            </Change>
            <Change id="1847">
               <Axiom>Clinical Data Interchange Standards Consortium Proposed Terminology SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="1877">
               <Axiom>Congestive Heart Failure SubClassOf Heart Failure</Axiom>
            </Change>
            <Change id="1878">
               <Axiom>Cyanocobalamin, Co-60 SubClassOf Radioconjugate</Axiom>
            </Change>
            <Change id="1879">
               <Axiom>Diagnosis Group SubClassOf Group</Axiom>
            </Change>
            <Change id="1880">
               <Axiom>Diagnostic Accuracy SubClassOf Statistical Technique</Axiom>
            </Change>
            <Change id="1881">
               <Axiom>Dianisidine SubClassOf Dye</Axiom>
            </Change>
            <Change id="1884">
               <Axiom>Dihydroergotamine Mesylate SubClassOf Dopamine Agonist</Axiom>
            </Change>
            <Change id="1885">
               <Axiom>Dihydroergotamine Mesylate SubClassOf Nonnarcotic Analgesic</Axiom>
            </Change>
            <Change id="1882">
               <Axiom>Dihydroergotamine SubClassOf Dopamine Agonist</Axiom>
            </Change>
            <Change id="1883">
               <Axiom>Dihydroergotamine SubClassOf Nonnarcotic Analgesic</Axiom>
            </Change>
            <Change id="1886">
               <Axiom>Disease_Excludes_Abnormal_Cell Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1887">
               <Axiom>Disease_Excludes_Abnormal_Cell Range NCI_Kind</Axiom>
            </Change>
            <Change id="1888">
               <Axiom>Disease_Excludes_Cytogenetic_Abnormality Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1889">
               <Axiom>Disease_Excludes_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
            </Change>
            <Change id="1890">
               <Axiom>Disease_Excludes_Finding Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1891">
               <Axiom>Disease_Excludes_Finding Range NCI_Kind</Axiom>
            </Change>
            <Change id="1892">
               <Axiom>Disease_Excludes_Metastatic_Anatomic_Site Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1893">
               <Axiom>Disease_Excludes_Metastatic_Anatomic_Site Range NCI_Kind</Axiom>
            </Change>
            <Change id="1894">
               <Axiom>Disease_Excludes_Molecular_Abnormality Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1895">
               <Axiom>Disease_Excludes_Molecular_Abnormality Range NCI_Kind</Axiom>
            </Change>
            <Change id="1896">
               <Axiom>Disease_Excludes_Normal_Cell_Origin Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1897">
               <Axiom>Disease_Excludes_Normal_Cell_Origin Range NCI_Kind</Axiom>
            </Change>
            <Change id="1898">
               <Axiom>Disease_Excludes_Normal_Tissue_Origin Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1899">
               <Axiom>Disease_Excludes_Normal_Tissue_Origin Range NCI_Kind</Axiom>
            </Change>
            <Change id="1900">
               <Axiom>Disease_Excludes_Primary_Anatomic_Site Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1901">
               <Axiom>Disease_Excludes_Primary_Anatomic_Site Range NCI_Kind</Axiom>
            </Change>
            <Change id="1902">
               <Axiom>Disease_Has_Abnormal_Cell Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1903">
               <Axiom>Disease_Has_Abnormal_Cell Range NCI_Kind</Axiom>
            </Change>
            <Change id="1904">
               <Axiom>Disease_Has_Associated_Anatomic_Site Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1905">
               <Axiom>Disease_Has_Associated_Anatomic_Site Range NCI_Kind</Axiom>
            </Change>
            <Change id="1906">
               <Axiom>Disease_Has_Associated_Disease Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1907">
               <Axiom>Disease_Has_Associated_Disease Range NCI_Kind</Axiom>
            </Change>
            <Change id="1908">
               <Axiom>Disease_Has_Cytogenetic_Abnormality Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1909">
               <Axiom>Disease_Has_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
            </Change>
            <Change id="1910">
               <Axiom>Disease_Has_Finding Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1911">
               <Axiom>Disease_Has_Finding Range NCI_Kind</Axiom>
            </Change>
            <Change id="1912">
               <Axiom>Disease_Has_Metastatic_Anatomic_Site Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1913">
               <Axiom>Disease_Has_Metastatic_Anatomic_Site Range NCI_Kind</Axiom>
            </Change>
            <Change id="1914">
               <Axiom>Disease_Has_Molecular_Abnormality Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1915">
               <Axiom>Disease_Has_Molecular_Abnormality Range NCI_Kind</Axiom>
            </Change>
            <Change id="1916">
               <Axiom>Disease_Has_Normal_Cell_Origin Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1917">
               <Axiom>Disease_Has_Normal_Cell_Origin Range NCI_Kind</Axiom>
            </Change>
            <Change id="1918">
               <Axiom>Disease_Has_Normal_Tissue_Origin Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1919">
               <Axiom>Disease_Has_Normal_Tissue_Origin Range NCI_Kind</Axiom>
            </Change>
            <Change id="1920">
               <Axiom>Disease_Has_Primary_Anatomic_Site Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1921">
               <Axiom>Disease_Has_Primary_Anatomic_Site Range NCI_Kind</Axiom>
            </Change>
            <Change id="1922">
               <Axiom>Disease_Is_Grade Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1923">
               <Axiom>Disease_Is_Grade Range NCI_Kind</Axiom>
            </Change>
            <Change id="1924">
               <Axiom>Disease_Is_Stage Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1925">
               <Axiom>Disease_Is_Stage Range NCI_Kind</Axiom>
            </Change>
            <Change id="1926">
               <Axiom>Disease_May_Have_Abnormal_Cell Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1927">
               <Axiom>Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
            </Change>
            <Change id="1928">
               <Axiom>Disease_May_Have_Associated_Disease Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1929">
               <Axiom>Disease_May_Have_Associated_Disease Range NCI_Kind</Axiom>
            </Change>
            <Change id="1930">
               <Axiom>Disease_May_Have_Cytogenetic_Abnormality Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1931">
               <Axiom>Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
            </Change>
            <Change id="1932">
               <Axiom>Disease_May_Have_Finding Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1933">
               <Axiom>Disease_May_Have_Finding Range NCI_Kind</Axiom>
            </Change>
            <Change id="1934">
               <Axiom>Disease_May_Have_Molecular_Abnormality Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1935">
               <Axiom>Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
            </Change>
            <Change id="1936">
               <Axiom>Disease_May_Have_Normal_Cell_Origin Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1937">
               <Axiom>Disease_May_Have_Normal_Cell_Origin Range NCI_Kind</Axiom>
            </Change>
            <Change id="1938">
               <Axiom>Disease_May_Have_Normal_Tissue_Origin Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1939">
               <Axiom>Disease_May_Have_Normal_Tissue_Origin Range NCI_Kind</Axiom>
            </Change>
            <Change id="1940">
               <Axiom>EO_Anatomic_Structure_Is_Physical_Part_Of Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1941">
               <Axiom>EO_Anatomic_Structure_Is_Physical_Part_Of Range NCI_Kind</Axiom>
            </Change>
            <Change id="1942">
               <Axiom>EO_Derived_By_Technique Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1943">
               <Axiom>EO_Derived_By_Technique Range NCI_Kind</Axiom>
            </Change>
            <Change id="1944">
               <Axiom>EO_Develops_Disease Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1945">
               <Axiom>EO_Develops_Disease Range NCI_Kind</Axiom>
            </Change>
            <Change id="1946">
               <Axiom>EO_Disease_Has_Associated_Cell_Type Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1947">
               <Axiom>EO_Disease_Has_Associated_Cell_Type Range NCI_Kind</Axiom>
            </Change>
            <Change id="1948">
               <Axiom>EO_Disease_Has_Associated_EO_Anatomy Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1949">
               <Axiom>EO_Disease_Has_Associated_EO_Anatomy Range NCI_Kind</Axiom>
            </Change>
            <Change id="1950">
               <Axiom>EO_Disease_Has_Property_Or_Attribute Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1951">
               <Axiom>EO_Disease_Has_Property_Or_Attribute Range NCI_Kind</Axiom>
            </Change>
            <Change id="1952">
               <Axiom>EO_Disease_Maps_To_Human_Disease Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1953">
               <Axiom>EO_Disease_Maps_To_Human_Disease Range NCI_Kind</Axiom>
            </Change>
            <Change id="1954">
               <Axiom>EO_Disease_Metastatic_To_EO_Anatomy Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1955">
               <Axiom>EO_Disease_Metastatic_To_EO_Anatomy Range NCI_Kind</Axiom>
            </Change>
            <Change id="1956">
               <Axiom>EO_Models_Human_Disease Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1957">
               <Axiom>EO_Models_Human_Disease Range NCI_Kind</Axiom>
            </Change>
            <Change id="1958">
               <Axiom>Ectopic Atrial Rhythm SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="1959">
               <Axiom>Ectopic Supraventricular Rhythm SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="1960">
               <Axiom>Ectopic Ventricular Rhythm SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="1962">
               <Axiom>Erythromycin Gluceptate SubClassOf Macrolide Antibiotic</Axiom>
            </Change>
            <Change id="1963">
               <Axiom>Eukaryota SubClassOf Other Organism Groupings</Axiom>
            </Change>
            <Change id="1964">
               <Axiom>F10 Gene SubClassOf Gene_Plays_Role_In_Process some Homeostasis</Axiom>
            </Change>
            <Change id="1965">
               <Axiom>F10 Gene SubClassOf Gene_Plays_Role_In_Process some Proteolytic Processing</Axiom>
            </Change>
            <Change id="1966">
               <Axiom>F10 wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
            </Change>
            <Change id="1967">
               <Axiom>F10 wt Allele SubClassOf Gene_In_Chromosomal_Location some 13q34</Axiom>
            </Change>
            <Change id="1968">
               <Axiom>Faropenem Medoxomil SubClassOf Beta-Lactam Antibiotic</Axiom>
            </Change>
            <Change id="1969">
               <Axiom>Femtomole per Gram SubClassOf Molality Unit</Axiom>
            </Change>
            <Change id="1970">
               <Axiom>Fenbenicillin SubClassOf Penicillin Antibiotic</Axiom>
            </Change>
            <Change id="1971">
               <Axiom>Fibracillin SubClassOf Penicillin Antibiotic</Axiom>
            </Change>
            <Change id="1972">
               <Axiom>First Ever Onset of Angina Pectoris Event SubClassOf History of Coronary Artery Disease</Axiom>
            </Change>
            <Change id="1973">
               <Axiom>First Ever Onset of Heart Failure Event SubClassOf History of Heart Failure</Axiom>
            </Change>
            <Change id="1974">
               <Axiom>Flomoxef SubClassOf Cephalosporin Antibiotic</Axiom>
            </Change>
            <Change id="1975">
               <Axiom>Floxacrine SubClassOf Antihelminthic Agent</Axiom>
            </Change>
            <Change id="1976">
               <Axiom>Fluorescein Sodium SubClassOf Dye</Axiom>
            </Change>
            <Change id="1977">
               <Axiom>Fuzlocillin SubClassOf Penicillin Antibiotic</Axiom>
            </Change>
            <Change id="1979">
               <Axiom>Garenoxacin Mesylate SubClassOf Quinolone Compound</Axiom>
            </Change>
            <Change id="1978">
               <Axiom>Garenoxacin SubClassOf Quinolone Compound</Axiom>
            </Change>
            <Change id="1980">
               <Axiom>Gene_Associated_With_Disease Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1981">
               <Axiom>Gene_Associated_With_Disease Range NCI_Kind</Axiom>
            </Change>
            <Change id="1982">
               <Axiom>Gene_Found_In_Organism Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1983">
               <Axiom>Gene_Found_In_Organism Range NCI_Kind</Axiom>
            </Change>
            <Change id="1984">
               <Axiom>Gene_Has_Abnormality Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1985">
               <Axiom>Gene_Has_Abnormality Range NCI_Kind</Axiom>
            </Change>
            <Change id="1986">
               <Axiom>Gene_Has_Physical_Location Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1987">
               <Axiom>Gene_Has_Physical_Location Range NCI_Kind</Axiom>
            </Change>
            <Change id="1988">
               <Axiom>Gene_In_Chromosomal_Location Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1989">
               <Axiom>Gene_In_Chromosomal_Location Range NCI_Kind</Axiom>
            </Change>
            <Change id="1990">
               <Axiom>Gene_Is_Biomarker_Of Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1991">
               <Axiom>Gene_Is_Biomarker_Of Range NCI_Kind</Axiom>
            </Change>
            <Change id="1992">
               <Axiom>Gene_Is_Biomarker_Type Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1993">
               <Axiom>Gene_Is_Biomarker_Type Range NCI_Kind</Axiom>
            </Change>
            <Change id="1994">
               <Axiom>Gene_Is_Element_In_Pathway Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1995">
               <Axiom>Gene_Is_Element_In_Pathway Range NCI_Kind</Axiom>
            </Change>
            <Change id="1996">
               <Axiom>Gene_Plays_Role_In_Process Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1997">
               <Axiom>Gene_Plays_Role_In_Process Range NCI_Kind</Axiom>
            </Change>
            <Change id="1998">
               <Axiom>Gene_Product_Encoded_By_Gene Domain NCI_Kind</Axiom>
            </Change>
            <Change id="1999">
               <Axiom>Gene_Product_Encoded_By_Gene Range NCI_Kind</Axiom>
            </Change>
            <Change id="2000">
               <Axiom>Gene_Product_Expressed_In_Tissue Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2001">
               <Axiom>Gene_Product_Expressed_In_Tissue Range NCI_Kind</Axiom>
            </Change>
            <Change id="2002">
               <Axiom>Gene_Product_Has_Abnormality Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2003">
               <Axiom>Gene_Product_Has_Abnormality Range NCI_Kind</Axiom>
            </Change>
            <Change id="2004">
               <Axiom>Gene_Product_Has_Associated_Anatomy Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2005">
               <Axiom>Gene_Product_Has_Associated_Anatomy Range NCI_Kind</Axiom>
            </Change>
            <Change id="2006">
               <Axiom>Gene_Product_Has_Biochemical_Function Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2007">
               <Axiom>Gene_Product_Has_Biochemical_Function Range NCI_Kind</Axiom>
            </Change>
            <Change id="2008">
               <Axiom>Gene_Product_Has_Chemical_Classification Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2009">
               <Axiom>Gene_Product_Has_Chemical_Classification Range NCI_Kind</Axiom>
            </Change>
            <Change id="2010">
               <Axiom>Gene_Product_Has_Malfunction_Type Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2011">
               <Axiom>Gene_Product_Has_Malfunction_Type Range NCI_Kind</Axiom>
            </Change>
            <Change id="2012">
               <Axiom>Gene_Product_Has_Organism_Source Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2013">
               <Axiom>Gene_Product_Has_Organism_Source Range NCI_Kind</Axiom>
            </Change>
            <Change id="2014">
               <Axiom>Gene_Product_Has_Structural_Domain_Or_Motif Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2015">
               <Axiom>Gene_Product_Has_Structural_Domain_Or_Motif Range NCI_Kind</Axiom>
            </Change>
            <Change id="2016">
               <Axiom>Gene_Product_Is_Biomarker_Of Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2017">
               <Axiom>Gene_Product_Is_Biomarker_Of Range NCI_Kind</Axiom>
            </Change>
            <Change id="2018">
               <Axiom>Gene_Product_Is_Biomarker_Type Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2019">
               <Axiom>Gene_Product_Is_Biomarker_Type Range NCI_Kind</Axiom>
            </Change>
            <Change id="2020">
               <Axiom>Gene_Product_Is_Element_In_Pathway Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2021">
               <Axiom>Gene_Product_Is_Element_In_Pathway Range NCI_Kind</Axiom>
            </Change>
            <Change id="2022">
               <Axiom>Gene_Product_Is_Physical_Part_Of Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2023">
               <Axiom>Gene_Product_Is_Physical_Part_Of Range NCI_Kind</Axiom>
            </Change>
            <Change id="2024">
               <Axiom>Gene_Product_Malfunction_Associated_With_Disease Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2025">
               <Axiom>Gene_Product_Malfunction_Associated_With_Disease Range NCI_Kind</Axiom>
            </Change>
            <Change id="2026">
               <Axiom>Gene_Product_Plays_Role_In_Biological_Process Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2027">
               <Axiom>Gene_Product_Plays_Role_In_Biological_Process Range NCI_Kind</Axiom>
            </Change>
            <Change id="2028">
               <Axiom>Gentamicin Sulfate SubClassOf Aminoglycoside Antibiotic</Axiom>
            </Change>
            <Change id="2029">
               <Axiom>Geriatric SubClassOf General Qualifier</Axiom>
            </Change>
            <Change id="2030">
               <Axiom>Gram per Animal SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2031">
               <Axiom>Gram per Animal per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2032">
               <Axiom>Gram per Animal per Week SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2033">
               <Axiom>Gram per Cage SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2034">
               <Axiom>Gram per Cage per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2035">
               <Axiom>Gram per Cage per Week SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2036">
               <Axiom>Gram per Capsule SubClassOf Capsule Dosing Unit</Axiom>
            </Change>
            <Change id="2037">
               <Axiom>Gram per Gram per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2038">
               <Axiom>Gram per Mole SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2039">
               <Axiom>Gram per Square Meter per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2040">
               <Axiom>Gram per Square Meter per Day SubClassOf Unit of Lung Diffusion Capacity</Axiom>
            </Change>
            <Change id="2041">
               <Axiom>Gram per Tablet SubClassOf Tablet Dosing Unit</Axiom>
            </Change>
            <Change id="2042">
               <Axiom>Gram per Vial SubClassOf Vial Dosing Unit</Axiom>
            </Change>
            <Change id="2043">
               <Axiom>Granisetron Hydrochloride SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Serotonin 5-HT-3 Receptor</Axiom>
            </Change>
            <Change id="2044">
               <Axiom>Granisetron Hydrochloride SubClassOf Serotonin Antagonist</Axiom>
            </Change>
            <Change id="2045">
               <Axiom>Granisetron SubClassOf Serotonin Antagonist</Axiom>
            </Change>
            <Change id="2046">
               <Axiom>Gravity SubClassOf Unit of Force</Axiom>
            </Change>
            <Change id="2047">
               <Axiom>Guaiacol Carbonate SubClassOf Expectorant</Axiom>
            </Change>
            <Change id="2071">
               <Axiom>HDAC Inhibitor SNDX-275 SubClassOf ((Chemical_Or_Drug_Affects_Gene_Product some Histone Deacetylase) and (Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition) and (Chemical_Or_Drug_Has_Physiologic_Effect some Cell Cycle Inhibition) and (Chemical_Or_Drug_Has_Physiologic_Effect some Cell Differentiation Induction) and (Chemical_Or_Drug_Has_Physiologic_Effect some Chromatin Structure Alteration) and (Chemical_Or_Drug_Has_Physiologic_Effect some Gene Expression Alteration)) or ((Chemical_Or_Drug_Has_Mechanism_Of_Action some Free Radical Formation) and (Chemical_Or_Drug_Has_Physiologic_Effect some Apoptosis) and (Chemical_Or_Drug_Has_Physiologic_Effect some Mitochondrial Damage))</Axiom>
            </Change>
            <Change id="2048">
               <Axiom>HLA-C wt Allele SubClassOf Gene_In_Chromosomal_Location some 6p21.3</Axiom>
            </Change>
            <Change id="2049">
               <Axiom>HLA-C wt Allele SubClassOf Gene_Is_Element_In_Pathway some Antigen Presentation Pathway</Axiom>
            </Change>
            <Change id="2050">
               <Axiom>Healthy Subject SubClassOf Human Study Subject</Axiom>
            </Change>
            <Change id="2051">
               <Axiom>Heart Block SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2052">
               <Axiom>Heart Failure Prompting Medical Attention Event SubClassOf History of Heart Failure</Axiom>
            </Change>
            <Change id="2053">
               <Axiom>Heart Malformation SubClassOf Non-Neoplastic Heart Disorder</Axiom>
            </Change>
            <Change id="2054">
               <Axiom>Hereditary SubClassOf General Qualifier</Axiom>
            </Change>
            <Change id="2055">
               <Axiom>Household Income SubClassOf Income</Axiom>
            </Change>
            <Change id="2056">
               <Axiom>Human Parainfluenza Virus 1 SubClassOf Parainfluenza Virus</Axiom>
            </Change>
            <Change id="2057">
               <Axiom>Immunocompromised SubClassOf General Qualifier</Axiom>
            </Change>
            <Change id="2058">
               <Axiom>Infective Otitis Externa SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2059">
               <Axiom>Inherited SubClassOf General Qualifier</Axiom>
            </Change>
            <Change id="2060">
               <Axiom>Iodohippurate Sodium, I-123 SubClassOf Radioconjugate</Axiom>
            </Change>
            <Change id="2061">
               <Axiom>Iodohippurate Sodium, I-131 SubClassOf Radioconjugate</Axiom>
            </Change>
            <Change id="2062">
               <Axiom>Isorhythmic Atrioventricular Dissociation SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2063">
               <Axiom>Junctional Rhythm SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2064">
               <Axiom>Knuckle Pads SubClassOf Connective and Soft Tissue Finding</Axiom>
            </Change>
            <Change id="2065">
               <Axiom>LY573636 SubClassOf Diarylsulfonylurea Compound</Axiom>
            </Change>
            <Change id="2066">
               <Axiom>Laboratory Finding SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2067">
               <Axiom>Lactic Acid, L- SubClassOf Industrial Aid</Axiom>
            </Change>
            <Change id="2068">
               <Axiom>Lethargic SubClassOf General Qualifier</Axiom>
            </Change>
            <Change id="2069">
               <Axiom>Licostinel SubClassOf Neuroprotective Agent</Axiom>
            </Change>
            <Change id="2070">
               <Axiom>Liter per Kilogram SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="1844">
               <Axiom>MDR Modulator CBT-1 SubClassOf Multidrug Resistance Modulator</Axiom>
            </Change>
            <Change id="2072">
               <Axiom>Magnesium Stearate SubClassOf Industrial Aid</Axiom>
            </Change>
            <Change id="2073">
               <Axiom>Mean Arterial Pressure SubClassOf Conceptual Entity</Axiom>
            </Change>
            <Change id="1961">
               <Axiom>Measurement of Left Ventricular Ejection Fraction SubClassOf Cardiac Function Study</Axiom>
            </Change>
            <Change id="2074">
               <Axiom>Median Income SubClassOf Income</Axiom>
            </Change>
            <Change id="2075">
               <Axiom>Medical Device Difficult to Flush SubClassOf Occlusion within Medical Device</Axiom>
            </Change>
            <Change id="2076">
               <Axiom>Memantine SubClassOf Neuroprotective Agent</Axiom>
            </Change>
            <Change id="2077">
               <Axiom>Methylselenocysteine SubClassOf Amino Acid Derivative</Axiom>
            </Change>
            <Change id="2078">
               <Axiom>Microequivalent SubClassOf Unit of Equivalent Weight</Axiom>
            </Change>
            <Change id="2079">
               <Axiom>Microgram per Animal SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2080">
               <Axiom>Microgram per Gram per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2081">
               <Axiom>Microgram per Gram per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2082">
               <Axiom>Microgram per Kilogram per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2083">
               <Axiom>Microgram per Kilogram per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2084">
               <Axiom>Microgram per Milligram Protein SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2085">
               <Axiom>Microgram per Square Meter per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2086">
               <Axiom>Microgram per Square Meter per Day SubClassOf Unit of Lung Diffusion Capacity</Axiom>
            </Change>
            <Change id="2087">
               <Axiom>Microgram per Square Meter per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2088">
               <Axiom>Microgram per Square Meter per Hour SubClassOf Unit of Lung Diffusion Capacity</Axiom>
            </Change>
            <Change id="2089">
               <Axiom>Microgram per Square Meter per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2090">
               <Axiom>Microgram per Square Meter per Minute SubClassOf Unit of Lung Diffusion Capacity</Axiom>
            </Change>
            <Change id="2091">
               <Axiom>Microliter per Nostril SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2092">
               <Axiom>Micromole per Milligram per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2093">
               <Axiom>Microosmole SubClassOf Unit of Osmotic Pressure</Axiom>
            </Change>
            <Change id="2094">
               <Axiom>Milliequivalent per Deciliter SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2095">
               <Axiom>Milliequivalent per Milliliter SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2096">
               <Axiom>Milliequivalent per Milliliter SubClassOf Normality Unit</Axiom>
            </Change>
            <Change id="2097">
               <Axiom>Milligram per Animal SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2098">
               <Axiom>Milligram per Capsule SubClassOf Capsule Dosing Unit</Axiom>
            </Change>
            <Change id="2099">
               <Axiom>Milligram per Gram per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2100">
               <Axiom>Milligram per Gram per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2101">
               <Axiom>Milligram per Gram per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2102">
               <Axiom>Milligram per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2103">
               <Axiom>Milligram per Square Meter per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2104">
               <Axiom>Milligram per Square Meter per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2105">
               <Axiom>Milligram per Vial SubClassOf Vial Dosing Unit</Axiom>
            </Change>
            <Change id="2106">
               <Axiom>Milliliter per Animal SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2107">
               <Axiom>Milliliter per Animal per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2108">
               <Axiom>Milliliter per Animal per Week SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2109">
               <Axiom>Milliliter per Breath SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2110">
               <Axiom>Milliliter per Cage SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2111">
               <Axiom>Milliliter per Cage per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2112">
               <Axiom>Milliliter per Cage per Week SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2113">
               <Axiom>Milliliter per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2114">
               <Axiom>Milliliter per Gram SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2115">
               <Axiom>Milliliter per Gram per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2116">
               <Axiom>Milliliter per Gram per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2117">
               <Axiom>Milliliter per Gram per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2118">
               <Axiom>Milliliter per Kilogram per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2119">
               <Axiom>Milliliter per Kilogram per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2120">
               <Axiom>Milliliter per Kilogram per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2121">
               <Axiom>Milliliter per Square Meter SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2122">
               <Axiom>Milliliter per Square Meter SubClassOf Unit of Lung Diffusion Capacity</Axiom>
            </Change>
            <Change id="2123">
               <Axiom>Milliliter per Square Meter per Day SubClassOf Unit of Lung Diffusion Capacity</Axiom>
            </Change>
            <Change id="2124">
               <Axiom>Milliliter per Square Meter per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2125">
               <Axiom>Milliliter per Square Meter per Hour SubClassOf Unit of Lung Diffusion Capacity</Axiom>
            </Change>
            <Change id="2126">
               <Axiom>Milliliter per Square Meter per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2127">
               <Axiom>Milliliter per Square Meter per Minute SubClassOf Unit of Lung Diffusion Capacity</Axiom>
            </Change>
            <Change id="2128">
               <Axiom>Millimeter of Mercury per Second SubClassOf Unit of Lung Diffusion Capacity</Axiom>
            </Change>
            <Change id="2129">
               <Axiom>Millipascal SubClassOf Derived Unit of International System of Units</Axiom>
            </Change>
            <Change id="2130">
               <Axiom>Millipascal SubClassOf Non-Manometric Unit of Pressure</Axiom>
            </Change>
            <Change id="2131">
               <Axiom>Mold SubClassOf Fungus</Axiom>
            </Change>
            <Change id="2132">
               <Axiom>Most Recent Angina Pectoris Event SubClassOf History of Coronary Artery Disease</Axiom>
            </Change>
            <Change id="2133">
               <Axiom>Most Recent Heart Failure Event SubClassOf History of Heart Failure</Axiom>
            </Change>
            <Change id="2134">
               <Axiom>Multifocal Atrial Tachycardia SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2135">
               <Axiom>N-Cadherin SubClassOf Gene_Product_Has_Organism_Source some Human</Axiom>
            </Change>
            <Change id="2136">
               <Axiom>Nanogram per Well SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2137">
               <Axiom>Nanosecond SubClassOf Unit of Time</Axiom>
            </Change>
            <Change id="2138">
               <Axiom>Non-Sustained Ventricular Tachycardia SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2139">
               <Axiom>Onset of Angina Pectoris Event SubClassOf History of Coronary Artery Disease</Axiom>
            </Change>
            <Change id="2140">
               <Axiom>Osteolysis SubClassOf Connective and Soft Tissue Finding</Axiom>
            </Change>
            <Change id="2141">
               <Axiom>Osteopenia SubClassOf Connective and Soft Tissue Finding</Axiom>
            </Change>
            <Change id="2142">
               <Axiom>Pancreatic Injury SubClassOf Gastrointestinal Injury</Axiom>
            </Change>
            <Change id="2143">
               <Axiom>Patent Foramen Ovale SubClassOf Non-Neoplastic Heart Disorder</Axiom>
            </Change>
            <Change id="2144">
               <Axiom>Patient Characteristics Qualifier SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2145">
               <Axiom>Patient Death SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2146">
               <Axiom>Pediatric SubClassOf General Qualifier</Axiom>
            </Change>
            <Change id="2147">
               <Axiom>Percentile SubClassOf Statistical Technique</Axiom>
            </Change>
            <Change id="2148">
               <Axiom>Peripheral Vascular Disease SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2149">
               <Axiom>Perzinfotel SubClassOf Neuroprotective Agent</Axiom>
            </Change>
            <Change id="2150">
               <Axiom>Phagocytic Cell SubClassOf Antigen Presenting Cell</Axiom>
            </Change>
            <Change id="2151">
               <Axiom>Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression))</Axiom>
            </Change>
            <Change id="2152">
               <Axiom>Phlebitis SubClassOf Vein Disorder</Axiom>
            </Change>
            <Change id="2153">
               <Axiom>Photosensitive Dermatitis SubClassOf Photodermatitis</Axiom>
            </Change>
            <Change id="2154">
               <Axiom>Picosecond SubClassOf Unit of Time</Axiom>
            </Change>
            <Change id="2155">
               <Axiom>Poikilotherms SubClassOf Other Organism Groupings</Axiom>
            </Change>
            <Change id="2156">
               <Axiom>Polycystic Ovarian Disease SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2157">
               <Axiom>Poor Vascular Access SubClassOf Cardiovascular System Finding</Axiom>
            </Change>
            <Change id="2158">
               <Axiom>Postencephalitic Parkinsonism SubClassOf Secondary Parkinsonism</Axiom>
            </Change>
            <Change id="2159">
               <Axiom>Primary Adrenal Insufficiency SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2160">
               <Axiom>Procedure_May_Have_Target_Anatomy Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2161">
               <Axiom>Procedure_May_Have_Target_Anatomy Range NCI_Kind</Axiom>
            </Change>
            <Change id="2162">
               <Axiom>Pyogenic Arthritis SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2163">
               <Axiom>Quantile SubClassOf Statistical Technique</Axiom>
            </Change>
            <Change id="2164">
               <Axiom>R-R Interval SubClassOf Conceptual Entity</Axiom>
            </Change>
            <Change id="2165">
               <Axiom>Range of Motion SubClassOf Conceptual Entity</Axiom>
            </Change>
            <Change id="2166">
               <Axiom>Raynaud's Disease SubClassOf Peripheral Vascular Disorder</Axiom>
            </Change>
            <Change id="2167">
               <Axiom>Recombinant Thymosin SubClassOf Miscellaneous Hormone Agent</Axiom>
            </Change>
            <Change id="2168">
               <Axiom>Regimen_Has_Accepted_Use_For_Disease Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2169">
               <Axiom>Regimen_Has_Accepted_Use_For_Disease Range NCI_Kind</Axiom>
            </Change>
            <Change id="2170">
               <Axiom>Risk Estimate SubClassOf Statistical Technique</Axiom>
            </Change>
            <Change id="2171">
               <Axiom>Salmonella Enterica Serovar Typhi Antigen SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2172">
               <Axiom>Salmonella Enterica Serovar Typhi Antigen, A SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2173">
               <Axiom>Se-Methyl-seleno-L-cysteine SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2174">
               <Axiom>Sedecamycin SubClassOf Macrolide Antibiotic</Axiom>
            </Change>
            <Change id="2175">
               <Axiom>Septic Arthritis SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2176">
               <Axiom>Serositis SubClassOf Non-Neoplastic Soft Tissue Disorder</Axiom>
            </Change>
            <Change id="2177">
               <Axiom>Sevelamer Hydrochloride SubClassOf Polyamine Compound</Axiom>
            </Change>
            <Change id="2178">
               <Axiom>Sinus Node Dysfunction SubClassOf Cardiovascular System Finding</Axiom>
            </Change>
            <Change id="2179">
               <Axiom>Socioeconomic Indicator SubClassOf Socioeconomic Factors</Axiom>
            </Change>
            <Change id="2180">
               <Axiom>Sodium Nitroprusside SubClassOf Diagnostic Reagent</Axiom>
            </Change>
            <Change id="2181">
               <Axiom>Sore Throat SubClassOf Head and Neck Finding</Axiom>
            </Change>
            <Change id="2182">
               <Axiom>Sprays per Nostril SubClassOf Spray Dosing Unit</Axiom>
            </Change>
            <Change id="2183">
               <Axiom>Square Micrometer SubClassOf Unit of Area</Axiom>
            </Change>
            <Change id="2184">
               <Axiom>Statistical Confidence SubClassOf Statistical Technique</Axiom>
            </Change>
            <Change id="2185">
               <Axiom>Statistical Significance SubClassOf Statistical Technique</Axiom>
            </Change>
            <Change id="2186">
               <Axiom>Statistically Significant SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2187">
               <Axiom>Stein-Leventhal Syndrome SubClassOf Syndrome</Axiom>
            </Change>
            <Change id="2188">
               <Axiom>Sustained Ventricular Tachycardia SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2189">
               <Axiom>Synovitis SubClassOf Non-Neoplastic Soft Tissue Disorder</Axiom>
            </Change>
            <Change id="2190">
               <Axiom>T-Cell Differentiation Antigen CD6 SubClassOf Gene_Product_Plays_Role_In_Biological_Process some Cell-Cell Adhesion</Axiom>
            </Change>
            <Change id="2191">
               <Axiom>T-Cell Differentiation Antigen CD6 SubClassOf Gene_Product_Plays_Role_In_Biological_Process some T-Cell Development</Axiom>
            </Change>
            <Change id="2192">
               <Axiom>Technique_Has_Associated_Condition Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2193">
               <Axiom>Technique_Has_Associated_Condition Range NCI_Kind</Axiom>
            </Change>
            <Change id="2194">
               <Axiom>Technique_Has_Purpose Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2195">
               <Axiom>Technique_Has_Purpose Range NCI_Kind</Axiom>
            </Change>
            <Change id="2196">
               <Axiom>Technique_Has_Sample_Or_Specimen_Anatomy Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2197">
               <Axiom>Technique_Has_Sample_Or_Specimen_Anatomy Range NCI_Kind</Axiom>
            </Change>
            <Change id="2198">
               <Axiom>Technique_Has_Sample_Or_Specimen_Chemical_Or_Drug Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2199">
               <Axiom>Technique_Has_Sample_Or_Specimen_Chemical_Or_Drug Range NCI_Kind</Axiom>
            </Change>
            <Change id="2200">
               <Axiom>Technique_Has_Target_Anatomy Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2201">
               <Axiom>Technique_Has_Target_Anatomy Range NCI_Kind</Axiom>
            </Change>
            <Change id="2202">
               <Axiom>Technique_Has_Target_Chemical_Or_Drug Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2203">
               <Axiom>Technique_Has_Target_Chemical_Or_Drug Range NCI_Kind</Axiom>
            </Change>
            <Change id="2204">
               <Axiom>Technique_Has_Target_Disease Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2205">
               <Axiom>Technique_Has_Target_Disease Range NCI_Kind</Axiom>
            </Change>
            <Change id="2206">
               <Axiom>Technique_Has_Target_Organism Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2207">
               <Axiom>Technique_Has_Target_Organism Range NCI_Kind</Axiom>
            </Change>
            <Change id="2208">
               <Axiom>Technique_Has_Target_Protein Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2209">
               <Axiom>Technique_Has_Target_Protein Range NCI_Kind</Axiom>
            </Change>
            <Change id="2210">
               <Axiom>Technique_Is_Used_In_Technique Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2211">
               <Axiom>Technique_Is_Used_In_Technique Range NCI_Kind</Axiom>
            </Change>
            <Change id="2212">
               <Axiom>Technique_Uses_Equipment Domain NCI_Kind</Axiom>
            </Change>
            <Change id="2213">
               <Axiom>Technique_Uses_Equipment Range NCI_Kind</Axiom>
            </Change>
            <Change id="2214">
               <Axiom>Thousand per Deciliter SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2215">
               <Axiom>Thousand per Deciliter SubClassOf Unit of Mass Density</Axiom>
            </Change>
            <Change id="2216">
               <Axiom>Thrombohemorrhagic Event SubClassOf Cardiovascular System Finding</Axiom>
            </Change>
            <Change id="2217">
               <Axiom>Ticarcillin Disodium SubClassOf Penicillin Antibiotic</Axiom>
            </Change>
            <Change id="2218">
               <Axiom>Titanium Dioxide SubClassOf Dye</Axiom>
            </Change>
            <Change id="2219">
               <Axiom>Torsades De Pointes SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2220">
               <Axiom>Tracheal Calcification SubClassOf Calcification</Axiom>
            </Change>
            <Change id="2221">
               <Axiom>Trigeminy SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2222">
               <Axiom>Type of Statistical Sample SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2223">
               <Axiom>UBD Gene SubClassOf Regulatory Gene</Axiom>
            </Change>
            <Change id="2224">
               <Axiom>Under No Medication SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2225">
               <Axiom>Under No Sedation SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="2226">
               <Axiom>Unit of Gravity SubClassOf Unit of Force</Axiom>
            </Change>
            <Change id="2227">
               <Axiom>Unit of Luminous Flux SubClassOf Unit of Illuminance</Axiom>
            </Change>
            <Change id="2228">
               <Axiom>Unit per Animal SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2229">
               <Axiom>Unit per Gram per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2230">
               <Axiom>Unit per Gram per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2231">
               <Axiom>Unit per Gram per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2232">
               <Axiom>Unit per Kilogram per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2233">
               <Axiom>Unit per Kilogram per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2234">
               <Axiom>Unit per Kilogram per Minute SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2235">
               <Axiom>Unit per Milligram SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2236">
               <Axiom>Unit per Milligram of Creatinine SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2237">
               <Axiom>Unit per Milligram of Protein SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2238">
               <Axiom>Unit per Square Meter per Day SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2239">
               <Axiom>Unit per Square Meter per Hour SubClassOf Dose Calculation Unit</Axiom>
            </Change>
            <Change id="2240">
               <Axiom>Unit per Square Meter per Minute SubClassOf Arbitrary Unit of Substance Rate</Axiom>
            </Change>
            <Change id="2241">
               <Axiom>Unit per Square Meter per Minute SubClassOf Unit of Lung Diffusion Capacity</Axiom>
            </Change>
            <Change id="2242">
               <Axiom>Vancomycin Hydrochloride SubClassOf Antibiotic</Axiom>
            </Change>
            <Change id="2243">
               <Axiom>Variance SubClassOf Statistical Technique</Axiom>
            </Change>
            <Change id="2244">
               <Axiom>Ventricular Couplet SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2245">
               <Axiom>Ventricular Flutter SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2246">
               <Axiom>Ventricular Premature Complex SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2247">
               <Axiom>Vertical SubClassOf Spatial Qualifier</Axiom>
            </Change>
            <Change id="2248">
               <Axiom>Viable Cell per Femur SubClassOf Cell-Based Unit</Axiom>
            </Change>
            <Change id="2249">
               <Axiom>Yeast SubClassOf Fungus</Axiom>
            </Change>
            <Change id="2250">
               <Axiom>Z-Average SubClassOf Parameter</Axiom>
            </Change>
            <Change id="2251">
               <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide SubClassOf Retired Concept</Axiom>
            </Change>
         </PureAddition>
         <PureAdditionWithNewTerms id="paddnt" size="42">
            <Change id="2252">
               <Axiom>ADME Finding SubClassOf Clinical Test Result</Axiom>
               <New_Terms>Clinical Test Result</New_Terms>
            </Change>
            <Change id="2253">
               <Axiom>Abnormal Patch Test Result SubClassOf Clinical Test Result</Axiom>
               <New_Terms>Clinical Test Result</New_Terms>
            </Change>
            <Change id="2254">
               <Axiom>Bacillus Calmette-Guerin Antigen, A SubClassOf Bacillus Calmette-Guerin Antigen</Axiom>
               <New_Terms>Bacillus Calmette-Guerin Antigen</New_Terms>
            </Change>
            <Change id="2255">
               <Axiom>Bacillus Calmette-Guerin Antigen, B SubClassOf Bacillus Calmette-Guerin Antigen</Axiom>
               <New_Terms>Bacillus Calmette-Guerin Antigen</New_Terms>
            </Change>
            <Change id="2256">
               <Axiom>Buccal Mucosa SubClassOf Oral Mucosa</Axiom>
               <New_Terms>Oral Mucosa</New_Terms>
            </Change>
            <Change id="2259">
               <Axiom>CDISC SDTM Age Unit Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2260">
               <Axiom>CDISC SDTM Country Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2261">
               <Axiom>CDISC SDTM Frequency Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2258">
               <Axiom>CDISC SDTM Laboratory Test Terminology by Code SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2257">
               <Axiom>CDISC SDTM Laboratory Test Terminology by Name SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2262">
               <Axiom>CDISC SDTM Not Done Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2263">
               <Axiom>CDISC SDTM Pharmaceutical Dosage Form Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2264">
               <Axiom>CDISC SDTM Route of Administration Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2265">
               <Axiom>CDISC SDTM Sex of Individual Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2266">
               <Axiom>CDISC SDTM Sex of Study Group Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2267">
               <Axiom>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology SubClassOf CDISC SEND Terminology</Axiom>
               <New_Terms>CDISC SEND Terminology</New_Terms>
            </Change>
            <Change id="2268">
               <Axiom>Cryptococcus neoformans SubClassOf Cryptococcus</Axiom>
               <New_Terms>Cryptococcus</New_Terms>
            </Change>
            <Change id="2269">
               <Axiom>Disintegration per Minute SubClassOf Unit of Radioactive Decay</Axiom>
               <New_Terms>Unit of Radioactive Decay</New_Terms>
            </Change>
            <Change id="2270">
               <Axiom>Donor Lymphocyte Infusion SubClassOf Donor Cellular Infusion</Axiom>
               <New_Terms>Donor Cellular Infusion</New_Terms>
            </Change>
            <Change id="2271">
               <Axiom>Escherichia coli SubClassOf Escherichia</Axiom>
               <New_Terms>Escherichia</New_Terms>
            </Change>
            <Change id="2272">
               <Axiom>False Positive SubClassOf Clinical Test Result</Axiom>
               <New_Terms>Clinical Test Result</New_Terms>
            </Change>
            <Change id="2273">
               <Axiom>Fluorescence Units SubClassOf Unit of Radiant Flux</Axiom>
               <New_Terms>Unit of Radiant Flux</New_Terms>
            </Change>
            <Change id="2274">
               <Axiom>Friday SubClassOf Day of the Week</Axiom>
               <New_Terms>Day of the Week</New_Terms>
            </Change>
            <Change id="2275">
               <Axiom>Insect SubClassOf Arthropoda</Axiom>
               <New_Terms>Arthropoda</New_Terms>
            </Change>
            <Change id="2289">
               <Axiom>Laboratory Test Result SubClassOf Clinical Test Result</Axiom>
               <New_Terms>Clinical Test Result</New_Terms>
            </Change>
            <Change id="2276">
               <Axiom>Monday SubClassOf Day of the Week</Axiom>
               <New_Terms>Day of the Week</New_Terms>
            </Change>
            <Change id="2277">
               <Axiom>Mucosa of the Lip SubClassOf Oral Mucosa</Axiom>
               <New_Terms>Oral Mucosa</New_Terms>
            </Change>
            <Change id="2278">
               <Axiom>N-Cadherin SubClassOf Gene_Product_Encoded_By_Gene some CDH2 Gene</Axiom>
               <New_Terms>CDH2 Gene</New_Terms>
            </Change>
            <Change id="2279">
               <Axiom>Negative Test Result SubClassOf Clinical Test Result</Axiom>
               <New_Terms>Clinical Test Result</New_Terms>
            </Change>
            <Change id="2280">
               <Axiom>Positive Test Result SubClassOf Clinical Test Result</Axiom>
               <New_Terms>Clinical Test Result</New_Terms>
            </Change>
            <Change id="2281">
               <Axiom>Proctosigmoiditis SubClassOf Proctocolitis</Axiom>
               <New_Terms>Proctocolitis</New_Terms>
            </Change>
            <Change id="2282">
               <Axiom>Prone Position SubClassOf Recumbent Position</Axiom>
               <New_Terms>Recumbent Position</New_Terms>
            </Change>
            <Change id="2283">
               <Axiom>Radiologic Finding SubClassOf Clinical Test Result</Axiom>
               <New_Terms>Clinical Test Result</New_Terms>
            </Change>
            <Change id="2284">
               <Axiom>Saccharomyces cerevisiae SubClassOf Ascomycota</Axiom>
               <New_Terms>Ascomycota</New_Terms>
            </Change>
            <Change id="2285">
               <Axiom>Saturday SubClassOf Day of the Week</Axiom>
               <New_Terms>Day of the Week</New_Terms>
            </Change>
            <Change id="2286">
               <Axiom>Schirmer Test Wetting SubClassOf Clinical Test Result</Axiom>
               <New_Terms>Clinical Test Result</New_Terms>
            </Change>
            <Change id="2287">
               <Axiom>Sunday SubClassOf Day of the Week</Axiom>
               <New_Terms>Day of the Week</New_Terms>
            </Change>
            <Change id="2288">
               <Axiom>Supine Position SubClassOf Recumbent Position</Axiom>
               <New_Terms>Recumbent Position</New_Terms>
            </Change>
            <Change id="2290">
               <Axiom>Thursday SubClassOf Day of the Week</Axiom>
               <New_Terms>Day of the Week</New_Terms>
            </Change>
            <Change id="2291">
               <Axiom>Toxoplasma SubClassOf Protozoa</Axiom>
               <New_Terms>Protozoa</New_Terms>
            </Change>
            <Change id="2292">
               <Axiom>Tuesday SubClassOf Day of the Week</Axiom>
               <New_Terms>Day of the Week</New_Terms>
            </Change>
            <Change id="2293">
               <Axiom>Wednesday SubClassOf Day of the Week</Axiom>
               <New_Terms>Day of the Week</New_Terms>
            </Change>
         </PureAdditionWithNewTerms>
         <NewModifiedDefinition id="stequiv" size="40">
            <Change id="2294">
               <Axiom>ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (((Disease_May_Have_Cytogenetic_Abnormality some inv(2)(p23q35)) and (Disease_May_Have_Molecular_Abnormality some ATIC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some ALO17-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(p23;q11)) and (Disease_May_Have_Molecular_Abnormality some MYH9-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;3)(p23;q21)) and (Disease_May_Have_Molecular_Abnormality some TFG-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;5)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some NPM-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q11-12;p23)) and (Disease_May_Have_Molecular_Abnormality some MSN-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
               <Source>
                  <Axiom>ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="2295">
               <Axiom>Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
               <Source>
                  <Axiom>Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
               </Source>
            </Change>
            <Change id="2312">
               <Axiom>Activated B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only BCL2 Gene mRNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD44 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Increased NFkappaB Pathway Activation) and (Disease_Has_Molecular_Abnormality only PKCbeta1 Messenger RNA Overexpression) and (Disease_Has_Normal_Cell_Origin only Activated B-Lymphocyte)</Axiom>
               <Source>
                  <Axiom>Activated B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only BCL2 Gene mRNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD44 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Increased NFkappaB Pathway Activation) and (Disease_Has_Molecular_Abnormality only PKCbeta1 Messenger RNA Overexpression) and (Disease_Has_Normal_Cell_Origin only Activated B-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="2296">
               <Axiom>Acute Adult T-Cell Leukemia/Lymphoma EquivalentTo Adult T-Cell Leukemia/Lymphoma and Leukemic Phase of Lymphoma and (((Disease_May_Have_Associated_Disease some Opportunistic Infection) and (Disease_May_Have_Associated_Disease some T-Cell Immunodeficiency)) or ((Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present)) or ((Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Finding only Pautrier-Like Microabscess Present)) or ((Disease_Has_Finding only Bone Marrow Involvement) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Finding only White Blood Cell Count Increased))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy)</Axiom>
               <Source>
                  <Axiom>Acute Adult T-Cell Leukemia/Lymphoma EquivalentTo Adult T-Cell Leukemia/Lymphoma and Leukemic Phase of Lymphoma and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy)</Axiom>
               </Source>
            </Change>
            <Change id="2297">
               <Axiom>Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;V)(p11;v)) and (Disease_May_Have_Molecular_Abnormality some MOZ-V Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
               <Source>
                  <Axiom>Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
               </Source>
            </Change>
            <Change id="2298">
               <Axiom>Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
               <Source>
                  <Axiom>Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
               </Source>
            </Change>
            <Change id="2299">
               <Axiom>Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some del(12p11p13)) and (Disease_May_Have_Finding some Bone Marrow Basophilia)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some DEK-CAN Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;21)(q22;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some AML1-ETO Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
               <Source>
                  <Axiom>Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
               </Source>
            </Change>
            <Change id="2300">
               <Axiom>Acute Myeloid Leukemia with Multilineage Dysplasia EquivalentTo Acute Myeloid Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some ins(3;3)) and (Disease_May_Have_Finding some Thrombocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some inv(3)(q21q26.2)) and (Disease_May_Have_Finding some Thrombocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;3)(q21;q26.2)) and (Disease_May_Have_Finding some Thrombocytosis))) and (Disease_May_Have_Abnormal_Cell some Large Multinucleated Erythroid Cell) and (Disease_May_Have_Abnormal_Cell some Megaloblast) and (Disease_May_Have_Abnormal_Cell some Micromegakaryocyte) and (Disease_May_Have_Abnormal_Cell some Monolobed Megakaryocyte) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Abnormal_Cell some Ringed Sideroblast) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 21) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 5q) and (Disease_May_Have_Cytogenetic_Abnormality some del(20)(q11)) and (Disease_May_Have_Cytogenetic_Abnormality some del(7)(q11;q36)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;5)(q25;q34)) and (Disease_May_Have_Finding some Granulocytopenia) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Pancytopenia) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines) and (Disease_Has_Finding only Ineffective Hematopoiesis) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells)</Axiom>
               <Source>
                  <Axiom>Acute Myeloid Leukemia with Multilineage Dysplasia EquivalentTo Acute Myeloid Leukemia and (Disease_May_Have_Abnormal_Cell some Large Multinucleated Erythroid Cell) and (Disease_May_Have_Abnormal_Cell some Megaloblast) and (Disease_May_Have_Abnormal_Cell some Micromegakaryocyte) and (Disease_May_Have_Abnormal_Cell some Monolobed Megakaryocyte) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Abnormal_Cell some Ringed Sideroblast) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 21) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 5q) and (Disease_May_Have_Cytogenetic_Abnormality some del(20)(q11)) and (Disease_May_Have_Cytogenetic_Abnormality some del(7)(q11;q36)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;5)(q25;q34)) and (Disease_May_Have_Finding some Granulocytopenia) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Pancytopenia) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines) and (Disease_Has_Finding only Ineffective Hematopoiesis) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells)</Axiom>
               </Source>
            </Change>
            <Change id="2301">
               <Axiom>Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression))) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
               <Source>
                  <Axiom>Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
               </Source>
            </Change>
            <Change id="2302">
               <Axiom>Acute Myelomonocytic Leukemia without Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_Excludes_Abnormal_Cell only Abnormal Eosinophil)</Axiom>
               <Source>
                  <Axiom>Acute Myelomonocytic Leukemia without Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_Excludes_Abnormal_Cell only Abnormal Eosinophil)</Axiom>
               </Source>
            </Change>
            <Change id="2303">
               <Axiom>Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               <Source>
                  <Axiom>Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               </Source>
            </Change>
            <Change id="2304">
               <Axiom>Alveolar Rhabdomyosarcoma EquivalentTo Rhabdomyosarcoma and Sarcoma Differentiation Score 3 and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;13)(q36;q14)) and (Disease_May_Have_Molecular_Abnormality some PAX3-FKHR Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;13)(q35;q14)) and (Disease_May_Have_Molecular_Abnormality some PAX7-FKHR Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;2)(q35;p23)) and (Disease_May_Have_Molecular_Abnormality some PAX3-NCOA1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q13;q35)) and (Disease_May_Have_Molecular_Abnormality some PAX3-AFX Fusion Protein Expression))) and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Round Cell with Primitive Myoblastic Differentiation)</Axiom>
               <Source>
                  <Axiom>Alveolar Rhabdomyosarcoma EquivalentTo Rhabdomyosarcoma and Sarcoma Differentiation Score 3 and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Round Cell with Primitive Myoblastic Differentiation)</Axiom>
               </Source>
            </Change>
            <Change id="2305">
               <Axiom>Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
               <Source>
                  <Axiom>Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
               </Source>
            </Change>
            <Change id="2306">
               <Axiom>Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               <Source>
                  <Axiom>Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               </Source>
            </Change>
            <Change id="2307">
               <Axiom>Brain Glioblastoma EquivalentTo Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
               <Source>
                  <Axiom>Brain Glioblastoma EquivalentTo Glioblastoma and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
               </Source>
            </Change>
            <Change id="2308">
               <Axiom>Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and Malignant Childhood Central Nervous System Neoplasm and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               <Source>
                  <Axiom>Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and Malignant Childhood Central Nervous System Neoplasm and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               </Source>
            </Change>
            <Change id="2309">
               <Axiom>Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;4)(q44;q12)) and (Disease_May_Have_Molecular_Abnormality some FIP1L1-PDGFRalpha Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell)) or ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               <Source>
                  <Axiom>Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               </Source>
            </Change>
            <Change id="2310">
               <Axiom>Classical Hodgkin Lymphoma EquivalentTo Hodgkin Lymphoma and (((Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Mature B-Lymphocyte at the Germinal Center Stage of Differentiation)) or ((Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Peripheral (Post-Thymic) T-Lymphocyte))) and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweats) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin Cell)</Axiom>
               <Source>
                  <Axiom>Classical Hodgkin Lymphoma EquivalentTo Hodgkin Lymphoma and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweats) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin Cell)</Axiom>
               </Source>
            </Change>
            <Change id="2330">
               <Axiom>DS Stage I Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Solitary Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage I)</Axiom>
               <Source>
                  <Axiom>DS Stage I Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage I)</Axiom>
               </Source>
            </Change>
            <Change id="2329">
               <Axiom>DS Stage III Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
               <Source>
                  <Axiom>DS Stage III Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
               </Source>
            </Change>
            <Change id="2313">
               <Axiom>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some inv(22q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p36.1;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ZSG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;21)(p11;q22)) and (Disease_May_Have_Molecular_Abnormality some FUS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q21;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-E1AF Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(21;22)(q22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(q33;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-FEV Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(7;22)(p22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ETV1 Fusion Protein Expression)) or ((Disease_May_Have_Molecular_Abnormality some EWS-FL1 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(q24;q12)) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
               <Source>
                  <Axiom>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(q24;q12)) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
               </Source>
            </Change>
            <Change id="2322">
               <Axiom>Extraskeletal Myxoid Chondrosarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Soft Tissue Sarcoma and (((Disease_May_Have_Cytogenetic_Abnormality some t(3;9)(q11-12;q22)) and (Disease_May_Have_Molecular_Abnormality some TFG-NR4A3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;15)(q22;q21)) and (Disease_May_Have_Molecular_Abnormality some TCF12-NR4A3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;17)(q22;q11)) and (Disease_May_Have_Molecular_Abnormality some RBP56-NR4A3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q22-31;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-NR4A3 Fusion Protein Expression))) and (Disease_May_Have_Finding some Cord-Like Pattern) and (Disease_May_Have_Finding some Cribriform Pattern) and (Disease_May_Have_Finding some Cystic Change) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Spindle Cell Pattern) and (Disease_Has_Abnormal_Cell only Malignant Cell with Eosinophilic Cytoplasm) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Extraosseous Lesion) and (Disease_Has_Finding only Multinodular Pattern) and (Disease_Has_Finding only Myxoid Stroma Formation)</Axiom>
               <Source>
                  <Axiom>Extraskeletal Myxoid Chondrosarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Soft Tissue Sarcoma and (Disease_May_Have_Finding some Cord-Like Pattern) and (Disease_May_Have_Finding some Cribriform Pattern) and (Disease_May_Have_Finding some Cystic Change) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Spindle Cell Pattern) and (Disease_Has_Abnormal_Cell only Malignant Cell with Eosinophilic Cytoplasm) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Extraosseous Lesion) and (Disease_Has_Finding only Multinodular Pattern) and (Disease_Has_Finding only Myxoid Stroma Formation)</Axiom>
               </Source>
            </Change>
            <Change id="2311">
               <Axiom>Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only A-myb Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Has_Molecular_Abnormality only BCL-6 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD10 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only LMO2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only REL Gene Amplification) and (Disease_Has_Normal_Cell_Origin only Germinal Center B-Lymphocyte)</Axiom>
               <Source>
                  <Axiom>Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only A-myb Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Has_Molecular_Abnormality only BCL-6 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD10 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only LMO2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only REL Gene Amplification) and (Disease_Has_Normal_Cell_Origin only Germinal Center B-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="2314">
               <Axiom>Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and (((Disease_May_Have_Finding some Splenic Rupture) and (Disease_Has_Finding only Splenomegaly)) or ((Disease_Has_Finding only Atypical Lymphocytes Present in Peripheral Blood) and (Disease_Has_Finding only Diffuse Immunoblastic Proliferation) and (Disease_Has_Finding only Polymorphic Cellular Infiltrate))) and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
               <Source>
                  <Axiom>Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="2315">
               <Axiom>Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
               <Source>
                  <Axiom>Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
               </Source>
            </Change>
            <Change id="2316">
               <Axiom>Integrin Alpha 5 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGA5 Gene) and (Gene_Product_Has_Chemical_Classification some Glycoprotein) and (Gene_Product_Is_Physical_Part_Of some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion)</Axiom>
               <Source>
                  <Axiom>Integrin Alpha 5 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGA5 Gene) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion)</Axiom>
               </Source>
            </Change>
            <Change id="2317">
               <Axiom>Integrin Beta-3 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGB3 Gene) and (Gene_Product_Has_Biochemical_Function some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation) and (Gene_Product_Plays_Role_In_Biological_Process some Protein-Protein Interaction) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling) and (Gene_Product_Plays_Role_In_Biological_Process some Wound Repair)</Axiom>
               <Source>
                  <Axiom>Integrin Beta-3 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGB3 Gene) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation)</Axiom>
               </Source>
            </Change>
            <Change id="2318">
               <Axiom>Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and (((Disease_May_Have_Associated_Disease some Anaplastic Large Cell Lymphoma) and (Disease_May_Have_Associated_Disease some Hodgkin Lymphoma) and (Disease_May_Have_Associated_Disease some Mycosis Fungoides)) or ((Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Complete Spontaneous Regression) and (Disease_Has_Finding only Cutaneous Involvement))) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
               <Source>
                  <Axiom>Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
               </Source>
            </Change>
            <Change id="2319">
               <Axiom>Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and (((Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm)) or ((Disease_May_Have_Finding some Marked Nuclear Atypia Present) and (Disease_May_Have_Finding some Mitotic Activity))) and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
               <Source>
                  <Axiom>Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
               </Source>
            </Change>
            <Change id="2320">
               <Axiom>Monoblastic Sarcoma EquivalentTo Myeloid Sarcoma and (((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression))) and (Disease_Excludes_Abnormal_Cell only Neoplastic Granulocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast)</Axiom>
               <Source>
                  <Axiom>Monoblastic Sarcoma EquivalentTo Myeloid Sarcoma and (Disease_Excludes_Abnormal_Cell only Neoplastic Granulocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast)</Axiom>
               </Source>
            </Change>
            <Change id="2321">
               <Axiom>Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin Lymphoma and Indolent Non-Hodgkin Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate)) or ((Disease_May_Have_Finding some Progressive Disease) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation))) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               <Source>
                  <Axiom>Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin Lymphoma and Indolent Non-Hodgkin Lymphoma and Mycosis Fungoides and Sezary Syndrome and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="2323">
               <Axiom>Myxoid/Round Cell Liposarcoma EquivalentTo Liposarcoma and (((Disease_May_Have_Cytogenetic_Abnormality some t(12;16)(q13;p11)) and (Disease_May_Have_Molecular_Abnormality some FUS-DDIT3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(12;22)(q13;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-DDIT3 Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13q) and (Disease_Has_Abnormal_Cell only Primitive Mesenchymal Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
               <Source>
                  <Axiom>Myxoid/Round Cell Liposarcoma EquivalentTo Liposarcoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13q) and (Disease_Has_Abnormal_Cell only Primitive Mesenchymal Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="2324">
               <Axiom>NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial EquivalentTo Oxidoreductase and (Gene_Product_Encoded_By_Gene some NDUFV1 Gene) and (Gene_Product_Has_Associated_Anatomy some Mitochondrion) and (Gene_Product_Has_Biochemical_Function some Oxidoreductase) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Respiration) and (Gene_Product_Plays_Role_In_Biological_Process some Oxidation)</Axiom>
               <Source>
                  <Axiom>NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial EquivalentTo Oxidoreductase and (Gene_Product_Encoded_By_Gene some NDUFV1 Gene) and (Gene_Product_Has_Associated_Anatomy some Mitochondrion) and (Gene_Product_Has_Biochemical_Function some Oxidoreductase) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Respiration) and (Gene_Product_Plays_Role_In_Biological_Process some Oxidation)</Axiom>
               </Source>
            </Change>
            <Change id="2325">
               <Axiom>Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;19)(q23;p13.3)) and (Disease_May_Have_Molecular_Abnormality some E2A-PBX1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
               <Source>
                  <Axiom>Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
               </Source>
            </Change>
            <Change id="2326">
               <Axiom>Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
               <Source>
                  <Axiom>Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
               </Source>
            </Change>
            <Change id="2327">
               <Axiom>Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
               <Source>
                  <Axiom>Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
               </Source>
            </Change>
            <Change id="2328">
               <Axiom>Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Abnormal_Cell some Lutzner Cell) and (Disease_May_Have_Abnormal_Cell some Sezary Cell) and (Disease_Has_Finding only Peripheral Blood Involvement)) or ((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate))) and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pruritus) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               <Source>
                  <Axiom>Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pruritus) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="2331">
               <Axiom>T-Box Transcription Factor TBX1 EquivalentTo Transcription Factor and (Gene_Product_Encoded_By_Gene some TBX1 Gene) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Proliferation) and (Gene_Product_Plays_Role_In_Biological_Process some Transcription)</Axiom>
               <Source>
                  <Axiom>T-Box Transcription Factor TBX1 EquivalentTo Transcription Factor and (Gene_Product_Plays_Role_In_Biological_Process some Cell Proliferation) and (Gene_Product_Plays_Role_In_Biological_Process some Transcription)</Axiom>
               </Source>
            </Change>
            <Change id="2332">
               <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and (((Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Epithelial Spindle Cell) and (Disease_May_Have_Finding some Monophasic Pattern)) or ((Disease_May_Have_Finding some Biphasic Pattern) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell))) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Slow Growing Mass)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Slow Growing Mass)</Axiom>
               </Source>
            </Change>
            <Change id="2333">
               <Axiom>Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
               <Source>
                  <Axiom>Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
               </Source>
            </Change>
         </NewModifiedDefinition>
         <NewModifiedDefinitionWithNewTerms id="stequivnt" size="0"/>
      </Effectual>
      <Ineffectual id="ineffadds" size="45">
         <AddedRedundancy id="ared" size="3">
            <Change id="2334">
               <Axiom>F10 Gene SubClassOf Gene_Plays_Role_In_Process some Coagulation</Axiom>
               <Source>
                  <Axiom shared="true">F10 Gene SubClassOf Coagulation Factor Gene</Axiom>
                  <Axiom shared="true">Coagulation Factor Gene SubClassOf Gene_Plays_Role_In_Process some Coagulation</Axiom>
               </Source>
            </Change>
            <Change id="2335">
               <Axiom>HLA-C wt Allele SubClassOf Gene_Found_In_Organism some Human</Axiom>
               <Source>
                  <Axiom shared="true">HLA-C wt Allele SubClassOf HLA-C Gene</Axiom>
                  <Axiom shared="true">HLA-C Gene SubClassOf MHC Class I Gene</Axiom>
                  <Axiom shared="true">MHC Class I Gene SubClassOf Gene_Found_In_Organism some Human</Axiom>
               </Source>
            </Change>
            <Change id="2336">
               <Axiom>N-Cadherin SubClassOf Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion</Axiom>
               <Source>
                  <Axiom shared="true">Cell Adhesion Molecule SubClassOf Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion</Axiom>
                  <Axiom shared="true">Cadherin SubClassOf Cell Adhesion Molecule</Axiom>
                  <Axiom shared="true">N-Cadherin SubClassOf Cadherin</Axiom>
               </Source>
            </Change>
         </AddedRedundancy>
         <AddedRewrite id="arws" size="0">
            <AddedCompleteRewrite id="arw" size="0"/>
            <AddedPartialRewrite id="aprw" size="0"/>
         </AddedRewrite>
         <AddedProspectiveRedundancy id="apred" size="42">
            <AddedReshuffleProspectiveRedundancy id="aavred" size="0"/>
            <AddedNewProspectiveRedundancy id="anpred" size="42">
               <AddedNovelProspectiveRedundancy id="weak" size="42">
                  <Change id="2337">
                     <Axiom>Abnormal Laboratory Test Result SubClassOf Laboratory Test Result</Axiom>
                     <Source>
                        <Axiom effectual="true">Laboratory Finding SubClassOf Laboratory Test Result</Axiom>
                        <Axiom effectual="true">Abnormal Laboratory Test Result SubClassOf Laboratory Finding</Axiom>
                     </Source>
                  </Change>
                  <Change id="2338">
                     <Axiom>Achalasia SubClassOf Gastrointestinal System Finding</Axiom>
                     <Source>
                        <Axiom shared="true">Gastrointestinal System Signs and Symptoms SubClassOf Gastrointestinal System Finding</Axiom>
                        <Axiom effectual="true">Achalasia SubClassOf Gastrointestinal System Signs and Symptoms</Axiom>
                     </Source>
                  </Change>
                  <Change id="2339">
                     <Axiom>Animal SubClassOf Organism</Axiom>
                     <Source>
                        <Axiom ineffectual="true">Eukaryota SubClassOf Organism</Axiom>
                        <Axiom effectual="true">Animal SubClassOf Eukaryota</Axiom>
                     </Source>
                  </Change>
                  <Change id="2340">
                     <Axiom>Bacitracin SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom effectual="true">Bacitracin SubClassOf Miscellaneous Antibiotic</Axiom>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2341">
                     <Axiom>Bacitracin Zinc SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                        <Axiom effectual="true">Bacitracin Zinc SubClassOf Miscellaneous Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2342">
                     <Axiom>Bioassay SubClassOf Laboratory Procedure</Axiom>
                     <Source>
                        <Axiom shared="true">Clinical Pathology Procedure SubClassOf Laboratory Procedure</Axiom>
                        <Axiom effectual="true">Bioassay SubClassOf Immunology Test</Axiom>
                        <Axiom shared="true">Immunology Test SubClassOf Clinical Pathology Procedure</Axiom>
                     </Source>
                  </Change>
                  <Change id="2345">
                     <Axiom>Clindamycin Hydrochloride SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                        <Axiom effectual="true">Clindamycin Hydrochloride SubClassOf Miscellaneous Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2346">
                     <Axiom>Clindamycin Phosphate SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom effectual="true">Clindamycin Phosphate SubClassOf Miscellaneous Antibiotic</Axiom>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2344">
                     <Axiom>Clindamycin SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                        <Axiom effectual="true">Clindamycin SubClassOf Miscellaneous Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2347">
                     <Axiom>Clinical Chemistry Finding SubClassOf Laboratory Test Result</Axiom>
                     <Source>
                        <Axiom effectual="true">Laboratory Finding SubClassOf Laboratory Test Result</Axiom>
                        <Axiom effectual="true">Clinical Chemistry Finding SubClassOf Laboratory Finding</Axiom>
                     </Source>
                  </Change>
                  <Change id="2348">
                     <Axiom>Clofazimine SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom effectual="true">Clofazimine SubClassOf Miscellaneous Antibiotic</Axiom>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2349">
                     <Axiom>Cloxyquin SubClassOf Anti-Infective Agent</Axiom>
                     <Source>
                        <Axiom shared="true">Antibacterial Agent SubClassOf Anti-Infective Agent</Axiom>
                        <Axiom effectual="true">Cloxyquin SubClassOf Antibacterial Agent</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Cloxyquin SubClassOf Antifungal Agent</Axiom>
                        <Axiom shared="true">Antifungal Agent SubClassOf Anti-Infective Agent</Axiom>
                     </Source>
                  </Change>
                  <Change id="2350">
                     <Axiom>Colistin Sulfate SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom effectual="true">Colistin Sulfate SubClassOf Miscellaneous Antibiotic</Axiom>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2351">
                     <Axiom>Drug Level Test Result SubClassOf Laboratory Test Result</Axiom>
                     <Source>
                        <Axiom effectual="true">Drug Level Test Result SubClassOf Laboratory Finding</Axiom>
                        <Axiom effectual="true">Laboratory Finding SubClassOf Laboratory Test Result</Axiom>
                     </Source>
                  </Change>
                  <Change id="2352">
                     <Axiom>External Ear Infection SubClassOf Ear Infection</Axiom>
                     <Source>
                        <Axiom effectual="true">External Ear Infection SubClassOf Otitis</Axiom>
                        <Axiom shared="true">Otitis SubClassOf Ear Infection</Axiom>
                     </Source>
                  </Change>
                  <Change id="2353">
                     <Axiom>Fungus SubClassOf Organism</Axiom>
                     <Source>
                        <Axiom ineffectual="true">Eukaryota SubClassOf Organism</Axiom>
                        <Axiom effectual="true">Fungus SubClassOf Eukaryota</Axiom>
                     </Source>
                  </Change>
                  <Change id="2354">
                     <Axiom>Internal Ear Infection SubClassOf Ear Infection</Axiom>
                     <Source>
                        <Axiom effectual="true">Internal Ear Infection SubClassOf Otitis</Axiom>
                        <Axiom shared="true">Otitis SubClassOf Ear Infection</Axiom>
                     </Source>
                  </Change>
                  <Change id="2355">
                     <Axiom>Intimal Dissection Of Blood Vessel SubClassOf Non-Neoplastic Vascular Disorder</Axiom>
                     <Source>
                        <Axiom effectual="true">Intimal Dissection Of Blood Vessel SubClassOf Arterial Disorder</Axiom>
                        <Axiom shared="true">Arterial Disorder SubClassOf Non-Neoplastic Vascular Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="2356">
                     <Axiom>Ionomycin SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                        <Axiom effectual="true">Ionomycin SubClassOf Miscellaneous Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2357">
                     <Axiom>Linezolid SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                        <Axiom effectual="true">Linezolid SubClassOf Miscellaneous Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2358">
                     <Axiom>Microequivalent SubClassOf Potency Unit</Axiom>
                     <Source>
                        <Axiom effectual="true">Microequivalent SubClassOf Animal Dosing Unit</Axiom>
                        <Axiom shared="true">Animal Dosing Unit SubClassOf Potency Unit</Axiom>
                     </Source>
                  </Change>
                  <Change id="2359">
                     <Axiom>Mixed Lymphocyte Reaction Test SubClassOf Immunology Test</Axiom>
                     <Source>
                        <Axiom effectual="true">Bioassay SubClassOf Immunology Test</Axiom>
                        <Axiom effectual="true">Mixed Lymphocyte Reaction Test SubClassOf Bioassay</Axiom>
                     </Source>
                  </Change>
                  <Change id="2360">
                     <Axiom>Normal Laboratory Test Result SubClassOf Laboratory Test Result</Axiom>
                     <Source>
                        <Axiom effectual="true">Normal Laboratory Test Result SubClassOf Laboratory Finding</Axiom>
                        <Axiom effectual="true">Laboratory Finding SubClassOf Laboratory Test Result</Axiom>
                     </Source>
                  </Change>
                  <Change id="2361">
                     <Axiom>Novobiocin SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                        <Axiom effectual="true">Novobiocin SubClassOf Miscellaneous Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2362">
                     <Axiom>Otitis Media SubClassOf Ear Infection</Axiom>
                     <Source>
                        <Axiom effectual="true">Otitis Media SubClassOf Otitis</Axiom>
                        <Axiom shared="true">Otitis SubClassOf Ear Infection</Axiom>
                     </Source>
                  </Change>
                  <Change id="2363">
                     <Axiom>Pirlimycin Hydrochloride SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom effectual="true">Pirlimycin Hydrochloride SubClassOf Miscellaneous Antibiotic</Axiom>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2364">
                     <Axiom>Plant SubClassOf Organism</Axiom>
                     <Source>
                        <Axiom effectual="true">Plant SubClassOf Eukaryota</Axiom>
                        <Axiom ineffectual="true">Eukaryota SubClassOf Organism</Axiom>
                     </Source>
                  </Change>
                  <Change id="2365">
                     <Axiom>Population Based Sampling SubClassOf Statistical Technique</Axiom>
                     <Source>
                        <Axiom effectual="true">Type of Statistical Sample SubClassOf Statistical Technique</Axiom>
                        <Axiom effectual="true">Population Based Sampling SubClassOf Type of Statistical Sample</Axiom>
                     </Source>
                  </Change>
                  <Change id="2367">
                     <Axiom>Povidone-Iodine Solution SubClassOf Anti-Infective Agent</Axiom>
                     <Source>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                        <Axiom shared="true">Antibiotic SubClassOf Anti-Infective Agent</Axiom>
                        <Axiom effectual="true">Povidone-Iodine Solution SubClassOf Miscellaneous Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2366">
                     <Axiom>Povidone-Iodine SubClassOf Anti-Infective Agent</Axiom>
                     <Source>
                        <Axiom effectual="true">Povidone-Iodine SubClassOf Miscellaneous Antibiotic</Axiom>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                        <Axiom shared="true">Antibiotic SubClassOf Anti-Infective Agent</Axiom>
                     </Source>
                  </Change>
                  <Change id="2343">
                     <Axiom>Precise Histogenesis Unknown SubClassOf Laboratory Test Result</Axiom>
                     <Source>
                        <Axiom effectual="true">Laboratory Finding SubClassOf Laboratory Test Result</Axiom>
                        <Axiom effectual="true">Precise Histogenesis Unknown SubClassOf Laboratory Finding</Axiom>
                     </Source>
                  </Change>
                  <Change id="2368">
                     <Axiom>Pulmonary Vascular Disorder SubClassOf Lung Disorder</Axiom>
                     <Source>
                        <Axiom effectual="true">Pulmonary Vascular Disorder SubClassOf Non-Neoplastic Lung Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Lung Disorder SubClassOf Lung Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="2369">
                     <Axiom>Radiation Colitis SubClassOf Enteritis</Axiom>
                     <Source>
                        <Axiom effectual="true">Radiation Colitis SubClassOf Radiation Enteritis</Axiom>
                        <Axiom shared="true">Radiation Enteritis SubClassOf Enteritis</Axiom>
                     </Source>
                  </Change>
                  <Change id="2370">
                     <Axiom>S3 Gallop SubClassOf Cardiovascular System Finding</Axiom>
                     <Source>
                        <Axiom shared="true">Cardiovascular System Signs and Symptoms SubClassOf Cardiovascular System Finding</Axiom>
                        <Axiom effectual="true">S3 Gallop SubClassOf Cardiovascular System Signs and Symptoms</Axiom>
                     </Source>
                  </Change>
                  <Change id="2371">
                     <Axiom>Secondary Adrenal Insufficiency SubClassOf Adrenal Cortical Insufficiency</Axiom>
                     <Source>
                        <Axiom shared="true">Addison's Disease SubClassOf Adrenal Cortical Insufficiency</Axiom>
                        <Axiom effectual="true">Secondary Adrenal Insufficiency SubClassOf Addison's Disease</Axiom>
                     </Source>
                  </Change>
                  <Change id="2372">
                     <Axiom>Sick Sinus Syndrome SubClassOf Non-Neoplastic Heart Disorder</Axiom>
                     <Source>
                        <Axiom effectual="true">Sick Sinus Syndrome SubClassOf Sinus Node Dysfunction</Axiom>
                        <Axiom effectual="true">Sinus Node Dysfunction SubClassOf Non-Neoplastic Heart Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="2373">
                     <Axiom>Stein-Leventhal Syndrome SubClassOf Ovarian Non-Neoplastic Disorder</Axiom>
                     <Source>
                        <Axiom effectual="true">Polycystic Ovarian Disease SubClassOf Ovarian Non-Neoplastic Disorder</Axiom>
                        <Axiom effectual="true">Stein-Leventhal Syndrome SubClassOf Polycystic Ovarian Disease</Axiom>
                     </Source>
                  </Change>
                  <Change id="2374">
                     <Axiom>Taurolidine SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom effectual="true">Taurolidine SubClassOf Miscellaneous Antibiotic</Axiom>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2375">
                     <Axiom>Tissue Differentiation Uncertain SubClassOf Laboratory Test Result</Axiom>
                     <Source>
                        <Axiom effectual="true">Laboratory Finding SubClassOf Laboratory Test Result</Axiom>
                        <Axiom effectual="true">Tissue Differentiation Uncertain SubClassOf Laboratory Finding</Axiom>
                     </Source>
                  </Change>
                  <Change id="2376">
                     <Axiom>Toxicology Finding SubClassOf Laboratory Test Result</Axiom>
                     <Source>
                        <Axiom effectual="true">Laboratory Finding SubClassOf Laboratory Test Result</Axiom>
                        <Axiom effectual="true">Toxicology Finding SubClassOf Laboratory Finding</Axiom>
                     </Source>
                  </Change>
                  <Change id="2377">
                     <Axiom>Triclosan SubClassOf Anti-Infective Agent</Axiom>
                     <Source>
                        <Axiom effectual="true">Triclosan SubClassOf Antibiotic</Axiom>
                        <Axiom shared="true">Antibiotic SubClassOf Anti-Infective Agent</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Antifungal Agent SubClassOf Anti-Infective Agent</Axiom>
                        <Axiom effectual="true">Triclosan SubClassOf Antifungal Agent</Axiom>
                     </Source>
                  </Change>
                  <Change id="2378">
                     <Axiom>Vancomycin SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom shared="true">Miscellaneous Antibiotic SubClassOf Antibiotic</Axiom>
                        <Axiom effectual="true">Vancomycin SubClassOf Miscellaneous Antibiotic</Axiom>
                     </Source>
                  </Change>
               </AddedNovelProspectiveRedundancy>
               <AddedPseudoNovelProspectiveRedundancy id="apseudopred" size="0"/>
            </AddedNewProspectiveRedundancy>
         </AddedProspectiveRedundancy>
      </Ineffectual>
   </Additions>
   <Removals id="rems" size="543">
      <Effectual id="effrems" size="447">
         <Weakening id="wk" size="0"/>
         <WeakeningWithRetiredTerms id="wkrt" size="0"/>
         <RetiredDescription id="retdesc" size="1">
            <Change id="2379">
               <Axiom>Required_Intake Range: string</Axiom>
               <Retired_Terms>Required_Intake</Retired_Terms>
            </Change>
         </RetiredDescription>
         <PureRemoval id="prem" size="443">
            <Change id="2380">
               <Axiom>ADME Finding SubClassOf Laboratory Test Result</Axiom>
            </Change>
            <Change id="2381">
               <Axiom>Abnormal Laboratory Test Result SubClassOf Laboratory Finding</Axiom>
            </Change>
            <Change id="2382">
               <Axiom>Abnormal Patch Test Result SubClassOf Laboratory Test Result</Axiom>
            </Change>
            <Change id="2383">
               <Axiom>Accelerated Idioventricular Rhythm SubClassOf Ventricular Arrhythmia</Axiom>
            </Change>
            <Change id="2384">
               <Axiom>Achalasia SubClassOf Gastrointestinal System Signs and Symptoms</Axiom>
            </Change>
            <Change id="2385">
               <Axiom>Age Group SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2386">
               <Axiom>Allele_Has_Activity Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2387">
               <Axiom>Allele_Has_Activity Range Properties_or_Attributes_Kind</Axiom>
            </Change>
            <Change id="2388">
               <Axiom>Allele_Is_Cancer_Related_Type Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2389">
               <Axiom>Allele_Is_Cancer_Related_Type Range Gene_Kind</Axiom>
            </Change>
            <Change id="2390">
               <Axiom>Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2391">
               <Axiom>Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug Range Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2392">
               <Axiom>Allylisopropylacetamide SubClassOf Protective Agent</Axiom>
            </Change>
            <Change id="2393">
               <Axiom>Aminohippuric Acid SubClassOf Radiopharmaceutical Compound</Axiom>
            </Change>
            <Change id="2394">
               <Axiom>Anatomic_Structure_Has_Location Domain Anatomy_Kind</Axiom>
            </Change>
            <Change id="2395">
               <Axiom>Anatomic_Structure_Has_Location Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2396">
               <Axiom>Anatomic_Structure_Is_Physical_Part_Of Domain Anatomy_Kind</Axiom>
            </Change>
            <Change id="2397">
               <Axiom>Anatomic_Structure_Is_Physical_Part_Of Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2398">
               <Axiom>Angina Pectoris Prompting Medical Attention Event SubClassOf Angina</Axiom>
            </Change>
            <Change id="2399">
               <Axiom>Animal SubClassOf Eukaryota</Axiom>
            </Change>
            <Change id="2400">
               <Axiom>Antigen Processing Cell SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Immune System</Axiom>
            </Change>
            <Change id="2401">
               <Axiom>Antigen Processing Cell SubClassOf Cell</Axiom>
            </Change>
            <Change id="2402">
               <Axiom>Atrial Flutter SubClassOf Supraventricular Tachycardia</Axiom>
            </Change>
            <Change id="2403">
               <Axiom>Atrial Premature Complex SubClassOf Supraventricular Arrhythmia</Axiom>
            </Change>
            <Change id="2404">
               <Axiom>Atrioventricular Nodal Reentry Tachycardia SubClassOf Nodal Arrhythmia</Axiom>
            </Change>
            <Change id="2405">
               <Axiom>Atrioventricular Nodal Reentry Tachycardia SubClassOf Paroxysmal Supraventricular Tachycardia</Axiom>
            </Change>
            <Change id="2406">
               <Axiom>Atrioventricular Reentrant Tachycardia SubClassOf Paroxysmal Supraventricular Tachycardia</Axiom>
            </Change>
            <Change id="2407">
               <Axiom>Average Fluorescence Units SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2408">
               <Axiom>Bacitracin SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2409">
               <Axiom>Bacitracin Zinc SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2410">
               <Axiom>Bigeminy SubClassOf Arrhythmia</Axiom>
            </Change>
            <Change id="2411">
               <Axiom>Bioassay SubClassOf Immunology Test</Axiom>
            </Change>
            <Change id="2412">
               <Axiom>Biological_Process_Has_Associated_Location Domain Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2413">
               <Axiom>Biological_Process_Has_Associated_Location Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2414">
               <Axiom>Biological_Process_Has_Initiator_Chemical_Or_Drug Domain Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2415">
               <Axiom>Biological_Process_Has_Initiator_Chemical_Or_Drug Range Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2416">
               <Axiom>Biological_Process_Has_Initiator_Process Domain Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2417">
               <Axiom>Biological_Process_Has_Initiator_Process Range Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2418">
               <Axiom>Biological_Process_Has_Result_Anatomy Domain Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2419">
               <Axiom>Biological_Process_Has_Result_Anatomy Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2420">
               <Axiom>Biological_Process_Has_Result_Biological_Process Domain Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2421">
               <Axiom>Biological_Process_Has_Result_Biological_Process Range Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2422">
               <Axiom>Biological_Process_Has_Result_Chemical_Or_Drug Domain Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2423">
               <Axiom>Biological_Process_Has_Result_Chemical_Or_Drug Range Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2424">
               <Axiom>Biological_Process_Is_Part_Of_Process Domain Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2425">
               <Axiom>Biological_Process_Is_Part_Of_Process Range Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2426">
               <Axiom>Birth Cohort SubClassOf Type of Statistical Sample</Axiom>
            </Change>
            <Change id="2427">
               <Axiom>Brodimoprim SubClassOf Antibacterial Agent</Axiom>
            </Change>
            <Change id="2429">
               <Axiom>CDISC SDTM Package 2 Terminology SubClassOf Clinical Data Interchange Standards Consortium Terminology</Axiom>
            </Change>
            <Change id="2430">
               <Axiom>Capsule per Animal SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2431">
               <Axiom>Cardiac Arrest SubClassOf Non-Neoplastic Heart Disorder</Axiom>
            </Change>
            <Change id="2432">
               <Axiom>Cells per Femur SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2434">
               <Axiom>Chemical_Or_Drug_Affects_Abnormal_Cell Domain Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2435">
               <Axiom>Chemical_Or_Drug_Affects_Abnormal_Cell Range Abnormal_Cell_Kind</Axiom>
            </Change>
            <Change id="2436">
               <Axiom>Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue Domain Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2437">
               <Axiom>Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2438">
               <Axiom>Chemical_Or_Drug_Affects_Gene_Product Domain Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2439">
               <Axiom>Chemical_Or_Drug_Affects_Gene_Product Range Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2440">
               <Axiom>Chemical_Or_Drug_FDA_Approved_For_Disease Domain Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2441">
               <Axiom>Chemical_Or_Drug_FDA_Approved_For_Disease Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2442">
               <Axiom>Chemical_Or_Drug_Has_Accepted_Therapeutic_Use_For Domain Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2443">
               <Axiom>Chemical_Or_Drug_Has_Accepted_Therapeutic_Use_For Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2444">
               <Axiom>Chemical_Or_Drug_Has_Mechanism_Of_Action Domain Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2445">
               <Axiom>Chemical_Or_Drug_Has_Mechanism_Of_Action Range Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2446">
               <Axiom>Chemical_Or_Drug_Has_Physiologic_Effect Domain Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2447">
               <Axiom>Chemical_Or_Drug_Has_Physiologic_Effect Range Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2448">
               <Axiom>Chemical_Or_Drug_Has_Study_Therapeutic_Use_For Domain Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2449">
               <Axiom>Chemical_Or_Drug_Has_Study_Therapeutic_Use_For Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2450">
               <Axiom>Chemical_Or_Drug_Is_Metabolized_By_Enzyme Domain Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2451">
               <Axiom>Chemical_Or_Drug_Is_Metabolized_By_Enzyme Range Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2452">
               <Axiom>Chemical_Or_Drug_Plays_Role_In_Biological_Process Domain Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2453">
               <Axiom>Chemical_Or_Drug_Plays_Role_In_Biological_Process Range Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2454">
               <Axiom>Chemotherapy_Regimen_Has_Component Domain Chemotherapy_Regimen_Kind</Axiom>
            </Change>
            <Change id="2455">
               <Axiom>Chemotherapy_Regimen_Has_Component Range Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2456">
               <Axiom>Cinacalcet SubClassOf Adjuvant</Axiom>
            </Change>
            <Change id="2458">
               <Axiom>Clindamycin Hydrochloride SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2459">
               <Axiom>Clindamycin Phosphate SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2457">
               <Axiom>Clindamycin SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2460">
               <Axiom>Clinical Chemistry Finding SubClassOf Laboratory Finding</Axiom>
            </Change>
            <Change id="2428">
               <Axiom>Clinical Data Interchange Standards Consortium Proposed Terminology SubClassOf Clinical Data Interchange Standards Consortium Terminology</Axiom>
            </Change>
            <Change id="2461">
               <Axiom>Clofazimine SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2463">
               <Axiom>Cloxyquin SubClassOf Antibacterial Agent</Axiom>
            </Change>
            <Change id="2462">
               <Axiom>Cloxyquin SubClassOf Antifungal Agent</Axiom>
            </Change>
            <Change id="2464">
               <Axiom>Colistin Sulfate SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2465">
               <Axiom>Diagnosis Group SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2466">
               <Axiom>Diagnostic Accuracy SubClassOf Statistics</Axiom>
            </Change>
            <Change id="2468">
               <Axiom>Dihydroergotamine Mesylate SubClassOf Serotonin Agonist</Axiom>
            </Change>
            <Change id="2467">
               <Axiom>Dihydroergotamine SubClassOf Serotonin Agonist</Axiom>
            </Change>
            <Change id="2523">
               <Axiom>Disease Vector SubClassOf Invertebrate</Axiom>
            </Change>
            <Change id="2469">
               <Axiom>Disease_Excludes_Abnormal_Cell Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2470">
               <Axiom>Disease_Excludes_Abnormal_Cell Range Abnormal_Cell_Kind</Axiom>
            </Change>
            <Change id="2471">
               <Axiom>Disease_Excludes_Cytogenetic_Abnormality Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2472">
               <Axiom>Disease_Excludes_Cytogenetic_Abnormality Range Molecular_Abnormality_Kind</Axiom>
            </Change>
            <Change id="2473">
               <Axiom>Disease_Excludes_Finding Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2474">
               <Axiom>Disease_Excludes_Finding Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2475">
               <Axiom>Disease_Excludes_Metastatic_Anatomic_Site Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2476">
               <Axiom>Disease_Excludes_Metastatic_Anatomic_Site Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2477">
               <Axiom>Disease_Excludes_Molecular_Abnormality Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2478">
               <Axiom>Disease_Excludes_Molecular_Abnormality Range Molecular_Abnormality_Kind</Axiom>
            </Change>
            <Change id="2479">
               <Axiom>Disease_Excludes_Normal_Cell_Origin Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2480">
               <Axiom>Disease_Excludes_Normal_Cell_Origin Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2481">
               <Axiom>Disease_Excludes_Normal_Tissue_Origin Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2482">
               <Axiom>Disease_Excludes_Normal_Tissue_Origin Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2483">
               <Axiom>Disease_Excludes_Primary_Anatomic_Site Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2484">
               <Axiom>Disease_Excludes_Primary_Anatomic_Site Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2485">
               <Axiom>Disease_Has_Abnormal_Cell Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2486">
               <Axiom>Disease_Has_Abnormal_Cell Range Abnormal_Cell_Kind</Axiom>
            </Change>
            <Change id="2487">
               <Axiom>Disease_Has_Associated_Anatomic_Site Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2488">
               <Axiom>Disease_Has_Associated_Anatomic_Site Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2489">
               <Axiom>Disease_Has_Associated_Disease Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2490">
               <Axiom>Disease_Has_Associated_Disease Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2491">
               <Axiom>Disease_Has_Cytogenetic_Abnormality Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2492">
               <Axiom>Disease_Has_Cytogenetic_Abnormality Range Molecular_Abnormality_Kind</Axiom>
            </Change>
            <Change id="2493">
               <Axiom>Disease_Has_Finding Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2494">
               <Axiom>Disease_Has_Finding Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2495">
               <Axiom>Disease_Has_Metastatic_Anatomic_Site Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2496">
               <Axiom>Disease_Has_Metastatic_Anatomic_Site Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2497">
               <Axiom>Disease_Has_Molecular_Abnormality Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2498">
               <Axiom>Disease_Has_Molecular_Abnormality Range Molecular_Abnormality_Kind</Axiom>
            </Change>
            <Change id="2499">
               <Axiom>Disease_Has_Normal_Cell_Origin Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2500">
               <Axiom>Disease_Has_Normal_Cell_Origin Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2501">
               <Axiom>Disease_Has_Normal_Tissue_Origin Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2502">
               <Axiom>Disease_Has_Normal_Tissue_Origin Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2503">
               <Axiom>Disease_Has_Primary_Anatomic_Site Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2504">
               <Axiom>Disease_Has_Primary_Anatomic_Site Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2505">
               <Axiom>Disease_Is_Grade Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2506">
               <Axiom>Disease_Is_Grade Range Properties_or_Attributes_Kind</Axiom>
            </Change>
            <Change id="2507">
               <Axiom>Disease_Is_Stage Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2508">
               <Axiom>Disease_Is_Stage Range Properties_or_Attributes_Kind</Axiom>
            </Change>
            <Change id="2509">
               <Axiom>Disease_May_Have_Abnormal_Cell Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2510">
               <Axiom>Disease_May_Have_Abnormal_Cell Range Abnormal_Cell_Kind</Axiom>
            </Change>
            <Change id="2511">
               <Axiom>Disease_May_Have_Associated_Disease Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2512">
               <Axiom>Disease_May_Have_Associated_Disease Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2513">
               <Axiom>Disease_May_Have_Cytogenetic_Abnormality Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2514">
               <Axiom>Disease_May_Have_Cytogenetic_Abnormality Range Molecular_Abnormality_Kind</Axiom>
            </Change>
            <Change id="2515">
               <Axiom>Disease_May_Have_Finding Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2516">
               <Axiom>Disease_May_Have_Finding Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2517">
               <Axiom>Disease_May_Have_Molecular_Abnormality Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2518">
               <Axiom>Disease_May_Have_Molecular_Abnormality Range Molecular_Abnormality_Kind</Axiom>
            </Change>
            <Change id="2519">
               <Axiom>Disease_May_Have_Normal_Cell_Origin Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2520">
               <Axiom>Disease_May_Have_Normal_Cell_Origin Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2521">
               <Axiom>Disease_May_Have_Normal_Tissue_Origin Domain Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2522">
               <Axiom>Disease_May_Have_Normal_Tissue_Origin Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2524">
               <Axiom>Disintegration per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2525">
               <Axiom>Drug Level Test Result SubClassOf Laboratory Finding</Axiom>
            </Change>
            <Change id="2526">
               <Axiom>EO_Anatomic_Structure_Is_Physical_Part_Of Domain EO_Anatomy_Kind</Axiom>
            </Change>
            <Change id="2527">
               <Axiom>EO_Anatomic_Structure_Is_Physical_Part_Of Range EO_Anatomy_Kind</Axiom>
            </Change>
            <Change id="2528">
               <Axiom>EO_Derived_By_Technique Domain Organism_Kind</Axiom>
            </Change>
            <Change id="2529">
               <Axiom>EO_Derived_By_Technique Range Activity_Kind</Axiom>
            </Change>
            <Change id="2530">
               <Axiom>EO_Develops_Disease Domain Organism_Kind</Axiom>
            </Change>
            <Change id="2531">
               <Axiom>EO_Develops_Disease Range EO_Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2532">
               <Axiom>EO_Disease_Has_Associated_Cell_Type Domain EO_Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2533">
               <Axiom>EO_Disease_Has_Associated_Cell_Type Range EO_Anatomy_Kind</Axiom>
            </Change>
            <Change id="2534">
               <Axiom>EO_Disease_Has_Associated_EO_Anatomy Domain EO_Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2535">
               <Axiom>EO_Disease_Has_Associated_EO_Anatomy Range EO_Anatomy_Kind</Axiom>
            </Change>
            <Change id="2536">
               <Axiom>EO_Disease_Has_Property_Or_Attribute Domain EO_Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2537">
               <Axiom>EO_Disease_Has_Property_Or_Attribute Range Properties_or_Attributes_Kind</Axiom>
            </Change>
            <Change id="2538">
               <Axiom>EO_Disease_Maps_To_Human_Disease Domain EO_Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2539">
               <Axiom>EO_Disease_Maps_To_Human_Disease Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2540">
               <Axiom>EO_Disease_Metastatic_To_EO_Anatomy Domain EO_Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2541">
               <Axiom>EO_Disease_Metastatic_To_EO_Anatomy Range EO_Anatomy_Kind</Axiom>
            </Change>
            <Change id="2542">
               <Axiom>EO_Models_Human_Disease Domain Organism_Kind</Axiom>
            </Change>
            <Change id="2543">
               <Axiom>EO_Models_Human_Disease Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2544">
               <Axiom>Ectopic Atrial Rhythm SubClassOf Supraventricular Arrhythmia</Axiom>
            </Change>
            <Change id="2545">
               <Axiom>Ectopic Supraventricular Rhythm SubClassOf Supraventricular Arrhythmia</Axiom>
            </Change>
            <Change id="2546">
               <Axiom>Ectopic Ventricular Rhythm SubClassOf Ventricular Arrhythmia</Axiom>
            </Change>
            <Change id="2548">
               <Axiom>Erythromycin Gluceptate SubClassOf Antibacterial Agent</Axiom>
            </Change>
            <Change id="2549">
               <Axiom>External Ear Infection SubClassOf Otitis</Axiom>
            </Change>
            <Change id="2550">
               <Axiom>False Positive SubClassOf Laboratory Test Result</Axiom>
            </Change>
            <Change id="2551">
               <Axiom>Femtomole per Gram SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2552">
               <Axiom>First Ever Onset of Angina Pectoris Event SubClassOf Angina</Axiom>
            </Change>
            <Change id="2553">
               <Axiom>First Ever Onset of Heart Failure Event SubClassOf Heart Failure</Axiom>
            </Change>
            <Change id="2554">
               <Axiom>Fluorescein Sodium SubClassOf Diagnostic Reagent</Axiom>
            </Change>
            <Change id="2555">
               <Axiom>Fluorescence Units SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2556">
               <Axiom>Fungus SubClassOf Eukaryota</Axiom>
            </Change>
            <Change id="2557">
               <Axiom>Fuzlocillin SubClassOf Antibacterial Agent</Axiom>
            </Change>
            <Change id="2558">
               <Axiom>Gene_Associated_With_Disease Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2559">
               <Axiom>Gene_Associated_With_Disease Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2560">
               <Axiom>Gene_Found_In_Organism Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2561">
               <Axiom>Gene_Found_In_Organism Range Organism_Kind</Axiom>
            </Change>
            <Change id="2562">
               <Axiom>Gene_Has_Abnormality Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2563">
               <Axiom>Gene_Has_Abnormality Range Molecular_Abnormality_Kind</Axiom>
            </Change>
            <Change id="2564">
               <Axiom>Gene_Has_Physical_Location Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2565">
               <Axiom>Gene_Has_Physical_Location Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2566">
               <Axiom>Gene_In_Chromosomal_Location Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2567">
               <Axiom>Gene_In_Chromosomal_Location Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2568">
               <Axiom>Gene_Is_Biomarker_Of Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2569">
               <Axiom>Gene_Is_Biomarker_Of Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2570">
               <Axiom>Gene_Is_Biomarker_Type Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2571">
               <Axiom>Gene_Is_Biomarker_Type Range Diagnostic_and_Prognostic_Factors_Kind</Axiom>
            </Change>
            <Change id="2572">
               <Axiom>Gene_Is_Element_In_Pathway Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2573">
               <Axiom>Gene_Is_Element_In_Pathway Range Pathway_Kind</Axiom>
            </Change>
            <Change id="2574">
               <Axiom>Gene_Plays_Role_In_Process Domain Gene_Kind</Axiom>
            </Change>
            <Change id="2575">
               <Axiom>Gene_Plays_Role_In_Process Range Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2576">
               <Axiom>Gene_Product_Encoded_By_Gene Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2577">
               <Axiom>Gene_Product_Encoded_By_Gene Range Gene_Kind</Axiom>
            </Change>
            <Change id="2578">
               <Axiom>Gene_Product_Expressed_In_Tissue Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2579">
               <Axiom>Gene_Product_Expressed_In_Tissue Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2580">
               <Axiom>Gene_Product_Has_Abnormality Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2581">
               <Axiom>Gene_Product_Has_Abnormality Range Molecular_Abnormality_Kind</Axiom>
            </Change>
            <Change id="2582">
               <Axiom>Gene_Product_Has_Associated_Anatomy Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2583">
               <Axiom>Gene_Product_Has_Associated_Anatomy Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2584">
               <Axiom>Gene_Product_Has_Biochemical_Function Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2585">
               <Axiom>Gene_Product_Has_Biochemical_Function Range Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2586">
               <Axiom>Gene_Product_Has_Chemical_Classification Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2587">
               <Axiom>Gene_Product_Has_Chemical_Classification Range Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2588">
               <Axiom>Gene_Product_Has_Malfunction_Type Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2589">
               <Axiom>Gene_Product_Has_Malfunction_Type Range Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2590">
               <Axiom>Gene_Product_Has_Organism_Source Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2591">
               <Axiom>Gene_Product_Has_Organism_Source Range Organism_Kind</Axiom>
            </Change>
            <Change id="2592">
               <Axiom>Gene_Product_Has_Structural_Domain_Or_Motif Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2593">
               <Axiom>Gene_Product_Has_Structural_Domain_Or_Motif Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2594">
               <Axiom>Gene_Product_Is_Biomarker_Of Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2595">
               <Axiom>Gene_Product_Is_Biomarker_Of Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2596">
               <Axiom>Gene_Product_Is_Biomarker_Type Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2597">
               <Axiom>Gene_Product_Is_Biomarker_Type Range Diagnostic_and_Prognostic_Factors_Kind</Axiom>
            </Change>
            <Change id="2598">
               <Axiom>Gene_Product_Is_Element_In_Pathway Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2599">
               <Axiom>Gene_Product_Is_Element_In_Pathway Range Pathway_Kind</Axiom>
            </Change>
            <Change id="2600">
               <Axiom>Gene_Product_Is_Physical_Part_Of Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2601">
               <Axiom>Gene_Product_Is_Physical_Part_Of Range Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2602">
               <Axiom>Gene_Product_Malfunction_Associated_With_Disease Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2603">
               <Axiom>Gene_Product_Malfunction_Associated_With_Disease Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2604">
               <Axiom>Gene_Product_Plays_Role_In_Biological_Process Domain Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2605">
               <Axiom>Gene_Product_Plays_Role_In_Biological_Process Range Biological_Process_Kind</Axiom>
            </Change>
            <Change id="2606">
               <Axiom>Gentamicin Sulfate SubClassOf Antibacterial Agent</Axiom>
            </Change>
            <Change id="2607">
               <Axiom>Geriatric SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2608">
               <Axiom>Gram per Animal SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2609">
               <Axiom>Gram per Animal per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2610">
               <Axiom>Gram per Animal per Week SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2611">
               <Axiom>Gram per Cage SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2612">
               <Axiom>Gram per Cage per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2613">
               <Axiom>Gram per Cage per Week SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2614">
               <Axiom>Gram per Capsule SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2615">
               <Axiom>Gram per Gram per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2616">
               <Axiom>Gram per Mole SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2617">
               <Axiom>Gram per Square Meter per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2618">
               <Axiom>Gram per Tablet SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2619">
               <Axiom>Gram per Vial SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2620">
               <Axiom>Granisetron SubClassOf Antiemetic Agent</Axiom>
            </Change>
            <Change id="2621">
               <Axiom>Gravity SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2622">
               <Axiom>Healthy Subject SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2623">
               <Axiom>Heart Block SubClassOf Arrhythmia</Axiom>
            </Change>
            <Change id="2624">
               <Axiom>Heart Failure Prompting Medical Attention Event SubClassOf Heart Failure</Axiom>
            </Change>
            <Change id="2625">
               <Axiom>Hereditary SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2626">
               <Axiom>Immunocompromised SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2627">
               <Axiom>Infective Otitis Externa SubClassOf External Ear Infection</Axiom>
            </Change>
            <Change id="2628">
               <Axiom>Inherited SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2629">
               <Axiom>Internal Ear Infection SubClassOf Otitis</Axiom>
            </Change>
            <Change id="2630">
               <Axiom>Intimal Dissection Of Blood Vessel SubClassOf Arterial Disorder</Axiom>
            </Change>
            <Change id="2631">
               <Axiom>Ionomycin SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2632">
               <Axiom>Isorhythmic Atrioventricular Dissociation SubClassOf Arrhythmia</Axiom>
            </Change>
            <Change id="2633">
               <Axiom>Junctional Rhythm SubClassOf Supraventricular Arrhythmia</Axiom>
            </Change>
            <Change id="2634">
               <Axiom>Knuckle Pads SubClassOf Non-Neoplastic Soft Tissue Disorder</Axiom>
            </Change>
            <Change id="2636">
               <Axiom>Laboratory Animal SubClassOf Animal</Axiom>
            </Change>
            <Change id="2635">
               <Axiom>Laboratory Finding SubClassOf Laboratory Test Result</Axiom>
            </Change>
            <Change id="2637">
               <Axiom>Lethargic SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2638">
               <Axiom>Licostinel SubClassOf Anticonvulsant Agent</Axiom>
            </Change>
            <Change id="2639">
               <Axiom>Linezolid SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2640">
               <Axiom>Liter per Kilogram SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2641">
               <Axiom>Mean Arterial Pressure SubClassOf Blood Pressure Finding</Axiom>
            </Change>
            <Change id="2547">
               <Axiom>Measurement of Left Ventricular Ejection Fraction SubClassOf Cardiovascular System Finding</Axiom>
            </Change>
            <Change id="2642">
               <Axiom>Medical Device Difficult to Flush SubClassOf Medical Device Maintenance Issue</Axiom>
            </Change>
            <Change id="2643">
               <Axiom>Microequivalent SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2644">
               <Axiom>Microgram per Animal SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2645">
               <Axiom>Microgram per Gram per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2646">
               <Axiom>Microgram per Gram per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2647">
               <Axiom>Microgram per Kilogram per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2648">
               <Axiom>Microgram per Kilogram per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2649">
               <Axiom>Microgram per Milligram Protein SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2650">
               <Axiom>Microgram per Square Meter per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2651">
               <Axiom>Microgram per Square Meter per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2652">
               <Axiom>Microgram per Square Meter per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2653">
               <Axiom>Microliter per Nostril SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2654">
               <Axiom>Micromole per Milligram per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2655">
               <Axiom>Microosmole SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2656">
               <Axiom>Milliequivalent per Milliliter SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2657">
               <Axiom>Milligram per Animal SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2658">
               <Axiom>Milligram per Capsule SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2659">
               <Axiom>Milligram per Gram per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2660">
               <Axiom>Milligram per Gram per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2661">
               <Axiom>Milligram per Gram per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2662">
               <Axiom>Milligram per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2663">
               <Axiom>Milligram per Square Meter per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2664">
               <Axiom>Milligram per Square Meter per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2665">
               <Axiom>Milligram per Vial SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2666">
               <Axiom>Milliliter per Animal SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2667">
               <Axiom>Milliliter per Animal per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2668">
               <Axiom>Milliliter per Animal per Week SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2669">
               <Axiom>Milliliter per Breath SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2670">
               <Axiom>Milliliter per Cage SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2671">
               <Axiom>Milliliter per Cage per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2672">
               <Axiom>Milliliter per Cage per Week SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2673">
               <Axiom>Milliliter per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2674">
               <Axiom>Milliliter per Gram SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2675">
               <Axiom>Milliliter per Gram per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2676">
               <Axiom>Milliliter per Gram per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2677">
               <Axiom>Milliliter per Gram per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2678">
               <Axiom>Milliliter per Kilogram per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2679">
               <Axiom>Milliliter per Kilogram per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2680">
               <Axiom>Milliliter per Kilogram per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2681">
               <Axiom>Milliliter per Square Meter SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2682">
               <Axiom>Milliliter per Square Meter per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2683">
               <Axiom>Milliliter per Square Meter per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2684">
               <Axiom>Millimeter of Mercury per Second SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2685">
               <Axiom>Millipascal SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2686">
               <Axiom>Mixed Lymphocyte Reaction Test SubClassOf Bioassay</Axiom>
            </Change>
            <Change id="2687">
               <Axiom>Mold SubClassOf Other Organism Groupings</Axiom>
            </Change>
            <Change id="2688">
               <Axiom>Most Recent Angina Pectoris Event SubClassOf Angina</Axiom>
            </Change>
            <Change id="2689">
               <Axiom>Most Recent Heart Failure Event SubClassOf Heart Failure</Axiom>
            </Change>
            <Change id="2690">
               <Axiom>Multifocal Atrial Tachycardia SubClassOf Supraventricular Tachycardia</Axiom>
            </Change>
            <Change id="2691">
               <Axiom>Nanogram per Well SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2692">
               <Axiom>Nanosecond SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2693">
               <Axiom>Negative Test Result SubClassOf Laboratory Test Result</Axiom>
            </Change>
            <Change id="2694">
               <Axiom>Nimesulide SubClassOf Phenol Compound</Axiom>
            </Change>
            <Change id="2695">
               <Axiom>Non-Sustained Ventricular Tachycardia SubClassOf Ventricular Tachycardia</Axiom>
            </Change>
            <Change id="2696">
               <Axiom>Normal Laboratory Test Result SubClassOf Laboratory Finding</Axiom>
            </Change>
            <Change id="2697">
               <Axiom>Novobiocin SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2698">
               <Axiom>Onset of Angina Pectoris Event SubClassOf Angina</Axiom>
            </Change>
            <Change id="2699">
               <Axiom>Osteolysis SubClassOf Non-Neoplastic Bone Disorder</Axiom>
            </Change>
            <Change id="2700">
               <Axiom>Osteopenia SubClassOf Non-Neoplastic Bone Disorder</Axiom>
            </Change>
            <Change id="2701">
               <Axiom>Otitis Media SubClassOf Otitis</Axiom>
            </Change>
            <Change id="2702">
               <Axiom>Patient Characteristics Qualifier SubClassOf Property or Attribute</Axiom>
            </Change>
            <Change id="2703">
               <Axiom>Patient Death SubClassOf Vital Status</Axiom>
            </Change>
            <Change id="2704">
               <Axiom>Pediatric SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2705">
               <Axiom>Percentile SubClassOf Statistics</Axiom>
            </Change>
            <Change id="2706">
               <Axiom>Peripheral Vascular Disease SubClassOf Non-Neoplastic Vascular Disorder</Axiom>
            </Change>
            <Change id="2707">
               <Axiom>Perzinfotel SubClassOf Analgesic Agent</Axiom>
            </Change>
            <Change id="2708">
               <Axiom>Picosecond SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2709">
               <Axiom>Pirlimycin Hydrochloride SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2710">
               <Axiom>Plant SubClassOf Eukaryota</Axiom>
            </Change>
            <Change id="2711">
               <Axiom>Poikilotherms SubClassOf Animal</Axiom>
            </Change>
            <Change id="2712">
               <Axiom>Polycystic Ovarian Disease SubClassOf Ovarian Non-Neoplastic Disorder</Axiom>
            </Change>
            <Change id="2713">
               <Axiom>Poor Vascular Access SubClassOf Non-Neoplastic Vascular Disorder</Axiom>
            </Change>
            <Change id="2714">
               <Axiom>Population Based Sampling SubClassOf Type of Statistical Sample</Axiom>
            </Change>
            <Change id="2715">
               <Axiom>Positive Test Result SubClassOf Laboratory Test Result</Axiom>
            </Change>
            <Change id="2717">
               <Axiom>Povidone-Iodine Solution SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2716">
               <Axiom>Povidone-Iodine SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2433">
               <Axiom>Precise Histogenesis Unknown SubClassOf Laboratory Finding</Axiom>
            </Change>
            <Change id="2718">
               <Axiom>Primary Adrenal Insufficiency SubClassOf Addison's Disease</Axiom>
            </Change>
            <Change id="2719">
               <Axiom>Procedure_May_Have_Target_Anatomy Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2720">
               <Axiom>Procedure_May_Have_Target_Anatomy Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2721">
               <Axiom>Pulmonary Vascular Disorder SubClassOf Non-Neoplastic Lung Disorder</Axiom>
            </Change>
            <Change id="2722">
               <Axiom>Pyogenic Arthritis SubClassOf Infective Arthritis</Axiom>
            </Change>
            <Change id="2723">
               <Axiom>Quantile SubClassOf Statistics</Axiom>
            </Change>
            <Change id="2724">
               <Axiom>R-R Interval SubClassOf Electrocardiographic Finding</Axiom>
            </Change>
            <Change id="2725">
               <Axiom>Radiation Colitis SubClassOf Radiation Enteritis</Axiom>
            </Change>
            <Change id="2726">
               <Axiom>Radiologic Finding SubClassOf Laboratory Test Result</Axiom>
            </Change>
            <Change id="2727">
               <Axiom>Range of Motion SubClassOf Connective and Soft Tissue Finding</Axiom>
            </Change>
            <Change id="2728">
               <Axiom>Raynaud's Syndrome SubClassOf Peripheral Vascular Disorder</Axiom>
            </Change>
            <Change id="2729">
               <Axiom>Regimen_Has_Accepted_Use_For_Disease Domain Chemotherapy_Regimen_Kind</Axiom>
            </Change>
            <Change id="2730">
               <Axiom>Regimen_Has_Accepted_Use_For_Disease Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2731">
               <Axiom>Risk Estimate SubClassOf Statistics</Axiom>
            </Change>
            <Change id="2732">
               <Axiom>S3 Gallop SubClassOf Cardiovascular System Signs and Symptoms</Axiom>
            </Change>
            <Change id="2733">
               <Axiom>Salmonella Enterica Serovar Typhi Antigen SubClassOf Antigen</Axiom>
            </Change>
            <Change id="2734">
               <Axiom>Salmonella Enterica Serovar Typhi Antigen, A SubClassOf Salmonella Enterica Serovar Typhi Antigen</Axiom>
            </Change>
            <Change id="2735">
               <Axiom>Schirmer Test Wetting SubClassOf Laboratory Test Result</Axiom>
            </Change>
            <Change id="2736">
               <Axiom>Se-Methyl-seleno-L-cysteine SubClassOf Amino Acid Derivative</Axiom>
            </Change>
            <Change id="2737">
               <Axiom>Secondary Adrenal Insufficiency SubClassOf Addison's Disease</Axiom>
            </Change>
            <Change id="2738">
               <Axiom>Septic Arthritis SubClassOf Bacterial Arthritis</Axiom>
            </Change>
            <Change id="2739">
               <Axiom>Serositis SubClassOf Inflammation</Axiom>
            </Change>
            <Change id="2740">
               <Axiom>Sevelamer Hydrochloride SubClassOf Adjuvant</Axiom>
            </Change>
            <Change id="2741">
               <Axiom>Sick Sinus Syndrome SubClassOf Sinus Node Dysfunction</Axiom>
            </Change>
            <Change id="2742">
               <Axiom>Sinus Node Dysfunction SubClassOf Non-Neoplastic Heart Disorder</Axiom>
            </Change>
            <Change id="2743">
               <Axiom>Socioeconomic Indicator SubClassOf Statistical Technique</Axiom>
            </Change>
            <Change id="2744">
               <Axiom>Sore Throat SubClassOf Non-Neoplastic Neck Disorder</Axiom>
            </Change>
            <Change id="2745">
               <Axiom>Sprays per Nostril SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2746">
               <Axiom>Square Micrometer SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2747">
               <Axiom>Staphylococcal Septic Arthritis SubClassOf Septic Arthritis</Axiom>
            </Change>
            <Change id="2748">
               <Axiom>Statistical Confidence SubClassOf Statistics</Axiom>
            </Change>
            <Change id="2749">
               <Axiom>Statistical Significance SubClassOf Statistics</Axiom>
            </Change>
            <Change id="2750">
               <Axiom>Statistically Significant SubClassOf Property or Attribute</Axiom>
            </Change>
            <Change id="2751">
               <Axiom>Stein-Leventhal Syndrome SubClassOf Polycystic Ovarian Disease</Axiom>
            </Change>
            <Change id="2752">
               <Axiom>Sustained Ventricular Tachycardia SubClassOf Ventricular Tachycardia</Axiom>
            </Change>
            <Change id="2753">
               <Axiom>Synovitis SubClassOf Connective and Soft Tissue Finding</Axiom>
            </Change>
            <Change id="2754">
               <Axiom>Synovitis SubClassOf Inflammation</Axiom>
            </Change>
            <Change id="2755">
               <Axiom>Taurolidine SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2756">
               <Axiom>Technique_Has_Associated_Condition Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2757">
               <Axiom>Technique_Has_Associated_Condition Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2758">
               <Axiom>Technique_Has_Purpose Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2759">
               <Axiom>Technique_Has_Purpose Range Activity_Kind</Axiom>
            </Change>
            <Change id="2760">
               <Axiom>Technique_Has_Sample_Or_Specimen_Anatomy Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2761">
               <Axiom>Technique_Has_Sample_Or_Specimen_Anatomy Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2762">
               <Axiom>Technique_Has_Sample_Or_Specimen_Chemical_Or_Drug Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2763">
               <Axiom>Technique_Has_Sample_Or_Specimen_Chemical_Or_Drug Range Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2764">
               <Axiom>Technique_Has_Target_Anatomy Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2765">
               <Axiom>Technique_Has_Target_Anatomy Range Anatomy_Kind</Axiom>
            </Change>
            <Change id="2766">
               <Axiom>Technique_Has_Target_Chemical_Or_Drug Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2767">
               <Axiom>Technique_Has_Target_Chemical_Or_Drug Range Chemicals_and_Drugs_Kind</Axiom>
            </Change>
            <Change id="2768">
               <Axiom>Technique_Has_Target_Disease Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2769">
               <Axiom>Technique_Has_Target_Disease Range Findings_and_Disorders_Kind</Axiom>
            </Change>
            <Change id="2770">
               <Axiom>Technique_Has_Target_Organism Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2771">
               <Axiom>Technique_Has_Target_Organism Range Organism_Kind</Axiom>
            </Change>
            <Change id="2772">
               <Axiom>Technique_Has_Target_Protein Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2773">
               <Axiom>Technique_Has_Target_Protein Range Gene_Product_Kind</Axiom>
            </Change>
            <Change id="2774">
               <Axiom>Technique_Is_Used_In_Technique Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2775">
               <Axiom>Technique_Is_Used_In_Technique Range Activity_Kind</Axiom>
            </Change>
            <Change id="2776">
               <Axiom>Technique_Uses_Equipment Domain Activity_Kind</Axiom>
            </Change>
            <Change id="2777">
               <Axiom>Technique_Uses_Equipment Range Equipment_Kind</Axiom>
            </Change>
            <Change id="2778">
               <Axiom>Thousand per Deciliter SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2779">
               <Axiom>Thrombohemorrhagic Event SubClassOf Non-Neoplastic Vascular Disorder</Axiom>
            </Change>
            <Change id="2780">
               <Axiom>Ticarcillin Disodium SubClassOf Antibacterial Agent</Axiom>
            </Change>
            <Change id="2781">
               <Axiom>Tissue Differentiation Uncertain SubClassOf Laboratory Finding</Axiom>
            </Change>
            <Change id="2782">
               <Axiom>Titanium Dioxide SubClassOf Pigment</Axiom>
            </Change>
            <Change id="2783">
               <Axiom>Torsades De Pointes SubClassOf Ventricular Tachycardia</Axiom>
            </Change>
            <Change id="2784">
               <Axiom>Toxicology Finding SubClassOf Laboratory Finding</Axiom>
            </Change>
            <Change id="2785">
               <Axiom>Toxoplasma SubClassOf Eukaryota</Axiom>
            </Change>
            <Change id="2786">
               <Axiom>Tracheal Calcification SubClassOf Non-Neoplastic Tracheal Disorder</Axiom>
            </Change>
            <Change id="2787">
               <Axiom>Triclosan SubClassOf Antibiotic</Axiom>
            </Change>
            <Change id="2788">
               <Axiom>Triclosan SubClassOf Antifungal Agent</Axiom>
            </Change>
            <Change id="2789">
               <Axiom>Trigeminy SubClassOf Arrhythmia</Axiom>
            </Change>
            <Change id="2790">
               <Axiom>Type of Statistical Sample SubClassOf Statistical Technique</Axiom>
            </Change>
            <Change id="2791">
               <Axiom>UBD Gene SubClassOf Ubiquitin Ligase Gene</Axiom>
            </Change>
            <Change id="2792">
               <Axiom>Under No Medication SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2793">
               <Axiom>Under No Sedation SubClassOf Patient Characteristics Qualifier</Axiom>
            </Change>
            <Change id="2794">
               <Axiom>Unit of Gravity SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2795">
               <Axiom>Unit per Animal SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2796">
               <Axiom>Unit per Gram per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2797">
               <Axiom>Unit per Gram per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2798">
               <Axiom>Unit per Gram per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2799">
               <Axiom>Unit per Kilogram per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2800">
               <Axiom>Unit per Kilogram per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2801">
               <Axiom>Unit per Kilogram per Minute SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2802">
               <Axiom>Unit per Milligram SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2803">
               <Axiom>Unit per Milligram of Creatinine SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2804">
               <Axiom>Unit per Milligram of Protein SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2805">
               <Axiom>Unit per Square Meter per Day SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2806">
               <Axiom>Unit per Square Meter per Hour SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2808">
               <Axiom>Vancomycin Hydrochloride SubClassOf Antibacterial Agent</Axiom>
            </Change>
            <Change id="2807">
               <Axiom>Vancomycin SubClassOf Miscellaneous Antibiotic</Axiom>
            </Change>
            <Change id="2809">
               <Axiom>Variance SubClassOf Statistics</Axiom>
            </Change>
            <Change id="2810">
               <Axiom>Ventricular Couplet SubClassOf Ventricular Arrhythmia</Axiom>
            </Change>
            <Change id="2811">
               <Axiom>Ventricular Flutter SubClassOf Ventricular Tachycardia</Axiom>
            </Change>
            <Change id="2812">
               <Axiom>Ventricular Premature Complex SubClassOf Ventricular Arrhythmia</Axiom>
            </Change>
            <Change id="2813">
               <Axiom>Vertical SubClassOf General Qualifier</Axiom>
            </Change>
            <Change id="2814">
               <Axiom>Viable Cell per Femur SubClassOf Animal Dosing Unit</Axiom>
            </Change>
            <Change id="2815">
               <Axiom>Yeast SubClassOf Other Organism Groupings</Axiom>
            </Change>
            <Change id="2816">
               <Axiom>Z-Average SubClassOf Population Parameter</Axiom>
            </Change>
            <Change id="2822">
               <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide SubClassOf Agent Combination Not Indexed in Open Clinical Trials</Axiom>
            </Change>
            <Change id="2817">
               <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide SubClassOf Chemotherapy_Regimen_Has_Component some Incomplete Freund's Adjuvant</Axiom>
            </Change>
            <Change id="2818">
               <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide SubClassOf Chemotherapy_Regimen_Has_Component some MART-1 Antigen</Axiom>
            </Change>
            <Change id="2819">
               <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide SubClassOf Chemotherapy_Regimen_Has_Component some Recombinant Interleukin-12</Axiom>
            </Change>
            <Change id="2820">
               <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide SubClassOf Chemotherapy_Regimen_Has_Component some Tyrosinase Peptide</Axiom>
            </Change>
            <Change id="2821">
               <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide SubClassOf Chemotherapy_Regimen_Has_Component some gp100 Antigen</Axiom>
            </Change>
         </PureRemoval>
         <PureRemovalWithRetiredTerms id="premrt" size="0"/>
         <RetiredModifiedDefinition id="wkequiv" size="3">
            <Change id="2823">
               <Axiom>Alveolar Rhabdomyosarcoma EquivalentTo Rhabdomyosarcoma and Sarcoma Differentiation Score 3 and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Round Cell with Primitive Myoblastic Differentiation)</Axiom>
               <Source>
                  <Axiom>Alveolar Rhabdomyosarcoma EquivalentTo Rhabdomyosarcoma and Sarcoma Differentiation Score 3 and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;13)(q36;q14)) and (Disease_May_Have_Molecular_Abnormality some PAX3-FKHR Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;13)(q35;q14)) and (Disease_May_Have_Molecular_Abnormality some PAX7-FKHR Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;2)(q35;p23)) and (Disease_May_Have_Molecular_Abnormality some PAX3-NCOA1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q13;q35)) and (Disease_May_Have_Molecular_Abnormality some PAX3-AFX Fusion Protein Expression))) and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Round Cell with Primitive Myoblastic Differentiation)</Axiom>
               </Source>
            </Change>
            <Change id="2824">
               <Axiom>Monoblastic Sarcoma EquivalentTo Myeloid Sarcoma and (Disease_Excludes_Abnormal_Cell only Neoplastic Granulocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast)</Axiom>
               <Source>
                  <Axiom>Monoblastic Sarcoma EquivalentTo Myeloid Sarcoma and (((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression))) and (Disease_Excludes_Abnormal_Cell only Neoplastic Granulocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast)</Axiom>
               </Source>
            </Change>
            <Change id="2825">
               <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Slow Growing Mass)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and (((Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Epithelial Spindle Cell) and (Disease_May_Have_Finding some Monophasic Pattern)) or ((Disease_May_Have_Finding some Biphasic Pattern) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell))) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Slow Growing Mass)</Axiom>
               </Source>
            </Change>
         </RetiredModifiedDefinition>
         <RetiredModifiedDefinitionWithRetiredTerms id="wkequivrt" size="0"/>
      </Effectual>
      <Ineffectual id="ineffrems" size="96">
         <RemovedRedundancy id="rred" size="0"/>
         <RemovedRewrite id="rrws" size="0">
            <RemovedCompleteRewrite id="rrw" size="0"/>
            <RemovedPartialRewrite id="rprw" size="0"/>
         </RemovedRewrite>
         <RemovedProspectiveRedundancy id="rpred" size="96">
            <RemovedReshuffleProspectiveRedundancy id="ravred" size="0"/>
            <RemovedNewProspectiveRedundancy id="rnpred" size="96">
               <RemovedNovelProspectiveRedundancy id="strength" size="74">
                  <Change id="2826">
                     <Axiom>Abnormal Hard Tissue Formation in Pulp SubClassOf Head and Neck Finding</Axiom>
                     <Source>
                        <Axiom effectual="true">Abnormal Hard Tissue Formation in Pulp SubClassOf Oral Cavity Finding</Axiom>
                        <Axiom shared="true">Oral Cavity Finding SubClassOf Head and Neck Finding</Axiom>
                     </Source>
                  </Change>
                  <Change id="2827">
                     <Axiom>Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
                     <Source>
                        <Axiom effectual="true">Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression))) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Morphologic Finding SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Auer Rods Present SubClassOf Morphologic Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression))) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Clinical Course of Disease SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Favorable Clinical Outcome SubClassOf Clinical Course of Disease</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2828">
                     <Axiom>Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                     <Source>
                        <Axiom effectual="true">Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                        <Axiom shared="true">Oncogene Deregulation SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">MDM2 Gene Mutation SubClassOf Oncogene Deregulation</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">MDM2 Gene Amplification SubClassOf MDM2 Gene Mutation</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">TP53 Gene Inactivation SubClassOf Tumor-Suppressor Gene Inactivation</Axiom>
                        <Axiom effectual="true">Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                        <Axiom shared="true">Tumor-Suppressor Gene Inactivation SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2829">
                     <Axiom>Algeldrate SubClassOf Adjuvant</Axiom>
                     <Source>
                        <Axiom shared="true">Combination Medication SubClassOf Adjuvant</Axiom>
                        <Axiom shared="true">Antacid Preparation SubClassOf Combination Medication</Axiom>
                        <Axiom effectual="true">Algeldrate SubClassOf Antacid Preparation</Axiom>
                     </Source>
                  </Change>
                  <Change id="2830">
                     <Axiom>Antitubercular Agent SubClassOf Anti-Infective Agent</Axiom>
                     <Source>
                        <Axiom shared="true">Antibacterial Agent SubClassOf Anti-Infective Agent</Axiom>
                        <Axiom effectual="true">Antitubercular Agent SubClassOf Antibacterial Agent</Axiom>
                     </Source>
                  </Change>
                  <Change id="2831">
                     <Axiom>Arbaclofen Placarbil SubClassOf Pharmacologic Substance</Axiom>
                     <Source>
                        <Axiom effectual="true">Arbaclofen Placarbil SubClassOf Adjuvant Analgesic</Axiom>
                        <Axiom shared="true">Adjuvant Analgesic SubClassOf Analgesic Agent</Axiom>
                        <Axiom shared="true">Analgesic Agent SubClassOf Pharmacologic Substance</Axiom>
                     </Source>
                  </Change>
                  <Change id="2832">
                     <Axiom>Bacillus Calmette-Guerin Antigen, A SubClassOf Antigen</Axiom>
                     <Source>
                        <Axiom effectual="true">Bacillus Calmette-Guerin Antigen SubClassOf Antigen</Axiom>
                        <Axiom effectual="true">Bacillus Calmette-Guerin Antigen, A SubClassOf Bacillus Calmette-Guerin Antigen</Axiom>
                     </Source>
                  </Change>
                  <Change id="2833">
                     <Axiom>Bacillus Calmette-Guerin Antigen, B SubClassOf Antigen</Axiom>
                     <Source>
                        <Axiom effectual="true">Bacillus Calmette-Guerin Antigen, B SubClassOf Bacillus Calmette-Guerin Antigen</Axiom>
                        <Axiom effectual="true">Bacillus Calmette-Guerin Antigen SubClassOf Antigen</Axiom>
                     </Source>
                  </Change>
                  <Change id="2834">
                     <Axiom>Bordetella Pertussis Antigen, B SubClassOf Antigen</Axiom>
                     <Source>
                        <Axiom shared="true">Bordetella Pertussis Antigen SubClassOf Antigen</Axiom>
                        <Axiom effectual="true">Bordetella Pertussis Antigen, B SubClassOf Bordetella Pertussis Antigen</Axiom>
                     </Source>
                  </Change>
                  <Change id="2835">
                     <Axiom>Bordetella Pertussis Antigen, C SubClassOf Antigen</Axiom>
                     <Source>
                        <Axiom shared="true">Bordetella Pertussis Antigen SubClassOf Antigen</Axiom>
                        <Axiom effectual="true">Bordetella Pertussis Antigen, C SubClassOf Bordetella Pertussis Antigen</Axiom>
                     </Source>
                  </Change>
                  <Change id="2836">
                     <Axiom>Bordetella Pertussis Antigen, D SubClassOf Antigen</Axiom>
                     <Source>
                        <Axiom shared="true">Bordetella Pertussis Antigen SubClassOf Antigen</Axiom>
                        <Axiom effectual="true">Bordetella Pertussis Antigen, D SubClassOf Bordetella Pertussis Antigen</Axiom>
                     </Source>
                  </Change>
                  <Change id="2837">
                     <Axiom>Bordetella Pertussis Antigen, E SubClassOf Antigen</Axiom>
                     <Source>
                        <Axiom effectual="true">Bordetella Pertussis Antigen, E SubClassOf Bordetella Pertussis Antigen</Axiom>
                        <Axiom shared="true">Bordetella Pertussis Antigen SubClassOf Antigen</Axiom>
                     </Source>
                  </Change>
                  <Change id="2838">
                     <Axiom>Bordetella Pertussis Antigen, F SubClassOf Antigen</Axiom>
                     <Source>
                        <Axiom shared="true">Bordetella Pertussis Antigen SubClassOf Antigen</Axiom>
                        <Axiom effectual="true">Bordetella Pertussis Antigen, F SubClassOf Bordetella Pertussis Antigen</Axiom>
                     </Source>
                  </Change>
                  <Change id="2839">
                     <Axiom>Bordetella Pertussis Antigen, G SubClassOf Antigen</Axiom>
                     <Source>
                        <Axiom shared="true">Bordetella Pertussis Antigen SubClassOf Antigen</Axiom>
                        <Axiom effectual="true">Bordetella Pertussis Antigen, G SubClassOf Bordetella Pertussis Antigen</Axiom>
                     </Source>
                  </Change>
                  <Change id="2840">
                     <Axiom>Bordetella Pertussis Antigen, H SubClassOf Antigen</Axiom>
                     <Source>
                        <Axiom effectual="true">Bordetella Pertussis Antigen, H SubClassOf Bordetella Pertussis Antigen</Axiom>
                        <Axiom shared="true">Bordetella Pertussis Antigen SubClassOf Antigen</Axiom>
                     </Source>
                  </Change>
                  <Change id="2841">
                     <Axiom>Bordetella Pertussis Antigen, I SubClassOf Antigen</Axiom>
                     <Source>
                        <Axiom effectual="true">Bordetella Pertussis Antigen, I SubClassOf Bordetella Pertussis Antigen</Axiom>
                        <Axiom shared="true">Bordetella Pertussis Antigen SubClassOf Antigen</Axiom>
                     </Source>
                  </Change>
                  <Change id="2842">
                     <Axiom>Brain Glioblastoma EquivalentTo Glioblastoma and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                     <Source>
                        <Axiom effectual="true">Brain Glioblastoma EquivalentTo Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                        <Axiom shared="true">TP53 Gene Inactivation SubClassOf Tumor-Suppressor Gene Inactivation</Axiom>
                        <Axiom shared="true">Tumor-Suppressor Gene Inactivation SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2843">
                     <Axiom>Buccal Mucosa SubClassOf Mucosa</Axiom>
                     <Source>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Oral Cavity SubClassOf Body Cavity</Axiom>
                        <Axiom shared="true">Body Cavity SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        <Axiom effectual="true">Anatomic_Structure_Has_Location Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Buccal Mucosa SubClassOf Anatomic_Structure_Has_Location some Oral Cavity</Axiom>
                        <Axiom shared="true">Oral Cavity SubClassOf Anatomic_Structure_Has_Location some Head</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Anatomic_Structure_Has_Location Range NCI_Kind</Axiom>
                        <Axiom shared="true">Buccal Mucosa SubClassOf Anatomic_Structure_Has_Location some Oral Cavity</Axiom>
                        <Axiom shared="true">Head SubClassOf Body Region</Axiom>
                        <Axiom shared="true">Oral Cavity SubClassOf Anatomic_Structure_Has_Location some Head</Axiom>
                        <Axiom shared="true">Body Region SubClassOf Anatomic Structure, System, or Substance</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Buccal Mucosa SubClassOf Oral Mucosa</Axiom>
                        <Axiom effectual="true">Oral Mucosa SubClassOf Mucosa</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Anatomic_Structure_Is_Physical_Part_Of Range NCI_Kind</Axiom>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Head and Neck SubClassOf Body Region</Axiom>
                        <Axiom shared="true">Head SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Head and Neck</Axiom>
                        <Axiom shared="true">Buccal Mucosa SubClassOf Anatomic_Structure_Has_Location some Oral Cavity</Axiom>
                        <Axiom shared="true">Oral Cavity SubClassOf Anatomic_Structure_Has_Location some Head</Axiom>
                        <Axiom shared="true">Body Region SubClassOf Anatomic Structure, System, or Substance</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Anatomic_Structure_Has_Location Range NCI_Kind</Axiom>
                        <Axiom shared="true">Oral Cavity SubClassOf Body Cavity</Axiom>
                        <Axiom shared="true">Body Cavity SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        <Axiom shared="true">Buccal Mucosa SubClassOf Anatomic_Structure_Has_Location some Oral Cavity</Axiom>
                     </Source>
                  </Change>
                  <Change id="2845">
                     <Axiom>Chenodiol SubClassOf Adjuvant</Axiom>
                     <Source>
                        <Axiom shared="true">Cholagogues or Choleretic Agents SubClassOf Adjuvant</Axiom>
                        <Axiom effectual="true">Chenodiol SubClassOf Cholagogues or Choleretic Agents</Axiom>
                     </Source>
                  </Change>
                  <Change id="2846">
                     <Axiom>Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and Malignant Childhood Central Nervous System Neoplasm and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                     <Source>
                        <Axiom effectual="true">Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and Malignant Childhood Central Nervous System Neoplasm and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                        <Axiom shared="true">Oncogene Deregulation SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">MDM2 Gene Mutation SubClassOf Oncogene Deregulation</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">MDM2 Gene Amplification SubClassOf MDM2 Gene Mutation</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and Malignant Childhood Central Nervous System Neoplasm and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                        <Axiom shared="true">TP53 Gene Inactivation SubClassOf Tumor-Suppressor Gene Inactivation</Axiom>
                        <Axiom shared="true">Tumor-Suppressor Gene Inactivation SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2847">
                     <Axiom>Congestive Heart Failure SubClassOf Non-Neoplastic Heart Disorder</Axiom>
                     <Source>
                        <Axiom shared="true">Heart Failure SubClassOf Non-Neoplastic Heart Disorder</Axiom>
                        <Axiom effectual="true">Congestive Heart Failure SubClassOf Heart Failure</Axiom>
                     </Source>
                  </Change>
                  <Change id="2848">
                     <Axiom>Cryptococcus neoformans SubClassOf Fungus</Axiom>
                     <Source>
                        <Axiom effectual="true">Cryptococcus SubClassOf Basidiomycota</Axiom>
                        <Axiom effectual="true">Basidiomycota SubClassOf Fungus</Axiom>
                        <Axiom effectual="true">Cryptococcus neoformans SubClassOf Cryptococcus</Axiom>
                     </Source>
                  </Change>
                  <Change id="2849">
                     <Axiom>Cyanocobalamin, Co-60 SubClassOf Radiopharmaceutical Compound</Axiom>
                     <Source>
                        <Axiom shared="true">Radioconjugate SubClassOf Radiopharmaceutical Compound</Axiom>
                        <Axiom effectual="true">Cyanocobalamin, Co-60 SubClassOf Radioconjugate</Axiom>
                     </Source>
                  </Change>
                  <Change id="2850">
                     <Axiom>Donor Lymphocyte Infusion SubClassOf Infusion Procedure</Axiom>
                     <Source>
                        <Axiom effectual="true">Donor Cellular Infusion SubClassOf Infusion Procedure</Axiom>
                        <Axiom effectual="true">Donor Lymphocyte Infusion SubClassOf Donor Cellular Infusion</Axiom>
                     </Source>
                  </Change>
                  <Change id="2851">
                     <Axiom>Escherichia coli SubClassOf Proteobacteria</Axiom>
                     <Source>
                        <Axiom effectual="true">Escherichia coli SubClassOf Escherichia</Axiom>
                        <Axiom effectual="true">Escherichia SubClassOf Proteobacteria</Axiom>
                     </Source>
                  </Change>
                  <Change id="2852">
                     <Axiom>Eukaryota SubClassOf Organism</Axiom>
                     <Source>
                        <Axiom shared="true">Other Organism Groupings SubClassOf Organism</Axiom>
                        <Axiom effectual="true">Eukaryota SubClassOf Other Organism Groupings</Axiom>
                     </Source>
                  </Change>
                  <Change id="2853">
                     <Axiom>Faropenem Medoxomil SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom effectual="true">Faropenem Medoxomil SubClassOf Beta-Lactam Antibiotic</Axiom>
                        <Axiom shared="true">Beta-Lactam Antibiotic SubClassOf Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2854">
                     <Axiom>Fenbenicillin SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom shared="true">Penicillin Antibiotic SubClassOf Antibiotic</Axiom>
                        <Axiom effectual="true">Fenbenicillin SubClassOf Penicillin Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2855">
                     <Axiom>Fibracillin SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom effectual="true">Fibracillin SubClassOf Penicillin Antibiotic</Axiom>
                        <Axiom shared="true">Penicillin Antibiotic SubClassOf Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2856">
                     <Axiom>Flomoxef SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom effectual="true">Flomoxef SubClassOf Cephalosporin Antibiotic</Axiom>
                        <Axiom shared="true">Cephalosporin Antibiotic SubClassOf Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2857">
                     <Axiom>Friday SubClassOf Temporal Qualifier</Axiom>
                     <Source>
                        <Axiom effectual="true">Friday SubClassOf Day of the Week</Axiom>
                        <Axiom effectual="true">Day of the Week SubClassOf Temporal Qualifier</Axiom>
                     </Source>
                  </Change>
                  <Change id="2859">
                     <Axiom>Garenoxacin Mesylate SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom shared="true">Quinolone Compound SubClassOf Antibiotic</Axiom>
                        <Axiom effectual="true">Garenoxacin Mesylate SubClassOf Quinolone Compound</Axiom>
                     </Source>
                  </Change>
                  <Change id="2858">
                     <Axiom>Garenoxacin SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom shared="true">Quinolone Compound SubClassOf Antibiotic</Axiom>
                        <Axiom effectual="true">Garenoxacin SubClassOf Quinolone Compound</Axiom>
                     </Source>
                  </Change>
                  <Change id="2860">
                     <Axiom>Granisetron Hydrochloride SubClassOf Antiemetic Agent</Axiom>
                     <Source>
                        <Axiom effectual="true">Gene_Plays_Role_In_Process Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Receptor Gene SubClassOf Ligand Binding Protein Gene</Axiom>
                        <Axiom shared="true">Serotonin 5-HT-3 Receptor EquivalentTo Cell Surface Receptor and (Gene_Product_Encoded_By_Gene some HTR3A Gene) and (Gene_Product_Has_Biochemical_Function some Receptor) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Neuronal Transmission) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling)</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">HTR3A Gene SubClassOf Receptor Gene</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom shared="true">Ligand Binding Protein Gene SubClassOf Gene</Axiom>
                        <Axiom shared="true">HTR3A Gene SubClassOf Gene_Plays_Role_In_Process some Receptor Signaling</Axiom>
                        <Axiom effectual="true">Granisetron Hydrochloride SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Serotonin 5-HT-3 Receptor</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Neurologic Process SubClassOf Organismal Process</Axiom>
                        <Axiom shared="true">Biological_Process_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Serotonin 5-HT-3 Receptor EquivalentTo Cell Surface Receptor and (Gene_Product_Encoded_By_Gene some HTR3A Gene) and (Gene_Product_Has_Biochemical_Function some Receptor) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Neuronal Transmission) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling)</Axiom>
                        <Axiom shared="true">Neuronal Transmission SubClassOf Biological_Process_Is_Part_Of_Process some Neurologic Process</Axiom>
                        <Axiom shared="true">Organismal Process SubClassOf Biological Process</Axiom>
                        <Axiom shared="true">Biological Process SubClassOf Biological_Process_Kind</Axiom>
                        <Axiom effectual="true">Granisetron Hydrochloride SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Serotonin 5-HT-3 Receptor</Axiom>
                        <Axiom effectual="true">Biological_Process_Is_Part_Of_Process Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Pharmacologic Substance SubClassOf Drug, Food, Chemical or Biomedical Material</Axiom>
                        <Axiom shared="true">Drug, Food, Chemical or Biomedical Material SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        <Axiom shared="true">Serotonin Antagonist SubClassOf Adjuvant</Axiom>
                        <Axiom shared="true">Adjuvant SubClassOf Pharmacologic Substance</Axiom>
                        <Axiom effectual="true">Chemical_Or_Drug_Affects_Gene_Product Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Chemicals_and_Drugs_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Granisetron Hydrochloride SubClassOf Serotonin Antagonist</Axiom>
                        <Axiom effectual="true">Granisetron Hydrochloride SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Serotonin 5-HT-3 Receptor</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Receptor Gene SubClassOf Ligand Binding Protein Gene</Axiom>
                        <Axiom shared="true">Serotonin 5-HT-3 Receptor EquivalentTo Cell Surface Receptor and (Gene_Product_Encoded_By_Gene some HTR3A Gene) and (Gene_Product_Has_Biochemical_Function some Receptor) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Neuronal Transmission) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling)</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom shared="true">Ligand Binding Protein Gene SubClassOf Gene</Axiom>
                        <Axiom effectual="true">Gene_Product_Encoded_By_Gene Range NCI_Kind</Axiom>
                        <Axiom shared="true">Receptor SubClassOf Gene_Product_Encoded_By_Gene some Receptor Gene</Axiom>
                        <Axiom effectual="true">Granisetron Hydrochloride SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Serotonin 5-HT-3 Receptor</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Drug, Food, Chemical or Biomedical Material SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        <Axiom shared="true">Serotonin 5-HT-3 Receptor EquivalentTo Cell Surface Receptor and (Gene_Product_Encoded_By_Gene some HTR3A Gene) and (Gene_Product_Has_Biochemical_Function some Receptor) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Neuronal Transmission) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling)</Axiom>
                        <Axiom effectual="true">Biological_Process_Has_Initiator_Chemical_Or_Drug Range NCI_Kind</Axiom>
                        <Axiom shared="true">Physiology-Regulatory Factor SubClassOf Drug, Food, Chemical or Biomedical Material</Axiom>
                        <Axiom shared="true">Chemicals_and_Drugs_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Neurotransmitter SubClassOf Physiology-Regulatory Factor</Axiom>
                        <Axiom shared="true">Neuronal Transmission SubClassOf Biological_Process_Has_Initiator_Chemical_Or_Drug some Neurotransmitter</Axiom>
                        <Axiom effectual="true">Granisetron Hydrochloride SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Serotonin 5-HT-3 Receptor</Axiom>
                     </Source>
                  </Change>
                  <Change id="2861">
                     <Axiom>Guaiacol Carbonate SubClassOf Pharmacologic Substance</Axiom>
                     <Source>
                        <Axiom effectual="true">Guaiacol Carbonate SubClassOf Expectorant</Axiom>
                        <Axiom shared="true">Adjuvant SubClassOf Pharmacologic Substance</Axiom>
                        <Axiom shared="true">Expectorant SubClassOf Adjuvant</Axiom>
                     </Source>
                  </Change>
                  <Change id="2862">
                     <Axiom>Household Income SubClassOf Socioeconomic Factors</Axiom>
                     <Source>
                        <Axiom shared="true">Income SubClassOf Socioeconomic Factors</Axiom>
                        <Axiom effectual="true">Household Income SubClassOf Income</Axiom>
                     </Source>
                  </Change>
                  <Change id="2863">
                     <Axiom>Human Parainfluenza Virus 1 SubClassOf Paramyxovirus</Axiom>
                     <Source>
                        <Axiom effectual="true">Human Parainfluenza Virus 1 SubClassOf Parainfluenza Virus</Axiom>
                        <Axiom shared="true">Parainfluenza Virus SubClassOf Paramyxovirus</Axiom>
                     </Source>
                  </Change>
                  <Change id="2864">
                     <Axiom>Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Epstein-Barr Virus Infection SubClassOf Viral Infection</Axiom>
                        <Axiom shared="true">Viral Infection SubClassOf Infectious Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and (((Disease_May_Have_Finding some Splenic Rupture) and (Disease_Has_Finding only Splenomegaly)) or ((Disease_Has_Finding only Atypical Lymphocytes Present in Peripheral Blood) and (Disease_Has_Finding only Diffuse Immunoblastic Proliferation) and (Disease_Has_Finding only Polymorphic Cellular Infiltrate))) and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Infectious Disorder SubClassOf Non-Neoplastic Disorder by Special Category</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder by Special Category SubClassOf Non-Neoplastic Disorder</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_Has_Finding Range NCI_Kind</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and (((Disease_May_Have_Finding some Splenic Rupture) and (Disease_Has_Finding only Splenomegaly)) or ((Disease_Has_Finding only Atypical Lymphocytes Present in Peripheral Blood) and (Disease_Has_Finding only Diffuse Immunoblastic Proliferation) and (Disease_Has_Finding only Polymorphic Cellular Infiltrate))) and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Morphologic Finding SubClassOf Finding</Axiom>
                        <Axiom shared="true">Non-Malignant Cellular Infiltrate SubClassOf Cellular Infiltrate</Axiom>
                        <Axiom shared="true">Cellular Infiltrate SubClassOf Morphologic Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Benign Lymphoproliferative Disorder EquivalentTo Lymphoproliferative Disorder and Non-Neoplastic Hematologic and Lymphocytic Disorder and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Finding only Non-Malignant Cellular Infiltrate)</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_Has_Finding Range NCI_Kind</Axiom>
                        <Axiom shared="true">Hematopoietic System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and (((Disease_May_Have_Finding some Splenic Rupture) and (Disease_Has_Finding only Splenomegaly)) or ((Disease_Has_Finding only Atypical Lymphocytes Present in Peripheral Blood) and (Disease_Has_Finding only Diffuse Immunoblastic Proliferation) and (Disease_Has_Finding only Polymorphic Cellular Infiltrate))) and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Lymphadenopathy SubClassOf Hematopoietic System Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Lymphoproliferative Disorder EquivalentTo Hematologic and Lymphocytic Disorder and (Disease_Excludes_Normal_Cell_Origin only Myeloid Cell) and (Disease_Has_Abnormal_Cell only Abnormal Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Lymphatic System)</Axiom>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Hematologic and Lymphocytic Disorder SubClassOf Hematopoietic and Lymphoid System Disorder</Axiom>
                        <Axiom shared="true">Disorder by Site SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and (((Disease_May_Have_Finding some Splenic Rupture) and (Disease_Has_Finding only Splenomegaly)) or ((Disease_Has_Finding only Atypical Lymphocytes Present in Peripheral Blood) and (Disease_Has_Finding only Diffuse Immunoblastic Proliferation) and (Disease_Has_Finding only Polymorphic Cellular Infiltrate))) and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Hematopoietic and Lymphoid System Disorder SubClassOf Disorder by Site</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Benign Lymphoproliferative Disorder EquivalentTo Lymphoproliferative Disorder and Non-Neoplastic Hematologic and Lymphocytic Disorder and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Finding only Non-Malignant Cellular Infiltrate)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Non-Neoplastic Hematologic and Lymphocytic Disorder SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and (((Disease_May_Have_Finding some Splenic Rupture) and (Disease_Has_Finding only Splenomegaly)) or ((Disease_Has_Finding only Atypical Lymphocytes Present in Peripheral Blood) and (Disease_Has_Finding only Diffuse Immunoblastic Proliferation) and (Disease_Has_Finding only Polymorphic Cellular Infiltrate))) and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder by Site SubClassOf Non-Neoplastic Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Benign Lymphoproliferative Disorder EquivalentTo Lymphoproliferative Disorder and Non-Neoplastic Hematologic and Lymphocytic Disorder and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Finding only Non-Malignant Cellular Infiltrate)</Axiom>
                     </Source>
                  </Change>
                  <Change id="2865">
                     <Axiom>Insect SubClassOf Invertebrate</Axiom>
                     <Source>
                        <Axiom effectual="true">Insect SubClassOf Arthropoda</Axiom>
                        <Axiom effectual="true">Arthropoda SubClassOf Invertebrate</Axiom>
                     </Source>
                  </Change>
                  <Change id="2866">
                     <Axiom>Integrin Alpha 5 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGA5 Gene) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion)</Axiom>
                     <Source>
                        <Axiom shared="true">Cell Adhesion Molecule SubClassOf Gene_Product_Encoded_By_Gene some Cell Adhesion Molecule Gene</Axiom>
                        <Axiom effectual="true">Integrin Alpha 5 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGA5 Gene) and (Gene_Product_Has_Chemical_Classification some Glycoprotein) and (Gene_Product_Is_Physical_Part_Of some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion)</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom shared="true">Ligand Binding Protein Gene SubClassOf Gene</Axiom>
                        <Axiom effectual="true">Gene_Product_Encoded_By_Gene Range NCI_Kind</Axiom>
                        <Axiom shared="true">Cell Adhesion Molecule Gene SubClassOf Ligand Binding Protein Gene</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Integrin Alpha 5 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGA5 Gene) and (Gene_Product_Has_Chemical_Classification some Glycoprotein) and (Gene_Product_Is_Physical_Part_Of some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion)</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom shared="true">Ligand Binding Protein Gene SubClassOf Gene</Axiom>
                        <Axiom effectual="true">Gene_Product_Encoded_By_Gene Range NCI_Kind</Axiom>
                        <Axiom shared="true">Ligand Binding Protein SubClassOf Gene_Product_Encoded_By_Gene some Ligand Binding Protein Gene</Axiom>
                        <Axiom shared="true">Cell Adhesion Molecule SubClassOf Ligand Binding Protein</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Integrin Alpha 5 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGA5 Gene) and (Gene_Product_Has_Chemical_Classification some Glycoprotein) and (Gene_Product_Is_Physical_Part_Of some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion)</Axiom>
                        <Axiom shared="true">Biological_Process_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Biochemical Reaction SubClassOf Subcellular Process</Axiom>
                        <Axiom shared="true">ITGA5 Gene SubClassOf Gene_Plays_Role_In_Process some Protein-Protein Interaction</Axiom>
                        <Axiom shared="true">Protein-Protein Interaction SubClassOf Biological_Process_Is_Part_Of_Process some Biochemical Reaction</Axiom>
                        <Axiom shared="true">Biological Process SubClassOf Biological_Process_Kind</Axiom>
                        <Axiom shared="true">Subcellular Process SubClassOf Biological Process</Axiom>
                        <Axiom effectual="true">Biological_Process_Is_Part_Of_Process Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Ligand Binding Protein SubClassOf Protein, Organized by Function</Axiom>
                        <Axiom effectual="true">Gene_Product_Encoded_By_Gene Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Gene Product SubClassOf Gene_Product_Kind</Axiom>
                        <Axiom effectual="true">Integrin Alpha 5 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGA5 Gene) and (Gene_Product_Has_Chemical_Classification some Glycoprotein) and (Gene_Product_Is_Physical_Part_Of some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion)</Axiom>
                        <Axiom shared="true">Protein, Organized by Function SubClassOf Protein</Axiom>
                        <Axiom shared="true">Gene_Product_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Protein SubClassOf Gene Product</Axiom>
                        <Axiom shared="true">Cell Adhesion Molecule SubClassOf Ligand Binding Protein</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Integrin Alpha 5 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGA5 Gene) and (Gene_Product_Has_Chemical_Classification some Glycoprotein) and (Gene_Product_Is_Physical_Part_Of some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion)</Axiom>
                        <Axiom shared="true">Cell Adhesion Molecule SubClassOf Gene_Product_Is_Biomarker_Type some Differentiation Antigen</Axiom>
                        <Axiom shared="true">Differentiation Antigen SubClassOf Biomarker</Axiom>
                        <Axiom effectual="true">Gene_Product_Is_Biomarker_Type Range NCI_Kind</Axiom>
                        <Axiom shared="true">Diagnostic or Prognostic Factor SubClassOf Diagnostic_and_Prognostic_Factors_Kind</Axiom>
                        <Axiom shared="true">Biomarker SubClassOf Diagnostic or Prognostic Factor</Axiom>
                        <Axiom shared="true">Diagnostic_and_Prognostic_Factors_Kind DisjointWith NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2867">
                     <Axiom>Integrin Beta-3 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGB3 Gene) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation)</Axiom>
                     <Source>
                        <Axiom effectual="true">Gene_Plays_Role_In_Process Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Cell Adhesion Molecule SubClassOf Gene_Product_Encoded_By_Gene some Cell Adhesion Molecule Gene</Axiom>
                        <Axiom effectual="true">Integrin Beta-3 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGB3 Gene) and (Gene_Product_Has_Biochemical_Function some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation) and (Gene_Product_Plays_Role_In_Biological_Process some Protein-Protein Interaction) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling) and (Gene_Product_Plays_Role_In_Biological_Process some Wound Repair)</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom shared="true">Ligand Binding Protein Gene SubClassOf Gene</Axiom>
                        <Axiom shared="true">Ligand Binding Protein Gene SubClassOf Gene_Plays_Role_In_Process some Ligand Binding</Axiom>
                        <Axiom shared="true">Cell Adhesion Molecule Gene SubClassOf Ligand Binding Protein Gene</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Ligand Binding SubClassOf Molecular Interaction</Axiom>
                        <Axiom shared="true">Biological_Process_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Integrin Beta-3 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGB3 Gene) and (Gene_Product_Has_Biochemical_Function some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation) and (Gene_Product_Plays_Role_In_Biological_Process some Protein-Protein Interaction) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling) and (Gene_Product_Plays_Role_In_Biological_Process some Wound Repair)</Axiom>
                        <Axiom shared="true">Ligand Binding Protein SubClassOf Gene_Product_Plays_Role_In_Biological_Process some Ligand Binding</Axiom>
                        <Axiom shared="true">Molecular Interaction SubClassOf Biophysical Process</Axiom>
                        <Axiom shared="true">Biological Process SubClassOf Biological_Process_Kind</Axiom>
                        <Axiom shared="true">Biophysical Process SubClassOf Subcellular Process</Axiom>
                        <Axiom effectual="true">Gene_Product_Plays_Role_In_Biological_Process Range NCI_Kind</Axiom>
                        <Axiom shared="true">Subcellular Process SubClassOf Biological Process</Axiom>
                        <Axiom shared="true">Cell Adhesion Molecule SubClassOf Ligand Binding Protein</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Integrin Beta-3 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGB3 Gene) and (Gene_Product_Has_Biochemical_Function some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation) and (Gene_Product_Plays_Role_In_Biological_Process some Protein-Protein Interaction) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling) and (Gene_Product_Plays_Role_In_Biological_Process some Wound Repair)</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom shared="true">Ligand Binding Protein Gene SubClassOf Gene</Axiom>
                        <Axiom effectual="true">Gene_Product_Encoded_By_Gene Range NCI_Kind</Axiom>
                        <Axiom shared="true">Ligand Binding Protein SubClassOf Gene_Product_Encoded_By_Gene some Ligand Binding Protein Gene</Axiom>
                        <Axiom shared="true">Cell Adhesion Molecule SubClassOf Ligand Binding Protein</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Platelet Aggregation SubClassOf Biological_Process_Is_Part_Of_Process some Coagulation</Axiom>
                        <Axiom shared="true">Biological_Process_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Multicellular Process SubClassOf Biological Process</Axiom>
                        <Axiom effectual="true">Integrin Beta-3 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGB3 Gene) and (Gene_Product_Has_Biochemical_Function some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation) and (Gene_Product_Plays_Role_In_Biological_Process some Protein-Protein Interaction) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling) and (Gene_Product_Plays_Role_In_Biological_Process some Wound Repair)</Axiom>
                        <Axiom effectual="true">Biological_Process_Is_Part_Of_Process Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Platelet Aggregation SubClassOf Multicellular Process</Axiom>
                        <Axiom shared="true">Biological Process SubClassOf Biological_Process_Kind</Axiom>
                        <Axiom shared="true">ITGB3 Gene SubClassOf Gene_Plays_Role_In_Process some Platelet Aggregation</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Gene_Plays_Role_In_Process Domain NCI_Kind</Axiom>
                        <Axiom effectual="true">Integrin Beta-3 EquivalentTo Cell Adhesion Molecule and (Gene_Product_Encoded_By_Gene some ITGB3 Gene) and (Gene_Product_Has_Biochemical_Function some Integrin) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Adhesion) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation) and (Gene_Product_Plays_Role_In_Biological_Process some Protein-Protein Interaction) and (Gene_Product_Plays_Role_In_Biological_Process some Receptor Signaling) and (Gene_Product_Plays_Role_In_Biological_Process some Wound Repair)</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom shared="true">Ligand Binding Protein Gene SubClassOf Gene</Axiom>
                        <Axiom shared="true">Ligand Binding Protein Gene SubClassOf Gene_Plays_Role_In_Process some Ligand Binding</Axiom>
                        <Axiom shared="true">Ligand Binding Protein SubClassOf Gene_Product_Encoded_By_Gene some Ligand Binding Protein Gene</Axiom>
                        <Axiom shared="true">Cell Adhesion Molecule SubClassOf Ligand Binding Protein</Axiom>
                     </Source>
                  </Change>
                  <Change id="2868">
                     <Axiom>Iodohippurate Sodium, I-123 SubClassOf Radiopharmaceutical Compound</Axiom>
                     <Source>
                        <Axiom shared="true">Radioconjugate SubClassOf Radiopharmaceutical Compound</Axiom>
                        <Axiom effectual="true">Iodohippurate Sodium, I-123 SubClassOf Radioconjugate</Axiom>
                     </Source>
                  </Change>
                  <Change id="2869">
                     <Axiom>Iodohippurate Sodium, I-131 SubClassOf Radiopharmaceutical Compound</Axiom>
                     <Source>
                        <Axiom shared="true">Radioconjugate SubClassOf Radiopharmaceutical Compound</Axiom>
                        <Axiom effectual="true">Iodohippurate Sodium, I-131 SubClassOf Radioconjugate</Axiom>
                     </Source>
                  </Change>
                  <Change id="2870">
                     <Axiom>LY573636 SubClassOf Antineoplastic Agent</Axiom>
                     <Source>
                        <Axiom shared="true">Diarylsulfonylurea Compound SubClassOf Antineoplastic Agent</Axiom>
                        <Axiom effectual="true">LY573636 SubClassOf Diarylsulfonylurea Compound</Axiom>
                     </Source>
                  </Change>
                  <Change id="2894">
                     <Axiom>Laboratory Test Result SubClassOf Finding</Axiom>
                     <Source>
                        <Axiom effectual="true">Laboratory Test Result SubClassOf Clinical Test Result</Axiom>
                        <Axiom effectual="true">Clinical Test Result SubClassOf Finding</Axiom>
                     </Source>
                  </Change>
                  <Change id="2871">
                     <Axiom>Lactic Acid, L- SubClassOf Industrial Product</Axiom>
                     <Source>
                        <Axiom shared="true">Industrial Aid SubClassOf Industrial Product</Axiom>
                        <Axiom effectual="true">Lactic Acid, L- SubClassOf Industrial Aid</Axiom>
                     </Source>
                  </Change>
                  <Change id="2872">
                     <Axiom>Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Cutaneous Precancerous Condition SubClassOf Skin Disorder</Axiom>
                        <Axiom shared="true">Disorder by Site SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and (((Disease_May_Have_Associated_Disease some Anaplastic Large Cell Lymphoma) and (Disease_May_Have_Associated_Disease some Hodgkin Lymphoma) and (Disease_May_Have_Associated_Disease some Mycosis Fungoides)) or ((Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Complete Spontaneous Regression) and (Disease_Has_Finding only Cutaneous Involvement))) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                        <Axiom shared="true">Skin Disorder SubClassOf Disorder by Site</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Clonal T-Cell Receptor Gamma Chain Gene Rearrangement SubClassOf Clonal T-Cell Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">T-Cell Proliferation of Uncertain Malignant Potential EquivalentTo Mature T-Cell and NK-Cell Neoplasm and Neoplasm of Uncertain Malignant Potential and Premalignant Hematologic Condition and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal T-Cell Receptor Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and (((Disease_May_Have_Associated_Disease some Anaplastic Large Cell Lymphoma) and (Disease_May_Have_Associated_Disease some Hodgkin Lymphoma) and (Disease_May_Have_Associated_Disease some Mycosis Fungoides)) or ((Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Complete Spontaneous Regression) and (Disease_Has_Finding only Cutaneous Involvement))) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">T-Cell Proliferation of Uncertain Malignant Potential EquivalentTo Mature T-Cell and NK-Cell Neoplasm and Neoplasm of Uncertain Malignant Potential and Premalignant Hematologic Condition and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal T-Cell Receptor Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Clonal T-Cell Receptor Beta Chain Gene Rearrangement SubClassOf Clonal T-Cell Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and (((Disease_May_Have_Associated_Disease some Anaplastic Large Cell Lymphoma) and (Disease_May_Have_Associated_Disease some Hodgkin Lymphoma) and (Disease_May_Have_Associated_Disease some Mycosis Fungoides)) or ((Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Complete Spontaneous Regression) and (Disease_Has_Finding only Cutaneous Involvement))) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Precancerous Condition SubClassOf Cancer-Related Condition</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Domain NCI_Kind</Axiom>
                        <Axiom shared="true">T-Cell Proliferation of Uncertain Malignant Potential EquivalentTo Mature T-Cell and NK-Cell Neoplasm and Neoplasm of Uncertain Malignant Potential and Premalignant Hematologic Condition and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Cancer-Related Condition SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Precancerous Condition by Site SubClassOf Precancerous Condition</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and (((Disease_May_Have_Associated_Disease some Anaplastic Large Cell Lymphoma) and (Disease_May_Have_Associated_Disease some Hodgkin Lymphoma) and (Disease_May_Have_Associated_Disease some Mycosis Fungoides)) or ((Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Complete Spontaneous Regression) and (Disease_Has_Finding only Cutaneous Involvement))) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                        <Axiom shared="true">Cutaneous Precancerous Condition SubClassOf Precancerous Condition by Site</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Indolent Clinical Course SubClassOf Clinical Course of Disease</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Clinical Course of Disease SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and (((Disease_May_Have_Associated_Disease some Anaplastic Large Cell Lymphoma) and (Disease_May_Have_Associated_Disease some Hodgkin Lymphoma) and (Disease_May_Have_Associated_Disease some Mycosis Fungoides)) or ((Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Complete Spontaneous Regression) and (Disease_Has_Finding only Cutaneous Involvement))) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                     </Source>
                  </Change>
                  <Change id="2844">
                     <Axiom>MDR Modulator CBT-1 SubClassOf Adjuvant</Axiom>
                     <Source>
                        <Axiom shared="true">Multidrug Resistance Modulator SubClassOf Adjuvant</Axiom>
                        <Axiom effectual="true">MDR Modulator CBT-1 SubClassOf Multidrug Resistance Modulator</Axiom>
                     </Source>
                  </Change>
                  <Change id="2873">
                     <Axiom>Magnesium Stearate SubClassOf Industrial Product</Axiom>
                     <Source>
                        <Axiom effectual="true">Magnesium Stearate SubClassOf Industrial Aid</Axiom>
                        <Axiom shared="true">Industrial Aid SubClassOf Industrial Product</Axiom>
                     </Source>
                  </Change>
                  <Change id="2874">
                     <Axiom>Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
                     <Source>
                        <Axiom effectual="true">Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and (((Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm)) or ((Disease_May_Have_Finding some Marked Nuclear Atypia Present) and (Disease_May_Have_Finding some Mitotic Activity))) and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Neoplasm by Morphology SubClassOf Neoplasm</Axiom>
                        <Axiom shared="true">Malignant Pericytic Neoplasm EquivalentTo Malignant Soft Tissue Neoplasm and Pericytic Neoplasm and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_Has_Abnormal_Cell only Malignant Connective and Soft Tissue Cell)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Mesenchymal Cell Neoplasm EquivalentTo Connective and Soft Tissue Neoplasm and Neoplasm by Morphology and (Disease_Excludes_Normal_Cell_Origin only Neuron, Neuroepithelial Cell, and Supporting Cell of the Nervous System) and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Tissue_Origin only Connective and Soft Tissue)</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Pericytic Neoplasm EquivalentTo Mesenchymal Cell Neoplasm and (Disease_Has_Finding only Perivascular Arrangement of Tumor Cells) and (Disease_Has_Normal_Cell_Origin only Pericyte)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Glomus Tumor EquivalentTo Pericytic Neoplasm and (Disease_Has_Abnormal_Cell only Glomus Cell)</Axiom>
                        <Axiom effectual="true">Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and (((Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm)) or ((Disease_May_Have_Finding some Marked Nuclear Atypia Present) and (Disease_May_Have_Finding some Mitotic Activity))) and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Neoplasm by Morphology SubClassOf Neoplasm</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Mesenchymal Cell Neoplasm EquivalentTo Connective and Soft Tissue Neoplasm and Neoplasm by Morphology and (Disease_Excludes_Normal_Cell_Origin only Neuron, Neuroepithelial Cell, and Supporting Cell of the Nervous System) and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Tissue_Origin only Connective and Soft Tissue)</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Pericytic Neoplasm EquivalentTo Mesenchymal Cell Neoplasm and (Disease_Has_Finding only Perivascular Arrangement of Tumor Cells) and (Disease_Has_Normal_Cell_Origin only Pericyte)</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and (((Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm)) or ((Disease_May_Have_Finding some Marked Nuclear Atypia Present) and (Disease_May_Have_Finding some Mitotic Activity))) and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Malignant Pericytic Neoplasm EquivalentTo Malignant Soft Tissue Neoplasm and Pericytic Neoplasm and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_Has_Abnormal_Cell only Malignant Connective and Soft Tissue Cell)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Soft Tissue Neoplasm EquivalentTo Connective and Soft Tissue Neoplasm and Soft Tissue Disorder and (Disease_Has_Abnormal_Cell only Neoplastic Cell) and (Disease_Has_Normal_Tissue_Origin only Soft Tissue)</Axiom>
                        <Axiom shared="true">Connective and Soft Tissue Neoplasm EquivalentTo Connective and Soft Tissue Disorder and Neoplasm by Site</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Malignant Soft Tissue Neoplasm EquivalentTo Soft Tissue Neoplasm and (Disease_Excludes_Finding only Indolent Clinical Course) and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Neoplasm by Site SubClassOf Neoplasm</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and (((Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm)) or ((Disease_May_Have_Finding some Marked Nuclear Atypia Present) and (Disease_May_Have_Finding some Mitotic Activity))) and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Malignant Pericytic Neoplasm EquivalentTo Malignant Soft Tissue Neoplasm and Pericytic Neoplasm and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_Has_Abnormal_Cell only Malignant Connective and Soft Tissue Cell)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Connective and Soft Tissue Neoplasm EquivalentTo Connective and Soft Tissue Disorder and Neoplasm by Site</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Mesenchymal Cell Neoplasm EquivalentTo Connective and Soft Tissue Neoplasm and Neoplasm by Morphology and (Disease_Excludes_Normal_Cell_Origin only Neuron, Neuroepithelial Cell, and Supporting Cell of the Nervous System) and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Tissue_Origin only Connective and Soft Tissue)</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Neoplasm by Site SubClassOf Neoplasm</Axiom>
                        <Axiom shared="true">Pericytic Neoplasm EquivalentTo Mesenchymal Cell Neoplasm and (Disease_Has_Finding only Perivascular Arrangement of Tumor Cells) and (Disease_Has_Normal_Cell_Origin only Pericyte)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Glomus Tumor EquivalentTo Pericytic Neoplasm and (Disease_Has_Abnormal_Cell only Glomus Cell)</Axiom>
                        <Axiom effectual="true">Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and (((Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm)) or ((Disease_May_Have_Finding some Marked Nuclear Atypia Present) and (Disease_May_Have_Finding some Mitotic Activity))) and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Connective and Soft Tissue Neoplasm EquivalentTo Connective and Soft Tissue Disorder and Neoplasm by Site</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Mesenchymal Cell Neoplasm EquivalentTo Connective and Soft Tissue Neoplasm and Neoplasm by Morphology and (Disease_Excludes_Normal_Cell_Origin only Neuron, Neuroepithelial Cell, and Supporting Cell of the Nervous System) and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Tissue_Origin only Connective and Soft Tissue)</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Neoplasm by Site SubClassOf Neoplasm</Axiom>
                        <Axiom shared="true">Pericytic Neoplasm EquivalentTo Mesenchymal Cell Neoplasm and (Disease_Has_Finding only Perivascular Arrangement of Tumor Cells) and (Disease_Has_Normal_Cell_Origin only Pericyte)</Axiom>
                     </Source>
                  </Change>
                  <Change id="2875">
                     <Axiom>Monday SubClassOf Temporal Qualifier</Axiom>
                     <Source>
                        <Axiom effectual="true">Monday SubClassOf Day of the Week</Axiom>
                        <Axiom effectual="true">Day of the Week SubClassOf Temporal Qualifier</Axiom>
                     </Source>
                  </Change>
                  <Change id="2876">
                     <Axiom>Mucosa of the Lip SubClassOf Mucosa</Axiom>
                     <Source>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Anatomic_Structure_Is_Physical_Part_Of Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Body Part SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        <Axiom shared="true">Lip SubClassOf Head and Neck Part</Axiom>
                        <Axiom shared="true">Lip SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Head</Axiom>
                        <Axiom shared="true">Mucosa of the Lip SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Lip</Axiom>
                        <Axiom shared="true">Head and Neck Part SubClassOf Body Part</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Anatomic_Structure_Is_Physical_Part_Of Range NCI_Kind</Axiom>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Lip SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Head</Axiom>
                        <Axiom shared="true">Mucosa of the Lip SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Lip</Axiom>
                        <Axiom shared="true">Head SubClassOf Body Region</Axiom>
                        <Axiom shared="true">Body Region SubClassOf Anatomic Structure, System, or Substance</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Anatomic_Structure_Is_Physical_Part_Of Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Lip SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Head</Axiom>
                        <Axiom shared="true">Mucosa of the Lip SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Lip</Axiom>
                        <Axiom shared="true">Head SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Head and Neck</Axiom>
                        <Axiom shared="true">Head SubClassOf Body Region</Axiom>
                        <Axiom shared="true">Body Region SubClassOf Anatomic Structure, System, or Substance</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Anatomic_Structure_Is_Physical_Part_Of Range NCI_Kind</Axiom>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Body Part SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        <Axiom shared="true">Lip SubClassOf Head and Neck Part</Axiom>
                        <Axiom shared="true">Mucosa of the Lip SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Lip</Axiom>
                        <Axiom shared="true">Head and Neck Part SubClassOf Body Part</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Mucosa of the Lip SubClassOf Oral Mucosa</Axiom>
                        <Axiom effectual="true">Oral Mucosa SubClassOf Mucosa</Axiom>
                     </Source>
                  </Change>
                  <Change id="2877">
                     <Axiom>Myxoid/Round Cell Liposarcoma EquivalentTo Liposarcoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13q) and (Disease_Has_Abnormal_Cell only Primitive Mesenchymal Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                     <Source>
                        <Axiom shared="true">Painless Mass SubClassOf Mass</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Mass SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Myxoid/Round Cell Liposarcoma EquivalentTo Liposarcoma and (((Disease_May_Have_Cytogenetic_Abnormality some t(12;16)(q13;p11)) and (Disease_May_Have_Molecular_Abnormality some FUS-DDIT3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(12;22)(q13;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-DDIT3 Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13q) and (Disease_Has_Abnormal_Cell only Primitive Mesenchymal Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                        <Axiom shared="true">Liposarcoma EquivalentTo Malignant Lipomatous Neoplasm and Sarcoma and (Disease_May_Have_Finding some Painless Mass)</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2878">
                     <Axiom>NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial EquivalentTo Oxidoreductase and (Gene_Product_Encoded_By_Gene some NDUFV1 Gene) and (Gene_Product_Has_Associated_Anatomy some Mitochondrion) and (Gene_Product_Has_Biochemical_Function some Oxidoreductase) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Respiration) and (Gene_Product_Plays_Role_In_Biological_Process some Oxidation)</Axiom>
                     <Source>
                        <Axiom shared="true">Biological_Process_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Biochemical Reaction SubClassOf Subcellular Process</Axiom>
                        <Axiom shared="true">Oxidation SubClassOf Biochemical Reaction</Axiom>
                        <Axiom shared="true">Biological Process SubClassOf Biological_Process_Kind</Axiom>
                        <Axiom effectual="true">NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial EquivalentTo Oxidoreductase and (Gene_Product_Encoded_By_Gene some NDUFV1 Gene) and (Gene_Product_Has_Associated_Anatomy some Mitochondrion) and (Gene_Product_Has_Biochemical_Function some Oxidoreductase) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Respiration) and (Gene_Product_Plays_Role_In_Biological_Process some Oxidation)</Axiom>
                        <Axiom effectual="true">Gene_Product_Plays_Role_In_Biological_Process Range NCI_Kind</Axiom>
                        <Axiom shared="true">Subcellular Process SubClassOf Biological Process</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Gene_Plays_Role_In_Process Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Enzyme Gene SubClassOf Gene</Axiom>
                        <Axiom shared="true">NDUFV1 Gene SubClassOf Oxidoreductase Gene</Axiom>
                        <Axiom shared="true">Oxidoreductase Gene SubClassOf Enzyme Gene</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">NDUFV1 Gene SubClassOf Gene_Plays_Role_In_Process some Oxidation</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom effectual="true">NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial EquivalentTo Oxidoreductase and (Gene_Product_Encoded_By_Gene some NDUFV1 Gene) and (Gene_Product_Has_Associated_Anatomy some Mitochondrion) and (Gene_Product_Has_Biochemical_Function some Oxidoreductase) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Respiration) and (Gene_Product_Plays_Role_In_Biological_Process some Oxidation)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Gene Product SubClassOf Gene_Product_Kind</Axiom>
                        <Axiom shared="true">Protein, Organized by Function SubClassOf Protein</Axiom>
                        <Axiom shared="true">Gene_Product_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Enzyme SubClassOf Protein, Organized by Function</Axiom>
                        <Axiom effectual="true">NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial EquivalentTo Oxidoreductase and (Gene_Product_Encoded_By_Gene some NDUFV1 Gene) and (Gene_Product_Has_Associated_Anatomy some Mitochondrion) and (Gene_Product_Has_Biochemical_Function some Oxidoreductase) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Respiration) and (Gene_Product_Plays_Role_In_Biological_Process some Oxidation)</Axiom>
                        <Axiom shared="true">Protein SubClassOf Gene Product</Axiom>
                        <Axiom shared="true">Oxidoreductase SubClassOf Gene_Product_Has_Biochemical_Function some Enzyme</Axiom>
                        <Axiom effectual="true">Gene_Product_Has_Biochemical_Function Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Mitochondrion SubClassOf Membranous Cytoplasmic Organelle</Axiom>
                        <Axiom shared="true">Cytoplasmic Organelle SubClassOf Cell Part</Axiom>
                        <Axiom shared="true">Cell Part SubClassOf Body Part</Axiom>
                        <Axiom shared="true">Body Part SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        <Axiom shared="true">Membranous Cytoplasmic Organelle SubClassOf Cytoplasmic Organelle</Axiom>
                        <Axiom effectual="true">Biological_Process_Has_Associated_Location Range NCI_Kind</Axiom>
                        <Axiom shared="true">Cell Respiration SubClassOf Biological_Process_Has_Associated_Location some Mitochondrion</Axiom>
                        <Axiom effectual="true">NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial EquivalentTo Oxidoreductase and (Gene_Product_Encoded_By_Gene some NDUFV1 Gene) and (Gene_Product_Has_Associated_Anatomy some Mitochondrion) and (Gene_Product_Has_Biochemical_Function some Oxidoreductase) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Respiration) and (Gene_Product_Plays_Role_In_Biological_Process some Oxidation)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Enzyme Gene SubClassOf Gene</Axiom>
                        <Axiom shared="true">NDUFV1 Gene SubClassOf Oxidoreductase Gene</Axiom>
                        <Axiom shared="true">Oxidoreductase Gene SubClassOf Enzyme Gene</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom effectual="true">NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial EquivalentTo Oxidoreductase and (Gene_Product_Encoded_By_Gene some NDUFV1 Gene) and (Gene_Product_Has_Associated_Anatomy some Mitochondrion) and (Gene_Product_Has_Biochemical_Function some Oxidoreductase) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Respiration) and (Gene_Product_Plays_Role_In_Biological_Process some Oxidation)</Axiom>
                        <Axiom effectual="true">Gene_Product_Encoded_By_Gene Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2879">
                     <Axiom>Pancreatic Injury SubClassOf Gastrointestinal System Finding</Axiom>
                     <Source>
                        <Axiom effectual="true">Pancreatic Injury SubClassOf Gastrointestinal Injury</Axiom>
                        <Axiom shared="true">Gastrointestinal Injury SubClassOf Gastrointestinal System Finding</Axiom>
                     </Source>
                  </Change>
                  <Change id="2880">
                     <Axiom>Phagocytic Cell SubClassOf Antigen Processing Cell</Axiom>
                     <Source>
                        <Axiom effectual="true">Anatomic_Structure_Is_Physical_Part_Of Range NCI_Kind</Axiom>
                        <Axiom shared="true">Organ System SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Antigen Presenting Cell SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Immune System</Axiom>
                        <Axiom shared="true">Immune System SubClassOf Organ System</Axiom>
                        <Axiom effectual="true">Phagocytic Cell SubClassOf Antigen Presenting Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Microanatomic Structure SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Anatomic_Structure_Is_Physical_Part_Of Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Antigen Presenting Cell SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Immune System</Axiom>
                        <Axiom shared="true">Antigen Presenting Cell SubClassOf Cell</Axiom>
                        <Axiom shared="true">Cell SubClassOf Microanatomic Structure</Axiom>
                        <Axiom effectual="true">Phagocytic Cell SubClassOf Antigen Presenting Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="2881">
                     <Axiom>Phlebitis SubClassOf Vascular Disorder</Axiom>
                     <Source>
                        <Axiom shared="true">Vein Disorder SubClassOf Non-Neoplastic Vascular Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Vascular Disorder SubClassOf Vascular Disorder</Axiom>
                        <Axiom effectual="true">Phlebitis SubClassOf Vein Disorder</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_Has_Finding Range NCI_Kind</Axiom>
                        <Axiom shared="true">Cardiovascular System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Varicose Vein SubClassOf Cardiovascular System Finding</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Phlebitis SubClassOf Vein Disorder</Axiom>
                        <Axiom shared="true">Vein Disorder SubClassOf Disease_Has_Finding some Varicose Vein</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                     </Source>
                  </Change>
                  <Change id="2882">
                     <Axiom>Photosensitive Dermatitis SubClassOf Dermatitis</Axiom>
                     <Source>
                        <Axiom shared="true">Photodermatitis SubClassOf Dermatitis</Axiom>
                        <Axiom effectual="true">Photosensitive Dermatitis SubClassOf Photodermatitis</Axiom>
                     </Source>
                  </Change>
                  <Change id="2883">
                     <Axiom>Postencephalitic Parkinsonism SubClassOf Non-Neoplastic Central Nervous System Disorder</Axiom>
                     <Source>
                        <Axiom shared="true">Secondary Parkinsonism SubClassOf Non-Neoplastic Central Nervous System Disorder</Axiom>
                        <Axiom effectual="true">Postencephalitic Parkinsonism SubClassOf Secondary Parkinsonism</Axiom>
                     </Source>
                  </Change>
                  <Change id="2884">
                     <Axiom>Proctosigmoiditis SubClassOf Non-Neoplastic Gastrointestinal Disorder</Axiom>
                     <Source>
                        <Axiom effectual="true">Proctocolitis SubClassOf Non-Neoplastic Gastrointestinal Disorder</Axiom>
                        <Axiom effectual="true">Proctosigmoiditis SubClassOf Proctocolitis</Axiom>
                     </Source>
                  </Change>
                  <Change id="2885">
                     <Axiom>Prone Position SubClassOf Body Position</Axiom>
                     <Source>
                        <Axiom effectual="true">Prone Position SubClassOf Recumbent Position</Axiom>
                        <Axiom effectual="true">Recumbent Position SubClassOf Body Position</Axiom>
                     </Source>
                  </Change>
                  <Change id="2886">
                     <Axiom>Raynaud's Disease SubClassOf Non-Neoplastic Vascular Disorder</Axiom>
                     <Source>
                        <Axiom shared="true">Peripheral Vascular Disorder SubClassOf Non-Neoplastic Vascular Disorder</Axiom>
                        <Axiom effectual="true">Raynaud's Disease SubClassOf Peripheral Vascular Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="2887">
                     <Axiom>Recombinant Thymosin SubClassOf Therapeutic Hormone</Axiom>
                     <Source>
                        <Axiom shared="true">Miscellaneous Hormone Agent SubClassOf Therapeutic Hormone</Axiom>
                        <Axiom effectual="true">Recombinant Thymosin SubClassOf Miscellaneous Hormone Agent</Axiom>
                     </Source>
                  </Change>
                  <Change id="2888">
                     <Axiom>Saccharomyces cerevisiae SubClassOf Fungus</Axiom>
                     <Source>
                        <Axiom effectual="true">Saccharomyces cerevisiae SubClassOf Ascomycota</Axiom>
                        <Axiom effectual="true">Ascomycota SubClassOf Fungus</Axiom>
                     </Source>
                  </Change>
                  <Change id="2889">
                     <Axiom>Saturday SubClassOf Temporal Qualifier</Axiom>
                     <Source>
                        <Axiom effectual="true">Saturday SubClassOf Day of the Week</Axiom>
                        <Axiom effectual="true">Day of the Week SubClassOf Temporal Qualifier</Axiom>
                     </Source>
                  </Change>
                  <Change id="2890">
                     <Axiom>Sedecamycin SubClassOf Antibiotic</Axiom>
                     <Source>
                        <Axiom effectual="true">Sedecamycin SubClassOf Macrolide Antibiotic</Axiom>
                        <Axiom shared="true">Macrolide Antibiotic SubClassOf Antibiotic</Axiom>
                     </Source>
                  </Change>
                  <Change id="2891">
                     <Axiom>Sunday SubClassOf Temporal Qualifier</Axiom>
                     <Source>
                        <Axiom effectual="true">Sunday SubClassOf Day of the Week</Axiom>
                        <Axiom effectual="true">Day of the Week SubClassOf Temporal Qualifier</Axiom>
                     </Source>
                  </Change>
                  <Change id="2892">
                     <Axiom>Supine Position SubClassOf Body Position</Axiom>
                     <Source>
                        <Axiom effectual="true">Supine Position SubClassOf Recumbent Position</Axiom>
                        <Axiom effectual="true">Recumbent Position SubClassOf Body Position</Axiom>
                     </Source>
                  </Change>
                  <Change id="2893">
                     <Axiom>T-Box Transcription Factor TBX1 EquivalentTo Transcription Factor and (Gene_Product_Plays_Role_In_Biological_Process some Cell Proliferation) and (Gene_Product_Plays_Role_In_Biological_Process some Transcription)</Axiom>
                     <Source>
                        <Axiom shared="true">Transcription Factor Gene SubClassOf Gene</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom effectual="true">T-Box Transcription Factor TBX1 EquivalentTo Transcription Factor and (Gene_Product_Encoded_By_Gene some TBX1 Gene) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Proliferation) and (Gene_Product_Plays_Role_In_Biological_Process some Transcription)</Axiom>
                        <Axiom shared="true">Transcription Factor SubClassOf Gene_Product_Encoded_By_Gene some Transcription Factor Gene</Axiom>
                        <Axiom effectual="true">Gene_Product_Encoded_By_Gene Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Transcription Factor SubClassOf Gene_Product_Has_Biochemical_Function some Transcription Regulatory Protein</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom shared="true">Transcription Regulatory Protein SubClassOf Regulatory Protein</Axiom>
                        <Axiom effectual="true">T-Box Transcription Factor TBX1 EquivalentTo Transcription Factor and (Gene_Product_Encoded_By_Gene some TBX1 Gene) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Proliferation) and (Gene_Product_Plays_Role_In_Biological_Process some Transcription)</Axiom>
                        <Axiom shared="true">Regulatory Gene SubClassOf Gene</Axiom>
                        <Axiom shared="true">Regulatory Protein SubClassOf Gene_Product_Encoded_By_Gene some Regulatory Gene</Axiom>
                        <Axiom effectual="true">Gene_Product_Encoded_By_Gene Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Tissue Growth SubClassOf Multicellular Process</Axiom>
                        <Axiom shared="true">Biological_Process_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Multicellular Process SubClassOf Biological Process</Axiom>
                        <Axiom shared="true">Cell Proliferation SubClassOf Biological_Process_Is_Part_Of_Process some Tissue Growth</Axiom>
                        <Axiom effectual="true">T-Box Transcription Factor TBX1 EquivalentTo Transcription Factor and (Gene_Product_Encoded_By_Gene some TBX1 Gene) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Proliferation) and (Gene_Product_Plays_Role_In_Biological_Process some Transcription)</Axiom>
                        <Axiom shared="true">Biological Process SubClassOf Biological_Process_Kind</Axiom>
                        <Axiom effectual="true">Biological_Process_Is_Part_Of_Process Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Gene_Plays_Role_In_Process Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Transcription Factor Gene SubClassOf Gene_Plays_Role_In_Process some Transcriptional Regulation</Axiom>
                        <Axiom shared="true">Transcription Factor Gene SubClassOf Gene</Axiom>
                        <Axiom shared="true">Gene_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Gene SubClassOf Gene_Kind</Axiom>
                        <Axiom effectual="true">T-Box Transcription Factor TBX1 EquivalentTo Transcription Factor and (Gene_Product_Encoded_By_Gene some TBX1 Gene) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Proliferation) and (Gene_Product_Plays_Role_In_Biological_Process some Transcription)</Axiom>
                        <Axiom shared="true">Transcription Factor SubClassOf Gene_Product_Encoded_By_Gene some Transcription Factor Gene</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Biological_Process_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Multicellular Process SubClassOf Biological Process</Axiom>
                        <Axiom shared="true">Cell Proliferation SubClassOf Multicellular Process</Axiom>
                        <Axiom effectual="true">T-Box Transcription Factor TBX1 EquivalentTo Transcription Factor and (Gene_Product_Encoded_By_Gene some TBX1 Gene) and (Gene_Product_Has_Organism_Source some Human) and (Gene_Product_Plays_Role_In_Biological_Process some Cell Proliferation) and (Gene_Product_Plays_Role_In_Biological_Process some Transcription)</Axiom>
                        <Axiom shared="true">Biological Process SubClassOf Biological_Process_Kind</Axiom>
                        <Axiom effectual="true">Gene_Product_Plays_Role_In_Biological_Process Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2895">
                     <Axiom>Thursday SubClassOf Temporal Qualifier</Axiom>
                     <Source>
                        <Axiom effectual="true">Thursday SubClassOf Day of the Week</Axiom>
                        <Axiom effectual="true">Day of the Week SubClassOf Temporal Qualifier</Axiom>
                     </Source>
                  </Change>
                  <Change id="2896">
                     <Axiom>Tuesday SubClassOf Temporal Qualifier</Axiom>
                     <Source>
                        <Axiom effectual="true">Tuesday SubClassOf Day of the Week</Axiom>
                        <Axiom effectual="true">Day of the Week SubClassOf Temporal Qualifier</Axiom>
                     </Source>
                  </Change>
                  <Change id="2897">
                     <Axiom>Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
                     <Source>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Light Chain Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Light Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Gene Rearrangement</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma EquivalentTo Mature B-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Large B-Lymphocyte) and (Disease_Has_Finding only Diffuse Pattern) and (Disease_Has_Normal_Cell_Origin only Mature B-Lymphocyte)</Axiom>
                        <Axiom effectual="true">Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma by Gene Expression Profile SubClassOf Diffuse Large B-Cell Lymphoma</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Aggressive Non-Hodgkin Lymphoma EquivalentTo Non-Hodgkin Lymphoma by Clinical Course and (Disease_May_Have_Finding some Aggressive Clinical Course)</Axiom>
                        <Axiom shared="true">Clinical Course of Disease SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Aggressive Clinical Course SubClassOf Clinical Course of Disease</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
                        <Axiom shared="true">Hematopoietic System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Lymphadenopathy SubClassOf Hematopoietic System Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Heavy Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma EquivalentTo Mature B-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Large B-Lymphocyte) and (Disease_Has_Finding only Diffuse Pattern) and (Disease_Has_Normal_Cell_Origin only Mature B-Lymphocyte)</Axiom>
                        <Axiom effectual="true">Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma by Gene Expression Profile SubClassOf Diffuse Large B-Cell Lymphoma</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Non-Hodgkin Lymphoma EquivalentTo Common Hematopoietic Neoplasm and Lymphoma and (Disease_Excludes_Abnormal_Cell only Reed-Sternberg Cell)</Axiom>
                        <Axiom shared="true">B-Cell Non-Hodgkin Lymphoma EquivalentTo B-Cell Neoplasm and Non-Hodgkin Lymphoma</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplasm by Special Category SubClassOf Neoplasm</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma EquivalentTo Mature B-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Large B-Lymphocyte) and (Disease_Has_Finding only Diffuse Pattern) and (Disease_Has_Normal_Cell_Origin only Mature B-Lymphocyte)</Axiom>
                        <Axiom shared="true">Mature B-Cell Non-Hodgkin Lymphoma EquivalentTo B-Cell Non-Hodgkin Lymphoma and Mature B-Cell Neoplasm and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma by Gene Expression Profile SubClassOf Diffuse Large B-Cell Lymphoma</Axiom>
                        <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                        <Axiom shared="true">Common Hematopoietic Neoplasm SubClassOf Common Neoplasm</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2898">
                     <Axiom>Unit of Luminous Flux SubClassOf Unit by Category</Axiom>
                     <Source>
                        <Axiom shared="true">Unit of Illuminance SubClassOf Unit by Category</Axiom>
                        <Axiom effectual="true">Unit of Luminous Flux SubClassOf Unit of Illuminance</Axiom>
                     </Source>
                  </Change>
                  <Change id="2899">
                     <Axiom>Wednesday SubClassOf Temporal Qualifier</Axiom>
                     <Source>
                        <Axiom effectual="true">Wednesday SubClassOf Day of the Week</Axiom>
                        <Axiom effectual="true">Day of the Week SubClassOf Temporal Qualifier</Axiom>
                     </Source>
                  </Change>
               </RemovedNovelProspectiveRedundancy>
               <RemovedPseudoNovelProspectiveRedundancy id="rpseudopred" size="26">
                  <Change id="2900">
                     <Axiom>ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
                     <Source>
                        <Axiom shared="true">Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Malignant Neoplasm and Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Anaplastic Large T-Lymphocyte) and (Disease_Has_Finding only CD30-Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Mature T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal T-Cell Receptor Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom effectual="true">ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (((Disease_May_Have_Cytogenetic_Abnormality some inv(2)(p23q35)) and (Disease_May_Have_Molecular_Abnormality some ATIC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some ALO17-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(p23;q11)) and (Disease_May_Have_Molecular_Abnormality some MYH9-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;3)(p23;q21)) and (Disease_May_Have_Molecular_Abnormality some TFG-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;5)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some NPM-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q11-12;p23)) and (Disease_May_Have_Molecular_Abnormality some MSN-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Clonal T-Cell Receptor Beta Chain Gene Rearrangement SubClassOf Clonal T-Cell Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Hematopoietic System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom effectual="true">ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (((Disease_May_Have_Cytogenetic_Abnormality some inv(2)(p23q35)) and (Disease_May_Have_Molecular_Abnormality some ATIC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some ALO17-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(p23;q11)) and (Disease_May_Have_Molecular_Abnormality some MYH9-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;3)(p23;q21)) and (Disease_May_Have_Molecular_Abnormality some TFG-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;5)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some NPM-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q11-12;p23)) and (Disease_May_Have_Molecular_Abnormality some MSN-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Lymphadenopathy SubClassOf Hematopoietic System Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Extranodal Disease SubClassOf Clinical Course of Disease</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (((Disease_May_Have_Cytogenetic_Abnormality some inv(2)(p23q35)) and (Disease_May_Have_Molecular_Abnormality some ATIC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some ALO17-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(p23;q11)) and (Disease_May_Have_Molecular_Abnormality some MYH9-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;3)(p23;q21)) and (Disease_May_Have_Molecular_Abnormality some TFG-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;5)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some NPM-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q11-12;p23)) and (Disease_May_Have_Molecular_Abnormality some MSN-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clinical Course of Disease SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Neoplastic Large Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom effectual="true">ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (((Disease_May_Have_Cytogenetic_Abnormality some inv(2)(p23q35)) and (Disease_May_Have_Molecular_Abnormality some ATIC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some ALO17-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(p23;q11)) and (Disease_May_Have_Molecular_Abnormality some MYH9-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;3)(p23;q21)) and (Disease_May_Have_Molecular_Abnormality some TFG-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;5)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some NPM-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q11-12;p23)) and (Disease_May_Have_Molecular_Abnormality some MSN-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Hodgkin-Like Cell SubClassOf Neoplastic Large Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Large Lymphocyte SubClassOf Neoplastic Large Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom effectual="true">ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (((Disease_May_Have_Cytogenetic_Abnormality some inv(2)(p23q35)) and (Disease_May_Have_Molecular_Abnormality some ATIC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some ALO17-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(p23;q11)) and (Disease_May_Have_Molecular_Abnormality some MYH9-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;3)(p23;q21)) and (Disease_May_Have_Molecular_Abnormality some TFG-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;5)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some NPM-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q11-12;p23)) and (Disease_May_Have_Molecular_Abnormality some MSN-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Neoplastic Large Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Hodgkin-Like Cell SubClassOf Neoplastic Large Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Neoplastic Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="2901">
                     <Axiom>Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                     <Source>
                        <Axiom shared="true">Gastrointestinal System Signs and Symptoms SubClassOf Gastrointestinal System Finding</Axiom>
                        <Axiom shared="true">Gastrointestinal System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Hepatomegaly SubClassOf Gastrointestinal System Signs and Symptoms</Axiom>
                        <Axiom effectual="true">Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Immature Myeloid Cells Increased in Bone Marrow SubClassOf Abnormal Bone Marrow Test Result</Axiom>
                        <Axiom effectual="true">Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                        <Axiom shared="true">Hematopoietic System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Abnormal Bone Marrow Test Result SubClassOf Abnormal Hematology Test Result</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematology Test Result SubClassOf Hematopoietic System Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                        <Axiom shared="true">Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells SubClassOf Immature Myeloid Cells Increased in Bone Marrow</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Thrombocytosis SubClassOf Abnormal Hematology Test Result</Axiom>
                        <Axiom effectual="true">Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                        <Axiom shared="true">Hematopoietic System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematology Test Result SubClassOf Hematopoietic System Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Mental and Behavioral Signs and Symptoms SubClassOf Symptom</Axiom>
                        <Axiom shared="true">Fatigue SubClassOf Mental and Behavioral Signs and Symptoms</Axiom>
                        <Axiom shared="true">Other Finding SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Symptom SubClassOf Other Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Gastrointestinal System Signs and Symptoms SubClassOf Symptom</Axiom>
                        <Axiom shared="true">Hepatomegaly SubClassOf Gastrointestinal System Signs and Symptoms</Axiom>
                        <Axiom effectual="true">Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Other Finding SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Symptom SubClassOf Other Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2912">
                     <Axiom>Activated B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only BCL2 Gene mRNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD44 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Increased NFkappaB Pathway Activation) and (Disease_Has_Molecular_Abnormality only PKCbeta1 Messenger RNA Overexpression) and (Disease_Has_Normal_Cell_Origin only Activated B-Lymphocyte)</Axiom>
                     <Source>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom effectual="true">Activated B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only BCL2 Gene mRNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD44 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Increased NFkappaB Pathway Activation) and (Disease_Has_Molecular_Abnormality only PKCbeta1 Messenger RNA Overexpression) and (Disease_Has_Normal_Cell_Origin only Activated B-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Heavy Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma EquivalentTo Mature B-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Large B-Lymphocyte) and (Disease_Has_Finding only Diffuse Pattern) and (Disease_Has_Normal_Cell_Origin only Mature B-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma by Gene Expression Profile SubClassOf Diffuse Large B-Cell Lymphoma</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom effectual="true">Activated B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only BCL2 Gene mRNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD44 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Increased NFkappaB Pathway Activation) and (Disease_Has_Molecular_Abnormality only PKCbeta1 Messenger RNA Overexpression) and (Disease_Has_Normal_Cell_Origin only Activated B-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Light Chain Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Light Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Gene Rearrangement</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma EquivalentTo Mature B-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Large B-Lymphocyte) and (Disease_Has_Finding only Diffuse Pattern) and (Disease_Has_Normal_Cell_Origin only Mature B-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma by Gene Expression Profile SubClassOf Diffuse Large B-Cell Lymphoma</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2902">
                     <Axiom>Acute Adult T-Cell Leukemia/Lymphoma EquivalentTo Adult T-Cell Leukemia/Lymphoma and Leukemic Phase of Lymphoma and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy)</Axiom>
                     <Source>
                        <Axiom shared="true">Neoplastic Medium-Sized T-Lymphocyte SubClassOf Neoplastic Medium-Sized Lymphocyte</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Acute Adult T-Cell Leukemia/Lymphoma EquivalentTo Adult T-Cell Leukemia/Lymphoma and Leukemic Phase of Lymphoma and (((Disease_May_Have_Associated_Disease some Opportunistic Infection) and (Disease_May_Have_Associated_Disease some T-Cell Immunodeficiency)) or ((Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present)) or ((Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Finding only Pautrier-Like Microabscess Present)) or ((Disease_Has_Finding only Bone Marrow Involvement) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Finding only White Blood Cell Count Increased))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy)</Axiom>
                        <Axiom shared="true">Neoplastic Medium-Sized Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Neoplastic Medium-Sized T-Lymphocyte SubClassOf Neoplastic Medium-Sized Lymphocyte</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Acute Adult T-Cell Leukemia/Lymphoma EquivalentTo Adult T-Cell Leukemia/Lymphoma and Leukemic Phase of Lymphoma and (((Disease_May_Have_Associated_Disease some Opportunistic Infection) and (Disease_May_Have_Associated_Disease some T-Cell Immunodeficiency)) or ((Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present)) or ((Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Finding only Pautrier-Like Microabscess Present)) or ((Disease_Has_Finding only Bone Marrow Involvement) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Finding only White Blood Cell Count Increased))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy)</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Neoplastic Medium-Sized Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Neoplastic Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Pleomorphic T-Lymphocyte SubClassOf Pleomorphic Lymphocyte</Axiom>
                        <Axiom shared="true">Pleomorphic Lymphocyte SubClassOf Pleomorphic Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Pleomorphic Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom shared="true">Polylobated T-Lymphocyte SubClassOf Pleomorphic T-Lymphocyte</Axiom>
                        <Axiom effectual="true">Acute Adult T-Cell Leukemia/Lymphoma EquivalentTo Adult T-Cell Leukemia/Lymphoma and Leukemic Phase of Lymphoma and (((Disease_May_Have_Associated_Disease some Opportunistic Infection) and (Disease_May_Have_Associated_Disease some T-Cell Immunodeficiency)) or ((Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present)) or ((Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Finding only Pautrier-Like Microabscess Present)) or ((Disease_Has_Finding only Bone Marrow Involvement) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Finding only White Blood Cell Count Increased))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy)</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Abnormal Lymphocyte SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Medium-Sized T-Lymphocyte SubClassOf Neoplastic Medium-Sized Lymphocyte</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom effectual="true">Acute Adult T-Cell Leukemia/Lymphoma EquivalentTo Adult T-Cell Leukemia/Lymphoma and Leukemic Phase of Lymphoma and (((Disease_May_Have_Associated_Disease some Opportunistic Infection) and (Disease_May_Have_Associated_Disease some T-Cell Immunodeficiency)) or ((Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present)) or ((Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Finding only Pautrier-Like Microabscess Present)) or ((Disease_Has_Finding only Bone Marrow Involvement) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Finding only White Blood Cell Count Increased))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy)</Axiom>
                        <Axiom shared="true">Neoplastic Medium-Sized Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Abnormal Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Acute Adult T-Cell Leukemia/Lymphoma EquivalentTo Adult T-Cell Leukemia/Lymphoma and Leukemic Phase of Lymphoma and (((Disease_May_Have_Associated_Disease some Opportunistic Infection) and (Disease_May_Have_Associated_Disease some T-Cell Immunodeficiency)) or ((Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present)) or ((Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Finding only Pautrier-Like Microabscess Present)) or ((Disease_Has_Finding only Bone Marrow Involvement) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Finding only White Blood Cell Count Increased))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy)</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Neoplastic Small T-Lymphocyte SubClassOf Neoplastic Small Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom shared="true">Pleomorphic Small T-Lymphocyte SubClassOf Neoplastic Small T-Lymphocyte</Axiom>
                        <Axiom shared="true">Neoplastic Small Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                     </Source>
                  </Change>
                  <Change id="2903">
                     <Axiom>Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
                     <Source>
                        <Axiom shared="true">Bone Marrow Neoplasm EquivalentTo Bone Marrow Disorder and Hematopoietic and Lymphoid System Neoplasm</Axiom>
                        <Axiom shared="true">Myeloid Leukemia EquivalentTo Leukemia and Myeloid Neoplasm and (Disease_Excludes_Normal_Cell_Origin only Lymphocyte)</Axiom>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Myeloid Neoplasm EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Malignant Bone Marrow Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Myeloid Cell) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell) and (Disease_Has_Normal_Tissue_Origin only Hematopoietic Tissue) and (Disease_Has_Primary_Anatomic_Site only Bone Marrow)</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Hematopoietic and Lymphoid System Neoplasm EquivalentTo Hematopoietic and Lymphoid System Disorder and Neoplasm by Site</Axiom>
                        <Axiom shared="true">Acute Myeloid Leukemia EquivalentTo Acute Leukemia and Common Hematopoietic Neoplasm and Myeloid Leukemia and (Disease_Excludes_Abnormal_Cell only Neoplastic Lymphoblast)</Axiom>
                        <Axiom effectual="true">Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;V)(p11;v)) and (Disease_May_Have_Molecular_Abnormality some MOZ-V Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Malignant Bone Marrow Neoplasm EquivalentTo Bone Marrow Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Neoplasm by Site SubClassOf Neoplasm</Axiom>
                        <Axiom shared="true">Acute Myeloid Leukemia not Otherwise Categorized EquivalentTo Acute Myeloid Leukemia and (Disease_Excludes_Finding only Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines)</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;V)(p11;v)) and (Disease_May_Have_Molecular_Abnormality some MOZ-V Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
                        <Axiom shared="true">Chromosomal Translocation SubClassOf Chromosomal Rearrangement</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Chromosomal Rearrangement SubClassOf Structural Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">t(7;11)(p15;p15) SubClassOf Chromosomal Translocation</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Structural Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">t(8;22)(p11;q13) SubClassOf Chromosomal Translocation</Axiom>
                        <Axiom effectual="true">Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;V)(p11;v)) and (Disease_May_Have_Molecular_Abnormality some MOZ-V Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
                        <Axiom shared="true">Chromosomal Translocation SubClassOf Chromosomal Rearrangement</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Chromosomal Rearrangement SubClassOf Structural Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Structural Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;V)(p11;v)) and (Disease_May_Have_Molecular_Abnormality some MOZ-V Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Unfavorable Clinical Outcome SubClassOf Clinical Course of Disease</Axiom>
                        <Axiom shared="true">Clinical Course of Disease SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;V)(p11;v)) and (Disease_May_Have_Molecular_Abnormality some MOZ-V Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
                        <Axiom shared="true">Hematopoietic System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Abnormal Bone Marrow Test Result SubClassOf Abnormal Hematology Test Result</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematology Test Result SubClassOf Hematopoietic System Finding</Axiom>
                        <Axiom shared="true">Hypercellular Bone Marrow SubClassOf Abnormal Bone Marrow Test Result</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2904">
                     <Axiom>Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
                     <Source>
                        <Axiom shared="true">Abnormal Granulocyte SubClassOf Abnormal Myeloid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Granulocyte SubClassOf Abnormal Granulocyte</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Myeloid Cell SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Neutrophilic Precursor SubClassOf Neoplastic Granulocyte</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Myeloid Cell SubClassOf Leukemic Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom effectual="true">Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
                        <Axiom shared="true">Neoplastic Granulocyte SubClassOf Neoplastic Myeloid Cell</Axiom>
                        <Axiom shared="true">Leukemic Cell SubClassOf Malignant Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Neutrophilic Precursor SubClassOf Neoplastic Granulocyte</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Malignant Cell SubClassOf Neoplastic Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Leukemic Cell SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Myeloid Cell SubClassOf Leukemic Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom effectual="true">Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
                        <Axiom shared="true">Neoplastic Granulocyte SubClassOf Neoplastic Myeloid Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Neutrophilic Precursor SubClassOf Neoplastic Granulocyte</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Neoplastic Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Leukemic Cell SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Myeloid Cell SubClassOf Leukemic Cell</Axiom>
                        <Axiom effectual="true">Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
                        <Axiom shared="true">Neoplastic Granulocyte SubClassOf Neoplastic Myeloid Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Neutrophilic Precursor SubClassOf Neoplastic Granulocyte</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Myeloid Cell SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
                        <Axiom shared="true">Neoplastic Granulocyte SubClassOf Neoplastic Myeloid Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Neutrophilic Precursor SubClassOf Neoplastic Granulocyte</Axiom>
                        <Axiom shared="true">Neoplastic Myeloid Cell SubClassOf Abnormal Myeloid Cell</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="2905">
                     <Axiom>Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
                     <Source>
                        <Axiom shared="true">Leukemic Cell SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Myeloid Cell SubClassOf Leukemic Cell</Axiom>
                        <Axiom effectual="true">Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some del(12p11p13)) and (Disease_May_Have_Finding some Bone Marrow Basophilia)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some DEK-CAN Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;21)(q22;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some AML1-ETO Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
                        <Axiom shared="true">Neoplastic Granulocyte SubClassOf Neoplastic Myeloid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Myeloblast SubClassOf Neoplastic Granulocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Neoplastic Myeloblast without Azurophilic Granules SubClassOf Neoplastic Myeloblast</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some del(12p11p13)) and (Disease_May_Have_Finding some Bone Marrow Basophilia)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some DEK-CAN Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;21)(q22;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some AML1-ETO Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Morphologic Finding SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Auer Rods Present SubClassOf Morphologic Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Myeloid Cell SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some del(12p11p13)) and (Disease_May_Have_Finding some Bone Marrow Basophilia)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some DEK-CAN Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;21)(q22;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some AML1-ETO Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
                        <Axiom shared="true">Neoplastic Granulocyte SubClassOf Neoplastic Myeloid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Myeloblast SubClassOf Neoplastic Granulocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Myeloid Cell SubClassOf Abnormal Myeloid Cell</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Neoplastic Myeloblast without Azurophilic Granules SubClassOf Neoplastic Myeloblast</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Myeloid Cell SubClassOf Leukemic Cell</Axiom>
                        <Axiom effectual="true">Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some del(12p11p13)) and (Disease_May_Have_Finding some Bone Marrow Basophilia)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some DEK-CAN Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;21)(q22;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some AML1-ETO Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Neoplastic Granulocyte SubClassOf Neoplastic Myeloid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Myeloblast SubClassOf Neoplastic Granulocyte</Axiom>
                        <Axiom shared="true">Leukemic Cell SubClassOf Malignant Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Malignant Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom shared="true">Neoplastic Myeloblast without Azurophilic Granules SubClassOf Neoplastic Myeloblast</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Neoplastic Myeloid Blast SubClassOf Neoplastic Myeloid Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Myeloid Cell SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (((Disease_May_Have_Cytogenetic_Abnormality some del(12p11p13)) and (Disease_May_Have_Finding some Bone Marrow Basophilia)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some DEK-CAN Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;21)(q22;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some AML1-ETO Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
                        <Axiom shared="true">Neoplastic Myeloblast SubClassOf Neoplastic Myeloid Blast</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Myeloid Cell SubClassOf Abnormal Myeloid Cell</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Neoplastic Myeloblast without Azurophilic Granules SubClassOf Neoplastic Myeloblast</Axiom>
                     </Source>
                  </Change>
                  <Change id="2827">
                     <Axiom>Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Myeloid Leukemia EquivalentTo Leukemia and Myeloid Neoplasm and (Disease_Excludes_Normal_Cell_Origin only Lymphocyte)</Axiom>
                        <Axiom effectual="true">Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression))) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Hematopoietic and Lymphoid Cell Neoplasm EquivalentTo Hematologic and Lymphocytic Disorder and Hematopoietic and Lymphoid System Neoplasm and Neoplasm by Morphology and (Disease_Has_Abnormal_Cell only Neoplastic Hematopoietic and Lymphoid Cell) and (Disease_Has_Normal_Cell_Origin only Hematopoietic and Lymphoid Cell)</Axiom>
                        <Axiom shared="true">Myeloid Neoplasm EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Malignant Bone Marrow Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Myeloid Cell) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell) and (Disease_Has_Normal_Tissue_Origin only Hematopoietic Tissue) and (Disease_Has_Primary_Anatomic_Site only Bone Marrow)</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Acute Myeloid Leukemia EquivalentTo Acute Leukemia and Common Hematopoietic Neoplasm and Myeloid Leukemia and (Disease_Excludes_Abnormal_Cell only Neoplastic Lymphoblast)</Axiom>
                        <Axiom shared="true">Acute Myelomonocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Neutrophilic Precursor) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_Has_Finding only Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic and Monocytic Lineages)</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Neoplasm by Morphology SubClassOf Neoplasm</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Acute Myeloid Leukemia not Otherwise Categorized EquivalentTo Acute Myeloid Leukemia and (Disease_Excludes_Finding only Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Acute Myelomonocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Neutrophilic Precursor) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_Has_Finding only Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic and Monocytic Lineages)</Axiom>
                        <Axiom shared="true">Non-Neoplastic Hematologic and Lymphocytic Disorder SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        <Axiom effectual="true">Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression))) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
                        <Axiom shared="true">Anemia SubClassOf Non-Neoplastic Hematologic and Lymphocytic Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder by Site SubClassOf Non-Neoplastic Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Range NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Acute Myelomonocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Neutrophilic Precursor) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_Has_Finding only Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic and Monocytic Lineages)</Axiom>
                        <Axiom shared="true">Hematologic and Lymphocytic Disorder SubClassOf Hematopoietic and Lymphoid System Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Hematologic and Lymphocytic Disorder SubClassOf Hematologic and Lymphocytic Disorder</Axiom>
                        <Axiom shared="true">Disorder by Site SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression))) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
                        <Axiom shared="true">Anemia SubClassOf Non-Neoplastic Hematologic and Lymphocytic Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Hematopoietic and Lymphoid System Disorder SubClassOf Disorder by Site</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Range NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2828">
                     <Axiom>Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                     <Source>
                        <Axiom effectual="true">Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                        <Axiom shared="true">Tumor-Suppressor Gene Inactivation SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">PTEN Gene Inactivation SubClassOf Tumor-Suppressor Gene Inactivation</Axiom>
                        <Axiom shared="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Chromosomal Deletion SubClassOf Structural Chromosomal Abnormality</Axiom>
                        <Axiom effectual="true">Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">del(10q23) SubClassOf Chromosomal Deletion</Axiom>
                        <Axiom shared="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Structural Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Loss of Chromosome 9p SubClassOf Chromosomal Loss</Axiom>
                        <Axiom effectual="true">Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Numerical Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                        <Axiom shared="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Chromosomal Loss SubClassOf Numerical Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2906">
                     <Axiom>Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Non-Neoplastic Hematologic and Lymphocytic Disorder SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        <Axiom shared="true">Anemia SubClassOf Non-Neoplastic Hematologic and Lymphocytic Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder by Site SubClassOf Non-Neoplastic Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Range NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">NRAS Gene Mutation SubClassOf Gene Abnormality</Axiom>
                        <Axiom effectual="true">Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Myelodysplastic/Myeloproliferative Disease EquivalentTo Myeloid Neoplasm and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Ineffective Hematopoiesis) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Blasts Under 20 Percent of Peripheral Blood White Cells)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Hematopoietic System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
                        <Axiom shared="true">Cytopenia SubClassOf Abnormal Hematology Test Result</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematology Test Result SubClassOf Hematopoietic System Finding</Axiom>
                        <Axiom shared="true">Thrombocytopenia SubClassOf Cytopenia</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Erythroid Precursor SubClassOf Abnormal Myeloid Cell</Axiom>
                        <Axiom shared="true">Abnormal Myeloid Cell SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Dysplastic Erythroid Precursor SubClassOf Abnormal Erythroid Precursor</Axiom>
                        <Axiom effectual="true">Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom effectual="true">Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
                        <Axiom shared="true">Loss of Chromosome 12p SubClassOf Chromosomal Loss</Axiom>
                        <Axiom shared="true">Numerical Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Chromosomal Loss SubClassOf Numerical Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2907">
                     <Axiom>Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                     <Source>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Loss of Chromosome Y SubClassOf Chromosomal Loss</Axiom>
                        <Axiom effectual="true">Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                        <Axiom shared="true">Numerical Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Chromosomal Loss SubClassOf Numerical Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">i(17q) SubClassOf Isochromosome</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom effectual="true">Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Isochromosome SubClassOf Cytogenetic Abnormality</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                        <Axiom shared="true">White Blood Cell Count Increased SubClassOf Abnormal Hematology Test Result</Axiom>
                        <Axiom shared="true">Hematopoietic System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematology Test Result SubClassOf Hematopoietic System Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Mental and Behavioral Signs and Symptoms SubClassOf Symptom</Axiom>
                        <Axiom shared="true">Fatigue SubClassOf Mental and Behavioral Signs and Symptoms</Axiom>
                        <Axiom shared="true">Other Finding SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Symptom SubClassOf Other Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                        <Axiom shared="true">Non-Neoplastic Hematologic and Lymphocytic Disorder SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        <Axiom shared="true">Anemia SubClassOf Non-Neoplastic Hematologic and Lymphocytic Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder by Site SubClassOf Non-Neoplastic Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Range NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2842">
                     <Axiom>Brain Glioblastoma EquivalentTo Glioblastoma and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                     <Source>
                        <Axiom shared="true">Headache SubClassOf Neurological Signs and Symptoms</Axiom>
                        <Axiom effectual="true">Brain Glioblastoma EquivalentTo Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Other Finding SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                        <Axiom shared="true">Symptom SubClassOf Other Finding</Axiom>
                        <Axiom shared="true">Neurological Signs and Symptoms SubClassOf Symptom</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Brain Glioblastoma EquivalentTo Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                        <Axiom shared="true">Neoplastic Glial Cell SubClassOf Neoplastic Neuroepithelial Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Astrocyte SubClassOf Neoplastic Glial Cell</Axiom>
                        <Axiom shared="true">Neoplastic Neuroepithelial Cell and Neoplastic Perineural Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                        <Axiom shared="true">Gemistocytic Neoplastic Astrocyte SubClassOf Neoplastic Astrocyte</Axiom>
                        <Axiom shared="true">Neoplastic Neuroepithelial Cell SubClassOf Neoplastic Neuroepithelial Cell and Neoplastic Perineural Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Brain Glioblastoma EquivalentTo Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                        <Axiom shared="true">Nervous System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Seizure SubClassOf Neurological Signs and Symptoms</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                        <Axiom shared="true">Neurological Signs and Symptoms SubClassOf Nervous System Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Brain Glioblastoma EquivalentTo Glioblastoma and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                        <Axiom shared="true">Chromosomal Deletion SubClassOf Structural Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">del(10q23) SubClassOf Chromosomal Deletion</Axiom>
                        <Axiom shared="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Structural Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                     </Source>
                  </Change>
                  <Change id="2846">
                     <Axiom>Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and Malignant Childhood Central Nervous System Neoplasm and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                     <Source>
                        <Axiom shared="true">Loss of Chromosome 9p SubClassOf Chromosomal Loss</Axiom>
                        <Axiom effectual="true">Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and Malignant Childhood Central Nervous System Neoplasm and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Numerical Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                        <Axiom shared="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Chromosomal Loss SubClassOf Numerical Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Chromosomal Deletion SubClassOf Structural Chromosomal Abnormality</Axiom>
                        <Axiom effectual="true">Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and Malignant Childhood Central Nervous System Neoplasm and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">del(10q23) SubClassOf Chromosomal Deletion</Axiom>
                        <Axiom shared="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Structural Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and Malignant Childhood Central Nervous System Neoplasm and (((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                        <Axiom shared="true">Nervous System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Seizure SubClassOf Neurological Signs and Symptoms</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                        <Axiom shared="true">Neurological Signs and Symptoms SubClassOf Nervous System Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2908">
                     <Axiom>Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Non-Neoplastic Heart Disorder SubClassOf Non-Neoplastic Cardiovascular Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Non-Neoplastic Cardiovascular Disorder SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        <Axiom shared="true">Endomyocardial Fibrosis SubClassOf Non-Neoplastic Heart Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder by Site SubClassOf Non-Neoplastic Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Range NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;4)(q44;q12)) and (Disease_May_Have_Molecular_Abnormality some FIP1L1-PDGFRalpha Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell)) or ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Loss of Chromosome 13q SubClassOf Chromosomal Loss</Axiom>
                        <Axiom shared="true">Numerical Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Chromosomal Loss SubClassOf Numerical Chromosomal Abnormality</Axiom>
                        <Axiom effectual="true">Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;4)(q44;q12)) and (Disease_May_Have_Molecular_Abnormality some FIP1L1-PDGFRalpha Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell)) or ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Chromosomal Translocation SubClassOf Chromosomal Rearrangement</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Chromosomal Rearrangement SubClassOf Structural Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">t(8;9)(p11;q32-34) SubClassOf Chromosomal Translocation</Axiom>
                        <Axiom effectual="true">Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;4)(q44;q12)) and (Disease_May_Have_Molecular_Abnormality some FIP1L1-PDGFRalpha Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell)) or ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Structural Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Disorder by Site SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Thoracic Disorder SubClassOf Respiratory and Thoracic Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Range NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Eosinophilic Endomyocardial Disease SubClassOf Heart Disorder</Axiom>
                        <Axiom shared="true">Respiratory and Thoracic Disorder SubClassOf Disorder by Site</Axiom>
                        <Axiom effectual="true">Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;4)(q44;q12)) and (Disease_May_Have_Molecular_Abnormality some FIP1L1-PDGFRalpha Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell)) or ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                        <Axiom shared="true">Heart Disorder SubClassOf Thoracic Disorder</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Anatomic Structure, System, or Substance SubClassOf Anatomy_Kind</Axiom>
                        <Axiom shared="true">Multipotent Stem Cell SubClassOf Stem Cell</Axiom>
                        <Axiom shared="true">Microanatomic Structure SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        <Axiom shared="true">Anatomy_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Multipotent Bone Marrow Stem Cell SubClassOf Multipotent Stem Cell</Axiom>
                        <Axiom shared="true">Stem Cell SubClassOf Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Normal_Cell_Origin Range NCI_Kind</Axiom>
                        <Axiom shared="true">Cell SubClassOf Microanatomic Structure</Axiom>
                        <Axiom effectual="true">Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;4)(q44;q12)) and (Disease_May_Have_Molecular_Abnormality some FIP1L1-PDGFRalpha Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell)) or ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression))) and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                     </Source>
                  </Change>
                  <Change id="2909">
                     <Axiom>Classical Hodgkin Lymphoma EquivalentTo Hodgkin Lymphoma and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweats) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin Cell)</Axiom>
                     <Source>
                        <Axiom shared="true">Molecular Pathway Deregulation SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Apoptotic Pathway Deregulation SubClassOf Molecular Pathway Deregulation</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Classical Hodgkin Lymphoma EquivalentTo Hodgkin Lymphoma and (((Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Mature B-Lymphocyte at the Germinal Center Stage of Differentiation)) or ((Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Peripheral (Post-Thymic) T-Lymphocyte))) and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweats) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin Cell)</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Reed-Sternberg Cell SubClassOf Neoplastic Large Lymphocyte</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Mummified Cell SubClassOf Reed-Sternberg Cell</Axiom>
                        <Axiom shared="true">Neoplastic Large Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom effectual="true">Classical Hodgkin Lymphoma EquivalentTo Hodgkin Lymphoma and (((Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Mature B-Lymphocyte at the Germinal Center Stage of Differentiation)) or ((Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Peripheral (Post-Thymic) T-Lymphocyte))) and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweats) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin Cell)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Reed-Sternberg Cell SubClassOf Neoplastic Large Lymphocyte</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Mummified Cell SubClassOf Reed-Sternberg Cell</Axiom>
                        <Axiom shared="true">Neoplastic Large Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom effectual="true">Classical Hodgkin Lymphoma EquivalentTo Hodgkin Lymphoma and (((Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Mature B-Lymphocyte at the Germinal Center Stage of Differentiation)) or ((Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Peripheral (Post-Thymic) T-Lymphocyte))) and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweats) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin Cell)</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Reed-Sternberg Cell SubClassOf Neoplastic Large Lymphocyte</Axiom>
                        <Axiom shared="true">Neoplastic Large Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Mummified Cell SubClassOf Reed-Sternberg Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Large Lymphocyte SubClassOf Neoplastic Large Cell</Axiom>
                        <Axiom effectual="true">Classical Hodgkin Lymphoma EquivalentTo Hodgkin Lymphoma and (((Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Mature B-Lymphocyte at the Germinal Center Stage of Differentiation)) or ((Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Peripheral (Post-Thymic) T-Lymphocyte))) and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweats) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin Cell)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Reed-Sternberg Cell SubClassOf Neoplastic Large Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal Lymphocyte SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Mummified Cell SubClassOf Reed-Sternberg Cell</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Abnormal Lymphocyte</Axiom>
                        <Axiom shared="true">Neoplastic Large Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom effectual="true">Classical Hodgkin Lymphoma EquivalentTo Hodgkin Lymphoma and (((Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Mature B-Lymphocyte at the Germinal Center Stage of Differentiation)) or ((Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Peripheral (Post-Thymic) T-Lymphocyte))) and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweats) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin Cell)</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="2910">
                     <Axiom>Coagulation Factor X SubClassOf Coagulation Factor</Axiom>
                     <Source>
                        <Axiom effectual="true">Coagulation Factor X EquivalentTo Coagulation Factor and (Gene_Product_Encoded_By_Gene some F10 Gene) and (Gene_Product_Has_Biochemical_Function some Coagulation Factor) and (Gene_Product_Is_Element_In_Pathway some Intrinsic Prothrombin Activation Pathway) and (Gene_Product_Plays_Role_In_Biological_Process some Coagulation) and (Gene_Product_Plays_Role_In_Biological_Process some Homeostasis) and (Gene_Product_Plays_Role_In_Biological_Process some Proteolytic Processing)</Axiom>
                     </Source>
                  </Change>
                  <Change id="2921">
                     <Axiom>DS Stage I Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage I)</Axiom>
                     <Source>
                        <Axiom effectual="true">DS Stage I Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Solitary Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage I)</Axiom>
                        <Axiom shared="true">Cyclin D1 Protein Overexpression SubClassOf Protein Deregulation</Axiom>
                        <Axiom shared="true">Protein Deregulation SubClassOf Deregulation of Protein and Messenger RNA Expression</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Deregulation of Protein and Messenger RNA Expression SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Chromosomal Translocation SubClassOf Chromosomal Rearrangement</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom effectual="true">DS Stage I Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Solitary Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage I)</Axiom>
                        <Axiom shared="true">t(11;14)(q13;q32) SubClassOf Chromosomal Translocation</Axiom>
                        <Axiom shared="true">Chromosomal Rearrangement SubClassOf Structural Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Structural Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Laboratory Test Result SubClassOf Clinical Test Result</Axiom>
                        <Axiom shared="true">Monoclonal Paraproteinemia SubClassOf Paraproteinemia</Axiom>
                        <Axiom shared="true">Paraproteinemia SubClassOf Abnormal Blood Chemistry and Hematology Test Result</Axiom>
                        <Axiom effectual="true">DS Stage I Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Solitary Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage I)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Blood Chemistry and Hematology Test Result SubClassOf Abnormal Laboratory Test Result</Axiom>
                        <Axiom effectual="true">Clinical Test Result SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom ineffectual="true">Abnormal Laboratory Test Result SubClassOf Laboratory Test Result</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom effectual="true">DS Stage I Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Solitary Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage I)</Axiom>
                        <Axiom shared="true">Loss of Chromosome 8 SubClassOf Chromosomal Loss</Axiom>
                        <Axiom shared="true">Numerical Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Chromosomal Loss SubClassOf Numerical Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Domain NCI_Kind</Axiom>
                        <Axiom effectual="true">DS Stage I Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Solitary Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage I)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                        <Axiom shared="true">Plasma Cell Myeloma EquivalentTo Common Hematopoietic Neoplasm and Plasma Cell Neoplasm and (Disease_Excludes_Finding only Localized Lesion) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Finding only Neoplastic Plasma Cells Present in Bone Marrow) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Bone Marrow-Homing Plasma Cell)</Axiom>
                        <Axiom shared="true">Common Hematopoietic Neoplasm SubClassOf Common Neoplasm</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Neoplasm by Special Category SubClassOf Neoplasm</Axiom>
                     </Source>
                  </Change>
                  <Change id="2920">
                     <Axiom>DS Stage III Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
                     <Source>
                        <Axiom shared="true">Neoplastic B-Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Pleomorphic Plasma Cell SubClassOf Neoplastic Plasma Cell</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom shared="true">Neoplastic Plasma Cell SubClassOf Neoplastic B-Lymphocyte</Axiom>
                        <Axiom effectual="true">DS Stage III Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Loss of Chromosome X SubClassOf Chromosomal Loss</Axiom>
                        <Axiom shared="true">Numerical Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Chromosomal Loss SubClassOf Numerical Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">DS Stage III Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Laboratory Test Result SubClassOf Clinical Test Result</Axiom>
                        <Axiom shared="true">Monoclonal Paraproteinemia SubClassOf Paraproteinemia</Axiom>
                        <Axiom shared="true">Paraproteinemia SubClassOf Abnormal Blood Chemistry and Hematology Test Result</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Blood Chemistry and Hematology Test Result SubClassOf Abnormal Laboratory Test Result</Axiom>
                        <Axiom effectual="true">Clinical Test Result SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom ineffectual="true">Abnormal Laboratory Test Result SubClassOf Laboratory Test Result</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">DS Stage III Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Chromosomal Translocation SubClassOf Chromosomal Rearrangement</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">t(11;14)(q13;q32) SubClassOf Chromosomal Translocation</Axiom>
                        <Axiom shared="true">Chromosomal Rearrangement SubClassOf Structural Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Structural Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                        <Axiom effectual="true">DS Stage III Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Cyclin D1 Protein Overexpression SubClassOf Protein Deregulation</Axiom>
                        <Axiom shared="true">Protein Deregulation SubClassOf Deregulation of Protein and Messenger RNA Expression</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Deregulation of Protein and Messenger RNA Expression SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                        <Axiom effectual="true">DS Stage III Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
                     </Source>
                  </Change>
                  <Change id="2913">
                     <Axiom>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(q24;q12)) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
                     <Source>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Round Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom shared="true">Malignant Small Round Cell SubClassOf Neoplastic Small Round Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Small Round Cell SubClassOf Neoplastic Round Cell</Axiom>
                        <Axiom effectual="true">Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some inv(22q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p36.1;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ZSG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;21)(p11;q22)) and (Disease_May_Have_Molecular_Abnormality some FUS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q21;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-E1AF Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(21;22)(q22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(q33;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-FEV Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(7;22)(p22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ETV1 Fusion Protein Expression)) or ((Disease_May_Have_Molecular_Abnormality some EWS-FL1 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(q24;q12)) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Non-Neoplastic Hematologic and Lymphocytic Disorder SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        <Axiom shared="true">Anemia SubClassOf Non-Neoplastic Hematologic and Lymphocytic Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder by Site SubClassOf Non-Neoplastic Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Range NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some inv(22q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p36.1;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ZSG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;21)(p11;q22)) and (Disease_May_Have_Molecular_Abnormality some FUS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q21;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-E1AF Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(21;22)(q22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(q33;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-FEV Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(7;22)(p22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ETV1 Fusion Protein Expression)) or ((Disease_May_Have_Molecular_Abnormality some EWS-FL1 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(q24;q12)) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Hemorrhagic Change SubClassOf Morphologic Finding</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Morphologic Finding SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some inv(22q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p36.1;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ZSG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;21)(p11;q22)) and (Disease_May_Have_Molecular_Abnormality some FUS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q21;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-E1AF Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(21;22)(q22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(q33;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-FEV Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(7;22)(p22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ETV1 Fusion Protein Expression)) or ((Disease_May_Have_Molecular_Abnormality some EWS-FL1 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(q24;q12)) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Chromosomal Translocation SubClassOf Chromosomal Rearrangement</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Chromosomal Rearrangement SubClassOf Structural Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">t(11;22)(q24;q12) SubClassOf Chromosomal Translocation</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom effectual="true">Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some inv(22q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p36.1;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ZSG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;21)(p11;q22)) and (Disease_May_Have_Molecular_Abnormality some FUS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q21;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-E1AF Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(21;22)(q22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(q33;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-FEV Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(7;22)(p22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ETV1 Fusion Protein Expression)) or ((Disease_May_Have_Molecular_Abnormality some EWS-FL1 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(q24;q12)) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Structural Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Malignant Small Round Cell SubClassOf Malignant Small Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Malignant Small Cell SubClassOf Malignant Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Malignant Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom effectual="true">Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some inv(22q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p36.1;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ZSG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;21)(p11;q22)) and (Disease_May_Have_Molecular_Abnormality some FUS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q21;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-E1AF Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(21;22)(q22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(q33;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-FEV Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(7;22)(p22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ETV1 Fusion Protein Expression)) or ((Disease_May_Have_Molecular_Abnormality some EWS-FL1 Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(q24;q12)) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
                     </Source>
                  </Change>
                  <Change id="2911">
                     <Axiom>Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only A-myb Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Has_Molecular_Abnormality only BCL-6 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD10 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only LMO2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only REL Gene Amplification) and (Disease_Has_Normal_Cell_Origin only Germinal Center B-Lymphocyte)</Axiom>
                     <Source>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom effectual="true">Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only A-myb Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Has_Molecular_Abnormality only BCL-6 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD10 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only LMO2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only REL Gene Amplification) and (Disease_Has_Normal_Cell_Origin only Germinal Center B-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Light Chain Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Light Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Gene Rearrangement</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma EquivalentTo Mature B-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Large B-Lymphocyte) and (Disease_Has_Finding only Diffuse Pattern) and (Disease_Has_Normal_Cell_Origin only Mature B-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma by Gene Expression Profile SubClassOf Diffuse Large B-Cell Lymphoma</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom effectual="true">Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma))) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only A-myb Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Has_Molecular_Abnormality only BCL-6 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD10 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only LMO2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only REL Gene Amplification) and (Disease_Has_Normal_Cell_Origin only Germinal Center B-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Heavy Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma EquivalentTo Mature B-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Large B-Lymphocyte) and (Disease_Has_Finding only Diffuse Pattern) and (Disease_Has_Normal_Cell_Origin only Mature B-Lymphocyte)</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">Diffuse Large B-Cell Lymphoma by Gene Expression Profile SubClassOf Diffuse Large B-Cell Lymphoma</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2914">
                     <Axiom>Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
                     <Source>
                        <Axiom shared="true">Neoplastic Connective and Soft Tissue Cell SubClassOf Abnormal Connective and Soft Tissue Cell</Axiom>
                        <Axiom effectual="true">Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
                        <Axiom shared="true">Abnormal Connective and Soft Tissue Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Stellate Cell SubClassOf Neoplastic Connective and Soft Tissue Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Neoplastic Stellate Cell SubClassOf Neoplastic Connective and Soft Tissue Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Connective and Soft Tissue Cell SubClassOf Neoplastic Cell</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Neoplastic Connective and Soft Tissue Cell SubClassOf Abnormal Connective and Soft Tissue Cell</Axiom>
                        <Axiom effectual="true">Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
                        <Axiom shared="true">Abnormal Connective and Soft Tissue Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Ganglion-Like Cell SubClassOf Neoplastic Connective and Soft Tissue Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression))) and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Ganglion-Like Cell SubClassOf Neoplastic Connective and Soft Tissue Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Connective and Soft Tissue Cell SubClassOf Neoplastic Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="2915">
                     <Axiom>Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin Lymphoma and Indolent Non-Hodgkin Lymphoma and Mycosis Fungoides and Sezary Syndrome and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Indolent Non-Hodgkin Lymphoma EquivalentTo Non-Hodgkin Lymphoma by Clinical Course and (Disease_May_Have_Finding some Indolent Clinical Course)</Axiom>
                        <Axiom shared="true">Hematologic and Lymphocytic Disorder SubClassOf Hematopoietic and Lymphoid System Disorder</Axiom>
                        <Axiom shared="true">Non-Hodgkin Lymphoma EquivalentTo Common Hematopoietic Neoplasm and Lymphoma and (Disease_Excludes_Abnormal_Cell only Reed-Sternberg Cell)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Non-Hodgkin Lymphoma by Clinical Course SubClassOf Non-Hodgkin Lymphoma</Axiom>
                        <Axiom shared="true">Lymphoma EquivalentTo Lymphocytic Neoplasm and (Disease_Excludes_Normal_Cell_Origin only Plasma Cell)</Axiom>
                        <Axiom effectual="true">Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin Lymphoma and Indolent Non-Hodgkin Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate)) or ((Disease_May_Have_Finding some Progressive Disease) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation))) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Lymphocytic Neoplasm EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Lymphoproliferative Disorder and (Disease_Has_Abnormal_Cell only Neoplastic Lymphocyte)</Axiom>
                        <Axiom shared="true">Lymphoproliferative Disorder EquivalentTo Hematologic and Lymphocytic Disorder and (Disease_Excludes_Normal_Cell_Origin only Myeloid Cell) and (Disease_Has_Abnormal_Cell only Abnormal Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Lymphatic System)</Axiom>
                        <Axiom shared="true">Disorder by Site SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Hematopoietic and Lymphoid System Disorder SubClassOf Disorder by Site</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma EquivalentTo Mature T-Cell and NK-Cell Neoplasm and T-Cell Non-Hodgkin Lymphoma</Axiom>
                        <Axiom shared="true">Non-Hodgkin Lymphoma EquivalentTo Common Hematopoietic Neoplasm and Lymphoma and (Disease_Excludes_Abnormal_Cell only Reed-Sternberg Cell)</Axiom>
                        <Axiom shared="true">T-Cell Non-Hodgkin Lymphoma EquivalentTo Non-Hodgkin Lymphoma and T-Cell and NK-Cell Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte and Neoplastic Natural Killer Cell) and (Disease_Has_Normal_Cell_Origin only T-Lymphocyte and Natural Killer Cell)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Mycosis Fungoides and Sezary Syndrome EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom effectual="true">Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin Lymphoma and Indolent Non-Hodgkin Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate)) or ((Disease_May_Have_Finding some Progressive Disease) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation))) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Neoplasm by Special Category SubClassOf Neoplasm</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                        <Axiom shared="true">Common Hematopoietic Neoplasm SubClassOf Common Neoplasm</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">T-Cell and NK-Cell Neoplasm EquivalentTo Lymphocytic Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte and Neoplastic Natural Killer Cell) and (Disease_Has_Normal_Cell_Origin only T-Lymphocyte and Natural Killer Cell)</Axiom>
                        <Axiom shared="true">Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma EquivalentTo Mature T-Cell and NK-Cell Neoplasm and T-Cell Non-Hodgkin Lymphoma</Axiom>
                        <Axiom shared="true">T-Cell Non-Hodgkin Lymphoma EquivalentTo Non-Hodgkin Lymphoma and T-Cell and NK-Cell Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte and Neoplastic Natural Killer Cell) and (Disease_Has_Normal_Cell_Origin only T-Lymphocyte and Natural Killer Cell)</Axiom>
                        <Axiom shared="true">Hematopoietic and Lymphoid Cell Neoplasm EquivalentTo Hematologic and Lymphocytic Disorder and Hematopoietic and Lymphoid System Neoplasm and Neoplasm by Morphology and (Disease_Has_Abnormal_Cell only Neoplastic Hematopoietic and Lymphoid Cell) and (Disease_Has_Normal_Cell_Origin only Hematopoietic and Lymphoid Cell)</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Mycosis Fungoides and Sezary Syndrome EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom effectual="true">Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin Lymphoma and Indolent Non-Hodgkin Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate)) or ((Disease_May_Have_Finding some Progressive Disease) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation))) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Lymphocytic Neoplasm EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Lymphoproliferative Disorder and (Disease_Has_Abnormal_Cell only Neoplastic Lymphocyte)</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Neoplasm by Morphology SubClassOf Neoplasm</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Cutaneous T-Cell Non-Hodgkin Lymphoma EquivalentTo Cutaneous Lymphoma and Cutaneous Mature T-Cell and NK-Cell Neoplasm and Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Mycosis Fungoides and Sezary Syndrome EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom effectual="true">Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin Lymphoma and Indolent Non-Hodgkin Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate)) or ((Disease_May_Have_Finding some Progressive Disease) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation))) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Cutaneous Mature T-Cell and NK-Cell Neoplasm EquivalentTo Cutaneous Hematopoietic and Lymphoid Cell Neoplasm and Cutaneous Lymphoproliferative Disorder and Mature T-Cell and NK-Cell Neoplasm</Axiom>
                        <Axiom shared="true">Neoplasm SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Skin Neoplasm EquivalentTo Neoplasm by Site and Skin Disorder and (Disease_Has_Associated_Anatomic_Site only Skin)</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Neoplasm by Site SubClassOf Neoplasm</Axiom>
                        <Axiom shared="true">Cutaneous Hematopoietic and Lymphoid Cell Neoplasm EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Skin Neoplasm</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Hematologic and Lymphocytic Disorder SubClassOf Hematopoietic and Lymphoid System Disorder</Axiom>
                        <Axiom shared="true">Cutaneous T-Cell Non-Hodgkin Lymphoma EquivalentTo Cutaneous Lymphoma and Cutaneous Mature T-Cell and NK-Cell Neoplasm and Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Lymphoma EquivalentTo Lymphocytic Neoplasm and (Disease_Excludes_Normal_Cell_Origin only Plasma Cell)</Axiom>
                        <Axiom effectual="true">Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin Lymphoma and Indolent Non-Hodgkin Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate)) or ((Disease_May_Have_Finding some Progressive Disease) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation))) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Lymphoma by Site SubClassOf Lymphoma</Axiom>
                        <Axiom shared="true">Lymphocytic Neoplasm EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Lymphoproliferative Disorder and (Disease_Has_Abnormal_Cell only Neoplastic Lymphocyte)</Axiom>
                        <Axiom shared="true">Lymphoproliferative Disorder EquivalentTo Hematologic and Lymphocytic Disorder and (Disease_Excludes_Normal_Cell_Origin only Myeloid Cell) and (Disease_Has_Abnormal_Cell only Abnormal Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Lymphatic System)</Axiom>
                        <Axiom shared="true">Disorder by Site SubClassOf Disease or Disorder</Axiom>
                        <Axiom shared="true">Cutaneous Lymphoma EquivalentTo Cutaneous Hematopoietic and Lymphoid Cell Neoplasm and Cutaneous Lymphoproliferative Disorder and Lymphoma by Site and Malignant Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Domain NCI_Kind</Axiom>
                        <Axiom shared="true">Hematopoietic and Lymphoid System Disorder SubClassOf Disorder by Site</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2916">
                     <Axiom>Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
                     <Source>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Light Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Gene Rearrangement</Axiom>
                        <Axiom effectual="true">Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;19)(q23;p13.3)) and (Disease_May_Have_Molecular_Abnormality some E2A-PBX1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement SubClassOf Clonal Immunoglobulin Light Chain Gene Rearrangement</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Hematopoietic System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom shared="true">Lymphadenopathy SubClassOf Hematopoietic System Finding</Axiom>
                        <Axiom effectual="true">Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;19)(q23;p13.3)) and (Disease_May_Have_Molecular_Abnormality some E2A-PBX1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Gastrointestinal System Signs and Symptoms SubClassOf Symptom</Axiom>
                        <Axiom shared="true">Hepatomegaly SubClassOf Gastrointestinal System Signs and Symptoms</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Other Finding SubClassOf Finding</Axiom>
                        <Axiom effectual="true">Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;19)(q23;p13.3)) and (Disease_May_Have_Molecular_Abnormality some E2A-PBX1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Symptom SubClassOf Other Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Loss of Chromosome 12p SubClassOf Chromosomal Loss</Axiom>
                        <Axiom effectual="true">Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;19)(q23;p13.3)) and (Disease_May_Have_Molecular_Abnormality some E2A-PBX1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
                        <Axiom shared="true">Numerical Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Chromosomal Loss SubClassOf Numerical Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Gastrointestinal System Signs and Symptoms SubClassOf Gastrointestinal System Finding</Axiom>
                        <Axiom shared="true">Gastrointestinal System Finding SubClassOf Finding by Site or System</Axiom>
                        <Axiom shared="true">Hepatomegaly SubClassOf Gastrointestinal System Signs and Symptoms</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Finding by Site or System SubClassOf Finding</Axiom>
                        <Axiom effectual="true">Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and (((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;19)(q23;p13.3)) and (Disease_May_Have_Molecular_Abnormality some E2A-PBX1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression))) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2917">
                     <Axiom>Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                        <Axiom shared="true">Non-Neoplastic Hematologic and Lymphocytic Disorder SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        <Axiom shared="true">Anemia SubClassOf Non-Neoplastic Hematologic and Lymphocytic Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder by Site SubClassOf Non-Neoplastic Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Range NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Neoplastic B-Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal Lymphocyte SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Abnormal Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Pleomorphic Plasma Cell SubClassOf Neoplastic Plasma Cell</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Neoplastic Plasma Cell SubClassOf Neoplastic B-Lymphocyte</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Laboratory Test Result SubClassOf Clinical Test Result</Axiom>
                        <Axiom shared="true">Monoclonal Paraproteinemia SubClassOf Paraproteinemia</Axiom>
                        <Axiom effectual="true">Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                        <Axiom shared="true">Paraproteinemia SubClassOf Abnormal Blood Chemistry and Hematology Test Result</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Blood Chemistry and Hematology Test Result SubClassOf Abnormal Laboratory Test Result</Axiom>
                        <Axiom effectual="true">Clinical Test Result SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom ineffectual="true">Abnormal Laboratory Test Result SubClassOf Laboratory Test Result</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                        <Axiom shared="true">Cyclin D1 Protein Overexpression SubClassOf Protein Deregulation</Axiom>
                        <Axiom shared="true">Protein Deregulation SubClassOf Deregulation of Protein and Messenger RNA Expression</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Deregulation of Protein and Messenger RNA Expression SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom effectual="true">Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                        <Axiom shared="true">Chromosomal Gain SubClassOf Numerical Chromosomal Abnormality</Axiom>
                        <Axiom shared="true">Cytogenetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Gain of Chromosome 5 SubClassOf Chromosomal Gain</Axiom>
                        <Axiom shared="true">Numerical Chromosomal Abnormality SubClassOf Cytogenetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Cytogenetic_Abnormality Range NCI_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                     </Source>
                  </Change>
                  <Change id="2918">
                     <Axiom>Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                     <Source>
                        <Axiom shared="true">Neoplastic B-Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Anaplastic Plasma Cell SubClassOf Neoplastic Plasma Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom effectual="true">Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom shared="true">Neoplastic Plasma Cell SubClassOf Neoplastic B-Lymphocyte</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Neoplastic B-Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Neoplastic Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom effectual="true">Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Pleomorphic Plasma Cell SubClassOf Neoplastic Plasma Cell</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Hematopoietic and Lymphoid Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom shared="true">Neoplastic Plasma Cell SubClassOf Neoplastic B-Lymphocyte</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Neoplastic B-Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal Lymphocyte SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Abnormal Lymphocyte</Axiom>
                        <Axiom effectual="true">Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Pleomorphic Plasma Cell SubClassOf Neoplastic Plasma Cell</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Neoplastic Plasma Cell SubClassOf Neoplastic B-Lymphocyte</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Neoplastic B-Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom effectual="true">Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Pleomorphic Plasma Cell SubClassOf Neoplastic Plasma Cell</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Malignant Cell</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Malignant Cell SubClassOf Neoplastic Cell</Axiom>
                        <Axiom shared="true">Neoplastic Plasma Cell SubClassOf Neoplastic B-Lymphocyte</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Neoplastic B-Lymphocyte SubClassOf Neoplastic Lymphocyte</Axiom>
                        <Axiom shared="true">Abnormal Lymphocyte SubClassOf Abnormal Hematopoietic and Lymphoid Cell</Axiom>
                        <Axiom shared="true">Anaplastic Plasma Cell SubClassOf Neoplastic Plasma Cell</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Abnormal_Cell Range NCI_Kind</Axiom>
                        <Axiom shared="true">Neoplastic Lymphocyte SubClassOf Abnormal Lymphocyte</Axiom>
                        <Axiom effectual="true">Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and (((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
                        <Axiom shared="true">Abnormal_Cell_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Abnormal Cell SubClassOf Abnormal_Cell_Kind</Axiom>
                        <Axiom shared="true">Abnormal Hematopoietic and Lymphoid Cell SubClassOf Abnormal Cell</Axiom>
                        <Axiom shared="true">Neoplastic Plasma Cell SubClassOf Neoplastic B-Lymphocyte</Axiom>
                     </Source>
                  </Change>
                  <Change id="2919">
                     <Axiom>Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pruritus) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                     <Source>
                        <Axiom shared="true">Disease or Disorder SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom shared="true">Erythroderma SubClassOf Non-Neoplastic Skin Disorder</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder by Site SubClassOf Non-Neoplastic Disorder</Axiom>
                        <Axiom shared="true">Non-Neoplastic Disorder SubClassOf Disease or Disorder</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Associated_Disease Range NCI_Kind</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Abnormal_Cell some Lutzner Cell) and (Disease_May_Have_Abnormal_Cell some Sezary Cell) and (Disease_Has_Finding only Peripheral Blood Involvement)) or ((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate))) and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pruritus) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Non-Neoplastic Skin Disorder SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal T-Cell Receptor Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Mycosis Fungoides and Sezary Syndrome EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom shared="true">Clonal T-Cell Receptor Beta Chain Gene Rearrangement SubClassOf Clonal T-Cell Receptor Gene Rearrangement</Axiom>
                        <Axiom effectual="true">Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Abnormal_Cell some Lutzner Cell) and (Disease_May_Have_Abnormal_Cell some Sezary Cell) and (Disease_Has_Finding only Peripheral Blood Involvement)) or ((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate))) and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pruritus) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Clonal T-Cell Receptor Gamma Chain Gene Rearrangement SubClassOf Clonal T-Cell Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal Gene Rearrangement SubClassOf Gene Abnormality</Axiom>
                        <Axiom shared="true">Clonal Antigen Receptor Gene Rearrangement SubClassOf Clonal Gene Rearrangement</Axiom>
                        <Axiom shared="true">Clonal T-Cell Receptor Gene Rearrangement SubClassOf Clonal Antigen Receptor Gene Rearrangement</Axiom>
                        <Axiom shared="true">Mycosis Fungoides and Sezary Syndrome EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Gene Abnormality SubClassOf Molecular Genetic Abnormality</Axiom>
                        <Axiom shared="true">Molecular Genetic Abnormality SubClassOf Molecular Abnormality</Axiom>
                        <Axiom effectual="true">Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Abnormal_Cell some Lutzner Cell) and (Disease_May_Have_Abnormal_Cell some Sezary Cell) and (Disease_Has_Finding only Peripheral Blood Involvement)) or ((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate))) and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pruritus) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Molecular Abnormality SubClassOf Molecular_Abnormality_Kind</Axiom>
                        <Axiom shared="true">Molecular_Abnormality_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Molecular_Abnormality Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Hyperkeratosis SubClassOf Morphologic Finding</Axiom>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Morphologic Finding SubClassOf Finding</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Abnormal_Cell some Lutzner Cell) and (Disease_May_Have_Abnormal_Cell some Sezary Cell) and (Disease_Has_Finding only Peripheral Blood Involvement)) or ((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate))) and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pruritus) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Findings_and_Disorders_Kind DisjointWith NCI_Kind</Axiom>
                        <Axiom shared="true">Pruritus SubClassOf Integumentary System Signs and Symptoms</Axiom>
                        <Axiom shared="true">Other Finding SubClassOf Finding</Axiom>
                        <Axiom shared="true">Integumentary System Signs and Symptoms SubClassOf Symptom</Axiom>
                        <Axiom shared="true">Disease, Disorder or Finding SubClassOf Findings_and_Disorders_Kind</Axiom>
                        <Axiom effectual="true">Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and (((Disease_May_Have_Abnormal_Cell some Lutzner Cell) and (Disease_May_Have_Abnormal_Cell some Sezary Cell) and (Disease_Has_Finding only Peripheral Blood Involvement)) or ((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate))) and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pruritus) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
                        <Axiom shared="true">Symptom SubClassOf Other Finding</Axiom>
                        <Axiom shared="true">Finding SubClassOf Disease, Disorder or Finding</Axiom>
                        <Axiom effectual="true">Disease_May_Have_Finding Range NCI_Kind</Axiom>
                     </Source>
                  </Change>
               </RemovedPseudoNovelProspectiveRedundancy>
            </RemovedNewProspectiveRedundancy>
         </RemovedProspectiveRedundancy>
      </Ineffectual>
   </Removals>
</root>
